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Abstract 
Excess dietary fructose is a major public health concern. Evidence shows increased 
fructose intake can cause insulin resistance, hepatic de novo lipogenesis, 
hypertriglyceridemia, obesity and non-alcoholic fatty liver disease (NAFLD). 
However, little is known about the effects of fructose during pregnancy and its 
influence on offspring development and predisposition to later-life disease. To 
determine whether moderately increased maternal fructose intake could have health 
future consequences on offspring, we have investigated the effects of 10% w/v 
fructose water intake during preconception and pregnancy in guinea pigs. Female 
Dunkin Hartley guinea pigs were fed a control diet (CD) or fructose diet (FD; 10% 
kcal from fructose) ad-libitum 60 days prior to mating and throughout gestation. 
Weanling Offspring were culled at weaning, day 21 (d21) and adolescent offspring at 
4-months (4M). Compared to CD dams, FD dams had altered glucose metabolism 
and increased milk free fatty acid content. Matsuda-DeFronzo insulin sensitivity 
index (M-ISI) from OGTT plasma showed no significant difference in whole-body 
insulin sensitivity between FD and CD dams 60 days post-dietary intervention and 
during mid-gestation. Fetal exposure to increased maternal fructose resulted in 
offspring with significantly altered serum free fatty acids at day 0, 7, 14 and 21 
(including pentadecanoic acid (15:0), dma16:0, margaric acid (17:0) palmitoleic acid, 
total omega-7 and total saturates), increased levels of uric acid and triglycerides were 
also observed at d21. In male and female fructose offspring, proteomic analysis 
revealed that key markers of mitochondria function, oxidative phosphorylation, 
NRF-2 pathways were significantly altered. Western blot analysis confirmed these 
findings by increased protein abundance in complex II & IV and key enzymes 
involved in hepatic de novo lipogenesis (FAS, SREBP-1C). In adult male and female 
fructose offspring (4 month) were observed to also have very similar changes in 
 XIII 
pathways involved in fatty acid B-oxidation, oxidative phosphorylation and 
mitochondrial function. Similar to d21 fructose offspring, adults also displayed 
programmed increases in key enzymes of de novo lipogenesis (FAS and SREBP-1c), 
mitochondrial function (Complex II & IV) and consistently increased palmitoleic acid 
at all time-points (day 0 to 4 month of age). We have demonstrated that excess 
maternal fructose intake during pregnancy and not lactation can cause significant 
changes in maternal metabolic function and milk composition, which programmes 
weanling and adult offspring hepatic mitochondrial function, de novo lipogenesis and 
metabolism. Taken together, these changes in pregnancy outcomes and feto-maternal 
condition may underlie their offspring’s predisposition to metabolic dysfunction 
during later-life.
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“Forces beyond your control can take away everything you possess 
except one thing, your freedom to choose how you will respond to the 
situation. You cannot control what happens to you in life, but you can 
always control what you will feel and do about what happens to you.” 
                                - Viktor E. Frankl, Man's Search for Meaning. 
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Introduction 
1.1 Developmental Origins and Predisposition to Metabolic Disease 
In recent years, a number of researchers have provided evidence that 
suboptimal maternal nutrition and subsequent nutrient availability supplied to 
the developing blastocyst, fetus, neonate and infant and timing of nutritional 
‘insults’ are important in determining fetal development and later-life health 
and disease. This concept is referred to as ‘developmental origins of health and 
disease (DOHaD). The theory is that the quality of nutrients received during 
the early phases of development can have programmed metabolic effects. 
Meaning, an individual’s biological function and phenotype are influenced in a 
predetermined way. Studies of heredity and maternal influence during 
pregnancy have existed since the 1800s (Shildrick, 2000, Müller-Wille & 
Rheinberger, 2012). A progression of understanding heritability and 
environmental factors on pregnancy then followed, albeit slowly. However, the 
first instance of  ‘modern’ developmental programming was published by 
Kermack et al. in 1934 (Kermack, McKendrick, & Mckinlay, 1934). These early 
epidemiological reports were also observed in animal studies using Shetland 
ponies (Walton & Hammond, 1938) and sheep (Barcroft, 1946). One of the first 
animal models of programming was reported by McCance and Widdowson, 
where they showed in a rat model that litter size and offspring growth were 
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dependant on maternal nutrition. Interestingly, effects on timing of nutrition 
were also observed, with nutrition during pregnancy exerting more of an effect 
than early postnatal nutrition (McCance & Widdowson, 1974). 
Following these observations, instances of relative isolated famine were 
experienced during and following the end of World War II. A number of 
observational cohorts and wealth of epidemiological data became available. 
Susser et al. first published findings on the Dutch Hunger Winter, reporting 
that men exposed to famine during early fetal life had increased rates of obesity 
than men exposed during late gestation (Ravelli, Stein, & Susser, 1976). From 
then up to Barker’s findings in the Hertfordshire cohort, a number of studies 
were published on the relationship of maternal morbidity, birth weight and 
adult offspring health and disease. Barker went on to propose the ‘Barker 
hypothesis,’ he proposed that “Adverse nutrition in early life, including 
prenatally as measured by birth weight, increased susceptibility to metabolic 
dysfunction which can include obesity, diabetes, insulin insensitivity, 
hypertension and hyperlipidemia, coronary heart disease and stroke”( Barker, 
Osmond, Winter, Margetts, & Simmonds, 1989). This hypothesis was born from 
epidemiological data in Hertfordshire, where he observed death rates from 
heart disease were correlated with low birth weight and some environmental 
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influences during early stages of development appeared to increase 
cardiovascular disease risk in adult life (Barker et al., 1989).  
Recent research has identified many different aspects that may be influencing 
developmental programming, and the advancements continually observed in 
scientific methodologies are producing ever-increasing, exciting avenues of 
DOHaD research to explore. We can now observe many more clinical and 
animal studies that, without doubt, prove the original DOHaD concept. 
Evidence has now shown that a range of specific macro-and micronutrient 
nutritional insults, environmental pollutants and pregnancy complications can 
affect offspring development, growth and the life-long predisposition to 
disease. Recent advancements in technologies have enabled scientists to 
investigate an ever-growing number of mechanisms involved in developmental 
programming and have brought about new branches of research such as the 
maternal microbiota and mitochondrial function as key targets of 
developmental programming of future health and disease in offspring. 
Furthermore, the development and refinement of animal models has begun to 
elucidate molecular aspects of programmed offspring predisposition to later-
life disease. Although this data may not be directly linked with human disease, 
due to logistical limitations of such long-term studies, animal studies are 
essential for understanding the mechanisms and critical time points during 
Chapter 1  Introduction 
 4 
early growth and later risk of disease states. These developmentally 
programmed effects or underlying predisposition to non-communicable 
diseases (NCDs) may also be amplified by an adverse diet or sedentary lifestyle 
during later life (Figure 1.1).   
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Figure 1.1. Developmental Origins and Predisposition to Metabolic Disease 
 
Figure 1.1. Life-course demonstration of metabolic disease predisposition and response to timely intervention. Risk to experiencing metabolic diseases increases as plasticity 
declines along with accumulating adverse environmental and lifestyle challenges across the life-course. Additionally, the risk increases due to the effect of a mismatch 
relationship between developmental and evolutionary influenced phenotype. While intervention at any stage is beneficial, the ability to decrease the predisposition to 
metabolic diseases is seen during the earliest stages of development as the prenatal developmental stages establish the dysregulation and risk set points via the relationship 
between genetic, epigenetic and environmental influences. (Permission from (Hanson & Gluckman, 2014). 
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1.2 Excess Maternal Fructose Intake and Offspring Predisposition to 
Metabolic Dysfunction 
Metabolic adaptations during pregnancy are necessary for appropriate 
metabolic demands supporting appropriate growth and development of the 
fetus and preparation for lactation. Human epidemiological studies and animal 
models have shown that poor quality nutrition during fetal growth can 
predispose the offspring to long-term health consequences (Segovia, Vickers, 
Gray, & Reynolds, 2014, Guilloteau, Zabielski, Hammon, & Metges, 2009). 
Unbalanced maternal nutrition, in particular, overnutrition, can have 
permanent effects on her offspring’s organ structure and function, 
predisposing them to adult-onset of NCDs such as; obesity, diabetes, non-
alcoholic fatty liver disease (NAFLD) and cardiovascular risk factors (Winett, 
Wallack, Richardson, Boone-Heinonen, & Messer, 2016, Regnault, Gentili, Sarr, 
Toop, & Sloboda, 2013, Cordain et al., 2005, Bayol, Simbi, Fowkes, & Stickland, 
2010). The contemporary western women consuming high levels of fructose 
before and/or during pregnancy may alter critical phases of pregnancy, such as 
embryogenesis, fetal-placental development, and milk production and quality 
(Clayton, Vickers, Bernal, Yap, & Sloboda, 2015, Regnault et al., 2013).  
However, very few studies have investigated the effects of increased or 
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excessive fructose and sugar consumption, in women of child-bearing age 
considering pregnancy and in pregnant women.  
Previous research in rodents has demonstrated that maternal consumption of 
10% fructose in water during pregnancy and lactation resulted in maternal 
hyperglycaemia, hyperinsulinemia and hypertriglyceridemia, which were 
associated with significantly elevated plasma insulin in offspring at weaning, 
suggesting offspring susceptibility to diabetes during adulthood (Rawana et al., 
1993). Further rodent studies demonstrated that in models where 20% of caloric 
intake was from fructose during gestation, resulted in maternal 
hyperinsulinemia and sex-specific effects in offspring, with female offspring 
having higher plasma leptin and glucose and displaying greater vulnerability 
to metabolic disturbances in neonatal life than male offspring (Vickers, 
Clayton, Yap, & Sloboda, 2011). Additionally, other studies have shown sex-
specific cardio-metabolic differences in the offspring of maternal 10% w/v 
fructose-fed dams (Gray, Gardiner, Elmes, & Gardner, 2016). Some studies 
have reported that high fructose intake alters β-oxidation, increases free fatty 
acids (FFA) and triglycerides, causing dyslipidaemia, hepatic lipid 
accumulation and insulin resistance (Havel, 2005, Herman & Samuel, 2016, 
Hannou, Haslam, McKeown, & Herman, 2018).  Evidence in clinical and animal 
studies of fructose-induced predisposition to metabolic diseases is substantial 
Chapter 1  Introduction 
  8 
and convincing. Studies have demonstrated that excess maternal fructose 
intake can cause adaptive increases in fetal hepatic enzyme activity involved in 
fructose uptake, metabolism, lipogenesis and inflammatory response, 
potentially predisposing offspring to metabolic diseases in later life (Regnault 
et al., 2013, Sloboda et al., 2014, Bezerra et al., 2001, A. F. Saad et al., 2016).  
1.3 History of Fructose in the Human Diet 
Fructose has been a part of the human ancestral diet, in the form of the 
monosaccharide fructose and disaccharide sucrose, in limited amounts, 
through seasonal honey, fruit and vegetables since humans were hunter-
gatherers (Yudkin, 1967, Regnault et al., 2013). Human dietary adaptations 
changed along with environmental conditions and increased worldwide 
nomadic migration (Eaton, 2006, Regnault et al., 2013). Over the last 15,000 
years, the change in human behaviour and non-nomadic lifestyles altered how 
humans survived without modifying genomic adaptations (Eaton, 2006, 
Cordain et al., 2005).  
From the 1950s and 1960s, techniques to produce High-Fructose Corn Syrup 
(HFCS) were developed, preceding its introduction into commercialization in 
1967 (Hallfrisch, 1990). HFCS has since remained a beneficial ingredient to 
commercial food industries because it enhances sweetness and palatability, is 
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stable in acidic products, easy to produce, and unlike sucrose, not susceptible 
to price and availability (Hallfrisch, 1990, Zhang, Jiao, & Kong, 2017, Johnson et 
al., 2007, White, 2008). The rise in fructose concentrations and availability 
dramatically increased fructose consumption from earlier human evolutionary 
history (Yudkin, 1967, Stanhope & Havel, 2010, DiNicolantonio & Berger, 2016). 
HFCS is produced from the hydrolysis of cornstarch, creating glucose syrup, 
which is isomerized to create a 42% fructose syrup (HFCS-42) (Hallfrisch, 1990, 
L. K. Stanhope & Havel, 2017). Fructose from the 42% fructose syrup can be 
extracted to make a 90% fructose syrup (HFSC-90) (L. K. Stanhope & Havel, 
2017). HFCS-90 is used to create a wider range of fructose concentrated HFCS 
ranging from 47% (HFCS-47) to 80% (HFCS-80) (White, 2008, L. K. Stanhope & 
Havel, 2017). The amount of fructose to glucose in these syrups, HFCS-47 
through HFCS-80, is dependent on how much HFCS-90 was added into the 
HFCS-42 to create the final HFCS product, making it difficult for consumers to 
be certain of how much fructose is in their HFCS sweetened foods and 
beverages (White, 2008, L. K. Stanhope & Havel, 2017). 
Excess dietary fructose intake per capita has continued to increase worldwide 
since its introduction to the United States in the early 1970s and remains more 
prevalent in Westernized countries (Lee, Wu, Leu, & Tain, 2018, Regnault et al., 
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2013, Johnson et al., 2007) (Figure 1.2). Excess fructose is consumed through a 
variety of processed foods; however, the highest contributors are SSB (Johnson 
et al., 2007, Havel, 2005, Elliott, Keim, Stern, Teff, & Havel, 2002, Marriott, Cole, 
& Lee, 2009). Current fructose quantities and concentrations consumed in a 
Westernized diet are difficult to obtain through natural whole food sources, 
whereas they are readily available in nutrient-poor foods and beverages 
(Yudkin, 1967, K. L. Stanhope & Havel, 2010, DiNicolantonio & Berger, 2016, 
Regnault et al., 2013). 
Developing countries, such as Mexico, Vietnam, the Philippines and Indonesia, 
have shown an increase in demand for HFCS, with exports from the United 
States escalating from 10-to 100-fold between 2005 and 2012 (Ferraris, Choe, & 
Patel, 2018). Whereas, developed countries, such as the United States, New 
Zealand, Australia, and many Scandinavian and European countries, have all 
reported stable or declining absolute (g/d) and relative (% energy) added sugar 
intake over recent years (Wittekind & Walton, 2014). However, the current 
amounts of added fructose consumed worldwide are still in excess and 
significantly above recommended daily intake levels (Ferraris et al., 2018). 
Recent data has shown the average caloric intake from added fructose can be 
between ~10-20% (Cordain et al., 2005, Sun, Anderson, Flickinger, Williamson-
Hughes, & Empie, 2011, Bray, 2008) and ~14% in pregnant women (George, 
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Hanss-Nuss, Milani, & Freeland-Graves, 2005). The World Health Organization 
(WHO) recommends simple sugars from processed foods and SSB should be 
less than 10% of total daily caloric intake (World Health Organization, 2015). In 
perspective, consuming a basal diet of 2,000 kcal/day with the addition of one 
~16oz SSB (or ~50-60g/day) would equate to an increase of ~10% of total 
kcal/day intake. Despite the relevancy of excess fructose being a significant 
component in the modern Westernised diet, there remains uncertainty 
regarding the long-term metabolic health of offspring where mothers 
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Figure 1.2. Fructose Intake per Capita in the USA 
  
Figure 1.2. Comparison of availability (loss adjusted) of sugar, high-fructose corn syrup (HFCS) added sugars and fructose from 1970-2012. Image taken from (Rippe & 
Angelopoulos, 2016).
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1.4 Fructose 
Fructose is a 6-carbon polyhydroxy ketone monosaccharide sharing the same 
chemical formula (C6H12O6) and an isomer of glucose (Ouellette, R. J. & Rawn, 
2018, Sloboda et al., 2014). When fructose is bound to glucose, it forms the 
disaccharide sucrose (Ouellette, R. J. & Rawn, 2018, Sloboda et al., 2014). 
Fructose is the sweetest carbohydrate in nature found in a variety of foods. 
Predominantly fructose is found in honey, fruit and some vegetables as 
fructose and sucrose (Hallfrisch, 1990, Zhang et al., 2017, Sloboda et al., 2014, 
Havel, 2005). 
1.4.1 Fructose Absorption 
Following consumption, fructose is absorbed by the small intestine, primarily 
the jejunum passing through the brush border of the intestinal wall by glucose 
transporters (Biro, 2018). Fructose is transported actively and passively into the 
enterocyte by glucose transporter 5 (GLUT5), which is specific to fructose, and 
through the basolateral pole primarily by glucose transporter 2 (GLUT2) and 
into systemic circulation via the hepatic portal vein and primarily transported 
to the liver for metabolism (Zhang et al., 2017, Biro, 2018, Sun & Empie, 2012), 
Douard & Ferraris, 2008). Additionally, glucose transporter 7 (GLUT7), glucose 
transporter 8 (GLUT8), glucose transporter 9 (GLUT9) and glucose transporter 
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11 (GLUT11) have been reported as capable fructose transport, in various 
degrees of specificity to fructose, due to their sequence homology to glucose 
transporter (GLUT) (Ter Horst & Serlie, 2017, Ferraris et al., 2018, Douard & 
Ferraris, 2008); however, a recent study demonstrated that GLUT7 and GLUT9 
don't transport fructose (Ebert et al., 2017). Hepatic fructose uptake from portal 
circulation is faster than glucose uptake (Dekker, Qiaozhu, Baker, Rutledge, & 
Adeli, 2010) because glucose is not only utilized in the liver but virtually all 
cells; therefore, glucose is transported from the portal vein to be used by other 
tissues in the body for energy (Baynes & Dominiczak, 2005). Conversely, 
fructose is minimally used (30-50%) by peripheral tissues such as kidney, fat, 
skeletal muscle, brain and testis (Hallfrisch, 1990, Regnault et al., 2013). 
Additionally, fructose is metabolised differently than glucose due to hepatic 
uptake (50-70%) and rapid conversion into glucose, glycogen, lactate and, more 
specifically, fat (Regnault et al., 2013, Tappy & Le, 2010). 
1.4.2 Fructose Hepatocyte Uptake and Metabolism 
The primary pathway of fructose metabolism occurs through phosphorylation 
by fructokinase/ketohexokinase. In comparison to glucose, fructose 
immediately bypasses phosphofructokinase, a main regulator of glycolysis and 
glucose metabolism, by negative feedback inhibition of intracellular ATP and 
citrate build-up. Instead, it is instantly phosphorylated by 
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fructokinase/ketohexokinase, which is specific to fructose, to produce fructose-
I-phosphate (fructose-1-P) (Zhang et al., 2017, Baynes & Dominiczak, 2005, 
Tappy, Lê, Tran, & Paquot, 2010, Campbell, Schlappal, Geller, & Castonguay, 
2014). Aldolase B initiates the lysis of fructose-1-P to produce 
dihydroxyacetone phosphate (DHAP) and glyceraldehyde (Zhang et al., 2017, 
Baynes & Dominiczak, 2005, Tappy et al., 2010, Campbell et al., 2014). 
Triokinase converts glyceraldehyde into glyceraldehyde-3-phosphate (Glyc-3-
P) (Havel, 2005, Baynes & Dominiczak, 2005, Campbell et al., 2014). Fructose 
enters glycolysis at the tri-phosphate level without encountering rate-limiting 
and regulatory enzymes, providing an unregulated source of both glycerol-3-
phosphate (G-3-P) and acetyl-CoA, increasing pyruvate availability to enter the 
mitochondrion for energy production or hepatic de novo lipogenesis (Elliott et 
al., 2002). Primary hepatic metabolites of fructose include glucose, glycogen, 
lactate, uric acid, free fatty acids (FFA), very low-density lipoproteins (VLDL) 
and triglycerides (TAG) (Zhang et al., 2017, Khitan & Kim, 2013) (Figure 1.3). 
Hepatocytes specialized ability to rapidly break down fructose is of key 
importance to support the body's energetic needs. When consumed with 
glucose, fructose catalyses glucose uptake and glycogen storage in the liver 
(Laughlin, 2014). When plasma levels of glucose or hepatic glycogen stores are 
low, fructose is able to enter the glycolytic pathway at the trio-phosphate level 
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to be used to create glucose, glycogen or lactate for oxidation in extrahepatic 
tissues (Laughlin, 2014). The metabolite uric acid is recognized as a biomarker 
of oxidative stress; however, it also acts as an antioxidant, scavenging singlet 
oxygen and free radicals (Ames, Cathcart, Schwiers, & Hochstein, 1981, Pasalic, 
Marinkovic, & Feher-Turkovic, 2012). Metabolites of FFA, VLDL and TAG are 
essential for cellular function and provide energy reserves in adipose tissue 
(Berg, Tymoczko, & Stryer, 2002). Whereas hepatic glucose metabolism is 
tightly regulated by the current energy status, fructose is unregulated, even in 
the presence of high energy availability (Regnault et al., 2013). This 
fundamental difference in metabolic regulation is suspected of initiating 
metabolic adversity in the presence of elevated fructose (Regnault et al., 2013).  
When glucose and glycogen are accessible for energy use, hepatic fructose 
metabolism favours lipogenesis; consequently, chronic consumption of excess 
fructose from sweetened processed foods and ‘sugar-sweetened’ beverages 
(SSB) increases fructose metabolism, increasing abnormal energy flux and 
hepatic de novo lipogenesis (Basaranoglu, Basaranoglu, Sabuncu, & Sentürk, 
2013, Havel, 2005) accelerating the release of FFA, TAG, and VLDL into 
circulation (Baynes & Dominiczak, 2005, Campbell et al., 2014). Increased 
lipogenesis has been the cornerstone of the preceding biochemical reactions 
induced by excess fructose consumption; however, recent evidence suggests 
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that activation of alternate physiological and signalling pathways may 
contribute to direct and indirect metabolic dysregulation (Zhang et al., 2017, 
Dekker et al., 2010, Havel, 2005). 
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Figure 1.3. Fructose Hepatocyte Uptake and Metabolism 
 
Figure 1.3. Fructose immediately bypasses phosphofructokinase, a main regulator of glycolysis, and is 
instantly phosphorylated by fructokinase/ketohexokinase to produce fructose-I-phosphate (fructose-1-P). 
Aldolase B initiates the lysis of fructose-1-P to produce dihydroxyacetone phosphate (DHAP) and 
glyceraldehyde. Triokinase converts glyceraldehyde into glyceraldehyde-3-phosphate (Glyc-3-P). 
Fructose enters glycolysis at the tri-phosphate level without encountering rate-limiting and regulatory 
enzymes, providing an unregulated source of both glycerol-3-phosphate (G-3-P) and acetyl-CoA, 
increasing pyruvate availability to enter the mitochondrion for energy production or hepatic de novo 
lipogenesis. Primary hepatic metabolites of fructose include glucose, glycogen, lactate, uric acid, free fatty 
acids (FFA), very low-density lipoproteins (VLDL) and triglycerides (TAG). Image taken from reference 
Dewdney, Roberts, Qiao, George, & Hebbard, 2020.  
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1.5 Adverse Effects of Excessive Fructose Intake 
Fructose is an important nutrient that has been a part of the human diet since 
hunter- gatherer times as a component of carbohydrate intake from whole 
natural food sources, to quickly provide energy, stored for use when energy 
reserves are low and remains a part of healthy balanced diets (Regnault et al., 
2013, Laughlin, 2014). However, in the modern Westernized diet, fructose 
intake from natural whole foods has declined while intake from sweetened 
processed foods and SSB supersedes levels beneficial for survival and health 
maintenance (Johnson, Andrews, Benner, & Oliver, 2010, Cordain et al., 2005). 
The typical daily intake of fructose in Westernized diets has become a major 
public health concern due to the paralleled increase of metabolic diseases such 
as; dyslipidemia, hyperlipidemia, insulin resistance, visceral adiposity, obesity, 
diabetes, high blood pressure, cardiovascular disease and NAFLD (Zhang et 
al., 2017, Lee et al., 2018, Bidwell, 2017, Lustig, Schmidt, & Brindis, 2012, 
Dekker et al., 2010, Basciano, Federico, & Adeli, 2005, Smith, Dyson, Berry, & 
Gray, 2020).  
The contribution of fructose in the rise of metabolic diseases has remained 
controversial despite the increasing evidence in human and experimental 
animal models (Dekker et al.,2010, Tappy & Le, 2010). Results from some 
animal studies may be conflicted as a consequence of models using 
Chapter 1  Introduction 
  20 
supraphysiological levels of dietary fructose as high as 30-70% (Smith et al., 
2020, Regnault et al., 2013, Johnson et al., 2007, Abdulla, Sattar, & Johns, 2011). 
Some human short-term mechanistic studies have also used levels greatly 
exceeding the typical level of dietary fructose ranging from 25%,35% and 50% 
of total caloric intake (K. L. Stanhope et al., 2009, Lê et al., 2009, McDevitt, 
Poppitt, Murgatroyd, & Prentice, 2000). While supraphysiological levels of 
dietary fructose used in animal and human studies are not comparable to 
current amounts consumed, they reinforce the adverse metabolic adverse 
effects of excess fructose intake. However, the use of animal and human studies 
using comparable ranges to the average dietary fructose intake still show 
features of hyperlipidemia, increased plasma lipid concentrations, increased 
triglycerides and VLDL, increased uric acid and dose dependant weight gain 
(Regnault et al., 2013, Sloboda et al., 2014, Smith et al., 2020, Herman & Samuel, 
2016, Theytaz et al., 2014, K. L. Stanhope et al., 2015). 
Some studies have argued that the rise in metabolic diseases may be associated 
with excess caloric intake rather than the form or quality of the calories 
consumed (Prinz, 2019, R. K. Johnson et al., 2009). It is critical to keep in mind 
that the form or quality of the calorie may be more metabolically influential 
than the caloric content itself. For example, even though glucose and fructose 
are calorically equal, 4kcal/gram (Baynes & Dominiczak, 2005), there are 
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fundamental differences in their metabolic regulation. The difference in 
metabolic regulation between glucose and fructose, not caloric content, is the 
primary implicating factor of fructose’s ability to initiate metabolic 
dysregulation (Regnault et al., 2013).   
Regardless, considering the impact of fructose on the prevalence of metabolic 
disease in Westernized countries, several factors appear clear. The pathways 
directing fructose’s metabolism are unregulated. In the presence of readily 
available hepatic glucose and glycogen stores, fructose metabolism favours 
lipogenesis. Consequently, chronic consumption of excess fructose initiates an 
adaptive series of synchronized responses with interrelated signalling 
pathways. These adaptive responses to an abnormal energy flux and hepatic de 
novo lipogenesis may contribute to direct and indirect metabolic dysregulation 
(Zhang et al., 2017, Dekker et al., 2010, Havel, 2005). To better understand 
offspring predisposition to metabolic disease following excess maternal 
fructose exposure in utero, it is imperative to understand the direct and indirect 
dysregulation associated with today’s fructose intake.  
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1.5.1 Excess Fructose and Hepatic De Novo Lipogenesis and Triglyceride 
Synthesis  
Hepatic de novo lipogenesis is the liver’s ability to create new lipids from excess 
non-lipid substrates (acetyl-CoA, DHAP and G-3-P), primarily from 
carbohydrates (Softic, Cohen, & Kahn, 2016, Hengist, Koumanov, & Gonzalez, 
2019, Ameer, Scandiuzzi, Hasnain, Kalbacher, & Zaidi, 2014, Sanders & Griffin, 
2016). Hepatic de novo lipogenesis is a highly regulated biosynthetic lipogenic 
pathway responsible for synthesizing fatty acids, elongation and desaturation 
of fatty acids and TAG synthesis.  
The resulting TAG are packaged as VLDL lipid droplets within hepatocytes 
(Dekker et al., 2010, Basciano et al., 2005, Sanders & Griffin, 2016). Within the 
liver, TAG-VLDL lipid droplets can be stored in the perisinusoidal space (space 
of Disse) as intra-hepatocellular lipids or exported from sinusoids to be 
released into circulation and stored as TAG in adipose tissue (Basciano et al., 
2005, Regnault et al., 2013, Sun & Empie, 2012, Sanders & Griffin, 2016, Postic & 
Girard, 2008). As the liver’s fundamental role is metabolism of macro-nutrients 
for energy homeostasis, hepatic de novo lipogenesis is an important biosynthetic 
pathway for survival. The lipid droplets stored within hepatocytes and liver 
tissue are energy reservoirs, which can be used when other energy sources are 
depleted (Thiam, Farese, & Walther, 2013). In addition, hepatic lipid droplets 
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provide reservoirs of structural elements for cellular membrane synthesis, such 
as sterols, fatty acids and phospholipids (Song, Xiaoli, & Yang, 2018, Thiam et 
al., 2013). The diverse functions of lipid droplets allow them to facilitate hepatic 
homeostasis.    
Hepatic de novo lipogenesis is a highly regulated biosynthetic pathway 
following glycolysis so that excess substrates can be stored in lipids for later 
energy production. Although glucose is a principal substrate for hepatic de novo 
lipogenesis, fructose favours lipogenesis (Dekker et al., 2010, Ameer et al., 
2014). Through a coordinated sequence of enzymatic reactions, de novo 
lipogenesis following fructose intake can initiate quickly through multiple 
pathways: 1) via entrance into glycolysis as Glyc-3-P via the unregulated 
accumulation of intermediates dihydroxyacetone phosphate (DHAP) and/or 
glyceraldehyde thereby, increasing the production of acetyl-CoA, and 2) via the 
more direct entrance of lipogenesis as G-3-P via the unregulated accumulation 
of intermediate DHAP (Softic et al., 2016, Hengist et al., 2019, Sanders & 
Griffin, 2016). Additionally, fructose availability could also indirectly activate 
hepatic de novo lipogenesis by increasing conversion of glucose and lactate to 
form triglycerides (Hengist et al., 2019). 
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Following fructose intake, the availability of acetyl-CoA entering the 
tricarboxylic acid (TCA) cycle increases. TCA intermediates accumulate and are 
released as citrate into the cytoplasm, where it is converted to acetyl-CoA by 
ATP-citrate lyase (Softic et al., 2016, Ameer et al., 2014, Song et al., 2018). 
Additionally, citrate is an allosteric activator of acetyl-Co-A carboxylase, which 
converts acetyl-CoA to malonyl-CoA (Softic et al., 2016, Ameer et al., 2014, 
Song et al., 2018). Fatty acid synthase, a biosynthetic enzyme, uses malonyl-
CoA as a substrate to produce palmitate, the first fatty acid product.  Palmitate 
can be elongated to fatty acid stearate by enzyme elongation of long-chain fatty 
acids protein 6 (Kawano & Cohen, 2013). The saturated fatty acids, palmitate 
and stearate, are desaturated by stearoyl-CoA desaturase to become 
monounsaturated fatty acids, palmitolate and oleate (Kawano & Cohen, 2013). 
Following desaturation, monounsaturated fatty acids may be esterified to the 
glycerophosphate backbone of G-3-P to produce additional complex lipids: 
fatty acids such as stearic acid, palmitoleic acid and oleic acid, membrane 
phospholipids, cholesterol esters and TAG (Byrne, Olufad, Bruce, Cagampang, 
& Ahmed, 2009, Song et al., 2018).  
G-3-P, fructose’s more direct entrance in de novo lipogenesis, favours 
esterification of unbound free fatty acid to produce TAG (Basciano et al., 2005, 
Hengist et al., 2019). Thereby, the first step of de novo TAG synthesis, fatty acid 
Chapter 1  Introduction 
  25 
acyl-Co-As, are added to G-3-P by glycerol-3-phosphate acyltransferase to 
produce lysophosphatidic acid. 1-acylglcyerol-3-phosphate acyltransferase 
adds another acyl-CoA to produce phosphatidic acid. Phosphatidic acid is then 
dephosphorylated by lipin1 to produce 1,2-diacylglycerol. Finally, 1,2-
diacylglycerol is esterified to a second acyl-CoA by diacylglycerol 
acyltransferase to form TAG (Sanders & Griffin, 2016, Kawano & Cohen, 2013). 
The TAG produced are packaged with apolipoprotein B 100 by the lipidation of 
microsomal triglyceride transfer protein and neutral lipids within the 
endoplasmic reticulum to form VLDL. The TAG-VLDL can either be stored in 
the liver in the space of Disse, as intra-hepatocellular lipids, or exported from 
sinusoids and released into blood circulation. Animal and human studies have 
shown that continued excessive dietary fructose intake increases activity of 
lipogenic liver enzymes, lipid synthesis and circulating LDL, VLDL, HDL and 
TAG concentrations in blood (Khitan & Kim, 2013, Zhang et al., 2017, Lee et al., 
2018, Saad et al., 2016, Smith et al., 2020).  
Hepatic de novo lipogenesis has been shown to be greatly responsive to changes 
in dietary intake, in particular, increased fructose. It has been established that 
dysregulations within the de novo lipogenesis pathway can give rise to 
metabolic diseases such as obesity, type 2 diabetes and NAFLD (Ameer et al., 
2014). It has been demonstrated that ~30% of hepatic TAG were in human 
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patients with pathogenic hepatic de novo lipogenesis (Postic & Girard, 2008, 
Lewis, Carpentier, Adeli, & Giacca, 2002). Excess fructose consumption has 
been shown to cause adaptive increased activity of hepatic enzymes involved 
in fructose uptake into the hepatocyte, metabolism and de novo lipogenesis of 
FFA and TAG (Sun & Empie, 2012). Chronic increase activation of hepatic 
enzymes can therefore cause continued metabolic dysregulation leading to 
obesity, type 2 diabetes and NAFLD. Continued metabolic dysregulation from 
increased fructose metabolism can lead to postprandial hypertriglyceridemia 
(Khitan & Kim, 2013), which results in accumulation of hepatic lipids, plasma 
VLDL, and visceral adipose deposition (Regnault et al., 2013, Khitan & Kim, 
2013). Visceral adiposity subsequently further contributes to hepatic TAG 
accumulation, and the increased portal delivery of FFA to the liver can result in 
hepatic insulin resistance (Khitan & Kim, 2013). Studies in humans and rodents 
(Storlien, Oakes, Pan, Kusunoki, & Jenkins, 1993, R. Herman, Zakim, & Stifel, 
1970, Inoue et al., 1995, Okazaki et al., 1994), dogs (Martinez, Rizza, & Romero, 
1994) and non-human primates (Srinivasan, Clevidence, Pargaonkar, 
Radhakrishnamurthy, & Berenson, 1979) have demonstrated that excess 
fructose or sucrose intake induces hyperlipidemia more than excessive glucose 
(K. L. Stanhope et al., 2009) or a high-fat diet (Lee et al., 2018). Additionally, it is 
the fructose component of sucrose that is considered to increase hepatic lipids 
(Reiser, 1985). (Figure 1.4) 
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Figure 1.4. Fructose and Hepatic De Novo Lipogenesis 
 
Figure 1.4. Fructose intake can initiate de novo lipogenesis quickly through multiple pathways: 1) via 
entrance into glycolysis as glyceraldehyde 3 phosphate (Glyc-3-P or GA3P) via the unregulated 
accumulation of intermediates dihydroxyacetone phosphate (DHAP) and/or glyceraldehyde thereby, 
increasing the production of acetyl-CoA, and 2) via the more direct entrance of lipogeneses as glycerol 3 
phosphate (G-3-P) via the unregulated accumulation of intermediate DHAP. In the presence of excess 
acetyl-CoA, following fructose intake, in the tricarboxylic acid (TCA) cycle, TCA intermediates 
accumulate and releases citrate into the cytoplasm. Citrate converted by ATP-citrate lyase (ACLY) to 
acetyl-CoA. Additionally, citrate is an allosteric activator of acetyl-Co-A carboxylase (ACC), which 
converts acetyl-CoA to malonyl-CoA. Fatty acid synthase (FAS), a biosynthetic enzyme, uses malonyl-
CoA as a substrate to produce palmitate (C16:0), the first fatty acid product. Palmitate (C16:0) can be 
elongated to fatty acid stearate (18:0) or longer fatty acids by enzyme elongation of very long chain fatty 
acids protein 6 (ELOVL6). The saturated fatty acids, palmitate (C16:0) and stearate (18:0), are desaturated 
by stearoyl-CoA desaturase (SCD1) to become monounsaturated fatty acids palmitolate (16:1) and oleate 
(18:1). Following desaturation, monounsaturated fatty acids may be esterified to the glycerophosphate 
backbone of G-3-P to produce addition complex lipids: fatty acids such as stearic acid, palmitoleic acid 
and oleic acid and triglycerides TAGs. fatty acid acyl-Co-As are added to G-3-P by glycerol-3-phosphate 
acyltransferase (GPAT) to produce lysophosphatidic acid (LPA). 1-acylglcerol-3-phosphate 
acyltransferase (AGPAT) adds another acyl-CoA to produce phosphatidic acid (PA). PA is then 
dephosphorylated by lipin1 (LPIN1) to produce 1,2-diacylglycerol (DAG). Finally, DAG is esterified to a 
second acyl-CoA by diacylglycerol acyltransferase (DGAT) to form TAGs (47,59,68). The TAGs produced 
are packaged with apolipoprotein B 100 (apoB100) to form VLDL. Image from Softic et al., 2016. 
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1.5.2 Fructose Intake and Insulin resistance 
The incidence of type 2 diabetes and insulin resistance has increased 
worldwide over the past 50 years (Chen et al., 2015). Imbalanced diet and 
patterns of nutrition that favour increased intake of simple sugars such as 
sucrose and fructose are related to insulin resistance and the development of 
type 2 diabetes. In particular, fructose has been implicated to play a major role 
in the increases in metabolic disease observed over the past few decades 
(Havel, 2005). The reasons being, fructose metabolism is unregulated, and 
therefore, lipogenic causing significant increases in circulating lipid, FFA and 
increased energy availability.  
It has been well established that fructose induces de novo lipogenesis and 
increased fatty liver in both animals (Vilà et al., 2011, Rebollo et al., 2014, 
Huang et al., 2011) and humans (Ouyang et al., 2008, Li et al., 2019). However, 
it is still under debate by which mechanism fructose-induced upregulated de 
novo lipogenesis. Chronically elevated insulin may cause NAFLD or excessive 
TAG production and hepatic accumulation precede and/or promote fructose-
induced insulin resistance (Chiu et al., 2014, Waddell & Fallon, 1973). 
Additionally, it has been shown that the lipogenic metabolism of fructose 
supports insulin resistance as fructose is insulin-dependent and can directly 
activate SREBP1c expression, a key gene involved in de novo lipogenesis. 
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In addition to its known lipogenic effects, dietary fructose has also been shown 
to induce weight gain and insulin response. Unlike glucose, fructose does not 
stimulate the production of insulin or leptin. This has been demonstrated in 
both animal and human studies (Ouyang et al., 2008). Due to fructose not 
stimulating insulin secretion, consumption of foods and sugar-sweetened 
beverages high in fructose produces smaller insulin excretion than similar 
glucose intake. Furthermore, a recent meta-analysis by Vartanian et al. showed 
that fructose consumption in SSB may be more detrimental than that of fructose 
contained in solid foods, as the excess calories are not offset by reduced food 
intake (Vartanian, Schwartz, & Brownell, 2007). A further study and 
subsequent follow-up study showed consumption of fructose was associated 
with dyslipidaemia and reduced insulin sensitivity (Welsh et al., 2010), and 
increased consumption of SSB was associated with an increased risk of diabetes 
in adults (De Koning, Malik, Rimm, Willett, & Hu, 2011). Epidemiological 
studies have implicated SSB intake with increased risk of weight gain, obesity, 
dyslipidaemia and insulin resistance. Researchers reporting on the 4 years 
Nurses Health Study observed young-middle-aged women consuming one or 
more SSB a day had increased weight gain and increased risk of insulin 
resistance and development of type 2 diabetes (Schulze et al., 2004). A 19 
months observational analysis of SSB intake in children 11-7 years of age 
demonstrated an increase in body weight and risk of developing obesity in 
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children consuming on average 9oz or more of SSB a day (Ludwig, Peterson, & 
Gortmaker, 2001). However, not all studies have reported altered insulin 
resistance following excess fructose intake.  A 4 weeks study assessing the 
effects of moderate fructose supplementation (1.5g/kg body weight/day) in 
healthy men observed increases in plasma TAG and VLDL without significant 
changes to body weight or insulin sensitivity (Lê et al., 2006). Regardless of the 
age group or sex, there is a clear indication that excess dietary fructose 
increases in de novo lipogenesis and alters lipid metabolism. The extent to 
which these effects increase weight gain, insulin sensitivity and risk of 
developing metabolic diseases depends on the dose and duration consumed. 
However, further work is required to elucidate the exact mechanisms to then 
be able to target key pathways involved in fructose intake and subsequent 
dyslipidaemia and insulin sensitivity.  
1.5.3 Excess Fructose and Uric Acid Production 
Uric acid is a product of the metabolism of purine nucleotides and is excreted 
in urine. When serum or circulating uric acid rises above 7.0mg/100mL, it is 
defined as hyperuricemia. Diets high in purine-rich foods and alcohol can 
increase circulating uric acid, which can lead to gout, kidney stones and renal 
dysfunction. An association between increased uric acid and cardiovascular 
disease risk has also been reported in humans and experimental rat models 
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(Menè & Punzo, 2008). As such, uric acid is now a recognised biomarker of 
increased cardio-metabolic risk. 
Interestingly, fructose intake has been shown to increase circulating uric acid 
levels and may contribute to metabolic dysfunction associated with excessive 
fructose intake. Studies in rats show a 10x increase in circulating uric acid 
following fructose bolus (Stavric, Johnson, Clayman, Gadd, & Chartrand, 1976), 
with similar findings observed in humans. Moreover, studies of developmental 
programming have observed increased uric acid production in the placenta of 
mothers following maternal fructose intake leading to adverse fetal outcomes 
(Asghar et al., 2016).  
1.6 Maternal Fructose Influences Programmed Metabolic Function 
Based on energy availability, insulin signals the hypothalamus to regulate food 
intake and energy homeostasis. It has been shown that fructose does not 
stimulate insulin secretion from pancreatic B-cells, most likely due to the low 
expression of GLUT5 fructose transporters in B-cells, and its effects are 
therefore independent of insulin secretion (Hawkins et al., 2002, Abraha, 
Humphreys, Clark, Matthews, & Frayn, 1998, Patel, Douard, Yu, Gao, & 
Ferraris, 2015). Furthermore, there is strong evidence in animal and human 
studies showing decreases in hepatic and muscle insulin sensitivity being 
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associated with ectopic lipid deposition and tissue-specific lipotoxicity 
following long-term excess fructose consumption (Lê et al., 2006, Lê et al., 2009, 
Tappy & Le, 2010). It is suggested that the increase in hepatic lipids following 
fructose intake increases the concentrations of diacylglycerol (DAG), which 
activates protein kinase C epsilon (PKCε ), leading to increased serine 
phosphorylation of the insulin receptor and insulin receptor substrate 1 (IRS-1), 
resulting in impaired insulin activation (Jornayvaz & Shulman, 2012, Samuel & 
Shulman, 2012).  
Typically, when excess lipids are stored within adipose tissue, adipocytes 
release the leptin peptide in proportion to the amount of adipose in the body. 
Leptin signals the hypothalamus when there is enough stored energy by 
decreasing appetite stimulation and food intake, increasing the sympathetic 
nervous system (SNS) to activate the metabolic rate, and decreasing insulin 
secretion from pancreatic beta cells to decrease energy storage (Myers, Cowley, 
& Münzberg, 2008). However, when fructose is consumed in excess, leptin's 
feedback signals are perturbed, and as a result, the unregulated over-abundant 
source of lipid synthesis, increasing energy availability within adipose tissue. 
Chronic high concentration of leptin results in leptin resistance, which inhibits 
satiety signals to the hypothalamus causing appetite dysregulation by 
overeating (Shapiro et al., 2008). Additionally, leptin secretion is dependent on 
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insulin-mediated glucose transport and metabolism, which is disrupted by 
excess fructose consumption, further limiting circulating leptin concentrations 
(Shapiro et al., 2008).   
Ghrelin is an orexigenic peptide hormone produced by endocrine cells in the 
stomach. It is involved in regulating food intake by stimulating neuropeptide Y 
and agouti-related protein neurons in the hypothalamus. It acts by decreasing 
fat oxidation and regulates energy homeostasis (Cummings & Shannon, 2003, 
Kojima & Kangawa, 2005). Dietary glucose has been shown to suppress ghrelin 
secretion, in contrast to fructose, which attenuates ghrelin secretion (Ma et al., 
2017, Teff et al., 2004). There is significant evidence suggesting that the 
consumption of fructose increases circulating ghrelin but having little effect on 
the secretion of insulin and leptin. The dysregulation may result in impaired 
intracellular communication of energy availability, contributing to metabolic 
and appetite dysregulation (Shapiro et al., 2008, Ma et al., 2017, Teff et al., 
2004). A recent study demonstrated that the maternal fructose-induced 
dysregulation of satiety signals via ghrelin pathways in the mother was 
vertically transmitted to the offspring, with both dams and pups having 
significantly increased ghrelin following maternal fructose intake (Kisioglu & 
Nergiz-Unal, 2020).   
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Leptin, ghrelin and insulin-like growth factors not only represent mediators of 
appetite and metabolism. They also play an important role in the brain somatic 
crosstalk and the complex axis, which controls the gastrointestinal tract and 
hypothalamic regulation of hunger and satiety. When excess fructose is 
consumed, circulating leptin decreases, causing increased appetite signals to 
the hypothalamus (Shapiro et al., 2008, Ma et al., 2017, Teff et al., 2004). Recent 
studies have demonstrated that maternal fructose intake of 10%w/v increased 
leptin signalling in the offspring (Kisioglu & Nergiz-Unal, 2020, Rodríguez et 
al., 2013). Kisioglu et al. also found that maternal fructose increased offspring 
leptin levels despite obesity-related leptin resistance. Indicating that fructose 
intake can affect appetite regulation in offspring from mothers that consumed 
increased fructose consumption during pregnancy without offspring 
consuming fructose themselves (Kisioglu & Nergiz-Unal, 2020).  
In context, dysregulation of the insulin-leptin-ghrelin axis may have important 
consequences for the development of energy homeostasis and appetite 
regulation in offspring. The long-term effects of excess maternal fructose 
consumption on offspring appetite regulation are largely unknown. However, 
it has been shown that added sugar and fructose in processed and SSB can alter 
hypothalamic response to appetite regulation via the imbalance of leptin and 
ghrelin secretion in offspring (Kisioglu & Nergiz-Unal, 2020, Rodríguez et al., 
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2013). The dysregulated signals of leptin and ghrelin on the hypothalamus 
stimulate appetite, causing increased consumption and likely, increased 
lipogenesis. There is an increasing body of literature highlighting a life-long 
susceptibility to adverse metabolic effects of dietary consumption of fructose in 
these offspring exposed to high fructose in utero. It is clear that further studies 
are needed to better understand the mechanisms underlying the effects of 
excess maternal fructose through pathways of insulin, leptin, ghrelin, and 
altered hypothalamic function, which may be important in acutely-fed 
individuals and maternally-fed offspring. 
However, there is a paucity of data examining the mechanistic impact of 
increased fructose intake before and during pregnancy and subsequent adverse 
effects on lactation, fetal development and offspring metabolic function. It is 
essential to determine how the vertical transmission of such deleterious 
metabolic effects might increase de novo lipogenesis, fatty acid acylation and 
subsequent metabolic programming in offspring. During fetal development, 
the liver will undergo many changes in structure and function, which can 
influence the rate of absorption and metabolism of nutrients received and 
supply of metabolites into circulation. It has been shown that the combination 
of increased plasma levels of VLDL and TAG and inhibition of fat oxidation 
following fructose consumption may lead to increased intracellular lipid 
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accumulation. Animal studies indicate that the fetal liver is highly influenced 
by the activation of these pathways when exposed to excess maternal fructose 
intake, making offspring vulnerable to insulin resistance later in life. In a rat 
model study, high fructose corn syrup increased insulin resistance in dams; 
however, free fructose had a greater effect on insulin resistance in pups (Jen, 
Rochon, Zhong, & Whitcomb, 1991). It was proposed that the effects of high 
fructose corn syrup may stem from the fructose content rather than sucrose. 
Indicating excess maternal fructose alters the regulation pathways of glucose 
and insulin and cell function during development.  
1.7 Mitochondrial Function as a Novel Candidate for Developmental 
Programming 
In brief, mitochondria are the maternally inherited ‘powerhouse’ of the cell and 
can also regulate cellular function, including cell survival and death. The 
mitochondria are membrane-bound organelles that are present in all nucleated 
cells. Cellular energy use and storage are allocated by the homeostatic flux of 
nutrients that are broken down into energy compounds and transferred by the 
mitochondria. This process is primarily performed in the mitochondria outer 
matrix, which contains enzymes of the tricarboxylic acid (TCA) cycle, which 
quickly metabolise nutrients into substrates that the mitochondria can further 
metabolise for energy production in the form of ATP. This process takes place 
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in the inner membrane of the mitochondria and is more commonly known as 
the electron transport chain (ETC). The ETC metabolises substrates supplied by 
the TCA cycle in-between and across the five key enzymes or complexes (I-V) 
of the ETC. Using a series of oxidation-reduction reactions, the complexes 
move electrons across the complexes to create an electron gradient more 
commonly known as oxidative phosphorylation, which ultimately produces 
ADP and ATP, providing energy for the cell.  
The presence of excess TCA cycle products from the metabolism of excess 
dietary carbohydrates and/or fat has been shown to cause increases in substrate 
metabolism via the metabolic mitochondrial pathway, leading to activation of 
mitochondrial respiratory activity, which can produce abnormally high ATP 
levels (Martínez-Reyes & Chandel, 2020). Similarly, mitochondrial activity, 
ATP increase and redox status in oocytes of mice from mothers that were obese 
during ovulation and pregnancy have also been observed (Igosheva et al., 
2010). Under normal physiological conditions and an optimal diet, this may not 
be of concern. However, when there is readily available intracellular glucose 
and glycogen, fructose will be converted to lipids as VLDL, free fatty acids and 
triglycerides. When the fatty acids are broken down and enter β-oxidation as a 
long-chain-acyl-CoA, they produce one acetyl-CoA from one cycle of β-
oxidation and then enter the TCA cycle. The NADH and FAD2 produced by 
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both β-oxidation and the TCA cycle are used by the electron transport chain to 
produce ATP.  Excess dietary fructose has been known to affect metabolic 
signalling pathways, namely, β-oxidation, TCA cycle and oxidative 
phosphorylation (complex I-V) (Jaiswal et al., 2015, Softic et al., 2019). These 
metabolic pathways are interconnected. Broken down to acetyl Co-A to enter 
the TCA cycle and converted to energy substrates NADH/FADH2 to enter 
oxidative phosphorylation. An electron carrier will take the NADH into 
complex I. Complex I establish the proton gradient of the electron transport 
chain as it pumps the H+ ions into the intermediate space and passes the 
electron to ubiquinone (Q). Complex II serves as an entrance for electrons from 
FAD2 to be donated to Q (now QH2) and releases hydrogen into the cytosol. 
Since complex II is not a proton pump, it does not directly contribute to the 
proton gradient. Since electrons from FAD2 do not contribute to the proton 
gradient, it produces fewer ATP than NADH. The presence of excess fructose 
and the accompanying circulating free fatty acids in utero may increase the 
influx of energy compounds in the fetal hepatic mitochondria leading to 
permanent maladaptive mitochondrial function and increased circulating free 
fatty acids in the offspring. 
All mitochondria are inherited maternally due to oocyte cytoplasmic donation 
to the embryo during early embryogenesis, and paternal mitochondria are 
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killed, except in very rare instances (Luo et al., 2018). Effectively, all animals 
carry maternal and paternal nuclear DNA but only maternal mtDNA. All of 
which have been implicated in different heritable diseases. Specifically, 
maternal mtDNA mutations have been shown to play a role in cellular aging, 
cell death, some cancers (Taylor & Turnbull, 2005). Research in the fetal origins 
of adult disease and the specific mechanisms underlying these programmed 
changes following different maternal nutritional insults have been studied 
extensively. However, the majority of studies are limited to investigating 
phenotype and organs of interest, with relatively few considering the role of 
mitochondria. Developmental programming of mitochondrial function and 
bioenergetics presents a key intracellular candidate underlying many 
phenotypes that are observed within the DOHaD paradigm. A limited number 
of studies exist that present evidence of programmed offspring mitochondrial 
function following gestational nutritional insults or environmental exposures. 
In a rat model of maternal high fat feeding, Pileggi et al. reported differences in 
mitochondrial activity in adult offspring skeletal muscle (Pileggi et al., 2016). 
They showed reduced expression of nuclear respiratory factor-1 (NRF1) and 
mitochondrial transcription factor-A (mtTFA), as well as a reduction in genes 
involved in the ERC and reduction in mitochondrial catalytic activity in ETC 
complex I and III (Pileggi et al., 2016). Further animal studies have shown links 
between programmed mitochondrial biology in offspring and increased 
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reactive oxygen species (ROS) production (Korshunov, Skulachev, & Starkov, 
1997, D’Autréaux & Toledano, 2007, Aiken, Tarry-Adkins, Penfold, Dearden, & 
Ozanne, 2016, Bruin et al., 2008, Tarry-Adkins et al., 2016) and this excess ROS 
may be associated with decreased ATP production (Pitkänen & Robinson, 
1996). Similarly, although human studies are limited to oocytes from obese 
mothers, oocytes were shown to have reduced mitochondrial function and 
impaired oxidative phosphorylation (Leary, Leese, & Sturmey, 2015). mtDNA 
content has been observed to be reduced in placentas from women exposed to 
environmental stimuli such as, smoking, obesity (Gruzieva et al., 2017, Hastie & 
Lappas, 2014), stress (Gruzieva et al., 2017, Brunst et al., 2018) and other 
environmental pollutants (Clemente et al., 2016, Janssen et al., 2015, Janssen et 
al., 2012). Furthermore, a recent review by Gyllenhammer et al. showed that 31 
human studies and 23 animal studies investigating various gestational 
exposures and subsequent offspring mitochondrial biology effects had been 
published (Gyllenhammer, Entringer, Buss, & Wadhwa, 2020). Current 
research indicates an important role for maternal nutritional status and/or 
extrinsic environmental factors in the developmental programming of offspring 
mitochondrial biology (Pileggi et al., 2016). In the context of the developmental 
programming of health and disease with regards to maternal fructose intake, 
there are very few published reports examining the impact of fructose intake 
before and during pregnancy and the adverse effects on fetal development and 
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lactation, and even fewer on the potential effects upon offspring mitochondrial 
function and how this may be associated with the onset or predisposition to 
adult disease states. 
1.8 Strengths of Guinea Pig Model for DOHaD 
The mechanisms underlying offspring long-term metabolic function following 
excess fructose exposure in utero remain unclear. Although human 
epidemiological studies provide evidence of an adverse effect of maternal 
fructose on offspring outcomes, it would be difficult to clearly establish the 
direct mechanistic effects in the first generation and the latency to then 
determine the long-term mechanistic effects would take decades.  Therefore, it 
is necessary to use appropriate translational animal models that closely reflect 
the pace of human fetal development to effectively determine the effects of 
maternal nutritional intake and offspring predisposition to metabolic disease in 
adult life.   
The use of guinea pigs in nutritional DOHaD research has been established as a 
beneficial clinically relevant translational animal model due to their in utero 
and metabolic similarities to humans (Morrison et al., 2018, Torres-Gonzalez, 
Volek, Sharman, Contois, & Fernandez, 2006). Compared to rats or mice, 
guinea pigs have a relatively long gestation (69-71 days) and comparable fetal 
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developmental maturation of organ systems to humans. This allows adaptions 
to an adverse in utero environment and identification of vulnerable 
developmental timepoints impacted (Briscoe et al., 2004). Additionally, the 
haemomonochorial placenta in a guinea pig allows similar maternal nutrient 
and hormonal transfer to the fetus (Morrison et al., 2018, Turner & Trudinger, 
2009). Like humans, guinea pigs are precocious and predominantly develop 
prenatally and are born relatively mature (Jones & Parer, 1983). Likewise, and 
similar to the human fetus, fetal guinea pigs accumulate brown and white 
adipose tissue during late gestation (Morrison et al., 2018). While the total fat 
content at birth in humans is ~10% (Carberry, Colditz, & Lingwood, 2010), 
guinea pigs have ~14% (Macé, Shahkhalili, Aprikian, & Stan, 2006). In humans, 
adipocyte cell number is established before puberty, and the ability to form 
new adipocytes in adulthood is limited (Spalding et al., 2008). A similar pattern 
was also observed in guinea pigs with adipogenesis, and lipid hyperplasia 
increased during early life while very low in adulthood (Castañeda-Gutiérrez 
et al., 2011).  
In the context of fructose feeding, following a lipogenic diet, guinea pigs have 
similar metabolic adaptations, lipid metabolism and lipid deposition as 
humans (Torres-Gonzalez, Leite, Volek, Contois, & Fernandez, 2008, Yang, 
Guo, Song, Liu, & Gao, 2011, Castañeda-Gutiérrez et al., 2011). Comparable to 
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humans, the majority of circulating cholesterol is transported in LDL 
(Fernandez & McNamara, 1989), have higher LDL/HDL ratios (Torres-
Gonzalez et al., 2008), higher hepatic concentrations of free cholesterol rather 
than esterified (M. L. Fernandez & McNamara, 1991, Angelin et al., 1992), and 
display moderate rates of hepatic cholesterol synthesis (Maria Luz Fernandez, 
Yount, & McNamara, 1990) and catabolism (Maria Luz Fernandez et al., 1995). 
Additionally, similar to humans, guinea pigs have both plasma cholesteryl 
ester transfer protein activity (CEPT) (Haa & Barter, 1982) and lecithin-
cholesterol acyltransferase (LCAT) (Grove & Pownall, 1991).  
Guinea pigs also show comparable insulin-regulated glucose metabolism to 
humans and have evidence for maternal diet programming effects of glucose 
metabolism (A. C. J. Ravelli et al., 1998). Like humans, guinea pig maximal 
glucose-uptake responses are similar (Horton, Saint, Owens, Gatford, & Kind, 
2017) and type 2 diabetes studies using lipogenic diets of high fat and high 
carbohydrates showed impaired glucose tolerance and hyperinsulinemia. 
(Podell et al., 2017).  
The use of small and large animal models of DOHaD is beneficial and 
necessary to evaluate the mechanisms by which maternal diet impacts 
offspring metabolic function throughout life. The comparable attributes shared 
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between humans and guinea pigs, such as pregnancy, fetal development, 
metabolic function, lipid synthesis and catabolism, will allow further in-depth 
assessment and establishment of the mechanisms underlying the offspring’s 
long-term metabolic effects following excess fructose exposure in utero. A 
deeper understanding of the offspring programmed effects obtained through 
the use of guinea pig models will allow for improved nutritional initiatives for 
those considering or during pregnancy.  
1.9 Hypothesis and Aims 
1.9.1 Hypothesis 
Excess maternal fructose intake alters dams metabolic profile, milk FFA 
composition. Excess maternal fructose alters offspring development and 
metabolism, permanently altering de novo lipogenesis, lipid metabolism and 
mitochondrial dysfunction, predisposing adult offspring to metabolic disease 
risk into adulthood. 
1.9.2 Aims 
Characterise the effects of excess maternal fructose consumption on maternal 
physiology, metabolic status and milk FFA composition through assessing: 
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• The non-pregnant and pregnant dams' total daily caloric intake, weight 
gain, plasma glucose and insulin levels, plasma metabolites and dams' 
milk FFA composition (Chapter 3). 
Investigate the programmed effects of excess fructose exposure in utero on 
offspring physiology, liver and visceral fat development, metabolic status, lipid 
synthesis and metabolism and mitochondrial function in the weanling and 
adult male and female offspring through assessing: 
• The weanling offspring weight gain, plasma glucose and insulin 
concentrations, plasma metabolites, liver weight and lipid deposition, 
visceral fat weights and cell size, hepatic protein expression and 
abundance and hepatic metabolic signalling pathways (Chapter 4). 
• The adult offspring weight gain, plasma glucose and insulin 
concentrations, plasma metabolites, liver weight and lipid deposition, 
visceral fat weights and cell size, hepatic protein expression and 
abundance and hepatic metabolic signalling pathways (Chapter 5). 
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Methods 
2.1 Overall Study Design 
This thesis is based upon one large study of pregnancy and offspring outcomes 
and presented as 3 distinct studies for analysis. 1) Maternal preconception and 
pregnancy measures (Chapter 3). 2) Offspring outcomes during early 
development (day 0) up to weaning (day 21) (Chapter 4). 3) The long-term 
effects of in utero fructose exposure in adult (4 month) offspring (Chapter 5).  
2.1.1 Summary of Study 1 
Study 1 (Figure 2.1) examined the effects of dietary fructose on dam pre-
pregnancy and pregnancy caloric intake, physiology, metabolic status and milk 
lipid concentration. Groups included control diet (CD) dams (n= 10) and 
fructose diet (FD) dams (n=9). During study 1, dam pre-pregnancy and 
pregnancy weights, water and food intake, as well as caloric intake, were 
calculated daily throughout the duration of the experiment. At sexual maturity 
(12 weeks (w)), dams were matched for weight and age and randomly assigned 
to CD and FD groups. At 6 months (6M) of age, dams were mated with a single 
non-lineage boar during estrous for 72h. Following mating, dams were 
returned to individual cages and continued their experimental diets 
throughout gestation. Oral glucose tolerance tests (OGTTs) were performed at 
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sexual maturity (12w), 60 days (60d) of experimental dietary consumption 
(prior to pregnancy) and during pregnancy at midgestation (35d). At 
spontaneous delivery (~69d gestation in our cohort (Smith et al., 2020), 
experimental dietary interventions were ceased (all dams and offspring 
maintained on CD following delivery). At ~69d dams’ milk samples were 
collected following the birth of the last pup. Pre-pregnancy and pregnancy 
metabolic status and maternal milk lipid concentrations were analysed. 
Pregnancy outcomes, including gestation length, litter size, live and 
stillborn/death during delivery, were also analysed. Following birth, pups were 
sexed and all litters were maintained at four pups (male=2, female=2). Excess 
pups were humanely euthanised following birth. Following delivery (~69d), 
dams were weighed weekly and signs of milk production were monitored 
daily. Each dam was housed with her pups and humanely euthanised at time 
of weaning (day 21). All reported results include CD dams (n= 10) and FD 
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Figure 2.1. Study 1: Guinea pig Pre-pregnancy and Maternal Fructose Dietary 
Intake Protocol 
 
Figure 2.1 Diagram represents the work flow undertaken throughout study 1. Two groups of matched 
weight and age virgin Dunkin Hartley females were randomly assigned to separate dietary groups (CD 
n=10, FD n=9). Dams were fed experimental diets for 60d prior to mating and throughout pregnancy to 
term delivery (~69d) and all dams continued a control diet. At 6M of age, dams mated with a single non-
lineage boar during estrous for 72h. Following mating, dams returned to individual cages and continued 
their experimental diets throughout gestation. Oral glucose tolerance tests (OGTT) were performed at 
sexual maturity (12w), 60d of experimental dietary consumption (prior to pregnancy) and during 
pregnancy at midgestation (35d). At spontaneous delivery (~69d gestation in our cohort (18)), 
experimental dietary interventions were ceased (all dams and offspring maintained on CD following 
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2.1.2 Summary of Study 2 
Study 2 (Figure 2.2) examined the effects of maternal dietary fructose exposure 
on day 21 (d21) weanling physiology, hepatic proteome, lipid metabolism, 
mitochondrial function and metabolic status were determined (CD males (n= 
7); FD males (n=7); CD females (n=7); and FD females (n=7)). Offspring were 
fed a control diet of standard guinea pig pellets, fresh silverbeet and carrots 
and Millipore filtered water supplemented with 1.2g/L of ascorbic acid. 
Following birth, weights were measured daily until age d21. Blood samples 
were taken from offspring at day 0 (prior to suckling), 7 and 14. An OGTT was 
performed on day 21. Upon completion of the OGTT, offspring in the weanling 
group (study 2), not assigned to the 4 month (4M) group (study 3), were 
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Figure 2.2. Study 2: Offspring Day 21 (Weanling) Protocol 
 
Figure 2.2 Diagram represents the work flow undertaken throughout study 2. CD and FD offspring were 
randomly allocated to weanling groups CD males (n= 7); FD males (n=7); CD females (n=7); and FD 
females (n=7). Offspring were fed control diets from d0 to d21. Blood samples were collected on d0 (prior 
to suckling), d7 and d14. On d21 offspring underwent an OGTT were a baseline and serial blood 
collections, following glucose load, was collected. Following the OGTT d21 offspring were humanely 
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2.1.3 Summary of Study 3 
Study 3 (Figure 2.3) examined the effects of maternal dietary fructose exposure 
on the developmental programming of adult physiology, body composition, 
hepatic proteome, lipid metabolism, mitochondrial function and metabolic 
status were determined. The offspring protocol used in study 2 (Figure 2.2) was 
followed until day 21 and one sibling of each sex was allowed to grow to 4M of 
age (CD males (n= 7); FD males (n=9); CD females (n=7); and FD females (n=6)). 
OGTTs were performed at day 21, 2 months and 4 months of age. All offspring 
were weaned at d21 and maintained a control diet of standard guinea pig 
pellets, hay, fresh silverbeet and carrots and Millipore filtered water 
supplemented with 1.2g/L of ascorbic acid until 4M of age. Following the final 
OGTT at 4M of age, offspring underwent a DXA scan. Offspring in the 4M 
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Figure 2.3. Study 3: Offspring 4 Months (Adult) Protocol 
 
Figure 2.3. Diagram represents the work flow undertaken throughout study 3. CD and FD offspring were 
randomly allocated to adult groups CD males (n= 7); FD males (n=9); CD females (n=7); and FD females 
(n=6). At day 21, 2 months and 4 months of age, offspring underwent OGTTs were a baseline and serial 
blood collections, following glucose load, were collected. Upon completion of the OGTT, all offspring 
were weaned, separated by sex and fed a control diet throughout the remainder of the experiment. 
Following the final OGTT at 4M of age, offspring underwent a DXA scan. Upon completion of the DXA 
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2.2 Materials and Methods 
2.2.1 Ethics 
All studies were conducted with the prior ethical approval of the University of 
Otago Wellington Animal Ethics Committee (AEC 7-15) and performed in line 
with the standards described in the Guide for the Care and Use of Laboratory 
Animals, 8th Edition, and the National Animal Ethics Advisory Commission, 
New Zealand (Nih, Od, Oer, & Olaw, 2011). Results are reported according to 
the ARRIVE guidelines (Kilkenny, Browne, Cuthill, Emerson, & Altman, 2010). 
2.2.2 Experimental Animals 
The Biomedical Research Unit (BRU) of the University of Otago, Wellington, 
supplied Dunkin Hartley guinea pigs. All animals were housed in 
polypropylene cages (Tecniplast, Australia) lined with untreated pine wood 
shavings in a sound-insulated room under a 12h day/night light cycle within a 
temperature (18-23˚C) and humidity-controlled facility. Pinewood shavings 
were changed twice weekly and food and water were available ad libitum 
before and during each study.  
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2.2.3 Control and Experimental Diet 
19 Virgin Dunkin Hartley females, controlled for similar weights, were 
randomly allocated to 2 different experimental groups: 1) Control diet (CD; 
n=10) and 2) Fructose diet (FD; n=9). Dams, weanling and adult offspring, 
received standard guinea pig pellets (guinea pig pellets; Sharpes Stock Feeds, 
NZ) (Table 1), hay ~10g, half a piece of fresh silverbeet and ~18g carrots daily. 
Millipore filtered water supplemented with 1.2g/L of ascorbic acid was 
available ad libitum. FD dams water was additionally supplemented with 
10g/ml of D-fructose (Sigma-Aldrich, USA) to create 10% fructose water from 
12w to term delivery (~69d). Dam caloric intake from pellets and water were 
measured daily, providing a representation of food and water consumption for 
the previous day. Total daily kcals from pellets (Table 2.1) and fructose solution 
were calculated using the following formula.  
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Table 2.1. Standard Guinea Pig Pellets Ingredients 
Feedstuff Fresh Weight (%) Nutrient Amount DM 100% 
Broll 381.00 38.10 Bulk 1.00 1.14 
Lucerne pellets 300.00 30.00 Dry Matter (%) 88.02 100.00 
Barley 220.00 22.00 RUM_MER (MJ/kg) 10.03 11.40 
Soya, extr, 47% 55.00 5.50 Crude Protein (%) 15.90 18.06 





   
Limestone 20.00 2.00 Crude Fibre (%) 12.37 14.05 
Salt 2.00 0.20 ADF (%) 15.31 17.39 
Rabbit Premix 2.00 0.20 NDF (%) 29.87 33.93 
Total 1000.00 kg 100.00 Starch (%) 20.92 23.77 
   Starch + Sugar (%) 26.57 30.19 




   Calcium (%) 1.32 1.50 
   Phosphorus (%) 0.55 0.62 
   Magnesium (%) 0.24 0.27 
   Sodium (%) 0.11 0.13 
Table 2.1. Sharpes Stock Feeds guinea pig pellets nutrition facts and ingredients provided from Nutritech (Nutritech International Ltd, NZ). Ruminants metabolisable energy 
(RUM_MER), acid detergent fiber (ADF) and neutral detergent fiber (NDF).
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2.2.4 Mating 
At 6M of age, dams were housed in a non-lineage harem with a single boar 
during estrous for a maximum of 72h to ensure timed mating with 24h 
considered as mate date. During the 72h mating protocol, all animals were fed 
a control diet and water ad libitum. Mating was confirmed by the presence of 
seminal fluid and/or vaginal plugs. Following mating, dams returned to 
individual cages and continued their experimental diets throughout gestation. 
Abdominal ultrasounds were performed by experienced technicians to confirm 
pregnancy at 3w post-mating.  
2.2.5 Delivery and Postnatal Care 
Dams delivered spontaneously, and all litters were maintained at four pups 
following delivery. Total offspring groups included: study 2) CD males (n=7); 
FD males (n=7); CD females (n=7); and FD females (n=7) and study 3) CD males 
(n=7); FD males (n=9); CD females (n=7); and FD females (n=6). Excess pups 
were humanely euthanised by intraperitoneal injection of 0.5ml of 
Pentobarbital. Each dam was housed with her pups until weaning at d21. Signs 
of lactation were tracked daily by gently squeezing and pulling the base of the 
teat downward for milk extraction. All animals consumed a control diet from 
day of delivery (d0), throughout the remainder of the experimental protocols.  
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2.2.6 Collection of Biometric Data 
Dams (study 1) were weighed twice weekly from 12w of age to term delivery 
and once weekly until offspring were weaned. Weanling offspring (study 2) 
were weighed daily from birth (d0) to d21. Adult offspring (study 3) were 
weighed twice weekly from weaning at d21 to 4M. 
2.2.7 Determination of Body Composition 
Dual-energy X-ray absorptiometry (DXA) (Hologic Horizon DXA System, 
Canada) whole-body scans were performed on adult offspring (study 3) at 4M 
of age to quantify fat mass, lean mass, total mass, bone mineral content (BMC) 
and bone mineral density (BMD). All DXA scans were performed by trained 
technicians. All animals were fasted for 14h overnight with ad libitum access to 
water. Prior to scanning, guinea pigs were weighed and then anaesthetised by 
an intramuscular injection mixture of ketamine (40mg/kg, PhoenixPharm, New 
Zealand) and medetomidine (0.5mg/kg, Domitor®, Pfizer Animal Health, New 
Zealand). Anthropometric parameters of body length and body weight were 
used to measure whole body composition. Guinea pigs were positioned 
pronated on scanning table with head, neck, torso and pelvis aligned with the 
red horizontal zone line of the scanner, both arms and legs pronated at the 
sides with feet paralleled with red vertical zone line of the scanner (Figure 
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2.4B). Following the first measurement, guinea pigs were lifted and re-
positioned on scanning table for the second measurement. Two consecutive 
scans were performed to verify reproducibility of the scan measurements. 
(Figure 2.4A-C) 
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Figure 2.4. Guinea Pig DXA Scan  
 
Figure 2.4. Guinea pig DXA scanning. A) DXA Scanner. B) Guinea pig positioning on table of scanner. C) Image of guinea pig scan. 
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2.2.8 Metabolic Assessments of Oral Glucose Tolerance Tests 
2.2.8.1 Glucose and Insulin Concentration Assessments 
OGTTs were performed on dams and offspring using our established protocol. 
All animals were fasted for 14h overnight with ad libitum access to un-
supplemented water only. Following a baseline blood collection, a 
standardised oral dextrose load (1000mg/kg, Dextrose 50%, Biomed Ltd., New 
Zealand) was administered with serial blood collections for glucose and insulin 
concentrations at 15, 30, 45, 60, 75, 90, 120 and 180min for dams and offspring 
at 2M and 4M of age and 30, 60, 120 and 180min for the offspring at d21, due to 
their smaller size. In addition, offspring blood samples were taken for glucose 
concentration at day 0 (prior to suckling), 7 and 14, following a 4h fast during 
which time food, but not water, was withdrawn. All blood samples were 
collected via the auricular ear vein, placed on ice, then centrifuged at 4000rpm 
for 15min. The plasma layer was extracted and stored at -80˚C pending 
analysis.  
2.2.8.2 Whole-Body Insulin Sensitivity  
The Matsuda-DeFronzo Insulin Sensitivity Index (M-ISI) was used to evaluate 
whole-body insulin sensitivity in dams. The M-ISI has been demonstrated as 
the most accurate calculation to evaluate whole-body insulin sensitivity from 
Chapter 2  Methods 
 61 
OGTT measurements because the results are comparable to the gold standard 
measurements performed by hyperinsulinemic-euglycemic clamp (Matsuda & 
DeFronzo, 1999, Lorenzo, Haffner, Stančáková, Kuusisto, & Laakso, 2015, 
(Mulvey et al., 2014, Furugen et al., 2012). Using M-ISI, whole-body insulin 
resistance is detectible at clinical measurements ≤2.5 (Stern et al., 2005, Kernan 
et al., 2003). The Matsuda-DeFronzo Insulin Sensitivity Index was calculated 
using the following formula:  
Matsuda-DeFronzo Insulin Sensitivity Index: 
1,000/√[(fasting	plasma	glucose	(mg/dL) × fasting	plasma		insulin	(µU/mL)) ×
(mean	glucose	(mg/dL) × mean	insulin	(µU/mL)]  
2.2.9 Post Mortem Collection of Tissues 
Immediately following OGTTs at d21 (study 2) and 4M (study 3), offspring 
were humanely euthanised, tissues collected and weighed, and divided into 
frozen and fixed samples. Tissues were snap-frozen in liquid nitrogen and 
stored at -80°C. Tissues were fixed in 10% neutral buffered formalin (Labserv, 
New Zealand) for 24h at 4°C before being rinsed and stored in 0.1M phosphate 
buffer (Appendix) for later analysis.  
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2.3 Histology 
2.3.1 Fixed Liver and Visceral Adipose Tissue 
Lower left lobes of all livers and visceral adipose tissue surrounding the left 
kidney were dissected and fixed in 10% formalin for 24h before storage in 0.1M 
phosphate buffer until further analysis.  
2.3.1.1 Fixed Liver and Visceral Adipose Tissue Preparation 
To prepare the fixed liver and visceral adipose tissues for paraffin sectioning, 
tissues were dehydrated using alcohol, cleared of the alcohol through 
replacement with xylol and infiltration with paraffin wax. This process was 
performed automatically using a Tissue-tek® VIP processor (Sakura® Finetek, 
USA) on an 11h cycle instead of the 13h cycle as tissues were in buffer and 
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Table 2.2. Ethanol (Labserv), xylene (Labserv), Paraplast Plus® paraffin wax (McCormick™ Scientific, USA), High Grade Absolute Alcohol (HGAA) (Axieo). * See appendix 
for solutions protocol. 
Reagent Duration Temperature Process  
70% ethanol* 1 h 37˚C Dehydration 
70% ethanol* 1 h 37˚C Dehydration 
90% ethanol*  1 h 37˚C Dehydration 
100% ethanol  1 h 37˚C Dehydration 
100% ethanol 1 h 37˚C Dehydration 
100% ethanol 1 h 37˚C Dehydration 
100% ethanol 1 h 37˚C Dehydration 
Xylene 1 h 37˚C Clearing of ethanol  
Xylene 1 h 37˚C Clearing of ethanol 
Paraffin wax 30 min  60˚C Infiltration of wax  
Paraffin wax 30 min  60˚C Infiltration of wax 
Paraffin wax 30 min  60˚C Infiltration of wax 
Paraffin wax  30 min  60˚C Infiltration of wax 
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2.3.1.2 Embedding 
Using a Tissue-Tek® Embedding centre (Sakura™), each tissue sample was 
embedded in a 30x20mm mould with paraffin wax heated to 60˚C. The 
embedded sample was cooled on a Tissue-Tek® Cryoconsole (Sakura™) before 
removal from the mould. 
2.3.1.3 Microtomy 
To prepare the embedded liver and visceral adipose tissues for haematoxylin 
and eosin (H&E) staining, 4µm thick tissue sections were cut using a Leica 
RM2235 microtome (Leica Biosystems, New Zealand) with feather S35 blades 
(Feather Safety Razor co., Japan) and floated on a 48˚C flotation waterbath 
(Thermo Scientific, New Zealand) for collection onto SuperFrost plus® 
microscope slides (Thermofisher, New Zealand). For each liver sample, 3 serial 
sections were taken from 3 tissue depths (levels) approximately 80µm apart.  
2.3.1.4 Haematoxylin and Eosin Staining 
H&E staining was batched according to level to ensure distribution of potential 
batch effects across all samples. All batches were stained using the same 
solutions following standard protocols from Pathology Department, Otago 
Wellington (Table 2.3 and Appendix). Following staining, tissue sections were 
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mounted with DPX and coverslipped (24 x 50) Menzel-Gläser, Thermo 
Scientific).
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Table 2.3. Haematoxylin & Eosin Protocol 
Reagent Duration Process  
Xylene 5 min Deparaffinization   
Xylene 5 min Deparaffinization   
100% ethanol  3 min Rehydrating starts from here 
100% ethanol 3 min Rehydrating 
70% ethanol* 3 min Rehydration 
Running H2O 3 min Rehydration  
Haematoxylin* 10 min Staining of nuclear detail 
H2O x1 dip Remove excess haematoxylin  
Acid Alcohol * x10 rapid dips Differentiation of haematoxylin 
Running  H2O 10 min Blueing of haematoxylin 
Eosin* 3 min  Staining of cytoplasm  
Running H2O x5 dips Remove excess Eosin  
70% ethanol* 3 min Dehydration 
100% ethanol  3 min Dehydration 
100% ethanol 3 min Dehydration 
Xylene 5 min Removes dehydration agents 
Xylene 5 min Clearing of alcohol 
Table 2.3. *See appendix for solutions protocol. 
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2.3.2 Frozen Liver Tissue 
Lower right lobes of all livers were dissected and snap-frozen in liquid nitrogen 
and stored at -80°C until further analysis.  
2.3.2.1 Embedding  
To prepare the frozen livers for cryosectioning, the widest part of the lobe was 
excised using a coping saw (Fuller, Canada) and placed into small plastic bag 
labelled with the subjects assigned random number. Tissue was embedded 
within Surgipath FSC 22 frozen section compound, Leica brand within a 
Tissue-Tek® cryostat (Sakura®) set at -20°C.  
2.3.2.2 Cryosectioning 
To prepare the frozen liver tissue for Oil-Red-O (ORO) staining, 6µm thick 
tissue sections were cut using feather S35 blades and collected onto Superfrost 
plus® slides. For each liver sample, 2 serial sections were taken from 2 tissue 
depths approximately 80µm apart. 
2.3.2.3 Oil-Red-O Staining 
ORO staining was batched according to level to ensure distribution of potential 
batch effects across all samples. All batches were stained using the same 
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solutions following standard protocols from Pathology Department, Otago 
Wellington (Table 2.4 and Appendix). Following staining, tissue sections were 
coverslipped using Shandon Immu-mount (Thermoscientific, New Zealand). 
Table 2.4. Oil-Red-O in Dextrin Staining Protocol 
Table 2.4. *See appendix for solutions protocol. 
 
2.3.3 Histological Analysis 
2.3.3.1 Microscopy and Photography 
Microscopy was performed on an Olympus BX51 microscope with images 
captured using an Olympus DP20 mounted camera (Olympus, New Zealand). 
Five fields of view at 100x, 200x, or 400x magnification (Hübner, Horch, 
Polykandriotis, Rau, & Dragu, 2014, Sarr, Thompson, Zhao, Lee, & Regnault, 
2014, Hong et al., 2018, Q. Zhang et al., 2018, Emanuele et al., 2009, Srisowanna 
et al., 2019) were captured from each section (3 sections for each sample). These 
5 fields of view were taken in random areas of each section. Randomization 
Reagent Duration Process  
Formalin  30 sec Fixation   
Oil-Red-O * 20 min Lipid staining   
Running  H2O x1 dip  
Gill II Haematoxylin * 20 sec Nuclear staining 
Running  H2O x1 dip Blueing of haematoxylin & 
washing away excess ORO 
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within these areas was ensured by positioning the slide upon the stage 
macroscopically, therefore ensuring microscopic details of the slide would not 
influence the area selected for sampling.  
2.4 Determination of Plasma Metabolites 
2.4.1 Plasma Metabolite Analysis by COBAS  
Maternal and offspring plasma was analysed by Cobas c 311 autoanalyzer 
(Roche, Auckland New Zealand) according to manufacture instructions for 
cholesterol (CHOL), triglycerides (TAG), low-density lipoprotein cholesterol 
(LDL), high-density lipoprotein cholesterol (HDL), fructosamine (FRUC), uric 
acid (UA), glutamate dehydrogenase (GLDH), Lipase (LIP). In addition, 
offspring plasma was analysed for high sensitivity C-Reactive Protein (hs-CRP)  
alkaline phosphatase (ALP), alanine transaminase (ALT), gamma-glutamyl 
transferase (GGT). Li-heparin plasma was defrosted on wet ice then 
centrifuged for ~8sec at 800rpm (5415 D Centrifuge, Eppendorf, Hamburg). 
200µL pipettors (Interlab, New Zealand) were used to pipette Li-heprin plasma 
in 2.5ml Hitachi sample cups (Roche, NZ).  
A 1:2 dilution (60µL sample:120µL distilled water) was used for pre-pregnancy 
and maternal plasma analysis. Neat (400µL) samples were used for offspring 
plasma analysis. All samples required a minimum of 100µL “dead volume,” 
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which is the amount of plasma needed that is not intended to be tested, in the 
standard 2.5ml Hitachi sample cup (Roche, NZ) for tests to run correctly. If the 
result fell outside of the technical limits, samples were re-run. Tests that 
provided null or inconclusive results during analysis were removed from 
analysis (apolipoprotein b (APOB), apolipoprotein a (APOA), lipoprotein a 
(LPA) and immunoglobulin a (IgA)). 
2.4.2 Insulin and Leptin Analysis by ELISA 
Maternal and offspring OGTT plasma insulin concentrations, as well as 
offspring post-mortem leptin concentrations, were determined by a guinea pig 
quantitative competitive immunoassay kit (ELISA) (ABclonal, USA) according 
to manufacturer’s instructions. Samples were diluted 1:5 with phosphate-
buffered saline (PBS) (0.01 M phosphate buffer, 0.0027 M potassium chloride 
and 0.137 M sodium chloride, pH 7.0-7.2) (Sigma-Aldrich, NZ), and analysed in 
duplicate. The optical density (OD) of each well was measured at 450nm using 
a Mutliskanä GO (Thermo Fisher Scientific, NZ) microplate reader (see Figure 
2.5 for representative standard curve). Results were analysed by SkanITä Re 
4.1 software (Thermo Fisher Scientific, NZ). 
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Figure 2.5. Representative Standard Curve for Insulin ELISA 
 
Figure 2.5. Representative insulin ELISA standard curve linear regression and signal and concentration logarithmic using Mutliskanä GO (Thermo Fisher Scientific, NZ) 
microplate reader. Results were analysed by SkanITä Re 4.1 software (Thermo Fisher Scientific, NZ).
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2.5 Determination of Polyunsaturated Fatty Acid Profiles 
Maternal milk and offspring whole blood FFA composition was determined 
using the dried milk spot (DMS) and dried blood spot (DBS) technology using 
the PUFAcoatä card (University of Adelaide, Australia) method (Liu, 
Mühlhäusler, & Gibson, 2014, Gao et al., 2018). Maternal milk and offspring 
whole blood FFA composition measurements were performed using a 
modified direct transesterification method (Lepage & Roy, 1986) at University 
of Adelaide, Australia. 
2.5.1 Dried Milk and Blood Spot PUFAcoatÔ Card Technology 
Our group used PUFAcoatä cards to ensure long-chain polyunsaturated FFA 
stability in milk and blood samples during air-drying and long-term storage. 
PUFAcoatä cards are manufactured using Whatman ion-exchange papers 
prepared with permeated silica gel at a concentration of 2mg/mL (Whatman, 
UK) coated with antioxidant butylated hydroxytoluene (BHT) (Sigma-Aldrich, 
USA) at a 2mg/ml concentration and chelating agent 
ethylenediaminetetraacetic acid (EDTA) (Chem-supply, AUS) at a 5mg/mL 
concentration in 70% ethanol (Liu et al., 2014, Gao et al., 2018).  
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2.5.2 Dam Milk Sample Collection 
Dams milk was extracted following the birth of the last pup. Approximately 
40µL of milk was applied to a DMS PUFAcoatÔ card. PUFAcoatÔ cards were 
dried at room temperature for ~1h and stored at room temperature until 
further analysis (Liu et al., 2014, 2014, Gao et al., 2018).   
2.5.3 Offspring Whole Blood Sample Collection 
Offspring blood was collected at d0 (prior to feeding), d7, d14, d21, 2M and 4M. 
Approximately 40µL of blood was collected from the auricular ear vein and 
applied to a DBS PUFAcoatÔ card. PUFAcoatÔ cards were dried at room 
temperature for ~1h and stored at room temperature until further analysis (Liu 
et al., 2014).  
2.5.4 Maternal milk and Offspring Whole Blood Fatty Acid Measurements 
Both maternal milk and offspring whole blood FFA composition measurements 
were performed using a modified direct transesterification method (Lepage & 
Roy, 1986) at University of Adelaide, Australia. Dried milk and blood spots 
were removed with sterile scissors and tweezers then placed in 
transmethylation solution. Fatty acids were transmethylated to fatty acid 
methyl esters (FAME) using 2mL of 1% (v/v) sulphuric acid H2SO4 (18M AR 
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grade, BDH, UK) in anhydrous methanol (Merck, Germany) in a 5mL sealed 
vial (Wheaton, USA) and heated for 3h at 70°C. This procedure allows for fatty 
acids to be released from structural lipids into an overall fatty acid pool. The 
sequential FAME were extracted into heptanes (Merck, Germany) for gas 
chromatography analysis (Liu et al., 2014, Gao et al., 2018, Gao, Liu, et al., 2018, 
Tu, Cook-Johnson, James, Mühlhäusler, & Gibson, 2010).  
FAME separation and quantification analysis were performed using a gas 
chromatograph Hewlett-Packard 6890 (Hewlett-Packard, USA) equipped with 
a BPx70 capillary column 50m x0.32mm, film thickness 0.25µm (SGC Pty Ltd. 
Australia), a temperature-programmed vaporization injector at 250°C and 
temperature-programmed flame ionisation detector (FID) at 300°C, along with 
the use of a program temperature ramp (140-240°C). Helium was used as a 
carrier gas with a flow rate of 35cm/second in the column, and the inlet split 
ratio was set at 20:1. Sample FAME identification and quantification were 
achieved by comparing the retention times and peak area values to those of the 
commercial lipid standards (Nu-Chek-Prep, USA) using the Hewlett-Packard 
Chemstation data system (Liu et al., 2014, Gao et al., 2018, Gao, Liu, et al., 2018, 
Tu et al., 2010). 
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2.6 Determination of Hepatic Triglycerides 
Offspring hepatic triglycerides were determined by enzymatic colorimetric 
assays (Triglyceride Colorimetric assay kit, Cayman Chemical, Ann Arbor, MI, 
USA) according to manufacturer’s instructions. 50mg of ground liver was 
homogenised by an electric tissue homogeniser in 500µL of diluted NP40 
Substitute Assay Reagent (Item No. 700732) containing 1µg/mL protease and 
phosphatase inhibitors (PPIs) (250µL Napp, 625µL Naf, 250µL of 100x PmSF 
and 25µL of 1000x leupeptin/aprotinin, premade by Western University Lab) 
and centrifuged at 1,000rpm for 10min at 4°C. The top layer of insoluble fat and 
supernatant was extracted. Samples were diluted 1:1 (20µl of sample:20µl 
diluted NP40 Substitute Assay Reagent with protease inhibitors) and analysed 
in duplicate. The plate was covered with foil and incubated at room 
temperature for 15min. Absorbance was measured at 540nm using a plate 
reader (Spectra Max M5 Multi-Mode Microplate reader, Molecular Devices 
LLC, San Jose CA, USA). Results from the assay were analyzed by Softmax pro 
7 software (Molecular Devices LLC, San Jose CA, USA). 
2.7 Hepatic Bottom-up/Shotgun Proteomics 
“Bottom-up”/shotgun proteomic analysis produces an indirect measurement of 
proteins through peptides obtained by proteolytic digestion of intact proteins 
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for identification and quantification of the hepatic proteome, including 
expression, cellular localization and interactions for bioinformatic data analysis 
(Y. Zhang et al., 2013) (Figure 2.6).  
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Figure 2.6. “Bottom-up”/Shotgun Proteomics Workflow 
 
Figure 2.6. “Bottom-up” Shotgun Proteomics Workflow. Numbers in parentheses correlates with each step within the proteomic methods section.  
Chapter 2  Methods 
 78 
2.7.1 Hepatic Proteins  
2.7.1.1 Protein Extraction 
Offspring experimental groups from study 2 and study 3 were represented by 
two biological replicates. 50mg of liver tissue were aliquoted and homogenised 
in 500µl of lysis buffer (100 mM Tris-HCl pH 8.8, 7M urea, 2M thiourea, 4% 3-
[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS)) on ice 
with 1-mL Dounce homogeniser ((Sigma-Aldrich, NZ). The homogenate was 
vortexed for ~30min and centrifuged at 13,000g for 10min and supernatants 
(protein extract) were collected. Proteins were resuspended in 50µL of 8M urea.  
5µl of each sample was used to determine protein concentration measured by 
Bradford Method (Bio-Rad Protein Assay) in a 96-well plate (Corning, USA). 
Bovine Serum Albumin (BSA) (ICP Biologicals, NZ) was made at 40mg/1mL in 
dH2O, resulting 40µg/µL of BSA. Standard curve was achieved by performing 
2-fold dilutions, starting at 40µg/µL. 12 dilutions were used to identify the 
lower end of the assay detection capacity. Solutions were added to each well as 
follows: 25µL reagent A -> 5µL sample/standard -> 200µL reagent B. Colour 
developed in 15min and stable for 1h.  
Standard curve showed a linear correlation between absorbance at 750nm and 
protein concentration between 1.5-0.2µg/µL using a plate reader (2300 EnSpire 
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Multilabel Reader 3.0, PerkinElmer, Turku, Finland) (Figure 2.7). Standard 
curve of sample data was analysed by Prism 8 software (GraphPad Software 
Inc., USA).  Protein concentrations were interpolated based on the non-linear 
relationship between absorbance and protein concentration. All samples for 
protein quantification were separated into two biological replicates and ran in 
duplicate (i.e., four analyses per liver) and compared to validate results. 
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Figure 2.7. Protein Concentration Analysis 
 
Figure 2.7. Bradford method protein concentration analysis. A) Bio-Rad protein assay. B) Measurement of liver protein concentration by 2300 EnSpire Multilabel Reader 3.0.  
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2.7.1.2 Protein Precipitation  
30µg of proteins from the supernatant were precipitated using ProteoExtract 
Protein Precipitation Kit (Merck Ltd., NZ) according to manufacturer’s 
instructions. To pellet proteins, 50µL of sample was mixed with 200µL of cold 
precipitate agent, vortexed, then incubated for 1h at -20°C and centrifuged at 
room temperature at 10,000g for 10min. The pellet was washed twice by 
aspirating the supernatant (without disturbing the pellet), adding 95µL cold 
wash, vortex and centrifuge at room temperature at 10,000g for 2min and 
aspirating supernatant. Pellet was left to air dry at room temperature for 1h, 
dissolved in digestion buffer (8M urea/100mM Tris-HCL, pH 8.5), to a final 
volume of 50µL, vortexed for 10min, centrifuged at room temperature at 
10,000g for 10min and retained remaining supernatant in a new Eppendorf.  
2.7.1.3 Protein Digestion  
Protein disulfide bonds of 50µL sample proteins were reduced with 5mM 
Dithiothreitol (DTT) (BioRad, NZ) for 35min in a water bath at 55°C. Resulting 
free thiols were alkylated with 10mM iodoacetamide (IAA) (GE Healthcare Life 
Sciences, UK) for 30min at room temperature in the dark. Reduced and 
alkylated protein samples were diluted 3-fold with 100mM Tris-HCl, pH 8.5, 
for a total urea concentration of 2M. Sample proteins were digested with 
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trypsin (Roche, modified sequencing grade) at an enzyme-to-substrate ratio of 
1:50 (wt/wt) with 1 mM CaCl2 and incubated at 37°C for 16h. To stop the 
reaction, 90% formic acid (FA) (Merck, NZ) was added to 4% final 
concentration (Bosch, Peng, & Kivell, 2015). 
2.7.2 Hepatic Peptides 
2.7.2.1 Peptide Purification  
Purification of resulting tryptic peptides was accomplished with OMIX C18 
Ziptips (Agilent Technologies Inc, USA) according to the manufacturer’s 
protocol. Peptide 2M urea 4% FA samples were divided into two groups of 
100µL each for elution by either 20µL of 0.15% FA in 50% acetonitrile (ACN) 
(Carl Roth, NZ) or 20µL of 0.15% FA in 70% ACN to obtain the most peptides 
at differing hydrophobicity. To purify peptides in each sample, 1) Ziptip was 
prewet with 0.4% TFA: ACN=1:1 solution by aspirating three times. 2) Ziptip 
was equilibrated with 0.4% TFA: H2O=1:1 solution by aspirating three times. 3) 
Peptides were bound by slowly aspirating 20x. 4) Ziptip was rinsed with 0.4% 
TFA: H2O=1:1 solution by aspirating three times. 5) Sample was eluted in either 
20µL of 0.15% FA in 50% ACN or in 20µL of 0.15% FA in 70% ACN by 
aspirating 15x.   
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Eluted samples were spun for ~30sec and eluent groups of 0.15% FA in 50% 
ACN and 0.15% FA in 70% ACN were combined together with corresponding 
sample into a 0.5mL Protein LoBind® tube (Eppendorf, GER) and concentrated 
to ~10µL at 35°C in a Centrivap Vacuum Concentrator System (Labconco, 
USA).  
10µL eluted peptides were added to 130µL 0.1% FA in H2O to make a final 
solution volume of 140µL, vortexed for 5min, centrifuged at room temperature 
at 10,000xg for 2min and transferred to HPLC vial, without air bubbles, for 
Liquid chromatography with tandem mass spectrometry (LC-MS/MS) analysis 
in triplicate. A simplified workflow from liver tissue to eluted peptides to be 
analysed by LC-MS/MS is demonstrated in Figure 2.8. 
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Figure 2.8. Simplified Workflow of Liver Tissue to Eluted Peptides for LC-MS/MS
 
Figure 2.8. Simplified workflow from liver tissue to eluted peptides. Liver samples were reduced to protein strands and digested into peptides and eluted to be analysed by 
liquid chromatography with tandem mass spectrometry.
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2.7.3 Orbitrap LC-MS/MS Peptide Analysis 
LC-MS/MS experiments were performed using a Dionex UltiMateTM 3000 
RSLCnano system coupled to an LTQ Orbitrap XL mass spectrometer via a 
nanospray ion source (Thermo Fisher Scientific, USA). The LC-MS/MS creates 
ions from analyte molecules, separate ions based on charge and mass, detect 
ions, determine their mass-to-charge ratio and select and fragment ions to 
provide structural information known as the mass spectrum (MS) (Figure 2.9).  
Sample peptides were loaded using an auto-sampler at 10°C. Sample peptides 
were fractioned on a PepMap C18 column at a content flow rate of 300nL/min 
(particle size: 3µm, pore size: 300 Å, dimension: 75µm×15cm length) based on 
their hydrophobicity with the least hydrophobic eluents exiting the column 
first (Bosch et al., 2015, Meissner & Mann, 2014). To maximise the number of 
proteins identified, a buffer gradient was constructed from 0.1% FA (Buffer A) 
and 0.1% FA in 80% ACN (Merck, NZ) (Buffer B): 2% B to start, 2–22% B for 
200min, 22–30% B for 60min, 30–98% for 60min, 98% for 5min, and 98–2% for 
2min. The ion spray voltage was set at 2.2kV, with the heated capillary 
temperature set at 200°C. Full ion MS scan range of m/z 200–1850 in profile 
mode was captured in the Orbitrap with 30,000 resolution (Bosch et al., 2015). 
The six most intense peptide ions from the full scan were selected and 
fragmented using collision-induced dissociation (CID) (normalised collision 
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energy, 35%; activation Q, 0.250; and activation time, 30ms). Dynamic exclusion 
was used with the following settings: repeat count, 2; repeat duration, 30s; 
exclusion list size, 500; exclusion duration, 90s (Bosch et al., 2015). The spectra 
were obtained using Xcalibur (version 2.1.0 SP1, Thermo Fisher Scientific). LC-
MS/MS experiments were separated into two biological samples, and then each 
ran in triplicate. In total, six analyses per liver and any potential variation in 
data sets were validated against each other in Scaffold. 
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Figure 2.9. LC-MS/MS Workflow 
 
Figure 2.9. LC-MS/MS workflow. Mass spectrometer using electrospray ionization and the fragment peptides are analysed by a tandem Mass spectrometer.  
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2.7.4 Peptide Identification and Label-Free Quantification  
Biological mass spectra were searched against the Cavia porcellus protein 
database through Uniprot with Proteome Discoverer (PD, version 2.1, Thermo 
Fisher Scientific) using SEQUEST algorithm (Figure 2.10). The search setting 
allowed carboxyamidomethylation of C as a fixed modification and oxidation 
on M as a dynamic modification. Parameters were set to allow 2 missed tryptic 
cleavage sites, mass tolerance of 0.80Da for fragment and 10.0ppm for parent 
ions in monoisotopic mode. Determination of a positive identification was a 
peptide with high confidence and minimum one peptide at rank 1 matched to a 
protein with the top score. The false discovery rate (FDR) threshold was <1% 
using a decoy database strategy (Bosch et al., 2015).  
2.7.5 Protein Assembly and Quantification  
Proteome discoverer output files were uploaded into Scaffold (version 4.3.2, 
Proteome Software Inc., USA) for protein identification and label-free 
quantification based on spectral counts (Figure 2.11). The three LC-MS/MS 
technical replicates for each of the eight groups, from study 2 (d21 weanling 
CD males, FD males, CD females and FD females) and study 3 (4M adult CD 
males, FD males, CD females and FD females), were uploaded and combined in 
Scaffold and the total number of MS/MS spectra calculated (B. Zhang et al., 
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2006). The built-in spectral count normalisation function and Fisher’s exact test 
were used for small sample sizes (B. Zhang et al., 2006, Bosch et al., 2015), were 
used to calculate the 2-fold changes and P-values of protein abundances 
between the control and fructose groups. Positive identification of proteins was 
considered and quantified when detected with 95% probability (Protein 
FDR=0.1%) assigned by ProteinProphet (Bosch et al., 2015, Nesvizhskii, Keller, 
Kolker, & Aebersold, 2003) containing at least one peptide that was detected 
with 95% probability (Peptide FDR=0.6%) assigned by PeptideProphet (Bosch 
et al., 2015, Keller, Nesvizhskii, Kolker, & Aebersold, 2002). Proteins were 
considered significantly differentially-expressed if P≤0.05 by t-test, with 
Benjamini-Hochberg multiple test correction (B. Zhang et al., 2006) and the fold 
change was ≥1.5. 
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Figure 2.10. Biological Mass Spectra With SEQUEST Algorithm 
 
Figure 2.10. Biological Mass Spectra With SEQUEST Algorithm. 
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Figure 2.11. Proteome Discoverer and Scaffold Analysis  
 
Figure 2.11. Representation of Proteome discoverer and scaffold analysis output.
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2.7.6 Biological Pathway Analysis  
Ingenuity Pathways Analysis (IPA) (QIAGEN, Redwood City, CA) was used 
for identifying biological networks by conducting a Core Analysis to interpret 
the differentially-expressed proteins in a biological context by identifying 
relationships, mechanisms, functions and their associated pathways. The list of 
470 differentially-expressed proteins with a significance p≤0.05 (for the most 
accurate representation of increased and decreased regulation) and 
corresponding fold changes (ranging from 0.1-8.4) for each of the eight groups, 
from study 2 (d21 weanling CD males, FD males, CD females and FD females) 
and study 3 (4M adult CD males, FD males, CD females and FD females), were 
uploaded into IPA.  
Reported analysis included determination of up-regulated and down-regulated 
proteins and networks of molecular interactions in association with biological 
functions and diseases. IPA’s Canonical Pathway Analysis was used to 
determine the most significantly affected signalling pathways based on 
increased or decreased protein expression and directionally theorised pathway 
activation or inhibition based on previously published evidence (Figure 2.12). 
IPA’s Toxicity Lists and Functions were used to evaluate the most significantly 
affected toxicity pathways and associated proteins based on previously 
published evidence. Based on protein expression, the toxicity analysis provided 
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identification of theorised signalling pathways with a potential predisposition 
towards disease. Proteins were displayed with their corresponding names and 
represented as nodes to categorise the functional class and the use of a dashed 
or solid line to represent the biological relationship between nodes. All 
relationships between nodes were supported by publications located in IPA’s 
Ingenuity Knowledge database of previously published research data. The 
pigment of node colour indicated an increase in expression (red) or decrease 
(green) (Figure 2.12). 
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Figure 2.12 Example of Ingenuity Pathway Analysis  
 
Figure 2.12. Example of canonical pathway analysis demonstrating biological networks and functions associated with differentially-expressed proteins.
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2.8 Western Blots  
2.8.1 Protein Concentration 
Protein concentrations were determined by Pierce Bicinchoninic acid (BCA) 
assay (ThermoFisher Scientific, Waltham, MA) according to manufacturer’s 
instructions. All reagents were equilibrated to room temperature. Proteins were 
extracted from 50mg homogenised snap-frozen ground liver in 500µL 
radioimmunoprecipitation assay (RIPA) lysis buffer containing PPIs (250µL 
Napp, 625µL Naf, 250µL of 100x PmSF and 25µL of 1000x leupeptin/aprotinin, 
premade by Western University Lab) and homogenised by an electric tissue 
homogeniser on ice. Homogenate was sonicated using Misonix S-400 Sonicator 
Ultrasonic Processor (Misonix, Inc. Farmingdale, NY) and centrifuged at 4°C 
for 10min at 1,000rpm. Resulting supernatant was collected for protein 
concentration analysis and placed in ice. 
10µL of liver lysates were added to 190µL RIPA/PPI solution (premade by 
Western University lab) for a final 1:20 dilution sample. 20µL of each sample 
was used in duplicate to determine protein concentration in a 96-well plate. 
Standard curve was achieved by performing 2-fold dilutions of BSA from 
2mg/µL to 0mg/µL. 8 serial dilutions were used to identify the lower end of the 
assay detection capacity. Reagent mixture was prepared, combining 25mL 
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Reagent A and 500µL Reagent B, making a final 50:1 dilution. Solutions were 
added to each well as follows:  20µL sample/standard->200µL reagent mixture. 
Plate was covered and incubated at 37°C for 30min, then cooled to room 
temperature.  
Absorbance was measured at 540nm using a plate reader (Spectra Max M5 
Multi-Mode Microplate reader, Molecular Devices LLC, San Jose CA, USA) and 
analyzed by Softmax pro 7 software (Molecular Devices LLC, San Jose CA, 
USA).  
2.8.2 Sample Preparation 
Samples were diluted to 10µg/µL using RIPA buffer and 2x Laemmli SDS-
PAGE sample buffer (60mM Tris-HCl pH 6.8; 20% glycerol; 2% SDS; 4% beta-
mercaptoethanol; 0.01% bromophenol blue), making a final 1:1 mixture of 
homogenised sample to Laemmli SDS-PAGE sample buffer. Samples were 
placed in a heating block at 95°C for 5min and centrifuge at room temperature 
for ~20-30sec at 1,000rpm. 
2.8.3 Gel Preparation 
Western blot protein quantification was conducted using the sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) method. SDS is an 
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anionic detergent that denatures and binds to proteins to negatively charge 
them, allowing proteins to separate by mass moving down towards the 
positively charged electrode when an electric current is applied. The “sieving” 
effect of the gel matrix allows the proteins with less mass to travel quickly 
towards the bottom of the gel. When a heavier protein is measured, a lower 
SDS % separating gel is needed. 
10µg/µL of protein in each sample were separated by handcast polyacrylamide 
gels (Table 2.3), 4% stacking gel, 10% and 15%  resolving gel for FAS and 6% 
and 15% resolving gel for mitochondrial Oxidative phosphorylation (OXPHOS) 
complexes protein abundance (MS604, MitoSciences, Oregon, USA) and 
SREBP-1c (sc366, Santa Cruz Inc. Texas, USA). ACC (36615, Cell Singalling 
Technology, Danvers, MA) and ChREBP-1c (ab157153, Abcam, Cambridge, 
UK) Western blots were unsuccessful following numerous protocols and 
antibodies; it was not possible to represent reliable results for these Westerns. 
Gels were cast starting with the preparation of either the 6%, 10% or 15% SDS 
resolving gel (Table 6). Gelling liquid was pipetted into each glass cast up to 
~1.5cm from the top of the ‘short’ glass plate. Isopropanol was pipetted ~0.5mL 
to the top of each gel to create a flat surface, prevent bubbles and allowing gel 
polymerization. Gelling liquid set for ~15-20min and isopropanol was 
removed. 4% stacking gelling liquid (Table 6) was pipetted on top of the 
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resolving gel to the top of the ‘short’ glass plate. 1.5mm lane combs were 
cleaned with 70% ethanol and placed between the two glass plates of the cast, 
ensuring no bubbles were trapped beneath. 4% stacking gel was polymerized 
for ~15-20min. Gels were wrapped in a wet paper towel and plastic wrap, 
placed in plastic Ziplock bags and stored at 4°C in a refrigerator overnight.
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Table 2.3. SDS Resolving and Stacking Gels 
6% Resolving Gel 10% Resolving Gel 15% Resolving Gel 4% Stacking Gel 
4 Gels 4 Gels 4 Gels 4 Gels 
Millipore water  21.23mL Millipore water  15.99mL Millipore water  9.32mL Millipore water  11.98mL 
Acrylamide 8mL Acrylamide 13.33mL Acrylamide 20mL Acrylamide 2.66mL 
Separating gel buffer 10mL Separating gel buffer 10mL Separating gel buffer 10mL Stacking gel buffer 5mL 
10% SDS 400µL 10% SDS 400µL 10% SDS 400µL 10% SDS 200µL 
10% Aps 250µL 10% Aps 250µL 10% Aps 250µL 10% Aps 125µL 
TEMED 25µL TEMED 25µL TEMED 25µL TEMED 25µL 
Total Volume 40mL Total Volume 40mL Total Volume 40mL Total Volume 40mL 
Table 2.3. Protocol for each Western Blot SDS Resolving and Stacking Gels used.
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2.8.4 Gel Electrophoresis 
Cassettes were assembled by removal of lane combs from gels, and both short 
plates faced the inside of the cassette, secured to create a tight seal and placed 
gel cassette into electrophoresis tank. Inside chamber of the gel casts were filled 
to the top of the ‘short’ glass plate, ensuring wells were filled with chilled 1x 
running buffer of 1:10 dilution made from 100mL of 10x running buffer and 
900mL Millipore water. Samples were vortexed and loaded into gels as follows: 
5µL pre-stained ladder of bromophenol blue dye into first well, 5µL pooled 
sample into the second well and 5µL of each sample into remaining wells. 
Electrophoresis tank was filled with chilled 1x running buffer up to the tops of 
the ‘short’ glass surrounding cassettes. Lid placed on top of the tank aligning 
electrodes correctly, positive with positive and negative with negative. 
Electrophoresis unit was placed into a larger container and filled with ice. Lid 
electrodes were then connected to the power unit, and proteins electrophoresed 
at 150V and ~2h. 
2.8.5 Wet Transfer 
Proteins were electrotransferred onto Immun-Blot polyvinylidene difluoride 
(PVDF) membranes (Bio-Rad, Hercules, CA). PVDF  membranes were hydrated 
by soaking in methanol for ~2min, rinsed in Millipore water and placed in 
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chilled 1x transfer buffer, along with pre-soaking sponges and filter paper. Gels 
were removed from plates and components of the transfer “sandwich” were 
stacked (Figure 2.13) while submerged in 1x transfer buffer. Air bubbles 
between gels and PVDF were rolled out with a small roller and pressure 
applied, closing the transfer “sandwich.” Transfer “sandwich” was placed in 
the transfer electrode module, white to red and black to black, module was 
packed with ice and filled with chilled 1x transfer buffer, closed with lid, 
placed in a second larger container and surrounded with ice. Lid electrodes 
were connected to the power unit and electrotransferred at 100V for 2h. 
Figure 2.13. Transfer “Sandwich” 
 
Figure 2.13. Diagrammatical representation of the Transfer "sandwich.” 
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2.8.6 Membrane Ponceau S Staining and Imaging  
Membranes were stained with Ponceau S on a shaker for 3min, rinsed with 
methanol on shaker for 3min and imaged using the Bio-Rad ChemiDoc Imager.  
2.8.7 Blocking, Primary Antibody and Secondary Antibody 
To examine hepatic protein in hepatic Oxidative phosphorylation (complex I, 
II, III, IV and V), VDAC, SREBP-1c and FAS, membranes were blocked for 1h at 
18°C in 5% BSA or 5% milk then probed with primary antibodies. OxPhos 
Rodent WB antibody cocktail binding mitochondrial complexes I-V (7076S, Cell 
Signalling Technology, Danvers, MA), and Recombinant anti-VDAC1/porin 
antibody (ab154856, Abcam, Cambridge, UK), both at final dilution 1:5,000 in 
5%BSA. SREBP-1c (sc366, Santa Cruz Inc. Texas, USA) and FAS (sc20140, Santa 
Cuz Inc. Texas, USA), both at final dilution 1:1,000 in 5% skim milk. All 
membranes were incubated overnight at 4°C. 
 Membranes were rinsed in TBST (Tris-buffered saline containing 0.1% Tween 
20) and probed with secondary antibodies, Rat anti-Mouse IgG (AB_466650, 
Thermofisher Scientific) and Anti-rabbit HRP-linked antibody (7074S, Cell 
Signalling Technology, Danvers, MA), both at final 1:5,000 in 5%BSA. OxPhos 
membranes were stripped with Antibody Stripping Buffer  (Gene Bio 
Application, Yavne, Israel) and rinsed with water prior to being blocked for 
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VDAC primary antibody. Anti-rabbit HRP-linked antibody (7074S, Cell 
Signalling Technology, Danvers, MA) at final dilution 1:1,000 in 5% skim milk 
and incubated 1h at room temperature, rinsed in TBST, then visualized using 
Bio-Rad Clarity ECL Substrate and Bio-Rad ChemiDoc Imager and analysed 
with Bio-Rad Image Lab.  
2.8.8 Membrane Image Analysis 
Western blots were ran in duplicate and protein content quantification of 
membrane images were anlaysed with Bio-Rad Image Lab (Version 6.0.1). Final 
membrane protein bands were anlaysed against relevant ponceau S blots to 
account for background. 
2.9 Statistics 
Statistical analyses were performed using IBM SPSS Statistics 25 software  
(IBM, USA). All data were graphed using Prism 8 software (GraphPad 
Software Inc., USA). Proteomics in d21 and 4M livers were performed using 
SEQUEST data filter, Scaffold’s t-test and IPA right-tailed Fisher’s exact test 
analysis where all data points have to meet specific criteria to be accepted in 
the data set results.  
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2.9.1 Two-Way Factorial Analysis of Variance  
The study was designed to investigate the effects of two different maternal 
diets on metabolic health of the resulting weanling and adult offspring in both 
sexes; therefore, a two-way (2x2) factorial analysis of variance (ANOVA) was 
used. The offspring experiments consisted of two different dietary (treatment) 
exposures, which differ in terms of the first factor of diet, control (CD) or 
fructose (FD) and a second factor of sex, male (M) or female (F). Therefore, 4 
offspring groups in total (CDM, FDM, FDM and FDF) within Study 1 and 
Study 2. The two-way ANOVA determines the main effects, which are 
differences observed as a result of dietary exposure, and interaction effects, 
which are differences observed between dietary exposure with the addition of 
differences observed when taking into account offspring sex. 
2.9.2 Repeated Measures, Generalized Estimating Equations  
Repeated measures, generalized estimating equations (GEE) was used to 
analyse longitudinal data (maternal water intake and both maternal and 
offspring weight gain) with the covariate of time to describe their relationship. 
GEE is based on the population-averaged data values and their standard errors.  
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2.9.3 Non-pregnant and Pregnant Dam Analysis 
Dam average caloric intake, average water intake, gestation length, 
stillbirth/death during delivery to live birth ratio, litter size, OGTT glucose, 
insulin and Matsuda-DeFronzo Insulin Sensitivity Index (M-ISI), plasma 
biochemistry and milk free fatty acids analyses were analysed by independent 
t-test in dams with Leven’s robust test for equality of variance. Dam weight 
gain and water intake were analysed by repeated measures GEE with diet and 
time as factors. Bonferroni post-hoc test was performed where indicated for 
multiple comparisons testing between groups. OGTT glucose and insulin 
response were analysed by AUC. Differences between groups were considered 
significant at P<0.05. All data are presented as mean ±SEM unless stated 
otherwise. 
2.9.4 Offspring Analysis 
Offspring weight at birth and cull, organ weights, base blood glucose and 
insulin, whole blood free fatty acids, plasma biochemistry, histological analysis, 
hepatic triglycerides, Western blot proteins were analysed using two-way 
ANOVA with diet and sex as factors and repeated measures GEE for offspring 
weight gain with diet, sex and time as factors. Bonferroni post-hoc test was 
performed where indicated for multiple comparisons testing between groups. 
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Offspring OGTT glucose, insulin and Matsuda-DeFronzo Insulin Sensitivity 
Index (M-ISI) were analysed by an independent t-test with Leven’s robust test 
for equality of variance. OGTT glucose and insulin response were analysed by 
AUC. Proteomics in d21 and 4M livers were performed using SEQUEST data 
filter, Scaffold t-test and IPA right-tailed Fisher’s exact test analysis where all 
data points have to meet specific criteria to be accepted in the data set results. 
Differences between groups were considered significant at P<0.05. All data are 
presented as mean ±SEM unless stated otherwise. 
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The Effects of Excess Maternal Fructose Intake on the 
Non-Pregnant and Pregnant Dams 
3.1 Study 1 Aims 
The aims of Study 1 were to investigate the effects of excess maternal fructose 
consumption on dams maternal physiology, weight gain, metabolic status and 
milk free fatty acid composition. To identify the effects of excess maternal 
fructose on dams, we conducted pre-pregnancy and pregnancy assessments. 
Dams were assessed for dietary effects on pre-pregnancy and pregnancy total 
caloric intake and weight gain. Alterations to dams’ pre-pregnancy and 
pregnancy metabolic status were determined by measuring plasma glucose and 
insulin concentrations and key plasma metabolites. Dietary effects of excess 
maternal fructose intake on milk FFA composition were also evaluated.  
3.2 Protocol  
Throughout the duration of study 1 (CD n=10 and FD n=10) dam pre-
pregnancy and pregnancy weights, water and food intake, along with total 
caloric intake, were measured daily. At sexual maturity (12w), dams were 
matched for weight and age and randomly assigned to CD and FD groups. At 
6M of age, dams were mated with a single non-lineage boar during estrous. 
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Following mating, dams were returned to individual cages and continued their 
experimental diets throughout gestation. OGTTs were assessed at sexual 
maturity at age 12w, 60d of dietary consumption (prior to pregnancy) and 
during pregnancy at midgestation (35d). At spontaneous delivery (~69d 
gestation in our cohort (Smith et al., 2020), experimental dietary interventions 
were ceased (all dams and offspring maintained on CD following delivery). At 
~69d dams’ milk samples were collected following the birth of the last pup. 
Pre-pregnancy and pregnancy metabolic status and maternal milk FFA 
concentrations were analysed. Pregnancy outcomes, including gestation length, 
litter size, live and stillborn/death during delivery, were also analysed. 
Following birth, pups were sexed and all litters were maintained at four pups 
(male=2, female=2). Excess pups were humanely euthanised following birth. 
Following delivery (~69d), dams were weighed weekly and signs of milk 
production were monitored daily. Each dam was housed with her pups and 
humanely euthanised at time of weaning (day 21) (Figure 3.1). All study 1 
protocols for analysis of caloric intake, physiology, plasma and milk FFA are 
provided in chapter 2.  
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Figure 3.1. Study 1: Guinea pig Pre-pregnancy and Maternal Fructose Dietary 
Intake Protocol 
 
Figure 3.1. Diagram represents the work flow undertaken throughout study one. Two groups of matched 
weight and age virgin Dunkin Hartley females were randomly assigned to separate dietary groups (CD 
n=10, FD n=9). Dams were fed experimental diets for 60d prior to mating and throughout pregnancy to 
term delivery (~d69) and all dams continued a control diet. At 6M of age, dams mated with a single non-
lineage boar during estrous. Following mating, dams returned to individual cages and continued their 
experimental diets throughout gestation. Baseline and oral glucose tolerance tests (OGTT) serial blood 
collections, following glucose load, were collected from the auricular vein from dams at sexual maturity at 
age 12w, 60d of dietary consumption prior to pregnancy and during pregnancy at midgestation (35d). 
Milk samples were collected on day of delivery. 
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3.3  Results 
3.3.1 Effects of Excess Fructose Intake on Pre-pregnancy and Pregnancy 
Water and Caloric Intake  
To identify specific differences in caloric intake between groups, 60d prior to 
pregnancy and during pregnancy, water and food intake, along with total 
caloric intake, were measured daily. Water intake was significantly greater in 
FD dams (P<0.0001) and increased over time (P<0.0001) compared to CD dams 
(Figure 3.2). Therefore, total caloric intake in FD dams was significantly 
increased, an effect of diet, 60d prior to pregnancy and throughout pregnancy 
when compared to CD dams (CD, 57.94 ±2.58 vs FD, 85.58 ±1.98Kcals; 
P<0.0001). Caloric intake from pellet food in CD and FD dams was not 
different. 10% fructose water intake during the 60d pre-pregnancy period and 
69 days of pregnancy, on average, contributed an extra 34.0 ±4.2 Kcal/day in 
fructose-fed dams. CD dams consumed, on average, 172.2Kcal/day throughout 
pre-gestation and pregnancy, whereas FD dams consumed, on average, 206.2 
Kcal/day with 10% fructose (w/v), contributing an extra 16.5% of total daily 
caloric intake in the fructose group (Table 3.1).  
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Figure 3.2. Dam Water Intake 
 
Figure 3.2. Dam average water intake. CD (n=10); FD (n=9). Graph represents average pre-pregnancy water intake (20-60d). All data were analysed as a 2x2 factorial 
design with diet*time*interaction included (repeated measures GEE) using IBM SPSS statistics 25 (IBM, USA). Data shown as standard error of the mean (SEM).
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Table 3.1. Pre-pregnancy and Pregnancy Average Caloric Intake 




from Water Intake 
%Kcal/day 
Control 172.2 0 0% 
Fructose 206.2 34 ±4.2 16.5% 
Table 3.1. Pre-pregnancy and pregnancy average caloric intake. CD(n=10); FD (n=9). All data were 
analysed using an independent t-test using IBM SPSS statistics 25. Average (Avg.) water kcal/day data 
presented as group mean ±SEM.  
 
3.3.2 Effects of Excess Fructose Intake on Pre-Pregnancy and Pregnancy 
Weight Gain 
To observe any differences in weight gain during pre-pregnancy and 
pregnancy, animals were weighed twice weekly. No significant differences in 
weight gain were observed between FD and CD dams prior to (Figure 3.3A) or 
during pregnancy (Figure 3.3B). 
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Figure 3.3. Effects of Excess Fructose Of Pre-pregnancy and Pregnancy Weight Gain 
 
Figure 3.3. Effects of excess fructose on pre-pregnancy and pregnancy weight gain during fructose-feeding A) dam pre-pregnancy and B) pregnancy weight gain. FD 
dams were fructose-fed for 60d prior to mating and throughout pregnancy. CD (n=10); FD (n=9). Graph A) represents average pre-pregnancy weight gain (12-20w), graph 
B) represents average pregnancy weight gain (1-11w). All data were analysed as a 2x2 factorial design with diet*time*interaction included (repeated measures GEE) using 
IBM SPSS statistics 25 (IBM, USA). Data shown as standard error of the mean (SEM). 
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3.3.3 Effects of Excess Fructose Intake on Maternal Plasma OGTT Glucose 
and Insulin  
To assess any potential effects of excess maternal intake on OGTT blood 
glucose and insulin concentrations and whole-body insulin sensitivity, an 
OGTT analysis was performed following 60d of consumption prior to 
pregnancy and consumption during pregnancy at 35d midgestation.  
There was a non-significant increase (P=0.06) in maternal blood glucose and 
insulin concentrations in FD dams following 60d pre-pregnancy fructose- 
feeding compared to CD dams (Figure 3.4A, 3.4B and  Table 3.2). At 
midgestation (35d), no significant differences were observed between CD and 
FD dam blood glucose or insulin concentrations (Figure 3.4C, 3.4D and Table 
3.2).  
M-ISI was calculated to evaluate whole-body insulin sensitivity. A non-
significant increase in M-ISI was also observed 60d post-dietary intervention in 
FD dams compared to CD dams, indicating more sensitivity to insulin than CD 
dams (CD, 2.64 ±0.27 vs FD, 4.94 ±1.04; P=0.06) (Table 3.2). At midgestation 
(35d), no significant differences were observed between CD and FD dam M-ISI 
(Table 3.2). 
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Figure 3.4. Dam Pre-pregnancy and Midgestation OGTT Blood Glucose and 
Plasma Insulin AUC 
 
 Figure 3.4. Effects of Excess Fructose on Dam pre-pregnancy and midgestation OGTT glucose AUC and 
insulin AUC. A) Dam blood glucose AUC in response to OGTT pre-pregnancy 60d post-dietary 
intervention. B) Dam blood glucose AUC in response to OGTT midgestation. C) Dam plasma insulin 
AUC in response to OGTT pre-pregnancy  60d post-dietary intervention. D) Dam plasma insulin AUC in 
response to OGTT midgestation. CD (n=10); FD (n=9). All data were analysed as a 2x2 factorial design 
with diet*time*interaction included (repeated measures GEE) using IBM SPSS statistics 25 (IBM, USA). 
Data shown as standard error of the mean (SEM). 
Chapter 3  Study 1 
 116 
Table 3.2. Dam 60 Days Post-Dietary Intervention and Midgestation OGTT 
Glucose, Insulin and Matsuda-ISI 











Blood Glucose (mmol/L) 




 Fructose 6.77 ±0.20 7.21 ±0.42 
30min Control 10.28 ±0.36 
0.46 
11.60 ±0.71 
0.75  Fructose 10.85 ±0.65 11.28 ±0.66 




 Fructose 12.62 ±0.81 12.96 ±0.87 




 Fructose 13.50 ±0.97 13.64 ±0.67 




 Fructose 13.64 ±1.00* 13.14 ±0.60 




 Fructose 12.02 ±0.85* 11.77 ±0.49 




 Fructose 7.93 ±0.43 9.51 ±0.27 




 Fructose 6.51 ±0.35 7.70 ±0.25 
Plasma Insulin (µU/ml) 
0min Control 2.08 ±0.48 
0.71 
1.22 ±0.25 
0.68  Fructose 1.82 ±0.48 1.08 ±0.21 




 Fructose 1.82 ±0.33* 1.60 ±0.13 




 Fructose 1.51 ±0.18* 1.36 ±0.07 




 Fructose 1.98 ±0.52 1.40 ±0.15 




 Fructose 2.13 ±0.65 1.26 ±0.10 




 Fructose 1.76 ±0.42 1.59 ±0.35 




 Fructose 2.02 ±0.42 1.39 ±0.24 
180min Control 2.49 ±0.40 0.45 1.50 ±0.26 0.68 
 Fructose 1.91 ±0.61 1.63 ±0.18 
Matsuda-ISI 




 Fructose 4.94 ±1.04 5.99 ±0.45 
Table 3.2. Effects of excess fructose on dam 60 days post-dietary intervention and midgestation OGTT 
Glucose, Insulin and Matsuda-ISI. CD (n=6); FD (n=6). All data were analysed using an independent t-test 
using IBM SPSS statistics 25. Data presented as group mean ± SEM. *denotes significance of P<0.05. 
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3.3.4 Effects of Excess Fructose Intake on Pre-Pregnancy and Pregnancy 
Plasma Metabolites  
To examine the effects of excess fructose following 60d of consumption prior to 
pregnancy and consumption during pregnancy at 35d midgestation, plasma 
metabolites were analysed. Excess Fructose was observed to have significant 
effects on dam plasma metabolites prior to and during pregnancy. Lipase (LIP) 
was observed to be significantly increased in FD dams compared to CD dams 
during pre-pregnancy at 60d post dietary intervention in FD dams (CD 7.99 
±1.54 vs FD, 21.83 ±1.87U/L; P<0.001) and at midgestation (CD 12.78 ±1.84 vs 
FD, 25.20 ±2.90U/L; P=0.002). HDL concentrations were significantly increased 
during pre-pregnancy following 60d fructose-feeding in FD dams compared to 
CD dams (CD, 0.03 ±0.01 vs FD, 0.15 ±0.01mmol/L; P<0.0001), but this was no 
longer significantly different during pregnancy. TAG were significantly 
increased in FD dams following 60d of fructose-feeding compared to CD dams 
(CD, 0.52 ±0.03 vs FD, 0.69 ±0.05mmol/L; P=0.03), but this was no longer 
significantly different during pregnancy. No significant differences in UA were 
observed between FD and CD dams during the 60d of fructose-feeding prior to 
pregnancy, whereas during midgestation, there was a significant increase in 
uric acid of FD dams when compared to CD dams (CD, 18.66 ±2.76 vs FD, 21.00 
±2.76µmol/L; P=0.007). No significant differences were observed between CD 
and FD dams pre-pregnancy and at midgestation for LDL, cholesterol (CHOL), 
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fructosamine (FRUC) and glutamate dehydrogenase (GLDH) (Table 3.3). 
Lipoprotein a (LPA), analysed by COBAS, provided unreliable and non-
detectable results and was therefore dropped from analysis.  
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LIP (U/L) Control 7.99 ±1.54 12.78 ±1.84 
 Fructose 21.83 ±1.87** 25.20 ±2.90** 
HDL (mmol/L) Control 0.03 ±0.01 0.02 ±0.00 
 Fructose 0.15 ±0.01** 0.03 ±0.00 
TAG (mmol/L) Control 0.52 ±0.03 1.53 ±0.35 
 Fructose 0.69 ±0.05* 1.43 ±0.29 
UA (µmol/L) Control 18.66 ±2.76 21.55 ±1.36 
 Fructose 21.00 ±2.67 28.75 ±1.88** 
LDL (mmol/L) Control 0.71 ±0.08 0.19 ±0.01 
 Fructose 0.72 ±0.05 0.22 ±0.02 
CHOL (mmol/L) Control 0.64 ±0.10 0.48 ±0.09 
 Fructose 0.64 ±0.05 0.37 ±0.03 
FRUC (µmol/L) Control 198.00 ±15.91 200.40 ±16.25 
 Fructose 186.50 ±6.90 185.25 ±15.28 
GLDH (U/L) Control 7.88 ±1.63 5.02 ±1.37 
 Fructose 13.00 ±1.78 8.02 ±2.59 
Table 3.3. Dam plasma metabolites at pre-pregnancy 60 days post-dietary intervention and midgestation. CD (n=10); FD (n=9). All data were analysed using an 
independent t-test using IBM SPSS statistics 25. Data presented as group mean ± SEM.* denotes significance of P<0.05; ** denotes significance of P<0.001. 
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3.3.5 Effects of Excess Fructose Intake on Pregnancy Outcomes 
To measure the effect of excess fructose consumption on general pregnancy 
and developmental outcomes, offspring litter size, stillbirths and birth weights 
were recorded at delivery. There was no significant difference between CD and 
FD dams in litter size, rate of stillbirth/death at delivery, or offspring birth 
weight (Table 3.4). 
Table 3.4. Pregnancy outcomes 
Dam Pregnancy Outcomes 
Day 0 
Control Fructose 
Litter Size 3.90 ±0.23 4.11 ±0.20 
Stillbirth/Death at Delivery 0 0.44 ±0.29 
Male Birth Weight 90.08 ±1.23 91.38 ±1.23 
Female Weight 90.56 ±1.23 88.71 ±1.23 
Litter Birth Weight 90.34 ±1.23 90.15 ±1.23 
Table 3.4. Dam pregnancy outcomes. Control (n=10) and fructose (n=9). Litter size and stillbirth/death at 
delivery data were analysed using an independent t-test while birth weight was analysed using a 2x2 
factorial design with diet, sex and interaction include (general analysis of variance) using IBM SPSS 
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3.3.6 Effects of Excess Fructose Intake on Maternal Milk Free Fatty Acid 
Composition  
To examine the effects of excess fructose consumption on milk FFA 
composition, a dried milk spot was collected on day of delivery for lipidomic 
analysis. Maternal excess fructose intake was observed to have significant 
effects on dams’ milk FFA composition.  
Out of the 33 milk FFA analysed, significant increases in FD dam milk were 
observed in myristic acid (P=0.04), total trans fatty acids (P=0.02), vaccenic acid 
(P<0.001), linoelaidic acid (P=0.002), cis-vaccenic (P=0.04), total omega-7 
(P=0.05) and gamma-linolenic acid (P=0.05). There were no differences between 
CD and FD in the other 26 milk FFA concentrations measured (Table 3.5).  
However, out of the 26 remaining fatty acids, on average, a non-significant 
increase was observed in 13 FFA in the fructose-fed dams, including total 
saturates, lauric acid, pentadecanoic acid, palmitic acid, margaric acid, 
lignoceric acid, elaidic acid, total monosaturates, palmitoleic acid, oleic acid, 
total omega-9, total omega-3 and arachidonic acid.  
Conversely, non-significant decreases in FD dams were observed in capric acid, 
stearic acid, arachidic acid, palmitelaidic acid, gondoic acid, alpha-linolenic 
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acid, docosapentaenoic acid, docosahexaenoic acid, total omega-6, linoleic acid, 
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Table 3.5. Dam Milk Free Fatty Acid Composition 




Myristic acid (14:0)  1.00 ±0.05 1.16 ±0.05* 
Total Trans Fatty acids  0.33 ±0.03 0.46 ±0.03* 
Vaccenic acid (t18:1n-7) 0.15 ±0.01 0.22 ±0.00* 
Linoelaidic acid (t18:2)  0.04 ±0.00 0.12 ±0.02* 
Cis-Vaccenic acid (18:1n-7)  1.14 ±0.06 1.31 ±0.04* 
Total Omega-7  2.39 ±0.12 2.71 ±0.08* 
GLA (18:3n-6) 0.06 ±0.00 0.08 ±0.00* 
Total Saturates 30.23 ±1.31 31.64 ±1.09 
Lauric acid (12:0) 0.03 ±0.00 0.03 ±0.00 
Pentadecanoic acid (15:0) 0.46 ±0.02 0.52 ±0.02 
Palmitic acid (16:0) 21.35 ±0.96 23.44 ±1.06 
Margaric acid (17:0) 0.86 ±0.02 0.91 ±0.03 
Lignoceric acid (24:0) 0.02 ±0.00 0.02 ±0.00 
Elaidic acid (t18:1n-9) 0.08 ±0.00 0.09 ±0.00 
Total Monosaturates 34.49 ±0.43 35.49 ±0.49 
Palmitoleic acid (16:1n-7) 1.24 ±0.08 1.39 ±0.05 
Total Omega-3 5.08 ±0.34 5.34 ±0.29 
AA (20:4n-6) 0.22 ±0.02 0.23 ±0.03 
Capric acid (10:0) 0.05 ±0.00 0.04 ±0.00 
Stearic acid (18:0) 5.49 ±0.32 5.48 ±0.34 
Arachidic acid (20:0) 0.12 ±0.00 0.11 ±0.00 
Palmitelaidic acid (t16:1) 0.06 ±0.02 0.04 ±0.00 
Gondoic acid (20:1n-9) 0.48 ±0.02 0.48 ±0.03 
ALA (18:3n-3) 5.35 ±0.46 5.18 ±0.30 
DPA (22:5n-3) 0.10 ±0.00 0.10 ±0.01 
DHA (22:6n-3) 0.04 ±0.00 0.04 ±0.00 
Total Omega-6 27.61 ±1.51 27.06 ±0.85 
LA (18:2n-6) 26.42 ±1.41 25.86 ±0.77 
Eicosadienoic acid (20:2n-6) 0.67 ±0.05 0.64 ±0.05 
DGLA (20:3n-6) 0.17 ±0.01 0.12 ±0.02 
Adrenic acid (22:4n-6) 0.10 ±0.01 0.09 ±0.015 
Oleic acid (18:1n-9) 32.11 ±0.55 32.28 ±0.42 
Total Omega-9 32.62 ±0.55 32.77 ±0.44 
Table 3.5. Dam Milk FFA Composition. Control (n=10) and fructose (n=9). All data were analysed using 
an independent t-test using IBM SPSS statistics 25. Data presented as group mean ± SEM.* denotes 
significance of P<0.05. 
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3.4 Summary of Significant Findings in Pre-Pregnant and Pregnant Dams 
FD Dam Pre-pregnant and Pregnant Metabolic Status and Milk Fatty Acid 
Composition 
• Pre-pregnant dams consuming excess fructose displayed elevated OGTT 
blood glucose, reduced insulin and elevated whole-body insulin 
sensitivity. Significant increases were also observed in TAG, HDL and 
LIP. 
• During midgestation, dams consuming excess fructose had significantly 
increased UA and LIP. 
• Out of the 33 milk FFA analysed, dams consuming excess fructose prior 
to and during pregnancy had significantly elevated FFA which include, 
myristic acid, total trans FFA, vaccenic acid, linoelaidic acid, cis-
vaccenic, total omega-7 and gamma-linoleic acid.   
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3.5 Discussion: Effects of Excess Maternal Fructose Intake on Dam 
Metabolic Status and Milk Fatty Acid Composition 
Previous research in rodents demonstrated that maternal consumption of 10% 
fructose in water during pregnancy and lactation resulted in maternal 
hyperglycemia, hyperinsulinemia and hypertriglyceridemia, which were 
associated with significantly elevated plasma insulin in offspring at weaning, 
suggesting offspring susceptibility to diabetes during adulthood (Rawana et al., 
1993). Further, rodent studies demonstrated that 20% of caloric intake from 
fructose during gestation resulted in maternal hyperinsulinemia and sex-
specific effects in offspring, with female offspring having higher plasma leptin 
and glucose and displaying greater vulnerability to metabolic disturbances in 
neonatal life than male offspring (Vickers et al., 2011). Additionally, we have 
previously shown sex-specific cardio-metabolic differences in the offspring of 
maternal 10% w/v fructose-fed dams (Gray et al., 2016). Previous studies have 
reported that high fructose intake alters β-oxidation, increases free fatty acids 
and triglycerides, causing dyslipidemia, hepatic lipid accumulation and insulin 
resistance (Havel, 2005, M. A. Herman & Samuel, 2016, Hannou et al., 2018). It 
is essential to determine how the vertical transmission of such deleterious 
metabolic effects might increase de novo lipogenesis, fatty acid acylation and 
subsequent metabolic programming in offspring. In the current study, we, 
therefore, aimed to  characterise the maternal physiological effects of a diet 
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moderately high in fructose, resembling a modern Western diet, in pre-
pregnant and pregnant dams in regards to appetite (food, water and caloric 
intake), weight gain, metabolism (reflected in plasma metabolite profiles) and 
milk lipid concentration (milk lipidomics).   
We hypothesised that changes in maternal nutritional status following fructose 
intake would alter dams metabolic profiles and milk FFA composition and that 
offspring metabolic profiles would also display signs of hyperlipidaemia. We 
demonstrated that an intake of excess fructose in guinea pigs, which closely 
resembles average human consumption (~10-20% (Regnault et al., 2013)), 
contributing 16.5% of total caloric intake during pregnancy, has a significant 
impact upon a pregnant dams’ metabolic status and negatively impacts milk 
FFA composition. These potentially deleterious changes in maternal metabolic 
status may likely have an effect of in utero excess fructose exposure on offspring 
metabolic function throughout life. 
With similar placental characteristics to humans, relatively long gestation, 
compared to other rodent models, and comparable developmental maturation 
of organ systems before birth (Morrison et al., 2018), the guinea pig is a relevant 
translational model to study the effects of maternal fructose intake on offspring 
development. In the current study, and previously shown in the rat model 
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(Gray et al., 2016), we show that water intake increased in fructose-fed mothers 
due to the addition of 10% fructose (w/v), making the water sweeter and more 
palatable (Yudkin, 1967). All mothers consumed, on average, 172Kcal/day from 
pelleted food while fructose-fed mothers ingested an extra 34 Kcal/day (16.5% 
total daily Kcal) from 10% fructose (w/v). Recent data has shown that average 
human caloric intake from fructose can be between ~10-20% (Regnault et al., 
2013). In a human context, consuming a basal diet of 2,000 kcal/day with the 
addition of one 16oz SSB would equate to an increase of up to 10% of total 
kcal/day intake. It has been recently reported that consumption of added 
fructose by pregnant women equates to around 14% of their average daily 
caloric intake (Regnault et al., 2013). Animal studies of fructose intake have 
ranged from the supraphysiological (30-70%; (Regnault et al., 2013, R. J. 
Johnson et al., 2007, Abdulla et al., 2011) to the more comparable ranges of 10-
20% fructose (w/v) (9,6) (Clayton et al., 2015, Vickers et al., 2011, Rodríguez et 
al., 2013).  
Animal and human studies have shown that continued excessive dietary 
fructose intake increases activity of lipogenic liver enzymes, lipid synthesis and 
circulating VLDL, LDL, HDL and TAG concentrations in blood as fructose 
favors lipogenesis (D.-M. Zhang et al., 2017, Khitan & Kim, 2013, Lee et al., 
2018, Saad et al., 2016). We show that prior to pregnancy, fructose intake 
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increased levels of TAG and HDL without an increase in LDL, but these 
differences were abolished during pregnancy. Similar to the current study, 
others have also shown no change in plasma LDL, HDL and TAG during 
pregnancy following fructose-feeding (A. Saad et al., 2019). The relationship 
between dietary fructose and insulin resistance in humans is uncertain as 
excess dietary fructose does not invariably cause elevated insulin 
concentrations (Tappy & Le, 2010). Bezerra et al. showed increased insulin in 
response to fructose-feeding and Vickers et al. published reports of fructose 
increasing insulin in rats (Bezerra et al., 2001, Vickers et al., 2011). In contrast, 
we show a non-significant increase in OGTT blood glucose concentrations and 
reduced insulin concentrations in dams exposed to fructose enriched diets. This 
has been shown previously (Litherland, Hajduch, Gould, & Hundal, 2004) and 
may involve reduced insulin response due to higher concentrations of FFA, 
TAG, HDL and LDL (Sears & Perry, 2015, Karpe, Dickmann, & Frayn, 2011). 
Our study uses a more physiologically relevant fructose intake (10%), and thus, 
the increases in plasma lipids observed in our pre-pregnant dams could have 
been ameliorated by blood volume expansion, increased metabolic demand 
that is placed upon the expectant mother, increased hepatic gluconeogenesis 
and FFA production, typically observed during pregnancy (Angueira et al., 
2015).  
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During pre-pregnancy and pregnancy, dams exposed to a fructose-rich diet 
had significantly higher plasma lipase concentrations. In humans, increased 
lipase has been associated with features of hyperlipidaemia and elevated TAG 
(Kota, Kota, Krishna, Modi, & Jammula, 2012). Similar to our results, rats fed a 
high fat/high fructose diet (addition of 10g fat, 5g fructose) induced 
hyperlipidaemia and elevated lipase (Nasri et al., 2018).  
The deleterious effects of elevated plasma UA concentrations following 
fructose consumption in non-pregnant subjects have been well established 
(Apovian, 2004, Gibson et al., 1983). Some research, but not all, have shown 
excessive maternal fructose intake to induce increased UA production during 
pregnancy by increasing adenosine triphosphate (ATP) degradation to 
adenosine monophosphate (AMP), a UA precursor (Asghar et al., 2016, Gibson 
et al., 1983, Fox & Kelley, 1972). Similar effects of maternal fructose intake are 
evident in our pre-pregnant and pregnant dams, with a significant increase in 
UA before pregnancy and during pregnancy. 
Research has shown that milk composition can be selectively affected by 
maternal nutritional status and even more so during lactation. In our current 
study, excess fructose dietary intervention ceased immediately following 
spontaneous delivery of offspring, and therefore, milk concentrations of 
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fructose were not assessed. However, it is worth mentioning two recent studies 
have shown that fructose is transferred from mother to infant during 
breastfeeding (Berger, Fields, Demerath, Fujiwara, & Goran, 2018, Goran et al., 
2013), and a positive association between level of fructose in breast milk and 
infant adiposity at 6 months of age.  
Following pregnancy, during lactation, we were particularly interested in 
dams’ milk FFA composition and the potential negative impact of altered milk 
composition on the vertical transmission of FFA from mother to offspring. In 
the present study, significantly increased FFA in maternal milk included 
myristic acid, total trans FFA, vaccenic acid, linolelaidic acid, cis-vaccenic acid, 
total omega-7 and gamma-linolenic acid, the majority of which are trans-fats. 
Studies have demonstrated that trans FFA content in lactating mothers is both 
directly associated with short and long-term maternal diet and independent of 
diet through maternal adipose tissue (Chappel, Clandinin, & Kearney-Volpe, 
1985, Mennitti et al., 2015).  
Data in this chapter show that excess fructose intake prior to and during 
pregnancy closely resembles average human consumption, contributing 16.5% 
of total caloric intake.  This increase in maternal fructose intake showed a 
significant impact upon metabolic status and milk lipid composition. The 
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following chapter (chapter 4) investigates how the altered maternal metabolic 
status may affect offspring physiology, hepatic architecture and proteomics, 
mitochondrial function, lipid metabolism and metabolic status following excess 
fructose exposure in utero.   
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The Effects of Excess Maternal Fructose Intake on the 
Weanling Offspring  
4.1 Study 2 Aims 
The aims of Study 2 were to investigate the effects of excess fructose exposure 
in utero on weanling offspring physiology, weight gain and organ weights, 
hepatic lipid deposition, visceral fat morphology, metabolic status, lipid 
synthesis and metabolism and mitochondrial function. To identify offspring 
early-life effects of excess fructose exposure in utero, we conducted weanling 
assessments. Weanlings were assessed to determine variations in early-life 
weight gain and liver and visceral fat weights. Variations in weanling offspring 
hepatic lipid deposition and visceral fat morphology were measured. 
Alterations to weanling offspring metabolic status were determined by 
measuring plasma glucose and insulin concentrations and key plasma 
metabolites. Variations in metabolic function were evaluated by characterising 
hepatic protein expression and abundance. Further analyses to determine the 
effects of excess fructose exposure in utero on key proteins involved in lipid 
synthesis and metabolism and mitochondrial function were also evaluated.  
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4.2 Protocol  
Following birth, weanling (CD males (n= 7); FD males (n=7); CD females (n=7); 
and FD females (n=7)) weights were measured daily until day 21. All offspring 
were fed a control diet of standard guinea pig pellets, fresh silverbeet and 
carrots and Millipore filtered water supplemented with 1.2g/L of ascorbic acid. 
Offspring blood samples were taken at day 0 (prior to suckling), 7 and 14 and 
OGTTs were performed on day 21. Upon completion of the OGTTs, offspring 
randomised to the weanling group were euthanised and blood and tissue 
samples were collected for further analysis (Figure 4.1). Detailed descriptions of 
all study 2 measurements, protocols and techniques for analysis of physiology, 
weight gain and organ weights, hepatic lipid deposition, visceral fat 
morphology, metabolic status, lipid synthesis and metabolism and 
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Figure 4.1. Study 2: Offspring Day 21 (Weanling) Protocol 
 
Figure 4.1. Diagram represents the work flow undertaken throughout study two. CD and FD offspring 
were randomly allocated to weanling groups CD males (n= 7); FD males (n=7); CD females (n=7); and FD 
females (n=7). Offspring were fed control diets from d0 to d21. Blood samples were collected on d0 (prior 
to suckling), d7 and d14. On d21, offspring underwent an OGTT baseline and serial blood collections, 
following glucose load, were collected. Following the OGTT d21 offspring were humanely euthanized 
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4.3 Results 
4.3.1 Effects of Excess Maternal Fructose Intake on Postnatal Weanling 
Weight Gain 
Offspring weights were taken daily from day 1 to day 21 of age to determine 
any effect of dams excess maternal fructose intake on growth trajectory. Excess 
maternal fructose intake was observed to have an overall significant effect of 
diet (P=0.05) on offspring weight gain in both males and females. FD offspring 
gained less weight than CD offspring from day 12 to day 21 of age (Figure 4.2).
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Figure 4.2. Effects of Excess Maternal Fructose Intake on Weanling Offspring Weight Gain  
 
Figure 4.2. Weanling offsprings’ weight gain from day 0 to day 21. Control males (n=5); fructose males (n=7); control females (n=6) and fructose females (n=7). All data were 
analysed using a 2x2 factorial design with repeated measures GEE, diet*sex*time*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. 
Data presented as group mean ±SEM.* denotes significance of P<0.05. 
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4.3.2 Effects of Excess Maternal Fructose Intake on Weanling Plasma 
Glucose 
To assess the effects of excess maternal fructose consumption on offspring 
baseline blood glucose concentrations, fasting blood glucose was assessed at 
days 0, 7, 14 and 21. Excess maternal fructose intake had a significant effect on 
blood glucose concentrations on d7, with an increase in FD male and female 
offspring compared to their CD counterparts (CDM, 7.40 ±0.21 vs. FDM, 8.40 
±0.21 vs. CDF, 7.20 ±0.21 vs. FDF, 8.08 ±0.21mmol/L; P=0.03). However, no 
significant differences were observed between CD and FD offspring on d0, d14 




Chapter 4  Study 2 
 138 
Table 4.1. Weanling Plasma Baseline Blood Glucose  
 
Weanling Offspring 
Plasma Biochemistry Sex 
Day 0 Day 7 Day 14 Day 21 
Control Fructose Control Fructose Control Fructose Control Fructose 
Base Blood Glucose (mmol/L) Male 6.73 ±0.16 7.02 ±0.16 7.40 ±0.21 8.40 ±0.21* 7.50 ±0.21 7.48 ±0.21 7.97 ±0.12 7.71 ±0.12 
 Female 6.00 ±0.16 6.65 ±0.16 7.20 ±0.21 8.08 ±0.21* 6.83 ±0.21 7.00 ±0.21 7.68 ±0.12 7.22 ±0.12 
 
Table 4.1. Plasma biochemistry of base blood glucose in weanling offspring. Control males (n=7); fructose males (n=7); control females (n=7) and fructose females (n=7). All 
data were analysed using a 2x2 factorial design with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group 
mean ±SEM.* denotes significance of P<0.05. 
 
Chapter 4  Study 2 
 139 
4.3.3 Effects of Excess Maternal Fructose Intake on Weanling OGTT 
Glucose and Insulin 
To assess the effects of excess maternal fructose consumption on weanling 
offspring OGTT blood glucose and insulin concentrations and whole-body 
insulin sensitivity, an OGTT analysis was performed on day 21. A significant 
effect of diet was shown by a decrease in FD male offspring OGTT glucose 
concentrations compared to CD males (CDM, 2260.50 ±114.38 vs. FDM, 1681.00 
±78.42mmol/L; P=0.002) (Figure 4.3A). No significant differences were observed 
between CD and FD male offspring OGTT insulin concentrations (Figure 3B). 
No significant differences were observed between CD and FD female offspring 
OGTT glucose and insulin concentrations (Figure 4.3C and 4.3D). 
At specific time points during the OGTT, a few significant differences were 
observed in glucose and insulin concentrations between groups. There was a 
significant effect of diet shown by a decrease in FD male offspring OGTT blood 
glucose compared to CD males at two time points, 60min (CDM, 18.43 ±1.05 vs. 
FDM, 12.20 ±1.12mmol/L; P=0.002) and 120min (CDM, 11.06 ±1.12 vs. FDM, 
7.00 ±0.60mmol/L; P=0.01) (Figure 4.3A, Table 4.2). There was a significant 
effect of diet shown by increased insulin concentrations in FD male offspring 
compared to CD males at 120min (CDM, 0.32 ±0.09 vs. FDM, 0.72 ±0.11µU/mL; 
P=0.03) (Figure 4.3B, Table 4.2).  
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There was a significant effect of diet shown by an increase in FD female 
offspring OGTT blood glucose compared to CD females at 180min (CDF, 7.48 
±0.26 vs. FDF, 8.23 ±0.12mmol/L; P=0.02). No significant differences were 
observed between CD and FD female offspring insulin concentrations at any 
specific time point during the OGTT (Figure 4.3C and 4.3D, Table 4.2).  
M-ISI was calculated to evaluate whole-body insulin sensitivity. No significant 
differences in M-ISI were observed between CD and FD males (Table 4.2). In 
females, however, FD offspring tended to have a higher M-ISI than their CD 
counterparts, indicating more sensitivity to insulin than CD females (CDF, 7.41 
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Figure 4.3. Weanling OGTT Blood Glucose and Plasma Insulin AUC  
 
Figure 4.3. Weanling offspring OGTT glucose AUC and insulin AUC. A) Represents male offspring blood 
glucose AUC in response to OGTT at d21. B) Represents male offspring plasma insulin AUC in response 
to OGTT at d21. C) Represents female offspring blood glucose AUC in response to OGTT at d21.  D) 
Represents female offspring plasma insulin AUC in response to OGTT at d21. Control males (n=6); 
fructose males (n=6); control females (n=5) and fructose females (n=6). All data were analysed as a 2x2 
factorial design with diet*sex*interaction as factors included (generalized linear model analysis) using 
IBM SPSS statistics 25 (IBM, USA). Data shown as standard error of the mean (SEM). Data presented as 
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Blood Glucose (mmol/L) 




 Fructose 7.50 ±0.25 7.54 ±0.22 




 Fructose 13.03 ±0.63 14.13 ±0.69 




 Fructose 12.20 ±1.12* 13.76 ±0.46 




 Fructose 7.00 ±0.60* 7.31 ±0.38 




 Fructose 6.95 ±0.31 8.23 ±0.12* 
Plasma Insulin (µU/ml) 




 Fructose 0.91 ±0.21 0.64 ±0.09 




 Fructose 0.68 ±0.17 0.83 ±0.13 




 Fructose 0.70 ±0.08 0.63 ±0.11 




 Fructose 0.72 ±0.11* 0.82 ±0.08 




 Fructose 0.61 ±0.11 0.82 ±0.18 
Matsuda-ISI 




 Fructose 7.16 ±0.63 11.03 ±1.35 
 
Table 4.2. Weanling offspring OGTT Glucose, Insulin and Matsuda-ISI. Control males (n=6); fructose 
males (n=6); control females (n=5) and fructose females (n=6) and Matsuda-ISI Control males (n=6); 
fructose males (n=6); control females (n=5) and fructose females (n=6). All data were analysed using an 
independent T-test using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes 
significance of P<0.05. 
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4.3.4 Effects of Excess Maternal Fructose Intake on Weanling Whole Blood 
Free Fatty Acid Composition 
To examine the effects of excess maternal fructose consumption on offspring 
whole blood FFA composition, a dried blood spot was collected at day 0, 7, 14 
and 21 and lipidomic analyses were performed. Excess maternal fructose intake 
was observed to have significant effects on offspring free fatty acid 
composition. Such that, out of the 33 whole blood FFA analysed, a significant 
diet effect was observed in pentadecanoic acid, dma16:0, margaric acid, 
palmitoleic acid, total omega-7, total saturates and total omega-6 in males and 
females of FD dams consistently across d0, d7, d14 and d21. Pentadecanoic acid 
was significantly increased in FD males and females compared to CD males 
and females, an effect of diet (P< 0.0001) at d0, in addition, there was an 
interaction effect of diet and sex (P<0.0001) with increased concentrations in FD 
males. An effect of diet continued with increased concentrations of 
pentadecanoic acid in FD offspring at d7 (P=0.02), d14 (P=0.01) and d21 
(P<0.0001). Dma16:0 was significantly increased in FD offspring, an effect of 
diet, at d0 (P<0.0001), d7 (P<0.0001), d14 (P=0.001) and d21 (P<0.0001). Margaric 
acid was significantly increased in FD offspring, an effect of diet, at d0 (P=0.02), 
d7 (P=0.02) and d14 (P=0.02) and d21 (P=0.005). Palmitoleic acid in FD male and 
female offspring were also observed to be significantly increased, an effect of 
diet, compared to CD at d0 (P=0.02), day 7 (P=0.007), d14 (P=0.002) and d21 
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(P<0.0001). Total omega-7 was observed to be significantly increased in FD 
male and female offspring compared to CD, an effect of diet, at d0 (P=0.05), d7 
(P=0.003), d14 (P<0.0001) and d21 (P<0.0001). Total saturates were observed to 
be significantly increased, an effect of diet, in both FD male and female total 
saturates at d0 (P=0.002) as well as a sex effect, with increased concentrations in 
FD females (P=0.02). The effect of diet on total saturates continued in FD 
offspring at d7 (P=0.02), d14 (P=0.05) and d21 (P<0.0001). Total omega-6 FFA 
were shown to be significantly decreased, an effect of diet, in FD male and 
female offspring consistently across d0 (P=0.02), d7 (P=0.01), d14 (P=0.05) and 
d21(P<0.0001) compared to CD offspring. (d0, Figure 4.4A; d7, Figure 4.4B; d14, 
Figure 4.4C; d21, Figure 4.4D; and Table 4.3) 
From the remaining 26 FFA analysed, total trans FFA were shown to be 
significantly increased, an effect of diet, at d7 (P=0.02), d14 (P<0.0001) and d21 
(P=0.001); vaccenic acid at d7 (P<0.0001), d14 (P=0.001) and d21 (P<0.0001); and 
palmitic acid at d14 (P=0.006) and d21 (P=0.007) in FD offspring compared to 
CD offspring. The remaining free fatty acids were either non-significant or not 
consistently significant across all time points (Table 4.3). 
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Figure 4.4 Weanling Fructose Offspring Whole Blood Free Fatty Acids  
 
Figure 4.4. FFA in fructose weanling offspring whole blood. Control males (n=7); fructose males (n=7); 
control females (n=7) and fructose females (n=7). Pentadecanoic acid (15:0), margaric acid (17:0), 
palmitoleic acid (16:1n-7) and total omega-7 (ω-7). A) Represents offspring day 0 whole blood FFA. B) 
Represents offspring day 7 whole blood FFA. C) Represents offspring day 14 whole blood FFA.  D) 
Represents offspring day 21 whole blood FFA. All data were analysed using a 2x2 factorial design with 
diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data 
presented as group mean ±SEM.* denotes significance of P<0.05. ** denotes significance of P<0.0001. 
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Table 4.3. Weanling Whole Blood Free Fatty Acids 
Continued… 
Weanling Offspring 
Whole Blood FFA 
(mg/100g) 
Sex 
Day 0 Day 7 Day 14 Day 21 
Control Fructose Control Fructose Control Fructose Control Fructose 
Pentadecanoic acid (15:0) Male 0.77 ±0.07 1.60 ±0.07 **,** 0.95 ±0.07   1.42 ±0.07*  0.94 ±0.08  1.56 ±0.08* 0.97 ±0.11 1.76 ±0.11** 
  Female 1.25 ±0.07 1.26 ±0.07**    1.24 ±0.07 1.42 ±0.07*  1.44 ±0.08  1.58 ±0.08* 1.30 ±0.11 2.06 ±0.11** 
dma16:0 Male  1.02 ±0.25 2.81 ±0.25**   1.26 ±0.30   3.37 ±0.30**  1.17 ±0.27  3.13 ±0.27* 1.43 ±0.42 5.78 ±0.42** 
  Female 1.45 ±0.25   3.17 ±0.25**   1.54 ±0.30  3.49 ±0.30**  1.90 ±0.27  3.47 ±0.27* 1.86 ±0.42 5.05 ±0.42** 
Margaric acid (17:0) Male 1.03  ±0.04 1.26 ±0.04*  0.97 ±0.03  1.09 ±0.03* 0.97 ±0.03 1.20 ±0.03* 1.07 ±0.05 1.39 ±0.05* 
  Female  1.15 ±0.04 1.31 ±0.04*  1.02 ±0.03   1.25 ±0.03* 1.08 ±0.03 1.14 ±0.03* 1.08 ±0.05 1.35 ±0.05* 
Palmitoleic acid (16:1n-7) Male 1.20 ±0.08 1.61 ±0.08*  0.93 ±0.05 1.27 ±0.05* 0.93 ±0.06 1.44 ±0.06* 0.85 ±0.08 1.47 ±0.08** 
  Female 1.36 ±0.08  1.70 ±0.08*   1.13 ±0.05 1.41 ±0.05* 1.22 ±0.06 1.50 ±0.06* 1.13 ±0.08 1.62 ±0.08** 
Total Omega-7 Male 2.46 ±0.08 2.75 ±0.08*   1.87 ±0.05  2.22 ±0.05* 1.85 ±0.06 2.40 ±0.06** 1.82 ±0.08 2.45 ±0.08** 
  Female  2.57 ±0.08  2.91 ±0.08*  2.06 ±0.05  2.36 ±0.05* 2.05 ±0.06 2.41 ±0.06** 2.00 ±0.08 2.57 ±0.08** 
Total Saturates Male 46.67 ±0.67 51.21 ±0.67*  48.45 ±0.46 51.55 ±0.46*  48.65 ±0.49  51.53 ±0.49* 49.91 ±0.61 55.09 ±0.61** 
  Female 50.04 ±0.69 53.13 ±0.67*,* 50.09 ±0.46 51.23 ±0.46*  50.61 ±0.49  51.48 ±0.49* 50.63 ±0.61 53.71 ±0.61** 
Total Omega-6 Male 30.99 ±0.39 29.27 ±0.39* 33.84  ±0.47  31.63 ±0.47* 32.92 ±0.42 31.02 ±0.42* 31.88 ±0.52 28.60 ±0.52** 
  Female 30.22 ±0.39 28.28 ±0.39*  33.34 ±0.47  31.02 ±0.47* 32.58 ±0.42 31.09 ±0.42* 33.11 ±0.52 29.21 ±0.52** 
          




Whole Blood FFA 
(mg/100g) 
Sex Day 0 Day 7 Day 14 Day 21 
Control Fructose Control Fructose Control Fructose Control Fructose 
Total Trans Fatty acids Male 0.51 ±0.04 0.53 ±0.04 0.40 ±0.04 0.58 ±0.04* 0.39 ±0.03 0.66 ±0.03** 0.36 ±0.07 0.90 ±0.07* 
  Female 0.60 ±0.04 0.64 ±0.04 0.47 ±0.04 0.65 ±0.04* 0.46 ±0.03 0.66 ±0.03** 0.43 ±0.07 0.88 ±0.07* 
Vaccenic acid (t18:1n-7) Male 0.26 ±0.02 0.28 ±0.02 0.19 ±0.03 0.33 ±0.03** 0.22 ±0.01 0.35 ±0.01* 0.20 ±0.04 0.44 ±0.04** 
  Female  0.36 ±0.02 0.34 ±0.02 0.22 ±0.03 0.40 ±0.03** 0.24 ±0.01 0.32 ±0.01* 0.26 ±0.04 0.64 ±0.04** 
Palmitic acid (16:0) Male 20.52 ±0.34 22.23 ±0.34 19.57 ±0.34 21.03 ±0.34  18.52 ±0.44 22.05 ±0.44* 18.57 ±0.44 20.97 ±0.44* 
  Female 22.07 ±0.34 21.81 ±0.34 20.96 ±0.34 20.71 ±0.34  20.94 ±0.44 21.89 ±0.44* 19.54 ±0.44 21.81 ±0.44* 
Elaidic acid (t18:1n-9) Male 0.14 ±0.01 0.17 ±0.01 0.10 ±0.01 0.16 ±0.01** 0.15 ±0.01 0.17 ±0.01 0.14 ±0.01 0.24 ±0.01* 
  Female 0.19 ±0.01 0.22 ±0.01 0.12 ±0.01 0.24 ±0.01** 0.13 ±0.01 0.18 ±0.01 0.13 ±0.01 0.22 ±0.01* 
Total Monosaturates Male 15.62 ±0.50 14.13 ±0.50 12.14 ±0.26 12.29 ±0.26 12.82 ±0.29 11.70 ±0.29 12.30 ±0.31 11.07 ±0.31* 
  Female  14.13 ±0.50 16.96 ±0.50* 11.27 ±0.26 12.36 ±0.26 12.58 ±0.29 12.93 ±0.29 10.25 ±0.31 12.15 ±0.31* 
dma18:0 Male 0.50 ±0.05 0.98 ±0.05* 0.70 ±0.06 1.01 ±0.06 0.61 ±0.05 0.95 ±0.05*  0.77 ±0.06 1.06 ±0.06 
  Female 0.79 ±0.05 0.61 ±0.05 0.88 ±0.06 0.85 ±0.06 0.90 ±0.05 0.69 ±0.05* 1.01 ±0.06 0.93 ±0.06 
Arachidic acid (20:0) Male 0.56 ±0.03 0.60 ±0.03 0.67 ±0.04 0.70 ±0.04 0.57 ±0.02 0.51 ±0.02 0.59 ±0.05 0.87 ±0.05* 
  Female 0.48 ±0.03  0.67 ±0.03 0.54 ±0.04 0.76 ±0.04 0.54 ±0.02 0.56 ±0.02 0.53 ±0.05 0.70 ±0.05* 
          
Continued… 






Whole Blood FFA 
(mg/100g) 
Sex 
Day 0 Day 7 Day 14 Day 21 
Control Fructose Control Fructose Control Fructose Control Fructose 
Behenic acid (22:0) Male 0.48 ±0.02 0.51 ±0.02 0.68 ±0.04 0.71 ±0.04 0.67 ±0.04  0.71 ±0.04 0.87 ±0.05* 0.78 ±0.05* 
  Female 0.47 ±0.02 0.54 ±0.02 0.59 ±0.04 0.63 ±0.04 0.61 ±0.04 0.67 ±0.04 0.61 ±0.05 0.62 ±0.05 
Adrenic acid (22:4n-6) + 
Docosatrienoate acid 
(22:3n-3) Male 1.17 ±0.05 1.42 ±0.05 1.51 ±0.06 1.69 ±0.06 1.49 ±0.21 1.52 ±0.21 1.88 ±0.04* 2.05 ±0.04* 
  Female 1.45 ±0.05 1.43 ±0.05 1.39 ±0.06 1.41 ±0.06 1.46 ±0.21 2.39 ±0.21 1.88 ±0.04 1.60 ±0.04 
AA (20:4n-6) Male 6.47 ±0.22 7.39 ±0.22 7.75 ±0.17 6.78 ±0.17* 7.79 ±0.14 6.9 ±0.14*  9.08 ±0.20 7.79 ±0.20* 
  Female 7.19 ±0.22  6.69 ±0.22 7.55 ±0.17 6.94 ±0.17* 7.57 ± 0.14 6.5 ±0.14* 8.76 ±0.20 7.67 ±0.20* 
 LA (18:2n-6) Male 21.54 ±0.42 18.65 ±0.42* 22.84 ±0.38 21.45 ±0.38* 21.88 ±0.35 20.73 ±0.35 19.16 ±0.44 16.72 ±0.44* 
  Female 19.80 ±0.42 18.30 ±0.42*  22.71 ±0.38 20.84 ±0.38* 21.94 ±0.35 20.50 ±0.35 20.68 ±0.44 18.07 ±0.44* 
DPA (22:5n-3) Male 1.43 ±0.05 1.50 ±0.05 1.67 ±0.04 1.39 ±0.04* 1.68 ±0.04 1.41 ±0.04* 1.90 ±0.06 1.88 ±0.06 
  Female 1.47 ±0.05 1.20 ±0.05 1.52 ±0.04 1.43 ±0.04* 1.51 ±0.04 1.36 ±0.04* 1.70 ±0.06 1.58 ±0.06 
Cis-Vaccenic acid (18:1n-7) Male 1.26 ±0.02 1.14 ±0.02 0.94 ±0.01 0.95 ±0.01 0.92 ±0.01* 0.96 ±0.01* 0.96 ±0.02 0.98 ±0.02 
  Female  1.21 ±0.02 1.20 ±0.02 0.93 ±0.01 0.95 ±0.01 0.83 ±0.01 0.91 ±0.01 0.87 ±0.02 0.95 ±0.02 
          





Whole Blood FFA 
(mg/100g) 
Sex 
Day 0 Day 7 Day 14 Day 21 
Control Fructose Control Fructose Control Fructose Control Fructose 
Eicosadienoic acid (20:2n-6) Male 0.63 ±0.01 0.55 ±0.01 0.44 ±0.01 0.45 ±0.01 0.68 ±0.02 0.59 ±0.02 0.68 ±0.02  0.82 ±0.02  
  Female 0.59 ±0.01 0.61 ±0.01 0.38 ±0.01 0.40 ±0.01 0.57 ±0.02 0.66 ±0.02 0.75 ±0.02  0.73 ±0.02  
Myristic acid (14:0) Male 1.22 ±0.07 0.99 ±0.07 0.93 ±0.03* 0.87 ±0.03* 0.88 ±0.02 0.85 ±0.02 1.08 ±0.04 0.96 ±0.04 
  Female  0.95 ±0.07 0.89 ±0.07 0.73 ±0.03 0.75 ±0.03 0.77 ±0.02 0.87 ±0.02 0.86 ±0.04 0.92 ±0.04 
Lignoceric acid (24:0) Male 1.70 ±0.08 2.08 ±0.08* 2.08 ±0.06 2.03 ±0.06 2.07 ±0.05 2.02 ±0.05 2.17 ±0.06 2.38 ±0.06 
  Female 1.92 ±0.08 2.23 ±0.08* 1.99 ±0.06 2.08 ±0.06 2.05 ±0.05 2.16 ±0.05 2.27 ±0.06 1.27 ±0.06 
Stearic acid (18:0) Male 18.72 ±0.40 21.63 ±0.40* 21.37 ±0.26  20.01 ±0.26* 22.14 ±0.34* 20.11 ±0.34* 20.24 ±0.62 20.64 ±0.62 
  Female 19.10 ±0.40 20.24 ±0.40* 20.57 ±0.26 19.74 ±0.26* 20.71 ±0.34  19.11 ±0.34* 19.03 ±0.62 21.53 ±0.62 
DHA (22:6n-3) Male 0.70 ±0.13 1.17 ±0.13 0.86 ±0.15 1.40 ±0.15 0.70 ±0.13 1.14 ±0.13 0.89 ±0.17 1.62 ±0.17 
  Female 0.93 ±0.13 1.11 ±0.13 1.12 ±0.15 1.56 ±0.15 1.22 ±0.13 1.54 ±0.13 1.01 ±0.17 1.24 ±0.17 
 Gondoic Acid (20:1n-9) Male 0.50 ±0.01 0.47 ±0.01 0.50 ±0.01 0.47 ±0.01 0.40 ±0.01 0.43 ±0.01 0.44 ±0.04 0.48 ±0.04 
  Female 0.48 ±0.01 0.52 ±0.01 0.48 ±0.01 0.52 ±0.01 0.37 ±0.01 0.38 ±0.01 0.46 ±0.04 0.61 ±0.04 
EPA (20:5n-3) Male 0.29 ±0.03 0.36 ±0.03 0.28 ±0.03 0.44 ±0.03 0.30 ±0.03 0.46 ±0.03 0.37 ±0.01 0.40 ±0.01 
  Female 0.38 ±0.03 0.41 ±0.03 0.34 ±0.03 0.41 ±0.03 0.31 ±0.03 0.28 ±0.03 0.31 ±0.01 0.37 ±0.01 
          




Table 4.3. FFA in weanling offspring whole blood. Control males (n=7); fructose males (n=7); control females (n=7) and fructose females (n=7). All data were analysed using a 
2x2 factorial design with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes 
significance of P<0.05; ** denotes significance of P<0.0001.  
Weanling Offspring 
Whole Blood FFA 
(mg/100g) 
Sex 
Day 0 Day 7 Day 14 Day 21 
Control Fructose Control Fructose Control Fructose Control Fructose 
Total Omega-3 Male 5.29 ±0.17 4.83 ±0.17 4.36 ±0.18 4.65 ±0.18 4.27 ±0.15 4.21 ±0.15 4.79 ±0.23 5.20 ±0.23 
  Female 4.99 ±0.17 4.61 ±0.17 4.28 ±0.18 4.71 ±0.18 4.23 ±0.15 4.58 ±0.15 4.19 ±0.23 4.45 ±0.23 
GLA (18:3n-6) Male 0.36 ±0.01 0.32 ±0.01 0.26 ±0.03 0.25 ±0.03 0.20 ±0.01 0.26 ±0.01 0.27 ±0.04 0.45 ±0.04 
  Female 0.32 ±0.01 0.39 ±0.01 0.31 ±0.03 0.43 ±0.03 0.22 ±0.01 0.18 ±0.01 0.22 ±0.04 0.29 ±0.04 
DGLA (20:3n-6) Male 0.80 ±0.02 0.92 ±0.02 0.86 ±0.02 0.83 ±0.02 0.81 ±0.03 0.80 ±0.03 0.79 ±0.02 0.75 ±0.02 
  Female 0.84 ±0.02 0.84 ±0.02 0.80 ±0.02 0.81 ±0.02 0.80 ±0.03 0.75 ±0.03 0.80 ±0.02 0.82 ±0.02 
ALA (18:3n-3) Male 2.85 ±0.14 1.78 ±0.14*  1.54 ±0.07 1.41 ±0.07 1.58 ±0.07 1.25 ±0.07 1.61 ±0.08 1.30 ±0.08 
  Female 2.21 ±0.14 1.87 ±0.14* 1.29 ±0.07 1.30 ±0.07 1.17 ±0.07 1.38 ±0.07 1.16 ±0.08 1.24 ±0.08 
Oleic acid (18:1n-9) Male 13.38 ±0.51 10.70 ±0.51 9.69 ±0.27 9.53 ±0.27 10.40 ±0.30 9.51 ±0.30 9.87 ±0.30 8.06 ±0.30 
  Female 10.84 ±0.51 11.45 ±0.51 8.68 ±0.27 9.25 ±0.27 9.10 ±0.30 9.92 ±0.30 8.38 ±0.30 8.19 ±0.30 
Total Omega-9 Male 13.91 ±0.50 11.18 ±0.50 10.13 ±0.27 9.98 ±0.27 10.80 ±0.30 9.98 ±0.30 10.34 ±0.30  8.55±0.30 
  Female 11.34 ±0.50 12.41 ±0.50 9.09 ±0.27 9.71 ±0.27 9.48 ±0.30 10.34 ±0.30 8.88 ±0.30 8.81 ±0.30 
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4.3.5 Effects of Excess Maternal Fructose Intake on Weanling Plasma 
Metabolites  
Key plasma metabolites were analysed at d21 to examine the effects of excess 
maternal fructose consumption on weanling plasma metabolite markers of 
fructose and lipid metabolism. TAG concentrations were observed to be 
significantly increased in FD males and females, an effect of diet, compared to 
CD males and females (P=0.01); additionally, there was an effect of sex (P=0.05) 
with increased concentrations in CD and FD females. UA concentrations were 
also significantly increased in FD male and female offspring, an effect of diet, 
when compared to their CD counterparts (P=0.004). LIP concentrations were 
observed to be significantly increased in FD male offspring, an interaction 
effect of diet and sex, when compared to any other group or sex (P=0.03). ALP 
concentrations were observed to be significantly increased in CD and FD male 
offspring, an effect of sex, when compared to CD and FD females (P=0.001), 
additionally there was an interaction effect of diet and sex (P=0.04) with 
decreased concentrations in FD males compared to CD males. A significant 
effect of sex was observed in CD and FD female offspring compared to CD and 
FD male offspring with increases in CHOL (P=0.001), LDL (P=0.005) and HDL 
(P=0.001) concentrations. (Table 4.4) 
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No significant differences were observed between CD and FD offspring for hs-
CRP, ALT, GGT and FRUC (Table 4.4). Leptin analysis by ELISA provided 
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TAG (mmol/L) Male 0.51 ±0.01 0.58 ±0.01* 
 Female 0.56 ±0.01* 0.68 ±0.01*,* 
UA (µmol/L) Male 42.33 ±3.90 69.40 ±3.90* 
 Female 46.50 ±3.90 62.75 ±3.90* 
LIP (U/L) Male 8.40 ±2.53 24.75 ±2.53* 
 Female 19.60 ±2.53 13.75 ±2.53 
ALP (U/L) Male 18.33 ±1.63* 13.66 ±1.63*,* 
 Female 3.83 ±1.63 9.33 ±1.63 
CHOL (mmol/L) Male 0.87 ±0.07 1.05 ±0.07 
 Female 1.50 ±0.07* 1.35 ±0.07* 
LDL (mmol/L) Male 0.79 ±0.06 1.04 ±0.06 
 Female 1.25 ±0.06* 1.22 ±0.06* 
HDL (mmol/L) Male 0.08 ±0.00 0.10 ±0.00 
 Female 0.12 ±0.00** 0.13 ±0.00** 
hs-CRP (mg/L) Male 0.12 ±0.01 0.19 ±0.01 
 Female 0.15 ±0.01 0.13 ±0.01 
ALT (U/L) Male 54.27 ±2.31 57.13 ±2.31 
 Female 53.54 ±2.31 63.10 ±2.31 
GGT (U/L) Male 8.16 ±0.75 11.16 ±0.75 
 Female 9.16 ±0.75 10.00 ±0.75 
FRUC (µmol/L) Male 165.85 ±2.15 176.66 ±2.15 
 Female 174.28 ±2.15 178.00±2.15 
 
Table 4.4. Weanling offspring plasma metabolites at d21. Control males (n=7); fructose males (n=7); 
control females (n=7) and fructose females (n=7). All data were analysed using a 2x2 factorial design with 
diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data 
presented as group mean ±SEM.* denotes significance of P<0.05; ** denotes significance of P<0.001 
 
Chapter 4  Study 2 
 154 
4.3.6 Effects of Excess Maternal Fructose Intake on Weanling Organ 
Weights 
To examine the effects of excess maternal fructose consumption on weanling 
offspring organ weights, specifically liver and visceral fat, tissue mass was 
analysed as absolute wet weight and proportionate weight (i.e., relative to total 
body weight) at d21. Excess maternal fructose intake was observed to have 
significant effects on offspring organ absolute and proportional mass at d21. 
Further analysis of weanling offspring organ weights (brain, heart, kidney and 
adrenal and subcutaneous fat) are provided in the Appendix. 
4.3.6.1 Weanling Liver Wight and Liver to Body Weight Ratio 
FD male and female offspring were shown to have significantly decreased liver 
weight, an effect of diet, compared to their CD counterparts (CMD, 6.36 ±0.17 
vs FDM, 5.14 ±0.17 vs CDF, 5.51 ±0.17 vs FDF 4.73 ±0.17g; P=0.001). In addition, 
liver weights were shown to be significantly decreased in CD and FD females, 
an effect of sex (P=0.02), compared to CD and FD males (Figure 4.5A). No 
significant differences were observed between CD and FD offspring liver to 
body weight ratio (Figure 4.5B). However, taking the results of the liver weight 
and liver to body weight ratio together, suggests there is a larger proportion of 
liver tissue/g of body weight in fructose offspring.  
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Figure 4.5. Weanling Liver Weight and Liver to Body Weight Ratio 
 
Figure 4.5. Weanling offspring liver weight and liver to body weight ratio. Control males (n=7); fructose males (n=6); control females (n=6) and fructose females (n=6). A) 
Represents offspring liver weight at d21. B) Represents offspring liver to body weight ratio at d21. All data were analysed using a 2x2 factorial design with diet*sex*interaction 
include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes diet significance of P<0.05. 
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4.3.6.2 Weanling Visceral Fat Weight and Visceral Fat to Body Weight Ratio  
FD males and females were observed to have significantly decreased visceral 
fat weights, an effect of diet compared to CD offspring (CMD, 0.95 ±0.87 vs 
FDM, 0.30 ±0.87 vs CDF, 0.44 ±0.87 vs FDF 0.22 ±0.87g; P=0.005). In addition, 
visceral fat weights were shown to be significantly decreased in CD and FD 
females, an effect of sex (P=0.04), compared to CD and FD males (Figure 4.6A).  
Visceral fat to body weight ratios were observed to be significantly decreased 
in FD males and females, an effect of diet, compared to CD offspring (CMD, 
0.004 ±0.00 vs FDM, 0.002 ±0.00 vs CDF, 0.002 ±0.00 vs FDF 0.001 ±0.00g; 
P=0.01). In addition, visceral fat to body weight ratios were shown to be 
significantly decreased in CD and FD females, an effect of sex (P=0.03) 
compared to CD and FD males (Figure 4.6B).  
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Figure 4.6. Weanling Visceral Fat Weight and Visceral Fat to Body Weight Ratio 
 
Figure 4.6. Weanling offspring visceral fat weight, visceral fat to body weight ratio and subcutaneous fat weight. Control males (n=7); fructose males (n=7); control females 
(n=7) and fructose females (n=7). A) Represents offspring visceral fat weight at d21. B) Represents offspring visceral fat to body weight ratio at d21. All data were analysed 
using a 2x2 factorial design with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* 
denotes diet significance of P<0.05. 
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4.3.7 Effects of Excess Maternal Fructose Intake on Weanling Hepatic Lipid 
Deposition  
To examine the effects of excess maternal fructose consumption on weanling 
offspring hepatic lipid deposition, Oil-Red-O histological assessments were 
performed on d21 livers. No significant differences were observed between CD 
and FD offspring total % hepatic lipid deposition or total % lipid deposition to 
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Figure 4.7. Weanling Hepatic Oil-Red-O Histology 
 
Figure 4.7. Weanling offspring hepatic lipid deposition example images of d21 offspring. All images are of 
6µm thick sections taken from frozen d21 liver tissue, stained with oil-red-o and photographed at 200x 
magnification. Lipid droplets (red) among hepatocytes (light blue) and hepatocyte nuclei (dark blue). A) 
Represents image of CDM offspring lipid deposition at d21. B) Represents image of FDM offspring lipid 
deposition at d21. C) Represents image of CDF offspring lipid deposition at d21. D) Represents image of 
FDF offspring lipid deposition at d21.
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Figure 4.8. Weanling Hepatic Lipid Deposition 
 
Figure 4.8. Weanling offspring hepatic total % lipid deposition and total % lipid deposition to liver weight ratio. Control males (n=6; fructose males (n=5); control females (n=5) 
and fructose females (n=6). A) Represents offspring hepatic total % lipid deposition at d21. B) Represents offspring liver weight to total % lipid deposition ratio at d21. All data 
were analysed using a 2x2 factorial design with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group 
mean ±SEM.  
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4.3.8 Effects of Excess Maternal Fructose Intake on Weanling Hepatic 
Triglyceride Content  
The effects of excess maternal fructose consumption on offspring hepatic TAG 
concentration were examined via a Triglyceride Colorimetric assay performed 
on d21 livers. CD and FD males were observed to be significantly increased 
hepatic triglyceride concentrations, an effect of sex, compared to their female 
counterparts (CMD, 9.00 ±0.50 vs FDM, 7.09 ±0.50 vs CDF, 5.31 ±0.50 vs FDF 
5.15 ±0.50mg/dl; P=0.002) (Figure 4.9A). Hepatic TAG to liver weight ratio was 
also shown to be significantly increased in CD and FD males, an effect of sex, 
compared to CD and FD females (CMD, 0.0014 ±0.00008 vs FDM, 0.0015 
±0.00008 vs CDF, 0.0009 ±0.00008 vs FDF 0.0011 ±0.00008g; P=0.01) (Figure 
4.9B).
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Figure 4.9. Weanling Hepatic Triglycerides 
 
Figure 4.9. Control males (n=5; fructose males (n=4); control females (n=5) and fructose females (n=6). A) Represents offspring hepatic triglyceride content at d21. B) Represents 
offspring hepatic triglyceride content to liver weight ratio at d21. All data were analysed using a 2x2 factorial design with diet*sex*interaction include as factors (general 
analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes significance of P<0.05.
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4.3.9 Effects of Excess Maternal Fructose Intake on Weanling Hepatic 
Proteome and Mitochondrial Pathway Signalling 
To examine the effects of excess maternal fructose consumption on weanling 
offspring hepatic biological and molecular interactions, the total hepatic 
proteome (>5,000 proteins) was analysed. IPA was used for identifying 
biological networks by conducting a Core Analysis to interpret the 
differentially-expressed proteins in a biological context by identifying 
relationships, mechanisms, functions and their associated pathways. The list of 
313 differentially-expressed proteins with a significance p≤0.05 (for the most 
accurate representation of increased and decreased regulation) and 
corresponding fold changes (ranging from 0.1-8.4) between CD and FD 
offspring were uploaded into IPA.  
Reported analysis included determination of up-regulated and down-regulated 
proteins (Appendix) and networks of the molecular interactions between 
proteins in association with biological functions and diseases. IPA’s Canonical 
Pathway Analysis was used to determine the most significantly affected 
signalling pathways based on increased or decreased protein expression and 
directionally theorised pathway activation or inhibition based on previously 
published evidence. IPA’s Toxicity Lists and Functions were used to evaluate 
the most significantly affected toxicity pathways and associated proteins based 
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on previously published evidence. Based on protein expression, the toxicity 
analysis provided identification of theorised signalling pathways with a 
potential predisposition towards disease. Proteins were displayed with their 
corresponding names, represented as nodes to categorise the functional class 
and the use of a dashed or solid line to represent the biological relationship 
between nodes. All relationships between nodes were supported by 
publications located in IPA’s Ingenuity Knowledge database of previously 
published research data. The pigment of node colour indicated an increase in 
expression (red) or decrease (green). 
4.3.9.1 Weanling FD Males 
Of the 313 differentially-expressed hepatic proteins identified by the total 
hepatic proteome analysis, excess maternal fructose intake was observed to 
have significant effects on 69 proteins in weanling male offspring at d21.    
4.3.9.1.1 Weanling FD Male Canonical Pathway Analysis 
Canonical Pathway Analysis was used to determine the most significantly 
affected signalling pathways based on increased or decreased protein 
expression and directionally theorised pathway activation or inhibition based 
on previously published evidence.  
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Significant pathways were calculated by the increased expression of networked 
proteins in the signalling pathways. Excess maternal fructose intake was 
observed to significantly increase FD males hepatic protein expression, 
compared to CD males, upregulating the pathways of oxidative 
phosphorylation (-log10P=1.9) (Figure 4.10), NRF2-mediated oxidative stress 
response (-log10P=3.82) (Figure 4.11) and mitochondrial dysfunction (-
log10P=3.83) (Figure 4.12). 
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Figure 4.10. Weanling FD Male Oxidative Phosphorylation 
 
Figure 4.10. Weanling FD male offspring oxidative phosphorylation. Control males (n=5) and fructose males (n=5). Figure represents most significantly affected signalling 
pathways based on increased protein expression and directionally theorised pathway activation in FD males compared to CD males. All data were analysed using Ingenuity 
Pathway Analysis (IPA). Red indicates up-regulation and grey indicates ineligible prediction. The P-values are calculated using IPA’s right-tailed Fisher’s exact test and -
log10P-values to represent significance.
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Figure 4.11. Weanling FD Male NRF2-mediated Oxidative Stress Response 
 
Figure 4.11. Weanling FD male offspring NRF2-mediated Oxidative Stress Response. Control males (n=5) 
and fructose males (n=5). Figure represents most significantly affected signalling pathways based on 
increased protein expression and directionally theorised pathway activation in FD males compared to CD 
males. All data were analysed using Ingenuity Pathway Analysis (IPA). Red indicates up-regulation and 
grey indicates ineligible prediction. The P-values are calculated using IPA’s right-tailed Fisher’s exact test 
and -log10P-values to represent significance.  
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Figure 4.12. Weanling FD Male Mitochondrial Dysfunction 
 
Figure 4.12. Weanling FD male offspring mitochondrial dysfunction. Control males (n=5) and fructose males (n=5). Figure represents most significantly affected signalling 
pathways based on increased protein expression and directionally theorised pathway activation FD males compared to CD males. All data were analysed using Ingenuity 
Pathway Analysis (IPA). Red indicates up-regulation and grey indicates ineligible prediction. The P-values are calculated using IPA’s right-tailed Fisher’s exact test and -
log10P-values to represent significance. 
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4.3.9.1.2 Weanling FD Male Toxicity Lists and Functions Analysis 
IPA’s Toxicity Lists and Functions were used to evaluate the most significantly 
affected toxicity pathways and associated proteins based on previously 
published evidence. Based on protein expression, the toxicity analysis provided 
identification of theorised signalling pathways with a potential predisposition 
towards disease.  
4.3.9.1.2.1 Weanling FD Male Toxicity Pathways 
Significant pathways were calculated by the increased expression of networked 
proteins in the signalling pathways with a potential predisposition towards 
disease. Excess maternal fructose intake was observed to significantly increase 
FD males hepatic protein expression, compared to CD males, upregulating the 
pathways of mitochondrial dysfunction (-log10P=3.98), nuclear factor erythroid 
2-related factor 2 (NRF2)-mediated oxidative stress response (-log10P=3.43), 
carboxylic acid reductase/retinoid X receptor (CAR/RXR) activation (-
log10P=3.10) and xenobiotic metabolism signalling (-log10P=2.82) (Table 4.5).  
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4.3.9.1.2.2 Weanling FD Male Toxicity Pathways and Associated Proteins  
Toxicity signalling pathway of mitochondrial dysfunction, in FD males 
compared to CD males, was observed to have significantly increased fold 
change and upregulated protein expression of cytochrome C oxidase subunit 
5B (COX5B) (3-fold, P=0.001), glutathione-disulfide reductase (GSR) (1.6-fold, 
P=0.007), monoamine oxidase B (MAOB) (2.5-fold, P=0.001) and 
NADH:ubiquinone oxidoreductase subunit B10 (NDUFB10) (2.8-fold, P=0.003) 
(Table 4.5).  
Toxicity signalling pathway of NRF2-mediated oxidative stress response, in FD 
males compared to CD males, was observed to have significantly increased fold 
change and upregulated protein expression of actin gamma 2 (ACTG2) (2.1-
fold, P=0.03), aldehyde oxidase 1 (AOX1) (1.2-fold, P=0.03), GSR (1.6-fold, 
P=0.007) and glutathione S-transferase A1 (GSTA1) (1.3-fold, P=0.008) (Table 
4.5).  
Toxicity signalling pathway of CAR/RXR activation, in FD males compared to 
CD males, was observed to have significantly increased fold change and 
upregulated protein expression of liver carboxylesterase 1 (CES1) (1.2-fold, 
P=0.01) and GSTA1 (1.3-fold, P=0.008) (Table 4.5).  
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Toxicity signalling pathway of xenobiotic metabolism, in FD males compared 
to CD males, was observed to have significantly increased fold change and 
upregulated protein expression of CES1 (1.2-fold, P=0.01), GSTA1 (1.3-fold, 
P=0.008), MAOB (2.5-fold, P=0.001) and prostaglandin E synthase 3 (PTGES3) 
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Table 4.5. Weanling FD Male Toxicity Pathways and Associated Proteins 
Toxicity Pathways and Proteins Fold 
Change 
P-value Location Type(s) 
Mitochondrial Dysfunction -log10P-value 3.98 
COX5B 3 0.001 Cytoplasm Enzyme 
GSR 1.6 0.007 Cytoplasm Enzyme 
MAOB 2.5 0.001 Cytoplasm Enzyme 
NDUFB10 2.8 0.003 Cytoplasm Enzyme 
NRF2-mediated Oxidative Stress Response -log10P-value 3.43 
ACTG2 2.1 0.03 Cytoplasm Other 
AOX1 1.2 0.03 Cytoplasm Enzyme 
GSR 1.6 0.007 Cytoplasm Enzyme 
GSTA1 1.3 0.008 Cytoplasm Enzyme 
CAR/RXR Activation -log10P-value 3.1 
CES1 1.2 0.01 Cytoplasm Enzyme 
GSTA1 1.3 0.008 Cytoplasm Enzyme 
Xenobiotic Metabolism Signalling -log10P-value 2.82 
CES1 1.2 0.01 Cytoplasm Enzyme 
GSTA1 1.3 0.008 Cytoplasm Enzyme 
MAOB 2.5 0.001 Cytoplasm Enzyme 
PTGES3 2.4 0.05 Cytoplasm Enzyme 
 
Table 4.5. Weanling FD male offspring pathways and associated proteins. Control males (n=5) and fructose males (n=5). Table represents signalling pathways with a potential 
predisposition towards disease in FD males compared to CD males. All data were analysed using Ingenuity Pathway Analysis (IPA). The P-values are calculated using IPA’s 
right-tailed Fisher’s exact test with -log10P-values to represent significance of pathological endpoint and P<0.05 to represent significance of specific protein expression 
upregulated within the pathological endpoint. 
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4.3.9.2 Weanling FD Females 
Of the 313 differentially-expressed hepatic proteins identified by the total 
hepatic proteome analysis, excess maternal fructose intake was observed to 
have significant effects on 42 proteins in weanling female offspring at d21.  
4.3.9.2.1 Weanling FD Female Canonical Pathway Analysis 
Canonical Pathway Analysis was used to determine the most significantly 
affected signalling pathways based on increased or decreased protein 
expression and directionally theorised pathway activation or inhibition based 
on previously published evidence.  
Significant pathways were calculated by the increased expression of networked 
proteins in the signalling pathways. Excess maternal fructose intake was 
observed to significantly increase FD females hepatic protein expression, 
compared to CD females, upregulating the pathways of fatty acid b-oxidation I 
(-log10P=3.12) (Figure 4.13) and NRF2-mediated oxidative stress response (-
log10P=3.2) (Figure 4.14). 
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Figure 4.13. Weanling FD Female Fatty Acid b-Oxidation I 
 
Figure 4.13. Weanling FD female offspring Fatty Acid b-Oxidation I. Control females (n=4) and fructose females (n=5). Figure represents most significantly affected signalling 
pathways based on increased protein expression and directionally theorised pathway activation in FD females compared to CD female. All data were analysed using Ingenuity 
Pathway Analysis (IPA). Red indicates up-regulation and grey indicates ineligible prediction. The P-values are calculated using IPA’s right-tailed Fisher’s exact test and -
log10P-values to represent significance.
Chapter 4  Study 2 
 175 
Figure 4.14. Weanling FD Female NRF2-mediated Oxidative Stress Response 
 
Figure 4.14. Weanling FD female offspring NRF2-Mediated Oxidative Stress. Control females (n=4) and 
fructose females (n=5). Figure represents most significantly affected signalling pathways based on 
increased protein expression and directionally theorised pathway activation in FD females compared to 
CD females. All data were analysed using Ingenuity Pathway Analysis (IPA). Red indicates up-regulation 
and grey indicates ineligible prediction. The P-values are calculated using IPA’s right-tailed Fisher’s exact 
test and -log10P-values to represent significance.  
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4.3.9.2.2 Weanling FD Female Toxicity Lists and Functional Analysis 
IPA’s Toxicity Lists and Functions were used to evaluate the most significantly 
affected toxicity pathways and associated proteins based on previously 
published evidence. Based on protein expression, the toxicity analysis provided 
identification of theorised signalling pathways with a potential predisposition 
towards disease.  
4.3.9.2.2.1 Weanling FD Female Toxicity Pathways 
Significant pathways were calculated by the increased expression of networked 
proteins in the signalling pathways with a potential predisposition towards 
disease. Excess maternal fructose intake was observed to significantly increase 
FD females hepatic protein expression, compared to CD females, upregulating 
the pathways of fatty acid metabolism (-log10P=3.81) and NRF2-mediated 
oxidative stress response (-log10P=2.91) (Table 4.6). 
Non-significant increases were observed in FD females hepatic protein 
expression, compared to CD females, upregulating the pathways of oxidative 
stress (-log10P=1.30) and pregnane X receptor/retinoid X receptor (PXR/RXR) 
activation (-log10P=1.24) compared to CD females (Table 4.6).
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4.3.9.2.3 Weanling FD Female Toxicity Pathways and Associated Proteins  
Toxicity signalling pathway of fatty acid metabolism, in FD females compared 
to CD females, was observed to have significantly increased fold change and 
upregulated protein expression of acyl-CoA dehydrogenase family member 8 
(ACAD8) (1.5-fold, P=0.05), acyl-CoA dehydrogenase very long chain 
(ACADVL) (1.6-fold, P=0.04) and peroxisomal multifunctional enzyme type 2 
(HSD17B4) (1.2-fold, P=0.01) (Table 4.6). 
Toxicity signalling pathway of NRF2-mediated oxidative stress response, in FD 
females compared to CD females, was observed to have significantly increased 
fold change and upregulated protein expression of T-complex protein 1 subunit 
eta (CCT7) (1.3-fold, P=0.05), peptidyl-prolyl cis-trans isomerase (PPIB) (1.7-
fold, P=0.02) and peroxiredoxin 1 (PRDX1) (2-fold, P=0.04) (Table 4.6). 
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Table 4.6. Weanling FD Female Toxicity Pathways and Associated Proteins 
Toxicity Pathways and Proteins Fold 
Change 
P-value Location Type(s) 
Fatty Acid Metabolism -log10P-value 3.81 
ACAD8 1.5 0.05 Cytoplasm Enzyme 
ACADVL 1.6 0.004 Cytoplasm Enzyme 
HSD17B4 1.2 0.01 Cytoplasm Enzyme 
NRF2-mediated Oxidative Stress Response -log10P-value 2.91 
CCT7 1.3 0.05 Cytoplasm Other 
PPIB 1.7 0.02 Cytoplasm Enzyme 
PRDX1 2 0.04 Cytoplasm Enzyme 
Oxidative Stress -log10P-value 1.3 
PRDX1 2 0.04 Cytoplasm Enzyme 
PXR/RXR Activation -log10P-value 1.24 
ABCB11 2.2 0.01 Plasma Membrane Transporter 
Table 4.6. Weanling FD female offspring pathways and associated proteins. Control females (n=4) and fructose females (n=5). Table represents signalling pathways with a 
potential predisposition towards disease in FD females compared to CD females. All data were analysed using Ingenuity Pathway Analysis (IPA). The P-values are calculated 
using IPA’s right-tailed Fisher’s exact test with -log10P-values to represent significance of pathological endpoint and P<0.05 to represent significance of specific protein 
expression upregulated within the pathological endpoint.
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4.3.10 Effects of Excess Maternal Fructose Intake on Key Hepatic Proteins  
Relative protein abundance was determined for key proteins identified by 
proteomic analysis and their role in lipid synthesis and metabolism, ATP 
production and diffusion of metabolites across the outer mitochondrial matrix. 
Western blot analyses were performed to determine relative protein abundance 
of oxidative phosphorylation (mitochondrial complexes I, II, III, IV and V), 
voltage-dependant anion-selective channel 1 (VDAC1), sterol regulatory 
element-binding protein-1c (SREBP-1c) and fatty acid synthase (FAS).  
Western blots for acetyl-CoA carboxylase (ACC) and carbohydrate response 
element-binding protein (ChREBP-1c) were unsuccessful following numerous 
protocols and antibodies; they could not represent reliable results for these 
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4.3.10.1 Weanling Oxidative Phosphorylation, Mitochondrial Complex-I 
No significant differences were observed between CD and FD offspring hepatic 
mitochondrial complex-I relative protein abundance (Figure 4.15). FD males 
were shown to have a decrease in relative fold change of mitochondrial 
complex-I compared to CD males, a difference of -0.31-relative fold. FD females 
were shown to have a decrease in relative fold change of mitochondrial 
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Figure 4.15. Weanling Hepatic Mitochondrial Complex-I 
 
Figure 4.15. Weanling offspring hepatic mitochondrial complex-I. Control males (n=6); fructose males 
(n=6); control females (n=6) and fructose females (n=6). A) Represents offspring hepatic mitochondrial 
complex-I relative protein abundance at d21. B) Represents Western blot image of offspring hepatic 
mitochondrial complex-I. All data were analysed using a 2x2 factorial design with diet*sex*interaction 
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4.3.10.2 Weanling Oxidative Phosphorylation, Mitochondrial Complex-II 
FD male and female offspring were shown to have significantly increased 
hepatic mitochondrial complex-II relative protein abundance compared to CD 
male and female offspring, an effect of diet (CMD, 0.04 ±0.03 vs FDM, 0.36 ±0.03 
vs CDF, 0.04 ±0.03 vs FDF 0.32 ±0.03; P<0.0001) (Figure 4.16). FD males were 
shown to have an increase in relative fold change of mitochondrial complex-II 
compared to CD males, a difference of 5.36-relative fold. FD females were 
shown to have an increase in relative fold change of mitochondrial complex-II 
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Figure 4.16. Weanling Hepatic Mitochondrial Complex-II 
 
Figure 4.16. Weanling offspring hepatic mitochondrial complex-II. Control males (n=6); fructose males 
(n=6); control females (n=6) and fructose females (n=6). A) Represents offspring hepatic mitochondrial 
complex-II relative protein abundance at d21. B) Represents Western blot image of offspring hepatic 
mitochondrial complex-II. All data were analysed using a 2x2 factorial design with diet*sex*interaction 
include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group 
mean ±SEM.*  denotes diet significance of P<0.0001. 
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4.3.10.3 Weanling Oxidative Phosphorylation, Mitochondrial Complex-III 
FD male and female offspring were shown to have significantly increased 
hepatic mitochondrial complex-III relative protein abundance compared to CD 
male and female offspring, an effect of diet (CMD, 9.80 ±0.68 vs FDM, 12.65 
±0.68 vs CDF, 7.79 ±0.68 vs FDF 10.54 ±0.68; P=0.04) (Figure 4.17). FD males 
were shown to have an increase in relative fold change of mitochondrial 
complex-III compared to CD males, a difference of 0.45-relative fold. FD 
females were shown to have an increase in relative fold change of 
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Figure 4.17. Weanling Hepatic Mitochondrial Complex-III 
 
Figure 4.17. Weanling offspring hepatic mitochondrial complex-III. Weanling offspring hepatic 
mitochondrial complex-III. Control males (n=6); fructose males (n=4); control females (n=5) and fructose 
females (n=6). A) Represents offspring hepatic mitochondrial complex-III relative protein abundance at 
d21. B) Represents Western blot image of offspring hepatic mitochondrial complex-III. All data were 
analysed using a 2x2 factorial design with diet*sex*interaction include as factors (general analysis of 
variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes significance of 
P<0.05. 
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4.3.10.4 Weanling Oxidative Phosphorylation, Mitochondrial Complex-IV 
FD male and female offspring were shown to have significantly increased 
hepatic mitochondrial complex-IV relative protein abundance compared to CD 
male and female offspring, an effect of diet (CMD, 0.015 ±0.00 vs FDM, 0.024 
±0.00 vs CDF, 0.019 ±0.00 vs FDF 0.022 ±0.00; P=0.01) (Figure 4.18). FD males 
were shown to have an increase in relative fold change of mitochondrial 
complex-IV compared to CD males, a difference of 0.29-relative fold. FD 
females were shown to have an increase in relative fold change of 
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Figure 4.18. Weanling Hepatic Mitochondrial Complex-IV 
 
Figure 4.18. Weanling offspring hepatic mitochondrial complex-IV. Control males (n=6); fructose males 
(n=6); control females (n=6) and fructose females (n=6). A) Represents offspring hepatic mitochondrial 
complex-IV relative protein abundance at d21. B) Represents Western blot image of offspring hepatic 
mitochondrial complex-IV. All data were analysed using a 2x2 factorial design with diet*sex*interaction 
include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group 
mean ±SEM.* denotes significance of P<0.05. 
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4.3.10.5 Weanling Oxidative Phosphorylation, Mitochondrial Complex-V 
FD male and female offspring were shown to have significantly increased 
hepatic mitochondrial complex-V relative protein abundance compared to CD 
male and female offspring, an effect of diet (CMD, 9.44 ±0.89 vs FDM, 13.60 
±0.89 vs CDF, 4.25 ±0.89 vs FDF 10.75 ±0.89; P<0.0001). In addition, there was a 
significant increase, an effect of sex (P=0.003), observed in CD and FD males 
compared to CD and FD females (Figure 4.19). FD males were shown to have 
an increase in relative fold change of mitochondrial complex-V compared to 
CD males, a difference of 0.66-relative fold. FD females were shown to have an 
increase in relative fold change of mitochondrial complex-V compared to CD 
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Figure 4.19. Weanling Hepatic Mitochondrial Complex-V 
 
Figure 4.19. Weanling offspring hepatic mitochondrial complex-V. Control males (n=6); fructose males 
(n=6); control females (n=6) and fructose females (n=6). A) Represents offspring hepatic mitochondrial 
complex-V relative protein abundance at d21. B) Represents Western blot image of offspring hepatic 
mitochondrial complex-V. All data were analysed using a 2x2 factorial design with diet*sex*interaction 
include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group 
mean ±SEM. * denotes diet significance of P<0.0001. 
 
 
Chapter 4  Study 2 
 190 
4.3.10.6 Weanling Hepatic VDAC1 
FD male and female offspring were shown to have significantly increased 
hepatic VDAC1 relative protein abundance compared to CD male and female 
offspring, an effect of diet (CMD, 0.09 ±0.01 vs FDM, 0.23 ±0.01 vs CDF, 0.22 
±0.01 vs FDF 0.25 ±0.01; P<0.0001) (Figure 4.20). FD males were shown to have 
an increase in relative fold change of VDAC1 compared to CD males, a 
difference of 0.61-relative fold. FD females were shown to have an increase in 
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Figure 4.20. Weanling Hepatic VDAC1 
 
Figure 4.20. Weanling offspring hepatic VDAC1. Control males (n=6); fructose males (n=6); control 
females (n=6) and fructose females (n=6). A) Represents offspring hepatic VDAC1 relative protein 
abundance at d21. B) Represents Western blot image of offspring hepatic VDAC1. All data were analysed 
using a 2x2 factorial design with diet*sex*interaction include as factors (general analysis of variance) 
using IBM SPSS statistics 25. Data presented as group mean ±SEM.*denotes significance of P<0.0001. 
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4.3.10.7 Weanling Hepatic SREBP-1c 
FD male and female offspring were shown to have significantly decreased 
hepatic SREBP-1c relative protein abundance compared to CD male and female 
offspring, an effect of diet (CMD, 158.41 ±10.01 vs FDM, 71.10 ±10.01 vs CDF, 
124.80 ±10.01 vs FDF 63.96 ±10.01; P<0.0001) (Figure 4.21). FD males were 
shown to have a decrease in relative fold change of SREBP-1c compared to CD 
males, a difference of -0.9-relative fold. FD females were shown to have a 
decrease in relative fold change of SREBP-1c compared to CD females, a 
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Figure 4.21. Weanling Hepatic SREBP-1c 
 
Figure 4.21. Weanling offspring hepatic SREBP-1c. Control males (n=6); fructose males (n=6); control 
females (n=6) and fructose females (n=6). A) Represents offspring hepatic SREBP-1c relative protein 
abundance at d21. B) Represents Western blot image of offspring hepatic SREBP-1c. All data were 
analysed using a 2x2 factorial design with diet*sex*interaction include as factors (general analysis of 
variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.*denotes significance of 
P<0.0001. 
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4.3.10.8 Weanling Hepatic FAS  
FD male and female offspring were shown to have significantly increased 
hepatic FAS relative protein abundance compared to CD male and female 
offspring, an effect of diet (CMD, 21.82 ±12.61 vs FDM, 135.74 ±12.61 vs CDF, 
46.17 ±12.61 vs FDF 80.55 ±12.61; P=0.001). In addition, there was a significant 
increase, an interaction effect of diet and sex (P=0.03), observed in FD male FAS 
relative protein abundance compared to any other group (Figure 4.22). FD 
males were shown to have an increase in relative fold change of FAS compared 
to CD males, a difference of 1.57-relative fold. FD females were shown to have 
an increase in relative fold change of FAS compared to CD females, a difference 
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Figure 4.22. Weanling Hepatic FAS 
 
Figure 4.22. Weanling offspring hepatic FAS. Control males (n=6); fructose males (n=5); control females 
(n=6) and fructose females (n=4). A) Represents offspring hepatic FAS relative protein abundance at d21. 
B) Represents Western blot image of offspring hepatic FAS. All data were analysed using a 2x2 factorial 
design with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 
25. Data presented as group mean ±SEM.* denotes significance of P<0.05. 
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4.4 Summary of FD Weanling Offspring Significant Findings  
FD Weanling Physiology 
• Offspring of fructose-fed dams were observed to weigh significantly less 
than CD offspring from day 12 to day 21.  
• Excess maternal fructose intake was observed to have significant effects 
on offspring organ absolute and proportional mass at d21. FD offspring 
were shown to have significantly decreased liver weight and 
significantly increased liver to body weight ratio, suggesting a larger 
proportion of liver tissue/g of body weight in FD offspring. FD offspring 
were shown to have significantly decreased visceral fat weight and 
visceral fat to body weight ratio.  
• At day 7 only, FD offspring displayed a significant increase in blood 
glucose concentrations. At day 21, FD male offspring OGTT blood 
glucose AUC was significantly decreased. 
• Significant increases were observed in FD offspring plasma triglycerides 
and uric acid. Additionally, FD males displayed a significant increase in 
lipase and decreased alkaline phosphatase. 
 
 
Chapter 4  Study 2 
 197 
FD Weanling Whole Blood Free Fatty Acids 
• Out of the 33 whole blood free fatty acids analysed, pentadecanoic acid, 
dma16:0, margaric acid, palmitoleic acid, total omega-7 and total 
saturates, in weanling offspring of fructose-fed dams, were observed to 
be significantly increased across all timepoints (d0, d7, d14 and d21). 
Additionally, total omega-6 in FD offspring was observed to be 
significantly decreased across all timepoints (d0, d7, d14 and d21) 
• From the remaining 26 free fatty acids analysed, significant increases 
were observed in FD offspring total trans fatty acids (at day 7, day 14 
and day 21), vaccenic acid (at day 7, day 14 and day 21) and palmitic 
acid at (day 14 and day 21).  
FD Male Weanling Hepatic Proteomic Analysis 
• Of the 313 differentially-expressed hepatic proteins identified by the 
total hepatic proteome analysis (>5,000 proteins), excess maternal 
fructose intake was observed to have significant effects on 69 proteins in 
weanling male offspring at d21.    
• Following the Canonical Pathway Analysis, excess maternal fructose 
intake was observed to significantly increase FD males hepatic protein 
expression upregulating the pathways of oxidative phosphorylation, 
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NRF2-mediated oxidative stress response and mitochondrial 
dysfunction. 
• Following the Toxicity Lists and Functions analysis, excess maternal 
fructose intake was observed to significantly increase FD males hepatic 
protein expression upregulating the signalling pathways with a 
potential predisposition towards disease. The toxicity pathways include 
mitochondrial dysfunction, NRF2-mediated oxidative stress response, 
CAR/RXR activation and xenobiotic metabolism signalling. 
FD Female Weanling Hepatic Proteomic Analysis 
• Of the 313 differentially-expressed hepatic proteins identified by the 
total hepatic proteome analysis (>5,000 proteins), excess maternal 
fructose intake was observed to have significant effects on 42 proteins in 
weanling female offspring at d21.  
• Following the Canonical Pathway Analysis, excess maternal fructose 
intake was observed to significantly increase FD females hepatic protein 
expression upregulating the pathways of fatty acid b-oxidation I and 
NRF2-mediated oxidative stress response. 
• Following the Toxicity Lists and Functions analysis, excess maternal 
fructose intake was observed to significantly increase FD females hepatic 
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protein expression upregulating the signalling pathways with a 
potential predisposition towards disease. The toxicity pathways include 
fatty acid metabolism and NRF2-mediated oxidative stress response.  
FD Weanling Western Blot Analysis 
• Excess maternal fructose intake was observed to have significant effects 
on male and female offspring relative protein abundance of key proteins 
identified by proteomic analysis and their role in lipid synthesis and 
metabolism, ATP production and diffusion of metabolites across the 
outer mitochondrial matrix. Significant effects in both FD male and FD 
female offspring were shown by significant increases in oxidative 
phosphorylation mitochondrial complexes II, III, IV and V, VDAC1, FAS 
and a significant decrease in SREBP-1c. 
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4.5 Discussion: Effects of Excess Maternal Fructose Intake on Weanling 
Metabolic Status 
Maternal nutrition during critical windows of plasticity has shown how an 
offspring’s health or susceptibility to disease during adulthood may be 
influenced by a maternal diet high in fructose and refined sugars. Few 
researchers have studied phenotypes showing marked effects on metabolic 
status, insulin sensitivity, glucose metabolism and hepatic dysfunction in 
animals and humans following acute fructose consumption (D.-M. Zhang et al., 
2017, Lee et al., 2018, Bidwell, 2017, Lustig et al., 2012, Dekker et al., 2010). 
Moreover, studies have also demonstrated that these effects can be 
‘programmed’ in the offspring of mothers consuming moderate levels of 
fructose during pregnancy, despite never consuming fructose themselves 
(Clayton et al., 2015, Regnault et al., 2013, Rawana et al., 1993). Furthermore, 
continued exposure to increased consumption of dietary fructose throughout 
life and especially in adulthood has the potential to increase these detrimental 
effects of in utero excess fructose exposure throughout life. Data presented in 
this thesis offers a number of novel findings to existing knowledge of excess 
maternal fructose intake and subsequent offspring disease risk. Furthermore, 
we reproduce and support some of the previously published findings from 
other researchers, detailing the potential adverse effects of fructose intake on 
maternal metabolic health and aspects of offspring metabolism. 
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Despite dams not having access to fructose during lactation in the current 
study, we show a reduced pup weight from d12-21. Zou et al. reported a 
reduction in pup weight over time from mothers that were fed fructose (63%) 
during pregnancy and lactation (Zou et al., 2012). Similarly, Rawana et al. 
reported reduced body weight and total litter weight at weaning in offspring of 
dams consuming 10% fructose (w/v) during pregnancy and lactation (Rawana 
et al., 1993). In contrast to our study, showing no differences in offspring birth 
weight, Alzamendi et al. reported that at d20 of gestation fetal:placental ratio 
was increased in dams fed 10% (w/v) fructose solution throughout pregnancy, 
suggesting that fructose offspring were heavier than the control group 
(Alzamendi et al., 2009). There is evidence to suggest that fructose intake is 
linked with inappropriate vascularisation of the placenta and further studies 
have shown irregularities in the zonal regions of the placenta (Vickers et al., 
2011). This may suggest a potential mechanism by which maternal fructose 
intake has deleterious effects on vascularisation in the placenta and nutrient 
transfer, contributing to reducing neonatal growth trajectory.  
We also show significantly increased plasma UA and TAG concentrations in 
fructose offspring at weaning, despite these pups never consuming fructose 
themselves. These results are likely to be a consequence of a) fructose dams and 
offspring producing high concentrations of UA due to the metabolic effects of 
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higher circulating FFA, which is causal of increased intracellular ATP resulting 
from excessive fructose (Gibson et al., 1983, Fox & Kelley, 1972), and/or b) UA 
is transferred to the fetus during pregnancy from the mother via the placenta. 
UA has been shown to cross the placenta freely, and increased exposure to UA 
in utero may potentially affect physiological set-points in the developing fetus 
(Laughon, Catov, Powers, Roberts, & Gandley, 2011, Asghar et al., 2016, 
Nakagawa et al., 2006). In the current study, increased uric acid observed in 
offspring is also likely to be a consequence of dyslipidemia and unregulated 
circulating FFA and potentially dysfunctional β-oxidation and increased 
accumulation of intracellular ATP in the offspring. However, which pathway is 
more likely to be playing the primary role in the current study is unknown at 
this stage. However, our proteomic and western blot analysis shows that this is 
likely a combination of the above factors and are multifactorial in nature as we 
have observed significant changes in all of these pathways in weanling and 
adult fructose offspring, which will be discussed in Chapter 5 (Offspring 
Programming of Hepatic and Mitochondrial Dysfunction in Weanling and 
Adult Offspring).  
FFA during fasting or in the absence of glucose are released from adipose 
tissue and are primarily metabolised by skeletal muscle and the liver (Boden, 
2008). It is well established that chronically increased levels of circulating FFA 
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can increase the risk of obesity, hepatic lipid deposition, insulin resistance, type 
2 diabetes and cardiovascular disease (Capurso & Capurso, 2012), and 
increased fatty acid synthesis has been shown to occur following fructose 
consumption (K. L. Stanhope & Havel, 2008, Zavaroni, Chen, & Reaven, 1982, 
(Vrána, Fábry, Slabochová, & Kazdová, 1974). The effect of fructose on fatty 
acid synthesis is likely to be dose-dependent due to the lipogenic effects of 
fructose. Long-term increases in circulating FFA have also been shown in 
offspring of mothers fed diets high in sucrose and high fructose corn syrup-
55(HFC-55). Toop et al. showed increased hepatic lipid composition and 
content in fructose offspring (Toop, Muhlhausler, O’Dea, & Gentili, 2017). They 
went on to hypothesise that increased hepatic de novo lipogenesis was caused, 
in part, by increased circulating FFA. In the current study, increases in FFAs 
were observed in pentadecanoic acid, dma16:0, margaric acid, palmitoleic acid, 
total omega-7 and total saturates and a decrease in total omega-6. More 
importantly, fructose offspring whole blood displayed these specific changes in 
whole blood FFA at day 0, when samples were taken prior to their first feed 
and before receiving any milk from the mother. These increases and decreases 
in circulating FFA were consistently significantly higher at all other time points 
(day 7, 14 and 21). This clearly indicates an in utero metabolic programming of 
offspring FFA metabolism. We would suggest that following breastfeeding, 
specific changes in milk FFA composition, as a result of gestational fructose 
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intake, may further contribute to the already increased circulating FFA profile 
observed in fructose offspring. This may indicate an additional route by which 
offspring are further exposed to the deleterious effects of maternal fructose-
feeding despite the mothers never receiving fructose during lactation. 
Our findings are of particular importance because of the consistency in the 
increase of specific FFA observed. Prolonged changes to FFA may also be a 
consequence of dysfunctional adipose lipolysis and altered β-oxidation 
function (Capurso & Capurso, 2012). Additionally, the specific type of FFA 
increases also has important metabolic implications (Puri et al., 2007). The 
majority of the FFA observed to be consistently increased in fructose offspring, 
and maternal milk were long-chain fatty acids which are primary components 
of storage triglycerides. The majority of saturated fats elevated in offspring 
whole blood are associated with hyperglycemia, hyperinsulinemia and insulin 
resistance. Chronic elevations of circulating FFA augment fat storage, insulin 
resistance and development of metabolic disease (Capurso & Capurso, 2012). 
Our results provide evidence of excess maternal fructose intake, closely 
resembling average human consumption, affects weanling offspring metabolic 
status and increases lipid synthesis and potentially the predisposition to 
metabolic disease in later-life.  
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To identify any underlying in utero programmed changes to hepatic molecular 
phenotype and proteomic signalling pathway activation or inhibition that may 
predispose offspring of maternally fructose-fed dams to metabolic diseases 
such as obesity, type 2 diabetes and NAFLD, we performed proteomics using 
the gold standard of LC-MS/MS technologies. 
Proteomics has the ability to identify and quantify all proteins of any given 
proteome. The ever-improving capabilities of proteomics analysis have been 
driven by the development of new technologies for peptide/protein separation, 
mass spectrometry and bioinformatic data analysis. In addition, dependent on 
extraction protocols and data analysis, this can also include expression, cellular 
localization, interactions, post-translational modifications and the ability to 
explore methylation profiles. In the current study, we chose to investigate 
relative expression of the complete hepatic proteome in offspring livers at 
weaning (d21) and adulthood (4 month). This is the first study of its kind; 
therefore, we employed a proteome-wide shotgun/bottom-up proteomic 
analysis to investigate any possible changes in protein expression that may or 
may not be observed. 
Following our analysis of the hepatic proteome, the main parameter for 
selection of a protein for validation was the role it may play in lipid metabolism 
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and mitochondrial function, and where possible, previously validated in the 
guinea pig. The secondary parameter was to select target proteins whose fold 
change was high enough in the pathways of interest that it may be further 
validated by Western blot. In the current study, we ran our samples in triplicate 
to further strengthen our observed results. This was also to ensure the potential 
impacts, if any, of technical and/or biological variance identified by the LC-
MS/MS. Since our datasets were derived from triplicate runs rather than in 
duplicate and from individual animals numbering a minimum of 6 per group, 
we are confident that our proteomic analysis and results are robust. The 
proteins identified and changes in expression associated with in utero excess 
fructose exposure were expected to be similar and were significantly similar 
throughout all 3 runs, giving us maximum confidence to proceed to data, 
network and pathway analysis. The significant overlap of the identified 
proteins reduced further when the data was filtered to retain only proteins with 
a P<0.05 and fold change of more ≥20% (Fold Change = 0.80 to 1.2). Targets 
identified for Western blot analysis included proteins identified in the dataset 
and key proteins that may play significant roles in the activation of pathways 
subsequently identified by Ingenuity Pathway Analysis. Functional analysis of 
the proteins suggested that the up-regulated proteins increased activation of 
metabolic pathways mainly involved in β-oxidation, oxidative phosphorylation 
Chapter 4  Study 2 
 207 
and mitochondrial function in fructose offspring livers. Using Western blots, 
we show the presence of key proteins observed in LC-MS/MS. 
We have shown consistent altered hepatic proteome expression profiles in both 
males and females of d21 weanling and 4M adult offspring of maternally 
fructose-fed dams. Therefore, we discuss the apparent programmed changes 
and the overlap in proteomic signalling pathway activation and protein 
abundance of key proteins in both weanling and adult offspring in chapter 5 
(Offspring Programming of Hepatic and Mitochondrial Dysfunction in 
Weanling and Adult Offspring). 
Despite dams not having access to fructose during lactation in the current 
study, nor did offspring consume added fructose themselves, data in this 
chapter shows that excess fructose exposure in utero significantly alters 
weanling offspring physiology, weight gain, liver and visceral fat weights,  
metabolic status, lipid synthesis and metabolism, mitochondrial function and 
expression of networked proteins in the signalling pathways. These underlying 
‘asymptomatic’ changes in molecular and physiological phenotype may lead to 
an increased predisposition to further or sustained metabolic dysregulation in 
offspring during adult life. The following chapter (chapter 5) investigates how 
the altered maternal metabolic status may affect adult offspring physiology, 
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metabolic status, lipid synthesis and metabolism and mitochondrial function 
following excess fructose exposure in utero.   
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The Effects of Excess Maternal Fructose Intake on 
Adult Offspring 
5.1 Study 3 Aims 
The aims of Study 3 were to investigate the long-term programmed effects of 
excess fructose exposure in utero on adult offspring physiology, weight gain 
and organ weights, hepatic lipid deposition, visceral fat morphology, metabolic 
status, lipid synthesis and metabolism and mitochondrial function. To identify 
the offspring programmed effects of excess fructose exposure in utero, we 
conducted adult assessments. Adults were assessed to determine programmed 
effects of excess fructose exposure in utero on weight gain from d21 to 4M, body 
composition and liver and visceral fat weights. Programmed variations in adult 
offspring hepatic lipid deposition and visceral fat morphology were measured. 
Programmed alterations to adult offspring metabolic status were determined 
by measuring plasma glucose and insulin concentrations and key plasma 
metabolites. Programmed variations in metabolic function were evaluated by 
characterising hepatic protein expression and abundance. Further analyses to 
determine the long-term effects of excess fructose exposure in utero on key 
proteins involved in lipid synthesis and metabolism and mitochondrial 
function were also evaluated.  
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5.2 Protocol  
The offspring protocol used in study 3 (Figure 5.1) was followed until d21. 
Upon completion of the OGTT at d21, adult offspring (CD males (n= 7); FD 
males (n=9); CD females (n=7); and FD females (n=6)) were weaned, separated 
by sex, fed a control diet of standard guinea pig pellets, fresh silverbeet and 
carrots and Millipore filtered water supplemented with 1.2g/L of ascorbic acid 
and weighed twice weekly until 4M of age. OGTTs were performed at d21, 2M 
and 4M of age. Following the 4M OGTT, adult offspring underwent a DXA 
scan. Upon completion of the DXA scan, all offspring were euthanized and 
blood and tissues samples were collected for further analysis (Figure 5.1). 
Detailed descriptions of all study 3 measurements, protocols and techniques for 
analysis of physiology, DXA scans weight gain and organ weights, hepatic 
lipid deposition, visceral fat morphology, metabolic status, lipid synthesis and 
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Figure 5.1. Study 3: Offspring 4 Months (Adult) Protocol 
 
Figure 5.1. Diagram represents the work flow undertaken throughout study three. CD and FD offspring 
were randomly allocated to adult groups CD males (n= 7); FD males (n=9); CD females (n=7); and FD 
females (n=6). At day 21, 2-months and 4-months of age, offspring underwent OGTTs were a baseline and 
serial blood collections, following glucose load, were collected. Upon completion of the OGTT at day 21, 
all offspring were weaned, separated by sex and fed a control diet throughout the remainder of the 
experiment. Following the final OGTT at 4M of age, offspring underwent a DXA scan. Upon completion 
of the DXA scan, all offspring were humanely euthanized and blood samples and tissues were collected. 
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5.3 Results 
5.3.1 Effects of Excess Maternal Fructose Intake on Adult Offspring Weight 
Gain 
Offspring weights were taken twice weekly from 3w to 16w of age to 
determine any effect of dams excess maternal fructose intake on growth 
trajectory. CD and FD male offspring were observed to have a significant 
increase in weight gain compared to CD and FD female offspring, an effect of 
sex (P<0.0001) (Figure 5.2).  
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Figure 5.2. Effects of Excess Maternal Fructose Intake on Adult Offspring Weight Gain 
 
Figure 5.2. Adult offspring weight gain from week 3 to week 16. Control males (n=7); fructose males (n=7); control females (n=7) and fructose females (n=7). Significant effects 
were shown in sex of offspring weight gain. All data were analysed using a 2x2 factorial design with repeated measures GEE, diet*sex*time*interaction included as factors 
(general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ± SEM.* denotes significance of P<0.0001.
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5.3.2 The Effects of Excess Maternal Fructose Intake on Adult OGTT 
Glucose and Insulin 
To assess the long-term effects of excess maternal fructose consumption on 
adult offspring OGTT blood glucose and insulin concentrations and whole-
body insulin sensitivity, an OGTT analysis was performed at 4M in offspring. 
No significant differences were observed between CD and FD male offspring 
OGTT glucose and insulin concentrations (Figure 5.3A and 5.3B). No significant 
differences were observed between CD and FD female offspring OGTT glucose 
and insulin concentrations (Figure 5.3C and 5.3D).  
At specific time points during the OGTT, there were no significant differences 
observed in glucose concentration between CD and FD male offspring (Figure  
5.3A; Table 5.1). However, there was a non-significant decrease in insulin 
concentration in FD male offspring compared to CD males at 120mins (CDM, 
2.18 ± 0.30 vs FDM, 1.44 ± 0.19; P=0.07) (Figure 5.3B; Table 5.1).  
There was a non-significant increase in FD female offspring OGTT blood 
glucose concentration compared to CD females at 75min (CDF, 11.06 ±0.64 vs 
FDF, 9.60 ±0.35; P=0.07) (Figure 5.3C; Table 5.1). No significant differences were 
observed between CD and FD female offspring insulin concentrations at any 
specific time point during the OGTT (5.3D; Table 5.1).  
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M-ISI was calculated to evaluate whole-body insulin sensitivity. No significant 
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Figure 5.3. Adult OGTT Blood Glucose and Plasma Insulin AUC 
 
Figure 5.3. Adult offspring OGTT glucose AUC and insulin AUC. A) Represents male offspring blood 
glucose AUC in response to OGTT at 4M. B) Represents female offspring blood glucose AUC in response 
to OGTT at 4M. C) Represents male offspring plasma insulin AUC in response to OGTT at 4M. D) 
Represents female offspring plasma insulin AUC in response to OGTT at 4M. Control males (n=6); 
fructose males (n=6); control females (n=6) and fructose females (n=6). All data were analysed as a 2x2 
factorial design with diet*sex*interaction as factors included (generalized linear model analysis) using 
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Blood Glucose (mmol/L) 
Baseline Control 6.94 ± 0.21 
0.78 
6.56 ± 0.14 
0.10 
 Fructose 6.83 ± 0.29 6.93 ± 0.14 
30mins Control 13.68 ± 0.93 
0.51 
11.18 ± 0.75 
0.68  Fructose 12.80 ± 0.92 11.63 ± 0.77 
45mins Control 15.00 ± 1.40 
0.95 
12.50 ± 0.80 
0.53 
 Fructose 15.10 ± 1.10 11.66 ± 1.00 
60mins Control 14.41 ± 1.20 
0.63 
11.64 ± 0.88 
0.41 
 Fructose 15.23 ± 1.14 10.80 ± 0.51 
75mins Control 13.11 ± 1.33 
0.57 
11.06 ± 0.64 
0.07 
 Fructose 14.11 ± 1.07 9.60 ± 0.35 
90mins Control 11.33 ± 1.10 
0.73 
8.68 ± 0.39 
0.62 
 Fructose 11.93 ± 1.35 8.38 ± 0.41 
120mins Control 7.78 ± 0.42 
0.98 
6.94 ± 0.26 
0.88 
 Fructose 7.80 ± 0.78 7.00 ± 0.31 
180mins Control 6.50 ± 0.10 
1.00 
6.30 ± 0.22 
0.20 
 Fructose 6.50 ± 0.09 6.86 ± 0.35 
Plasma Insulin (µU/ml) 
Baseline Control 2.13 ± 0.41 0.62 2.15 ± 0.45 0.90 
 Fructose 1.85 ± 0.37 2.23 ± 0.49 
30min Control 2.02 ± 0.33 
0.22 
2.35 ± 0.41 
0.45 
 Fructose 1.53 ± 0.19 1.84 ± 0.48 
45min Control 1.88 ± 0.31 
0.19 
2.54 ± 0.33 
0.17  Fructose 1.40 ± 0.13 1.77 ± 0.40 
60mins Control 1.74 ± 0.38 
0.56 
2.26 ± 0.32 
0.20 
 Fructose 1.46 ± 0.26 1.63 ± 0.33 
75mins Control 1.38 ± 0.15 
0.82 
2.35 ± 0.45 
0.26 
 Fructose 1.44 ± 0.19 1.66 ± 0.36 
90mins Control 1.71 ± 0.27 
0.39 
2.44 ± 0.39 
0.13 
 Fructose 1.40 ± 0.20 1.58 ± 0.87 
120mins Control 2.18 ± 0.30 
0.07 
2.40 ± 0.51 
0.32 
 Fructose 1.44 ± 0.19 1.73 ± 0.39 
180mins Control 1.98 ± 0.19 
0.24 
2.38 ± 0.39 
0.33 
 Fructose 1.61 ± 0.23 1.80 ± 0.53 
Matsuda-ISI 
 Control 3.38 ± 0.50 
0.33 
3.61 ± 0.67 
0.50 
 Fructose 4.11 ± 0.51 4.35 ± 0.86 
 
Table 5.1. Adult offspring OGTT Glucose, Insulin and Matsuda-ISI. Adult offspring OGTT Glucose, 
Insulin and Matsuda-ISI. Control males (n=6); fructose males (n=6); control females (n=6) and fructose 
females (n=6). All data were analysed using an independent T-test using IBM SPSS statistics 25. Data 
presented as group mean ± SEM. 
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5.3.3 Effects of Excess Maternal Fructose Intake on Adult Whole Blood 
Fatty Acid Composition 
To examine the effects of excess maternal fructose consumption on offspring 
whole blood FFA composition, a dried blood spot was collected at 4M and a 
lipidomic analysis was performed. Excess maternal fructose intake was 
observed to have significant effects on offspring FFA composition, such that, 
out of the 33 whole blood FFA analysed, a significant diet effect was observed 
in palmitoleic acid (P=0.05), total omega-7 (P=0.05), alpha-linolenic acid (ALA) 
(P=0.05), total omega-3 (P=0.04) and total monosaturated FFA (P=0.05) in males 
and females of FD dams at 4M (Figure 5.4; Table 5.2).  
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Figure 5.4. Adult Fructose Offspring Whole Blood Free Fatty Acids  
 
Figure 5.4. FFA in fructose adult offspring whole blood. Control males (n=7); fructose males (n=9); control females (n=7) and fructose females (n=6). Figure represents offspring 
month 4 whole blood FFA.  Palmitoleic acid (16:1n-7), Total omega-7 (ω-7), alpha linolenic acid (ALA), total omega-3 (ω-7). All data were analysed using a 2x2 factorial design 
with diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes significance of P<0.05. 
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From the remaining 28 FFA analysed, there were significant effects in 
eicosapentaenoic acid, linoleic acid (LA), myristic acid, arachidic acid, total 
trans FFA, gondoic acid, gamma-linolenic acid (GLA) and dihomo- γ-linolenic 
acid (DGLA) at 4M. The remaining FFA were not significant between CD and 
FD offspring (Table 5.2). Eicosapentaenoic acid was significantly increased in 
CD and FD females compared to their CD and FD counterparts, an overall 
effect of sex (P=0.05). Linoleic acid was observed to be significantly increased in 
FD females compared to any other group, an interaction effect of diet and sex 
(P=0.03). Myristic acid was significantly decreased in FD male and female 
offspring compared to CD male and female offspring, an effect of diet (P=0.01). 
Arachidic acid was significantly increased in FD males compared to CD males, 
and FD females were significantly decreased compared to any other group, an 
interaction effect (P=0.001). Total trans FFA were significantly increased in FD 
male and FD female offspring compared to CD males and CD females, an effect 
of diet (P=0.04). Gondoic acid was significantly increased in FD males 
compared to any other group, and FD females were significantly decreased 
compared to CD females, an interaction effect (P=0.002). Gamma-linolenic acid 
was significantly decreased in FD males and FD females compared to CD males 
and females, an effect of diet (P=0.003). Dihomo- γ-linolenic acid was 
significantly increased in CD female and FD female offspring compared to CD 
male and FD male offspring, an effect of sex (P=0.05).
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Table 5.2. Adult Whole Blood Free Fatty Acids 





Palmitoleic acid (16:1n-7) Male 0.89 ±0.04  1.11 ±0.04*  
  Female 1.04 ±0.04  0.88 ±0.04*  
Total Omega-7 Male 1.90 ±0.05  2.14 ±0.05*  
  Female 2.00 ±0.05  1.83 ±0.05*  
ALA (18:3n-3) Male 2.41 ±0.11  1.91 ±0.11*  
  Female 2.06 ±0.11  2.50 ±0.11*  
Total Omega-3 Male 5.00 ±0.12  4.66 ±0.12*  
  Female 4.58 ±0.12  5.28 ±0.12* 
Total Monosaturated fats Male 13.28 ±0.42  14.57 ±0.42*  
  Female 15.45 ±0.42  13.31 ±0.42*  
EPA (20:5n-3) Male 0.14 ±0.01  0.15 ±0.01  
  Female 0.22 ±0.01*  0.20 ±0.01*  
LA (18:2n-6) Male 19.86 ±0.40  19.31 ±0.40  
  Female 18.05 ±0.40*  21.04 ±0.40*  
Total Saturates Male 48.09 ±0.32*  48.52 ±0.32*  
  Female 46.92 ±0.32  46.65 ±0.32  
Myristic acid (14:0) Male 1.04 ±0.04  0.17 ±0.04*  
 Female 0.95 ±0.04  0.80 ±0.04*  
Arachidic acid (20:0) Male 0.68 ±0.19  0.76 ±0.19*  
  Female 0.79 ±0.19  0.62 ±0.19*  
Total Trans Fatty acids Male 0.65 ±0.09  1.01 ±0.09*  
 Female 0.68 ±0.09  1.15 ±0.09*  
Gondoic Acid (20:1n-9) Male 0.48 ±0.08  1.14 ±0.08*  
 Female 0.83 ±0.08  0.52 ±0.08*  
GLA (18:3n-6) Male 0.22 ±0.01  0.13 ±0.01*  
 Female 0.18 ±0.01  0.13 ±0.01*  
DGLA (20:3n-6) Male 0.36 ±0.01  0.37 ±0.01  
 Female 0.43 ±0.01*  0.43 ±0.01*  
Margaric acid (17:0) Male 1.45 ±0.02  1.45 ±0.02  
 Female 1.36 ±0.02  1.37 ±0.02  
DHA (22:6n-3) Male 0.45 ±0.02  0.54 ±0.02  
 Female 0.56 ±0.02  0.56 ±0.02  
Pentadecanoic acid (15:0) Male 0.84 ±0.04  0.90 ±0.04  
 Female 0.83 ±0.04  0.69 ±0.04  
dma16:0 Male 0.40 ±0.06  0.72 ±0.06  
 Female 0.50 ±0.06  0.44 ±0.06  
Total Omega-6 Male 31.32 ±0.49  31.07 ±0.49  
 Female 30.83 ±0.49  33.58 ±0.49  
Vaccenic acid (t18:1n-7) Male 0.28 ±0.01  0.36 ±0.01  
 Female 0.28 ±0.01  0.31 ±0.01  
Palmitic acid (16:0) Male 15.50 ±0.19  15.26 ±0.19  
 Female 15.20 ±0.19  15.64 ±0.19  
Elaidic acid (t18:1n-9) Male 0.21 ±0.01  0.19 ±0.01  
 Female 0.24 ±0.01  0.20 ±0.01  
dma18:0 Male 0.42 ±0.08  0.85 ±0.08  
 Female 0.45 ±0.08  0.54 ±0.08  
Behenic acid (22:0) Male 0.94 ±0.04  0.94 ±0.04  
  Female 1.04 ±0.04  0.92 ±0.04  
Continued…    
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Table 5.2. 





Adrenic acid (22:4n-6) + 
Docosatrienoate acid (22:3n-3) Male 2.32 ±0.05  2.27 ±0.05  
  Female 2.24 ±0.05  2.20 ±0.05  
AA (20:4n-6) Male 8.62 ±0.15  8.47 ±0.15  
 Female 8.57 ±0.15  8.97 ±0.15  
DPA (22:5n-3) Male 2.15 ±0.06  1.91 ±0.06  
 Female 1.97 ±0.06  1.97 ±0.06  
Cis-Vaccenic acid (18:1n-7) Male 0.97 ±0.01  0.98 ±0.01  
 Female 0.97 ±0.01  0.97 ±0.01  
Eicosadienoic acid (20:2n-6) Male 0.77 ±0.02  0.74 ±0.02  
 Female 0.66 ±0.02  0.71 ±0.02  
Lignoceric acid (24:0) Male 1.65 ±0.06  1.67 ±0.06  
  Female 1.79 ±0.06  1.77 ±0.06  
Stearic acid (18:0) Male 24.75 ±0.32  25.33 ±0.32   
 Female 23.47 ±0.32  24.17 ±0.32  
Oleic acid (18:1n-9) Male 9.59 ±0.18  9.77 ±0.18  
  Female 10.16 ±0.18  10.40 ±0.18  
Total Omega-9 Male 10.42 ±0.19  10.94 ±0.19  
 Female 11.46 ±0.19  10.95 ±0.19  
 
Table 5.2. FFA in fructose adult offspring whole blood at month 4. Control males (n=7); fructose males 
(n=9); control females (n=7) and fructose females (n=6). All data were analysed using a 2x2 factorial design 
with diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. 
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5.3.4 Effects of Excess Maternal Fructose Intake on Adult Plasma 
Metabolites 
Key plasma metabolites were analysed at 4M to examine the effects of excess 
maternal fructose consumption on weanling plasma metabolite markers of 
fructose and lipid metabolism. TAG concentrations were observed to be 
significantly increased in FD males and FD females, an effect of diet, compared 
to CD males and females (P=0.03), additionally there was an effect of sex 
(P=0.007) with increased concentrations in CD and FD female offspring 
compared to CD and FD male offspring. A significant effect of sex was 
observed in CD and FD female offspring compared to CD and FD male 
offspring with increased CHOL (P=0.006) and LDL (P=0.04). FRU 
concentrations were significantly increased in FD females compared to any 
other group or sex, an interaction effect of diet and sex (P=0.05). ALP 
concentrations were significantly decreased in FD male and female offspring 
compared to their CD counterparts (P=0.05). (Table 5.3) 
No significant differences were observed between CD and FD offspring for 
HDL, UA, LIP, hs-CRP, ALT, GGT or ELISA test leptin (Table 5.3). Cobas 
analysis for plasma concentrations of Lipoprotein A, APOAT, APOBT, IGA, 
GLDH provided unreliable and non-detectable results and was dropped from 
analysis.  
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TAG (mmol/L) Male 0.55 ±0.05 0.62 ±0.05* 
 Female 0.69 ±0.05* 1.05 ±0.05*,* 
CHOL (mmol/L) Male 0.72 ±0.05 0.98 ±0.05 
 Female 0.82 ±0.05* 1.12 ±0.05* 
LDL (mmol/L) Male 0.67 ±0.05 0.71 ±0.05 
 Female 0.88 ±0.05* 0.96 ±0.05* 
FRUC (umol/L) Male 240.16 ±6.57 222.57 ±6.57 
 Female 239.00 ±6.57 270.80 ±6.57* 
ALP (U/L) Male 13.33 ±1.37 4.88 ±1.37* 
 Female 5.16 ±1.37 3.50 ±1.37* 
HDL (mmol/L) Male 0.03 ±0.00 0.41 ±0.00 
 Female 0.03 ±0.00 0.05 ±0.00 
UA (µmol/L Male 16.33 ±2.18 24.88 ±2.18 
 Female 21.50 ±2.18 26.83 ±2.18 
LIP (U/L) Male 6.20 ±0.81 10.18 ±0.81 
 Female 6.88 ±0.81 07.31 ±0.81 
hs-CRP (mg/L) Male 0.10 ±0.01 0.09 ±0.01 
 Female 0.14 ±0.01 0.09 ±0.01 
ALT (U/L) Male 72.82 ±9.13 99.33 ±9.13 
 Female 66.50 ±9.13 91.51 ±9.13 
GGT (U/L) Male 171.80 ±15.93 168.85 ±15.93 
 Female 89.40 ±15.93 156.75 ±15.93 
Leptin (ng/nL) Male 4.85 ±0.41 3.98 ±0.41 
 Female 3.93 ±0.41 4.34 ±0.41 
 
Table 5.3. Adult offspring plasma metabolites at 4M. Control males (n=7); fructose males (n=9); control 
females (n=7) and fructose females (n=6). All data were analysed using a 2x2 factorial design with 
diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data 
presented as group mean ±SEM.* denotes significance of P<0.05; **denotes significance of P<0.0001. 
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5.3.5 Effects of Excess Maternal Fructose Intake on Adult DXA Body 
Composition 
5.3.5.1 Adult Bone Mineral Content and Density  
To determine any effects of excess maternal fructose intake on offspring body 
composition, whole-body DXA scan analyses were performed at age 4M. 
Excess maternal fructose intake was observed to have significant effects on 
adult offspring bone mineral content (BMC) and bone mineral density (BMD). 
FD males and FD females had significantly decreased BMC compared to CD 
offspring, an effect of diet (CDM, 24.28 ±0.46 vs. FDM, 22.96 ±0.46 vs. CDF, 19.6 
±0.46 vs. FDF, 18.98 ±0.46g; P=0.05). As would be expected, there was a 
significant increase in CD and FD male BMC and BMD compared to CD and 
FD females, an effect of sex (P<0.0001 in both cases) (Figure 5.5A and 5.5B). 
However, FD males and females had significantly decreased BMD compared to 
CD offspring, an effect of diet (CDM, 0.24 ±0.00 vs. FDM, 0.23 ±0.00 vs. CDF, 
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Figure 5.5. Adult Offspring Bone Mineral Content and Bone Mineral Density  
 
Figure 5.5. Adult Offspring Bone Mineral Content and Bone Mineral Density. Control males (n=6); fructose males (n=9); control females (n=7) and fructose females (n=6). A) 
Represents adult offspring bone mineral content at month 4. B) Represents adult offspring bone mineral density at month 4. All data were analysed using a 2x2 factorial design 
with diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ± SEM.* denotes significance of P<0.05. 
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5.3.5.2 Adult Fat, Lean, Total Mass and Weight 
There was a significant increase in CD and FD female fat mass compared to CD 
and FD males, an effect of sex (CDM, 74.10 ±4.44 vs. FDM, 67.02 ±4.44 vs. CDF, 
94.85 ±4.44 vs. FDF, 104.54 ±4.44g; P<0.0001) (Figure 5.6A). As expected, a sex 
effect was observed in CD and FD male offspring compared to CD and FD 
females with significantly increased lean mass (CDM, 687.99 ±14.0 vs. FDM, 
669.47 ±14.0 vs. CDF, 548.24 ±14.0 vs. FDF, 563.04 ±14.0g; P<0.0001), total mass 
(CDM, 786.39 ±13.43 vs. FDM, 753.92 ±13.43 vs. CDF, 667.00 ±13.43 vs. FDF, 
669.90 ±13.43g; P<0.0001) and body weight (CDM, 0.78 ±0.05 vs. FDM, 0.75 
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Figure 5.6. Adult Offspring Fat, Lean, Total Mass and Weight  
 
Figure 5.6. Adult Offspring fat mass, lean mass, total mass and weight. Control males (n=6); fructose 
males (n=9); control females (n=7) and fructose females (n=6). A) Represents adult offspring fat mass at 
month 4. B) Represents adult offspring lean mass at month 4. C) Represents adult offspring total mass at 
month 4. D) Represents adult offspring weight at month 4. All data were analysed using a 2x2 factorial 
design with diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS 
statistics 25. Data presented as group mean ± SEM.* denotes significance of P<0.05.  
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Figure 5.7. Adult Offspring DXA Scans 
 
Figure 5.7. Adult offspring DXA scan images at month 4.Control males (n=6); fructose males (n=9); control 
females (n=7) and fructose females (n=6). A) Represents control male DXA scan image. B) Represents 
fructose male DXA scan image. C) Represents control female DXA scan image. D) Represents fructose 
female DXA scan image.  
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5.3.6 Effects of Excess Maternal Fructose Intake on Adult Organ Weights 
To examine the effects of excess maternal fructose consumption on adult 
offspring organ weights, specifically, liver and visceral fat, tissue mass was 
analysed as absolute wet weight and proportionate weight (i.e., relative to total 
body weight) at 4M. Excess maternal fructose intake was observed to have 
significant effects on offspring organ absolute and proportional mass at 4M. 
Further analysis of adult offspring organ weights (brain, heart, kidney and 
adrenal and subcutaneous fat) are provided in the Appendix. 
5.3.6.1 Adult Liver Weight and Liver to Body Weight Ratio 
FD male and female offspring liver weight were shown to have significantly 
increased liver weight compared to CD counterparts, an effect of diet (CDM, 
22.30 ±0.56 vs. FDM, 23.73 ±0.56 vs. CDF, 18.88 ±0.56 vs. FDF, 21.65 ±0.56g; 
P=0.02). In addition, there was a significant increase in CD and FD male 
offspring liver weight compared to CD and FD females, an effect of sex 
(P=0.006) (Figure 5.8A). FD male and females offspring liver to body weight 
ratio was shown to be significantly increased compared to CD counterparts, an 
effect of diet (CDM, 0.02 ±0.00 vs. FDM, 0.03 ±0.00 vs. CDF, 0.02 ±0.00 vs. FDF, 
0.03 ±0.00g; P=0.02) (Figure 5.8B). 
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Figure 5.8. Adult Liver Weight and Liver to Body Weight Ratio 
 
Figure 5.8. Adult Offspring liver weight and brain to liver weight ratio. Control males (n=5); fructose males (n=7); control females (n=6) and fructose females (n=6). A) 
Represents offspring liver weight at month 4. B) Represents offspring liver to body weight ratio at month 4. All data were analysed using a 2x2 factorial design with 
diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ± SEM.* denotes significance of P<0.05. 
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5.3.6.2 Adult Visceral Fat Weight and Visceral Fat to Body Weight Ratio 
CD and FD females were observed to have significantly increased visceral fat 
weight compared to CD and FD counterparts, an effect of sex (CDM, 5.12±0.23 
vs. FDM, 4.99 ±0.23 vs. CDF, 6.70 ±0.23 vs. FDF, 5.62 ±0.23g; P=0.01) (Figure 
5.9A). FD male and female offspring visceral fat to body weight ratios were 
shown to be significantly decreased compared to CD and FD counterparts, an 
effect of diet (CDM, 0.006 ±0.00 vs. FDM, 0.006 ±0.00 vs. CDF, 0.01 ±0.00 vs. 
FDF, 0.008 ±0.00g; P=0.02). In addition, CD and FD female offspring visceral fat 
to body weight ratio was significantly increased compared to CD and FD 
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Figure 5.9. Adult Visceral Fat Weight and Visceral Fat to Body Weight Ratio 
 
Figure 5.9. Adult Offspring visceral fat weight and visceral fat to body weight ratio. Control males (n=5); fructose males (n=7); control females (n=6) and fructose females (n=6). 
A) Represents offspring visceral fat weight at month 4. B) Represents offspring visceral fat to body weight ratio at month 4. All data were analysed using a 2x2 factorial design 
with diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ± SEM.* denotes significance of P<0.05. 
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5.3.7 Effects of Excess Maternal Fructose Intake on Adult Hepatic Lipid 
Deposition and Visceral Fat Morphology  
To examine the effects of excess maternal fructose consumption on adult 
offspring hepatic lipid deposition and visceral fat morphology, hepatic 
histological assessment of Oil-Red-O analysis and visceral fat H&E analysis 
were performed on 4M post mortem tissues. 
5.3.7.1 Adult Offspring Hepatic Lipid Deposition 
No significant differences were observed between CD and FD offspring total % 
hepatic lipid deposition or total % lipid deposition to liver weight ratio (Figure 
5.10A-D; Figure 5.11A-D). 
5.3.7.2 Adult Offspring Visceral Fat Morphology  
No significant differences were observed between CD and FD offspring 
visceral fat cell morphology (Figure 5.12; Figure 5.13A-D). 
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Figure 5.10. Adult Hepatic Oil-Red-O Histology 
 
Figure 5.10. Adult Offspring hepatic lipid deposition example images of 4M offspring. Control males 
(n=7); fructose males (n=9); control females (n=7) and fructose females (n=6). All images are of 6µm thick 
sections taken from frozen 4M liver tissue, stained with oil-red-o and photographed at 400x 
magnification. Lipid droplets (red) among hepatocytes (light blue) and hepatocyte nuclei (dark blue). A) 
Represents image of CDM offspring lipid deposition at 4M. B) Represents image of FDM offspring lipid 
deposition at 4M. C) Represents image of CDF offspring lipid deposition at 4M. D) Represents image of 
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Figure 5.11. Adult Hepatic Lipid Deposition  
 
Figure 5.11. Adult offspring hepatic total % lipid deposition and total % lipid deposition to liver weight 
ratio. Control males (n=7); fructose males (n=9); control females (n=7) and fructose females (n=6). A) 
Represents offspring 200 magnification hepatic total % lipid deposition at month 4. B) Represents 
offspring 200 magnification liver weight to total % lipid deposition ratio at month 4. C) Represents 
offspring 400 magnification hepatic total % lipid deposition at month 4. D) Represents offspring 400 
magnification liver weight to total % lipid deposition ratio at month 4. All data were analysed using a 2x2 
factorial design with diet*sex*interaction included as factors (general analysis of variance) using IBM 
SPSS statistics 25. Data presented as group mean ± SEM. 
Chapter 5  Study 3 
 237 
Figure 5.12. Adult Visceral Fat H&E Histology 
 
Figure 5.12. Adult Offspring visceral fat H&E example images of 4M offspring. Control males (n=7); 
fructose males (n=7); control females (n=6) and fructose females (n=6). All images are of 4µm thick 
sections taken from fixed 4M visceral fat tissue, stained with H&E and photographed at 200x 
magnification. A) Represents image of CDM offspring visceral fat morphology at 4M. B) Represents 
image of FDM offspring visceral fat morphology at 4M. C) Represents image of CDF offspring visceral fat 
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Figure 5.13. Adult Visceral Fat Morphology 
 
Figure 5.13. Adult Offspring visceral fat morphology. Control males (n=7); fructose males (n=7); control 
females (n=6) and fructose females (n=6). All data were analysed using a 2x2 factorial design with 
diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data 
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5.3.8 Effects of Excess Maternal Fructose Intake on Adult Hepatic 
Triglyceride Content 
The effects of excess maternal fructose consumption on offspring hepatic TAG 
concentration were examined via a Triglyceride Colorimetric assay performed 
on 4M livers. There was a significant decrease shown in FD offspring hepatic 
TAG compared to CD offspring, an effect of diet (CDM, 3.02 ±0.18 vs. FDM, 
1.82 ±0.18 vs. CDF, 2.27 ±0.18 vs. FDF, 1.60 ±0.18 mg/dl; P=0.009) (Figure 5.14A). 
In addition, there was a significant decrease observed in FD offspring hepatic 
TAG to liver weight ratio compared to CD offspring, an effect of diet (CDM, 
0.00014 ±0.00001 vs. FDM, 0.00008 ±0.00001 vs. CDF, 0.00012 ±0.00001 vs. FDF, 
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Figure 5.14. Adult Hepatic Triglyceride Content 
 
Figure 5.17. Adult offspring hepatic triglycerides. Control males (n=4; fructose males (n=6); control females (n=6) and fructose females (n=6). A) Represents offspring hepatic 
triglyceride content at 4M. B) Represents offspring hepatic triglyceride content to liver weight ratio at 4M. All data were analysed using a 2x2 factorial design with 
diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes significance of P<0.05. 
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5.3.9 Effects of Excess Maternal Fructose Intake on Adult Hepatic Proteome 
and Mitochondrial Pathway Signalling 
To examine the effects of excess maternal fructose consumption on adult 
offspring hepatic biological and molecular interactions, the total hepatic 
proteome (>5,000 proteins) was analysed. IPA was used for identifying 
biological networks by conducting a Core Analysis to interpret the 
differentially-expressed proteins in a biological context by identifying 
relationships, mechanisms, functions and their associated pathways. The list of 
313 differentially-expressed proteins with a significance p≤0.05 (for the most 
accurate representation of increased and decreased regulation) and 
corresponding fold changes (ranging from 0.1-8.4) between CD and FD 
offspring were uploaded into IPA.  
Reported analysis included determination of up-regulated and down-regulated 
proteins (Appendix) and networks of the molecular interactions between 
proteins in association with biological functions and diseases. IPA’s Canonical 
Pathway Analysis was used to determine the most significantly affected 
signalling pathways based on increased or decreased protein expression and 
directionally theorised pathway activation or inhibition based on previously 
published evidence. IPA’s Toxicity Lists and Functions were used to evaluate 
the most significantly affected toxicity pathways and associated proteins based 
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on previously published evidence. Based on protein expression, the toxicity 
analysis provided identification of theorised signalling pathways with a 
potential predisposition towards disease. Proteins were displayed with their 
corresponding names, represented as nodes to categorise the functional class 
and the use of a dashed or solid line to represent the biological relationship 
between nodes. All relationships between nodes were supported by 
publications located in IPA’s Ingenuity Knowledge database of previously 
published research data. The pigment of node colour indicated an increase in 
expression (red) or decrease (green). 
5.3.9.1 Adult FD Males  
Of the 416 differently-expressed hepatic proteins identified by the total hepatic 
proteome analysis, excess maternal fructose intake was observed to have 
significant effects on 84 proteins in adult male offspring at 4M.  
5.3.9.1.1 Adult FD Male Canonical Pathway Analysis 
Canonical Pathway Analysis was used to determine the most significantly 
affected signalling pathways based on increased or decreased protein 
expression and directionally theorised pathway activation or inhibition based 
on previously published evidence.  
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Significant pathways were calculated by the increased expression of networked 
proteins in the signalling pathways. Excess maternal fructose intake was 
observed to significantly increase FD males hepatic protein expression, 
compared to CD males, upregulating the pathway of mitochondrial 
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Figure 5.15. Adult FD Male Mitochondrial Dysfunction 
 
Figure 5.15. Adult FD male offspring mitochondrial dysfunction. Control males (n=5) and fructose males (n=5). Figure represents most significantly affected signalling 
pathways based on increased protein expression and directionally theorised pathway activation in FD males compared to CD males. All data were analysed using Ingenuity 
Pathway Analysis (IPA). Red indicates up-regulation and grey indicates ineligible prediction. The P-values are calculated using IPA’s right-tailed Fisher’s exact test and -
log10P-values to represent significance.
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5.3.9.1.2 Adult FD Male Top Toxicity List s and Functions Analysis 
IPA’s Toxicity Lists and Functions were used to evaluate the most significantly 
affected toxicity pathways and associated proteins based on previously 
published evidence. Based on protein expression, the toxicity analysis provided 
identification of theorised signalling pathways with a potential predisposition 
towards disease.  
5.3.9.1.2.1 Adult FD Male Toxicity Pathways 
Significant pathways were calculated by the increased expression of networked 
proteins in the signalling pathways with a potential predisposition towards 
disease. Excess maternal fructose intake was observed to significantly increase 
FD males hepatic protein expression, compared to CD males, upregulating the 
pathways of fatty acid metabolism (-log10P=1.96) and mitochondrial 
dysfunction (-log10P=1.96). In addition, there was a non-significant increase in 
the pathway of decreases depolarization of mitochondrial and mitochondrial 
membrane (-log10P=1.36) (Table 5.4).  
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5.3.9.1.2.2 Adult FD Male Toxicity Pathways and Associated Proteins 
Toxicity signalling pathway of fatty acid metabolism, in FD males compared to 
CD males, was observed to have significantly increased fold change and 
upregulated protein expression of acyl-CoA oxidase 2 (ACOX2) (1.2-fold, 
P=0.009) and HSD17B4 (1.3-fold, P=0.0001) in the identified toxicity network of 
fatty acid metabolism compared to CD males (Table 5.4). 
Toxicity signalling pathway of mitochondrial dysfunction, in FD males 
compared to CD males, was observed to have significantly increased fold 
change and upregulated protein expression of cytochrome B5 reductase 
(CYB5R3) (1.8-fold, P=0.05) and VDAC1 (1.2-fold, P=0.03) (Table 5.4). 
Toxicity signalling pathway of decreases depolarization of mitochondrial 
membrane, in FD males compared to CD males, was observed to have 
significantly increased fold change and upregulated protein expression of 
VDAC1 (1.2-fold, P=0.03) (Table 5.4). 
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Table 5.4. Adult FD Male Toxicity Pathways and Associated Proteins 
Toxicity Pathways and Proteins  Fold Change P-value Location Type(s) 
Fatty Acid Metabolism -log10P-value 1.96 
ACOX2 1.2 0.009 Cytoplasm Enzyme 
HSD17B4 1.3 0.0001 Cytoplasm Enzyme 
Mitochondrial Dysfunction -log10P-value 1.65 
CYB5R3 1.8 0.05 Cytoplasm Enzyme 
VDAC1 1.2 0.03 Cytoplasm Ion Channel 
Decreases Depolarization of Mitochondria and Mitochondrial Membrane -log10P-value 1.36 
VDAC1 1.2 0.03 Cytoplasm Ion Channel 
 
Table 5.4. Adult FD male offspring networks and associated proteins. Control males (n=5) and fructose males (n=5). Table represents signalling pathways with a potential 
predisposition towards disease in FD males compared to CD males. All data were analysed using Ingenuity Pathway Analysis (IPA). The P-values are calculated using IPA’s 
right-tailed Fisher’s exact test with -log10P-values to represent significance of pathological endpoint and P<0.05 to represent significance of specific protein expression 
upregulated within the pathological endpoint. 
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5.3.9.2 Adult FD Females   
Of the 416 differently-expressed hepatic proteins identified by total hepatic 
proteome analysis, excess maternal fructose intake was observed to have 
significant effects on 102 proteins in adult female offspring at 4M.  
5.3.9.2.1 Adult FD Female Canonical Pathway Analysis 
Canonical Pathway Analysis was used to determine the most significantly 
affected signalling pathways based on increased or decreased protein 
expression and directionally theorised pathway activation or inhibition based 
on previously published evidence.  
Significant pathways were calculated by the increased expression of networked 
proteins in the signalling pathways. Excess maternal fructose intake was 
observed to significantly increase FD females hepatic protein expression, 
compared to CD females, upregulating the pathways of fatty acid b-oxidation 
III (-log10P=1.87) (Figure 5.16), oxidative phosphorylation (-log10P=1.53) (Figure 
5.17) and mitochondrial dysfunction (-log10P=2.06) (Figure 5.18).  
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Figure 5.16. Adult FD Female Fatty Acid ß-Oxidation III 
 
Figure 5.16. Adult FD female offspring Fatty Acid b-Oxidation III. Control females (n=5) and fructose females (n=5). Data represents most significantly affected signalling 
pathways based on increased expression, directionally inferred pathway activation and association of hepatic proteins with predicted pathway activation or inhibition of 
analysed hepatic proteins with alterations in FD females compared to CD female. All data were analysed using Ingenuity Pathway Analysis (IPA). Red indicates up-regulation 
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Figure 5.17. Adult FD Female Oxidative Phosphorylation 
 
Figure 5.17. Adult FD female offspring oxidative phosphorylation. Control females (n=5) and fructose females (n=5). Data represents most significantly affected signalling 
pathways based on increased expression, directionally inferred pathway activation and association of hepatic proteins with predicted pathway activation or inhibition of 
analysed hepatic proteins with alterations in FD females compared to CD females. All data were analysed using Ingenuity Pathway Analysis (IPA). Red indicates up-
regulation and grey indicates ineligible prediction. The P-values are calculated using IPA’s right-tailed Fisher’s exact test and -log10P-values to represent significance. 
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Figure 5.18. Adult FD Female Mitochondrial Dysfunction 
 
Figure 5.18. Adult FD female offspring mitochondrial dysfunction. Control females (n=5) and fructose females (n=5). Figure represents most significantly affected signalling 
pathways based on increased protein expression and directionally theorised pathway activation in FD males compared to CD males. All data were analysed using Ingenuity 
Pathway Analysis (IPA). Red indicates up-regulation and grey indicates ineligible prediction. The P-values are calculated using IPA’s right-tailed Fisher’s exact test and -
log10P-values to represent significance.
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5.3.9.2.2 Adult FD Female Toxicity Lists and Functional Analysis 
IPA’s Toxicity Lists and Functions were used to evaluate the most significantly 
affected toxicity pathways and associated proteins based on previously 
published evidence. Based on protein expression, the toxicity analysis provided 
identification of theorised signalling pathways with a potential predisposition 
towards disease.  
5.3.9.2.2.1 Adult FD Female Toxicity Pathways 
Significant pathways were calculated by the increased expression of networked 
proteins in the signalling pathways with a potential predisposition towards 
disease. Excess maternal fructose intake was observed to significantly increase 
FD females hepatic protein expression, compared to CD females, upregulating 
the pathways of PXR/RXR activation (-log10P=3.37), xenobiotic metabolism 
signalling (-log10P=2.95), carboxylic acid reductase/retinoid X receptor 
(CAR/RXR) activation (-log10P=2.71) and mitochondrial dysfunction (-
log10P=2.16) (Table 5.5). 
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5.3.9.2.3 Adult FD Female Toxicity Pathways and Associated Proteins 
Toxicity signalling pathway of PXR/RXR activation, in FD females compared to 
CD females, was observed to have significantly increased fold change and 
upregulated protein expression of glucose-6-phosphatase catalytic subunit 
(G6PC) (4.6-fold, P=0.007), cytochrome P450 2B6 (CYP2B6) (1.4-fold, P=0.007) 
and UDP-glucuronosyltransferase family 1 member A1 (UGT1A1) (1.4-fold, 
P=0.007) (Table 5.5). 
Toxicity signalling pathway of xenobiotic metabolism signalling, in FD females 
compared to CD females, was observed to have significantly increased fold 
change and upregulated protein expression of epoxide hydrolase 2 (EPHX2) 
(1.3-fold, P=0.05), CYP2B6 (1.4-fold, P=0.007), UGT1A1 (1.4-fold, P=0.03), UDP-
glucuronosyltransferase family 1 member A4 (UGT1A4) (1.3-fold, P=0.05) and 
dihydrodiol dehydrogenase (DHDH) (1.6-fold, P=0.04) (Table 5.5). 
Toxicity signalling pathway of CAR/RXR activation, in FD females compared 
to CD females, was observed to have significantly increased fold change and 
upregulated protein expression of CYP2B6 (1.4-fold, P=0.007) and UGT1A1 
(1.4-fold, P=0.03) (Table 5.5). 
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Toxicity signalling pathway of mitochondrial dysfunction signalling, in FD 
females compared to CD females, was observed to have significantly increased 
fold change and upregulated protein expression of ATP synthase F1 subunit 
gamma (ATP5F1C) (1.3-fold, P=0.04), voltage dependant anion channel 2 
(VDAC2) (1.5-fold, P=0.01) and NADH dehydrogenase ubiquinone 
flavoprotein 1 (NDUFV1) (3.6-fold, P=0.04) (Table 5.5). 
Toxicity signalling pathway of glutathione depletion-hepatocellular 
hypertrophy, in FD females compared to CD females, was observed to have 
significantly increased fold change and upregulated protein expression of 
CYP2B6  (1.4-fold, P=0.007) (Table 5.5). 
Toxicity signalling pathway of fatty acid metabolism, in FD females compared 
to CD females, was observed to have significantly increased fold change and 
upregulated protein expression of CYP2B6  (1.4-fold, P=0.007) enoyl-CoA 
hydratase and 3-hydroxyacyl CoA dehydrogenase (EHHADH) (1.1-fold, 
P=0.01) (Table 5.5). 
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Table 5.5. Adult FD Female Toxicity Pathways and Associated Proteins 
Toxicity Pathways and Proteins  Fold 
Change 
P-value Location Type(s) 
PXR/RXR Activation -log10P-value 3.37 
G6PC 4.6 0.01 Cytoplasm Phosphatase 
CYP2B6 1.4 0.007 Cytoplasm Enzyme 
UGT1A1 1.4 0.03 Cytoplasm Enzyme 
Xenobiotic Metabolism Signalling -log10P-value 2.95 
EPHX2 1.3 0.05 Cytoplasm Enzyme 
CYP2B6 1.4 0.007 Cytoplasm Enzyme 
UGT1A1 1.4 0.03 Cytoplasm Enzyme 
UGT1A4 1.3 0.05 Cytoplasm Enzyme 
DHDH 1.6 0.04 Other Enzyme 
CAR/RXR Activation -log10P-value 2.71 
CYP2B6 1.4 0.007 Cytoplasm Enzyme 
UGT1A1 1.4 0.03 Cytoplasm Enzyme 
Mitochondrial Dysfunction -log10P-value 2.16 
ATP5F1C 1.3 0.04 Cytoplasm Transporter 
VDAC2 1.5 0.01 Cytoplasm Ion Channel 
NDUFV1 3.6 0.04 Cytoplasm Enzyme 
Glutathione Depletion-Hepatocellular Hypertrophy -log10P-value 1.75 
CYP2B6 1.4 0.007 Cytoplasm Enzyme 
Fatty Acid Metabolism -log10P-value 2.6 
CYP2B6 1.4 0.007 Cytoplasm Enzyme 
EHHADH 1.1 0.01 Cytoplasm Enzyme 
 
Table 5.5. Adult FD female offspring networks and associated proteins. Control females (n=5) and 
fructose females (n=5). Table represents signalling pathways with a potential predisposition towards 
disease in FD males compared to CD males. All data were analysed using Ingenuity Pathway Analysis 
(IPA). The P-values are calculated using IPA’s right-tailed Fisher’s exact test with -log10P-values to 
represent significance of pathological endpoint and P<0.05 to represent significance of specific protein 
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5.3.10 Effects of Excess Maternal Fructose Intake on Key Hepatic Proteins 
Relative protein abundance was determined for key proteins identified by 
proteomic analysis and their role in lipid synthesis and metabolism, ATP 
production and diffusion of metabolites across the outer mitochondrial matrix. 
Western blot analyses were performed to determine relative protein abundance 
of oxidative phosphorylation (mitochondrial complexes I, II, III, IV and V), 
VDAC1, SREBP-1c and FAS.  
Western blots for ACC and ChREBP-1c were unsuccessful following numerous 
protocols and antibodies; they could not represent reliable results for these 
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5.3.10.1 Adult Oxidative Phosphorylation, Mitochondrial Complex-I 
No significant differences were observed between CD and FD offspring hepatic 
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Figure 5.19. Adult Hepatic Mitochondrial Complex-I 
 
Figure 5.19. Adult offspring hepatic mitochondrial complex-I. Control males (n=6); fructose males (n=6); 
control females (n=5) and fructose females (n=6). A) Represents offspring hepatic mitochondrial complex-I 
relative protein abundance at 4M. B) Represents Western blot image of offspring hepatic mitochondrial 
complex-I. All data were analysed using a 2x2 factorial design with diet*sex*interaction include as factors 
(general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM. 
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5.3.10.2 Adult Oxidative Phosphorylation, Mitochondrial Complex-II 
FD male and female offspring were observed to have significantly increased 
hepatic mitochondrial complex-II relative protein abundance compared to CD 
male and female offspring, an effect of diet (CDM, 0.03 ±0.00 vs. FDM, 0.08 
±0.00 vs. CDF, 0.03 ±0.00 vs. FDF, 0.08 ±0.00; P=0.001) (Figure 5.20). FD males 
were shown to have an increase in relative fold change of mitochondrial 
complex-II compared to CD males, a difference of 3.66-relative protein fold. FD 
females were shown to have an increase in relative fold change of 
mitochondrial complex-II compared to FD females, a difference of 3.64-relative 
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Figure 5.20. Adult Hepatic Mitochondrial Complex-II 
 
Figure 5.20. Adult offspring hepatic mitochondrial complex-II. Control males (n=6); fructose males (n=6); 
control females (n=6) and fructose females (n=6). A) Represents offspring hepatic mitochondrial complex-
II relative protein abundance at 4M. B) Represents Western blot image of offspring hepatic mitochondrial 
complex-II. All data were analysed using a 2x2 factorial design with diet*sex*interaction include as factors 
(general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.*denotes 
significance of P=0.001. 
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5.3.10.3 Adult Oxidative Phosphorylation, Mitochondrial Complex-III 
No significant differences were observed between CD and FD offspring hepatic 
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Figure 5.21. Adult Hepatic Mitochondrial Complex-III 
 
Figure 5.21. Adult offspring hepatic mitochondrial complex-III. Control males (n=5); fructose males (n=5); 
control females (n=6) and fructose females (n=5). A) Represents offspring hepatic mitochondrial complex-
III relative protein abundance at 4M. B) Represents Western blot image of offspring hepatic mitochondrial 
complex-III. All data were analysed using a 2x2 factorial design with diet*sex*interaction include as 
factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM. 
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5.3.10.4 Adult Oxidative Phosphorylation, Mitochondrial Complex-IV 
FD male and female offspring were observed to have significantly increased 
hepatic mitochondrial complex-IV relative protein abundance compared to CD 
male and female offspring, an effect of diet (CDM, 0.01 ±0.00 vs. FDM, 0.03 
±0.00 vs. CDF, 0.01 ±0.00 vs. FDF, 0.03 ±0.00; P<0.0001) (Figure 5.22). FD males 
were shown to have an increase in relative fold change of mitochondrial 
complex-IV compared to CD males, a difference of 0.57-relative protein fold. 
FD females were shown to have an increase in relative fold change of 
mitochondrial complex-IV compared to FD females, a difference of 0.48-relative 
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Figure 5.22. Adult Hepatic Mitochondrial Complex-IV 
 
Figure 5.22. Adult offspring hepatic mitochondrial complex-IV. Control males (n=6); fructose males (n=6); 
control females (n=6) and fructose females (n=6). A) Represents offspring hepatic mitochondrial complex-
IV relative protein abundance at 4M. B) Represents Western blot image of offspring hepatic mitochondrial 
complex-IV. All data were analysed using a 2x2 factorial design with diet*sex*interaction include as 
factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean 
±SEM.*denotes significance of P<0.0001. 
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5.3.10.5 Adult Oxidative Phosphorylation, Mitochondrial Complex-V 
No significant differences were observed between CD and FD offspring hepatic 
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Figure 5.23. Adult Hepatic Mitochondrial Complex-V 
 
Figure 5.23. Adult offspring hepatic mitochondrial complex-V. Control males (n=6); fructose males (n=6); 
control females (n=6) and fructose females (n=6). A) Represents offspring hepatic mitochondrial complex-
V relative protein abundance at 4M. B) Represents Western blot image of offspring hepatic mitochondrial 
complex-V. All data were analysed using a 2x2 factorial design with diet*sex*interaction include as factors 
(general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM. 
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5.3.10.6 Adult Hepatic VDAC1 
FD male and female offspring were observed to have significantly decreased 
hepatic VDAC1 relative protein abundance compared to CD male and female 
offspring, an effect of diet (CDM, 0.38 ±0.02 vs. FDM, 0.15 ±0.02 vs. CDF, 0.25 
±0.02 vs. FDF, 0.14 ±0.02; P<0.0001). Additionally, CD and FD females were 
shown to have significantly decreased VDAC1 compared to CD and FD males, 
an effect of sex (P=0.01). An interaction effect of diet and sex (P=0.05) in FD 
males VDAC1 was also shown to be significantly decreased compared to any 
other group (Figure 5.24). FD males were shown to have a decrease in relative 
fold change of VDAC1 compared to CD males, a difference of -0.8-relative 
protein fold. FD females were shown to have a decrease in relative fold change 
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Figure 5.24. Adult Hepatic VDAC1 
 
Figure 5.24. Adult offspring hepatic VDAC1. Control males (n=6); fructose males (n=6); control females 
(n=6) and fructose females (n=6). A) Represents offspring hepatic VDAC1 relative protein abundance at 
4M. B) Represents Western blot image of offspring hepatic VDAC1. All data were analysed using a 2x2 
factorial design with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS 
statistics 25. Data presented as group mean ±SEM. * denotes significance of P<0.05; **denotes significance 
of P<0.05. 
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5.3.10.7 Adult Hepatic SREBP-1c 
FD male and female offspring were observed to have significantly increased 
hepatic SREBP-1c relative protein abundance compared to CD male and female 
offspring, an effect of diet (CDM, 261.79 ±52.86 vs. FDM, 764.68 ±52.86 vs. CDF, 
318.25 ±152.86 vs. FDF, 498.61 ±52.86; P<0.0001). An interaction effect of diet 
and sex (P=0.04) in FD males SREBP-1c was also shown to be significantly 
increased compared to any other group (Figure 5.25). FD males were shown to 
have an increase in relative fold change of SREBP-1c compared to CD males, a 
difference of 1.32-relative protein fold. FD females were shown to have an 
increase in relative fold change of SREBP-1c compared to FD females, a 
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Figure 5.25. Adult Hepatic SREBP-1c 
 
Figure 5.25. Adult offspring hepatic SREBP-1C. Control males (n=6); fructose males (n=5); control females 
(n=6) and fructose females (n=6). A) Represents offspring hepatic SREBP-1c relative protein abundance at 
4M. B) Represents Western blot image of offspring hepatic SREBP-1c. All data were analysed using a 2x2 
factorial design with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS 
statistics 25. Data presented as group mean ±SEM.** denotes significance of P<0.0001. 
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5.3.10.8 Adult Hepatic FAS 
FD male and female offspring were observed to have significantly increased 
hepatic FAS relative protein abundance compared to CD male and female 
offspring, an effect of diet (CDM, 0.66 ±1.22 vs. FDM, 4.86 ±1.22 vs. CDF, 3.46 
±1.22 vs. FDF, 12.61 ±1.22; P=0.001). In addition, there was a significant increase 
in CD and FD female FAS compared to CD and FD males, an effect of sex 
(P=0.005) (Figure 5.26). FD males were shown to have an increase in relative 
fold change of FAS compared to CD males, a difference of 0.73-relative protein 
fold. FD females were shown to have an increase in relative fold change of FAS 
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Figure 5.26. Adult Hepatic FAS 
 
Figure 5.26. Adult offspring hepatic FAS. Control males (n=6); fructose males (n=5); control females (n=6) 
and fructose females (n=6). A) Represents offspring hepatic FAS relative protein abundance at 4M. B) 
Represents western blot image of offspring hepatic FAS. All data were analysed using a 2x2 factorial 
design with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 
25. Data presented as group mean ±SEM.* denotes significance of P<0.05. 
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5.4 Summary of FD Adult Offspring Significant Findings 
FD Adult Physiology  
• A continued significant increase was observed in adult FD offspring 
plasma triglycerides. Additionally, FD offspring had significantly 
decreased alkaline phosphatase, which was also present in FD males at 
d21.  
• FD male and female adult offspring had significantly increased liver 
weight and liver to body weight ratios.  
• Both FD male and female offspring organ weights, visceral fat and 
general physiology appeared to be phenotypically normal. However, 
with the expected effects of sex (i.e., males larger than females). 
FD Adult Whole Blood Free Fatty Acids 
• From 33 whole blood FFA analysed, a clear programmed effect on fatty 
acid metabolism in adult male and female offspring of fructose-fed dams 
were evident. Palmitoleic acid (16:1n-7) and total omega-7, across all 
time points (day 0, day 7, day 14, day 21, month 2 and month 4). While 
palmitoleic acid and total omega-7 remained significantly increased in 
FD males throughout life, these FFA switched from being significantly 
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increased to being significantly decreased in FD females at month 2 and 
month 4. 
FD Male Adult Hepatic Proteomic Analysis 
• Of the 416 differently-expressed hepatic proteins identified by the total 
hepatic proteome analysis (>5,000 proteins), excess maternal fructose 
intake was observed to have significant effects on 84 proteins in adult 
male offspring at 4M.  
• Following the Canonical Pathway Analysis, excess maternal fructose 
intake was observed to significantly increase FD male hepatic protein 
expression upregulating the pathway of mitochondrial dysfunction.  
• Following the Toxicity Lists and Functions analysis, excess maternal 
fructose intake was observed to significantly increase FD male hepatic 
protein expression upregulating the signalling pathways with a 
potential predisposition towards disease. The toxicity pathways include 
fatty acid metabolism and mitochondrial dysfunction pathways.  
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FD Female Adult Hepatic Proteomic Analysis 
• From 416 differently-expressed hepatic proteins identified by the total 
hepatic proteome analysis (>5,000 proteins), excess maternal fructose 
intake was observed to have significant effects on 102 proteins in adult 
female offspring at 4M.  
• Following the Canonical Pathway Analysis, excess maternal fructose 
intake was observed to significantly increase FD female hepatic protein 
expression upregulating the pathways of fatty acid b-oxidation III, 
oxidative phosphorylation and mitochondrial dysfunction.  
• Following the Toxicity Lists and Functions analysis, excess maternal 
fructose intake was observed to significantly increase FD female hepatic 
protein expression upregulating the signalling pathways with a 
potential predisposition towards disease. The toxicity pathways include 
PXR/RXR activation, xenobiotic metabolism signalling, CAR/RXR 
activation and mitochondrial dysfunction pathways. 
FD Adult Western Blot Analysis 
• Excess maternal fructose intake was observed to have significant effects 
on male and female offspring relative protein abundance of key proteins 
identified by proteomic analysis and their role in lipid synthesis and 
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metabolism, ATP production and diffusion of metabolites across the 
outer mitochondrial matrix. Significant programmed effects of excess 
maternal fructose intake are clearly shown by the continued significant 
increases in oxidative phosphorylation complex-II and complex-IV and 
increased FAS in both males and females of fructose-fed dams. A non-
significant trend of increased complex-V was observed in adult FD male 
and female offspring. Programmed effects in FD male and female adult 
offspring were also observed, having significantly decreased VDAC1 
and increased SREBP-1c, opposite to observations in FD male and 
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5.5 Discussion: Effects of Excess Maternal Fructose Intake on Offspring 
Programming of Hepatic and Mitochondrial Dysfunction 
Human epidemiological studies and animal models have shown that poor 
quality nutrition during fetal growth can predispose the offspring to long-term 
health consequences (Segovia et al., 2014, Guilloteau et al., 2009). Although 
there is a lack of human studies showing the long-term in utero effects of excess 
maternal fructose intake, there is evidence that excess fructose during 
pregnancy negatively effects pregnancy outcomes. (Zheng, Feng, Zhang, Wang, 
& Xiao, 2016, Guilloteau et al., 2009, Regnault et al., 2013) Additionally, animal 
models have shown that excess maternal fructose intake can contribute to 
adverse metabolic outcomes in offspring, including obesity, metabolic 
syndrome and NAFLD (Lee et al., 2018, A. F. Saad et al., 2016, Regnault et al., 
2013, Sloboda et al., 2014). Therefore, it could be postulated that excessive 
fructose and/or sugar intake may be an important risk factor for the 
development of hepatic lipid deposition and subsequent liver damage during 
adulthood. Recently, two human studies have shown that newborns from 
pregnancies complicated by maternal obesity increased hepatocellular lipid 
content. Modi et al. observed an association of an 8% increase in hepatic lipid 
content for each incremental increase in BMI (Modi et al., 2011). Brumbaugh et 
al. also showed a 68% increase in hepatic lipid content in newborns from obese 
mothers (Brumbaugh et al., 2013). Interestingly, they both found, neonatal 
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hepatic lipid deposition was more likely driven by hepatic fat storage and, 
similar to the current study, excess serum lipids rather than overall newborn 
adiposity. In animal models, excessive maternal fructose intake clearly shows 
an association with hepatic lipid accretion and, potentially, early on-set 
NAFLD. However, our hepatic histological assessment of hepatic fat content by 
oil-red-o and hepatic triglyceride content analysis at both d21and 4M showed 
no overt differences in total hepatic lipid accumulation and less hepatic 
triglyceride content throughout life when compared to control offspring. This 
was despite male and female fructose offspring having increased liver weights 
and differential molecular markers of hepatic de novo lipogenesis throughout 
life when compared to control offspring. Although, the hepatic histological and 
triglyceride results may not be entirely unexpected as we would not expect to 
observe neonates and young adults with such significantly increased hepatic 
lipid content from in utero exposure to 10%w/v maternal fructose. Further in-
depth analysis such as hepatic metabolomics analysis may reveal more subtle 
significant differences in specific FFA, acyls and sphingolipids. Additionally, 
similar to the central hypothesis, on a molecular level, these animals are more 
likely to have an underlying asymptomatic phenotype and subsequently 
increased predisposition to liver dysfunction. Perhaps at an older age and/or 
following a ‘second hit’ of acute fructose administration in adult offspring diet 
would this asymptomatic predisposition and perturbed molecular phenotype 
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would become apparent in the form of fatty liver observable by the histological 
technique used in the current study. Furthermore, this pro-steatotic phenotype 
persisted into adulthood in the form of increased palmitoleic acid and total 
omega-7, across all time points (day 0, day 7, day 14, day 21, month 2 and 
month 4), suggesting a programming effect of in utero exposure to excessive 
fructose on palmitoleic acid and/or FA oxidation and metabolism and 
subsequent excessive palmitoleic acid production.  
Palmitoleic acid is an omega-7 monosaturated fatty acid that is synthesised 
from palmitic acid by stearoyl-CoA desaturase-1. It is the second most 
abundant fatty acid and is found in high concentrations in the liver and 
triglycerides of adipose tissue (Carta, Murru, Banni, & Manca, 2017). 
Additionally, palmitoleic acid is thought to be anti-inflammatory and may help 
in reducing insulin sensitivity, with some studies showing a correlation 
between palmitoleic acid and reduced insulin sensitivity, although the data are 
conflicting in the current literature (Tricò et al., 2020). A paradox exists in that 
the substrate of palmitoleic acid is palmitic acid which has been implicated in 
the progression of fatty liver disease and NAFLD (Ogawa et al., 2018). Recent 
research has shown that palmitoleic acid is associated with and may be a 
biomarker for de novo lipogenesis and progression of NAFLD. 
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Limited information exists with regards to the impact of palmitoleic acid in a 
DOHaD context. An interesting study by Okada et al. showed that increased 
serum palmitoleic acid was correlated with abdominal adiposity in obese 
children, and endogenous lipogenesis may be an important factor in the 
pathogenesis of obesity in children (Okada et al., 2005). Another recent study 
investigated the effects of palmitoleic acid on white adipose tissue 
bioenergetics using cell culture. The same group had previously reported that 
palmitoleic acid can increase adipocyte lipolysis via PPARa-dependent 
mechanisms (Bolsoni-Lopes et al., 2013). The same group demonstrated, 
treatment with palmitoleic acid enhanced mitochondrial activity and increased 
gene expression of key catalytic enzymes in electron transport chain complexes 
II, III and V (Cruz et al., 2018). They concluded that palmitoleic acid plays an 
important role in white adipose tissue metabolism and may be considered a 
therapeutic candidate in obesity. A study by Bernardi et al. investigated early 
life stress and subsequent metabolic outcomes following dietary deficiency of 
omega-3 fats. They demonstrated an exacerbated programmed response in 
circulating palmitoleic acid during adulthood following maternal/neonatal 
separation stress leading to insulin and leptin resistance and increased levels of 
palmitoleic acid (Bernardi et al., 2013). Given the evidence of beneficial effects 
observed following palmitoleic acid administration, it may be possible that in 
the current study, the significant increases of palmitoleic acid across the 
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lifespan of both male and female offspring of maternally fructose-fed dams 
may be an adaptive protective mechanism. By which, the effects we have 
observed such as the increased activation of fatty acid β-oxidation, an 
indication of increased de novo lipogenesis by the increases in key regulatory 
proteins of fatty acid synthesis, namely FAS and SREBP-1c (specifically at 4M) 
and elevated whole blood TAG concentrations observed in fructose weanlings 
at d21 and 4M are being preferentially metabolised to the less lipotoxic 
palmitoleic acid.  
The mechanism by which palmitoleic acid in whole blood is consistently 
significantly elevated at multiple time points from birth to adulthood is 
unclear. As increases in serum palmitoleic acid are correlated and represent a 
shift of carbon from carbohydrates to free fatty acids and visceral lipid cell 
lipolysis (Carta et al., 2017, Ogawa et al., 2018, Okada et al., 2005). However, in 
the current study, we do not observe any significant differences in visceral fat 
cell size or number between offspring groups and decreased visceral fat weight 
to body weight ratios in offspring of maternally fructose-fed dams. 
Additionally, no differences in body weight were observed between offspring 
groups, apart from the expected sex difference in that males weighed more 
than females. However, whole body analysis of fat negates this potential 
observation, and the crude dissection/weighing of visceral fat may not have 
Chapter 5  Study 3 
 282 
been precise enough to tease any significance. Perhaps if DXA analysis could 
have been split by specific body region, there may have been differences 
observed. Unfortunately, this analysis on our DXA is not possible. 
SREBP proteins are transcription factors that exist in three forms, 1a, 1c and 2. 
Activation of SREBP-1c leads to the initiation of SREBP-1c-dependent lipogenic 
signalling pathway and increased ACC, both crucial steps of de novo 
lipogenesis and key in the development and progression of hepatic steatosis. It 
has been shown that SREBP-1a is much less expressed in the mammalian liver 
than SREBP-1c, but there is evidence of SREBP-1a also playing a role in 
regulating SREBP-1c (Eberlé, Hegarty, Bossard, Ferré, & Foufelle, 2004, 
(Jideonwo, Hou, Ahn, Surendran, & Morral, 2018). Therefore, in the current 
study, we focussed on the effects of SREBP-1c and abundance in the offspring 
liver.  In our study, we show up-regulation of SREBP-1c and FAS in the 4M 
adult FD offspring, and this may play a pathologic role in the predisposition to 
liver dysfunction. Furthermore, others have shown increased expression of 
SREBP-1c in rats caused a 26-fold increase in fatty acid synthesis and significant 
increases in fat accumulation. SREBP-1c has also been shown to increase fatty 
acid elongation and TAG production. Few studies have investigated similar 
models to our own. However, a previous study using a rat model by Clayton et 
al. (Clayton et al., 2015) showed that genes related to hepatic lipogenesis 
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(SREBP-1c) were increased in neonate offspring (postnatal d10) of dams 
consuming 10% fructose w/v (20% of total caloric intake), producing a 
phenotype with increases in lipogenic gene expression. In addition, research 
shows the upregulation and effects of insulin on lipogenesis can be mediated 
by SREBP-1c (Eberlé et al., 2004, Jideonwo et al., 2018). However, we observe 
no change in insulin and/or glucose tolerance in our 4M adult offspring, 
despite significantly increased SREBP-1c. 
Elevated de novo lipogenesis is now recognised as an important risk factor for 
increased intrahepatic cell triglyceride concentration, dysregulated fatty acid 
oxidation and increased insulin sensitivity in the progression of NAFLD 
(Lambert, Ramos-Roman, Browning, & Parks, 2014). The role of dietary 
fructose in the increase of de novo lipogenesis and progression of fatty liver 
disease has also been postulated (Softic et al., 2016). Products of de novo 
lipogenesis, such as fatty acids, are generally saturated, which, when present in 
excess, can have detrimental effects on cellular function. However, without 
isotopically measuring de novo lipogenesis products, direct confirmation can be 
difficult due to recent dietary intake and the dynamic flux of VLDL-triglyceride 
fatty acid composition in circulation. However, key markers of de novo 
lipogenesis such as increased key regulatory proteins involved in fatty acid 
synthesis and triglyceride production such as Acetyl-CoA, SREBP-1a & c, FAS 
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and stearoyl-CoA desaturase (SCD) can be an early indicator of dysfunctional 
de novo lipogenesis. Similarly, we present data that confirms previous findings 
with similar programmed effects of maternal fructose intake on offspring 
hepatic FAS and SREBP-1c that is present throughout life. In the livers of 
weanling and adults of maternally fructose-fed dams prior to birth, we clearly 
show markers of de novo lipogenesis with additional increased fatty acid 
products, further evidence of increased de novo lipogenesis was observed.  
Studies have shown a potential regulatory effect of SREBP-1a on SREBP-1c in 
the liver, with hepatic liver cells producing up to 50% less SREBP-1c when 
SREBP-1a is activated (Shimano et al., 1997). Interestingly, a study by Bitter et 
al. showed in isolated human hepatocytes that SREBP-1a is associated with the 
PXR pathway (Bitter et al., 2015). This could also be a pathway of interest in the 
current study as we also see an upregulation of PXR related protein activity in 
female, but not male fructose adult offspring. Our results show female 
offspring of maternally fructose-fed dams had elevated PXR pathway activity 
at d21, which became significantly increased at 4 month and increased SREBP-
1c activity in all offspring of maternally fructose-fed dams only during 
adulthood. Interestingly, at the weanling stage, PXR activation was present and 
SREBP-1c was decreased when compared to controls. Without PXR activation, 
this may rule out this pathway, as the down-regulation of SREBP-1c in 
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weanlings and increased regulation in adults may point to a more 
adaptive/protective role for PXR in regulating SREBP-1c, potentially trying to 
blunt the mechanism of de novo lipogenesis, dysregulation of the fatty acid 
oxidation and mitochondrial dysfunction also observed. A study by Frederico 
et al. had shown that inhibition of SREBP-1c can reverse NAFLD (Frederico et 
al., 2011). Due to the differential activity of SREBP-1c over time, we would 
consider FAS as a better target of early developmental programming. The 
consistent increase in FAS expression throughout life and increased levels of 
palmitoleic acid that requires FAS to convert palmitic acid would also support 
this hypothesis. FAS is an enzyme that stimulates de novo lipogenesis and is 
essential in catalysing malonyl-CoA to palmitate. Increases in FAS and 
associated de novo lipogenic enzymes have been widely reported in models of 
fructose feeding and in humans following acute fructose feeding. Likewise, 
some studies investigating maternal fructose intake have reported potential pro 
de novo lipogenic enzymes, increased plasma and hepatic triglyceride 
accumulation and increased circulating fatty acids, as we also present in this 
thesis. However, it would be interesting to determine hepatic lipogenic enzyme 
activity and activation of specific pathways and gene expression to investigate 
a 'true' programming or causal effects of maternal fructose intake and 
perturbed offspring hepatic metabolism. While the precise mechanism driving 
the offspring hyperlipidaemia and deleterious FFA profile are not fully 
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understood, the current study clearly demonstrates how maternal fructose can 
influence the developmental programming of offspring lipid metabolism 
during critical windows of plasticity prior to suckling, which may alter an 
individual’s later-life susceptibility to metabolic disease.  
5.5.1 Offspring Programming of Mitochondrial Signalling Pathways 
All cells rely on the TCA cycle and β-oxidation to supply NADH and FADH2 to 
the mitochondrial electron transport chain. Under ‘normal ‘ physiological 
conditions, metabolites of oxidative phosphorylation are transported from the 
TCA cycle and β-oxidation to mitochondrial complex I (supplied by energy 
compound NADH), complex II (supplied by energy compound FADH2) and 
passes electrons to complex III, IV and V where oxygen is reduced to H2O and 
an H+ gradient is generated to activate ATP synthase activity (Pfanner, 
Warscheid, & Wiedemann, 2019). ATP generation and the efficiency of the 
electron transport are reliant on cytochrome C oxidase (complex IV) and 
VDAC1. Altered expression and/or inhibition of mitochondrial enzymes results 
in decreased electron chain respiration, build-up of electrons and increases in 
superoxide ions altering the redox state and therefore increased ROS (Zorov, 
Juhaszova, & Sollott, 2006). Electron donors NADPH and FADH2, in addition 
to being used for energy production, also govern intracellular redox state. 
NADH oxidation in mitochondria produces ROS whereas, NADPH oxidation 
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serves to modulate antioxidant defences by peroxiredoxins, thioredoxin and 
oxidized glutathione (Blacker & Duchen, 2016). Therefore, mitochondrial 
functions have an impact on the intracellular redox state via regeneration of 
antioxidant pathways and via ROS production (Igosheva et al., 2010). Research 
has shown altered hepatic mitochondrial protein expression is associated with 
hepatic dysfunction, de novo lipogenesis, increased intrahepatic lipid 
accumulation, which can contribute to insulin resistance, lipotoxicity, NASH 
and NAFLD. We have presented proteomic data following Ingenuity Pathway 
Analysis that has revealed increases in specific protein expression involved in 
the activation of signalling pathways that overlap and are reliant on each other. 
These include fatty acid oxidation, oxidative phosphorylation and 
mitochondrial function, which are present in weanlings and adults, but not in 
all instances. In our fructose weanlings, male and female offspring showed 
significant activation of proteins that play a key role in the NRF2-mediated 
oxidative stress response. NRF2 is an adaptive transcription factor and can 
regulate gene expression of a range of cytoprotective antioxidant and anti-
inflammatory proteins in response to cellular injury or stress. NRF2 has been 
recognised to influence the structure, function and membrane integrity of the 
mitochondria. Abdullah et al. reported that NRF2 can regulate the expression of 
ATP synthase subunit-a in the liver (Abdullah et al., 2012) and the main 
mechanism by which NRF2 has an effect on substrate production. In NRF2 
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knockout cells it has been shown that NADH metabolism by oxidative 
phosphorylation complex I and production of NADPH by the TCA cycle is 
reduced. Moreover, NRF2 is correlated with complex I and II oxygen 
consumption, with oxygen consumption and ATP products increasing when 
NRF2 is reactivated (Holmström et al., 2013). Additionally, NRF2 under 
homeostatic conditions can influence fatty acid oxidation, availability of 
NADH, FADH2, succinate and ATP synthase for respiration, as well as the 
mitochondria membrane potential. Interestingly, NRF2 knockout isolated liver 
cells show a reduced capacity to initiate mitochondrial fatty acid oxidation 
following glucose-deprived cells being fed palmitic acid when NRF2 is 
activated. The literature clearly shows an important role for NRF2, which is 
adaptive to its environment and can potentially alter components of the TCA 
cycle, β-oxidation, mitochondrial integrity and mitochondrial substrate 
production. It has also been recognised as a candidate for the treatment of liver 
disease in humans. 
Data presented here shows NRF2 pathway activation in male and female 
weanling livers is altered by maternal fructose intake. Cioffi et al. found that 
NRF2 was increased, and mitochondrial VDAC expression was reduced 
following fructose feeding in a rat model (Cioffi et al., 2017). Similarly, we also 
show increased NRF2, however, reduced VDAC1 protein abundance 
Chapter 5  Study 3 
 289 
(discussed below) in weanling offspring. However, these changes in male and 
female weanling NRF2 pathway activation were not present during adulthood 
in either sex. This may suggest NRF2 is increased during early neonatal growth 
due to the significant increases observed in fatty acid production is likely an 
adaptive protective response during early life as these changes in whole blood 
fatty acids and NRF2 were not observed during adulthood. The differential 
changes that did occur in pathways of fructose offspring are intimately linked, 
and clearly, NRF2, fatty acid oxidation, mitochondrial function and 
mitochondrial cytosolic crosstalk is complex with many components, and 
further work will be required to investigate the specific roles of each pathway 
in the hepatic mitochondrial and de novo lipogenic programming in fructose 
offspring. 
We go on to show significant increased hepatic VDAC1 expression in male and 
female weanling livers and, conversely, significant reduction in VDAC1 
expression during adulthood which was exacerbated in the male and female 
fructose groups. Three isoforms of VDAC have been identified, with VDAC1 
being the most abundantly expressed. The specific functions of VDAC isoforms 
are yet to be fully understood. However, they are believed to play a major role 
in the coupling of cellular energy uptake to mitochondrial ATP production and 
are thought to be involved in the transport of substrates across the outer 
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mitochondrial membrane (Camara, Zhou, Wen, Tajkhorshid, & Kwok, 2017). 
Recent observations have shown that VDAC1 is and thought to play a major 
role in controlling metabolic function of the mitochondria for effective energy 
transfer and efficient electron transport chain function. Huizing et al. has 
previously shown that reduction in VDAC1 is detrimental to pyruvate and 
ATP production (Huizing et al., 1996). Moreover, further studies have shown 
reduced mitochondrial VDAC1 expression causes multiple deficiencies in the 
electron transport chain and ATP production. 
There is limited evidence that indicates excess fructose feeding and the 
metabolic dysfunction that follows is associated with oxidative stress and 
mitochondrial dysfunction. However, mitochondrial damage as a consequence 
of fructose feeding and pathways involved in mitochondrial dysfunction are 
yet to be fully investigated. Although not fully understood, some studies have 
shown oxidative stress to be an influencing factor in mitochondrial dysfunction 
(Blacker & Duchen, 2016, X. Liu & Chen, 2017, Guo, Sun, Chen, & Zhang, 2013, 
Galley, 2011). Mitochondria produce ROS via oxidative phosphorylation, and 
excess ROS production by mitochondria can be counteracted by important 
antioxidant enzymes, which form a large part of the redox regulation of ROS. 
Dysregulation of oxidative stress is implicated to play a role in the 
development of metabolic dysfunction such as insulin resistance, metabolic 
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syndrome, NASH and NAFLD. This may, in part, explain the role of fructose in 
the aetiology of fructose-induced insulin resistance, de novo lipogenesis, hepatic 
inflammation and hepatic lipid deposition previously reported in studies 
(George A. Bray, 2013, Jegatheesan & De Bandt, 2017, Abdelmalek et al., 2010). 
Whereas, we are reporting remarkably similar effects following maternal 
fructose intake where offspring had no exposure or access to fructose 
themselves apart from in utero. 
In the context of developmental programming, few studies have considered the 
in utero effects of excess maternal fructose intake on offspring mitochondrial 
function, and to the best of my knowledge, none in the liver. Mortensen et al. 
has reported a programming effect of maternal fructose on oxidative 
phosphorylation in adult offspring brain mitochondria in the rat (Mortensen et 
al., 2014). They showed, following maternal fructose exposure, both male and 
female offspring had increased uncoupling protein 5 (UCP-5) expression in the 
brain, which plays a role in decreasing oxidative phosphorylation efficiency. 
Studies examining human placentas of pregnancies from mothers with 
increased adiposity were observed to correlate with placental mitochondrial 
dysfunction and reduced complex I–V proteins as well as reduced VDAC1 
expression (Mele, Muralimanoharan, Maloyan, & Myatt, 2014, (Mandò et al., 
2018). Data presented here shows a programming effect of fructose in male and 
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female offspring hepatic mitochondrial function, specifically in complex II and 
IV. Up-regulation of β-oxidation increases production of acetyl-CoA, 
overloading the TCA cycle and increasing energy compounds NADH and 
FADH2 entering oxidative phosphorylation for ATP production. β-oxidation 
also provides NADH and FADH2 to oxidative phosphorylation parallel to the 
TCA cycle. NADH enters complex I, and FADH2 enters complex II. Complex II 
serves as another source of electrons donated to Q (ubiquinone), which 
becomes QH2 and releasing hydrogen into the cytosol. It is important to note 
that complex II is not a proton pump and does not contribute to the proton 
gradient. Complex III accepts electrons from Complex I and Q and transfers 
electrons one at a time to complex IV. In complex IV, the elections, hydrogen 
and oxygen react to form H2O. Complex IV is the last complex, transferring 
four protons across the mitochondrial membrane and establishing the proton 
gradient, which will allow Complex V to produce ATP. 
Mitochondrial function is thought to play a predominant role in adapting 
metabolism and ATP production in response to excess ROS or other extrinsic 
processes such as de novo lipogenesis and increase of fatty acid oxidation. 
Additionally, a recent paper by Hoffman et al. also considers the mitochondria 
as a central pathway and major detrimental factor in a wide range of 
nutritionally programmed models with similar phenotypes (Hoffmann & 
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Spengler, 2018). Our study shows reduced activity in VDAC1 during 
adulthood, indicative of mitochondrial dysfunction with an increased NRF2 
activation rather than decreases in NRF1 and 2 as reported in a previous study 
by Cioffi et al. (Cioffi et al., 2017), which leads us to believe this is an adaptive 
response to programmed mitochondrial dysfunction and an assumed increase 
in oxidative stress in livers of fructose offspring. Thompson et al. had 
previously reported in the hearts of guinea pigs from hypoxic pregnancies also 
displayed differences in mitochondrial oxidative phosphorylation complex 
functionality with pronounced sex differences (Thompson, Song, & Polster, 
2019). Similar to previous studies, in both our proteomics and Western blot 
analysis, we also show an increase in early life weanling VDAC1 expression. 
Further increases in fructose offspring are likely due to increased de novo 
lipogenesis and whole blood FFAs. This has also been shown in sheep by 
Yakubu et al. They reported an abundance of VDAC1 peaks at 140 days of 
gestation and up to day 1 following birth in the lungs, kidney and liver 
(Yakubu et al., 2007). VDAC1 abundance was then reduced across all tissues by 
6 months of age. Similar to results presented here, these findings suggest a 
tissue-specific, time-dependent expression of VDAC1 that may reflect tissue 
metabolic demand and functional adaptation following birth. The significant 
metabolic impact of excess maternal fructose on hepatic mitochondrial 
functional pathways and VDAC1 expression in male and female fructose 
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offspring further reflects these tissue and time-dependent adaptations. An 
increase in VDAC1 abundance is likely due to the exponential and 
responsiveness to rapid cell turnover and increased metabolism during 
neonatal development. This was also observed to be significantly greater in 
weanling male and female fructose offspring and significantly reduced in our 
adult fructose offspring. Reduced VDAC1 in combination with significant 
differential protein activity in electron transport chain complexes II and IV in 
adult fructose offspring may indicate hepatic mitochondrial dysfunction. 
To date, there is a paucity of data on the sex-specific effects of excess maternal 
fructose intake in offspring. Previous studies have shown sex-specific effects of 
excess maternal fructose intake in adult offspring metabolic and cardiovascular 
function. Surprisingly, we show few effects of sex within offspring groups 
following maternal fructose-feeding. Moreover, both male and female fructose 
offspring show elevated uric acid at d21, elevated plasma triglycerides and a 
consistent pattern of elevated palmitoleic acid throughout life. The lack of sex-
specific effects observed in our study may be influenced by the model and 
physiologically relevant level of fructose used. This could potentially mask 
subtle underlying sex effects that may be observed later in life given a higher 
dose of maternal fructose, as seen in previous studies. Furthermore, sex effects 
in the proteomic analysis were performed; however, the results were separated 
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from the main story of the effects of diet. The data sets in results sections would 
become difficult to assess and lose focus of this thesis’s ultimate aim. It would 
be of great interest to examine sex-specific effects in older offspring (12-18 
months) with continued exposure to added fructose providing a potential 
‘second hit.’ Perhaps introducing our ‘malprogrammed’ offspring to the same 
10%w/v fructose during adulthood may exacerbate the results presented here. 
There is limited published data on the developmental programming of 
oxidative phosphorylation and/or the specific mechanisms of oxidative 
phosphorylation, such as complexes I – V activity. No other study has reported 
data as presented here with regards to excess maternal fructose intake and 
offspring developmental programming of hepatic mitochondrial function. 
Results shown here clearly show a programmed differential expression of 
hepatic mitochondrial proteins. This is shown by our proteomic signalling 
pathway analysis and further validated by or western blot analysis of 
mitochondrial relative protein abundance in complexes II and IV and VDAC1. 
We also show that our offspring were affected by programmed alterations in de 
novo lipogenesis and/or fatty acid oxidation, which is hown by up-regulation of 
FAS and SREBP-1c. We hypothesize that the mechanisms involved in the 
programming of liver function in fructose offspring are clearly multifactorial, 
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and further work is required to identify any specific gene/protein changes 
within these and/or associated pathways.  
For the first time, we have shown highly significant consistent changes in 
young offspring FFA whole blood profiles, despite offspring consuming no 
fructose themselves. Specifically, palmitoleic acid was increased prior to 
suckling at d0 and persisted to d21 and 4M of age and including increased 
plasma triglycerides throughout life in offspring of maternally fructose-fed 
dams. Taken together, we provide evidence that indicates unregulated de novo 
lipogenesis in weanling and adult offspring from mothers fed a moderate 10% 
(w/v) fructose water prior to and during pregnancy. We would suggest that 
imbalanced maternal diets, particularly those high in fructose and refined 
sugars, contribute to the rise in metabolic diseases observed over the last 40-50 
years. Along with other current research, our study emphasises the importance 
of limiting added refined fructose, often consumed from SSB intake, and 
promoting a more nutritionally balanced diet in women prior to and during 
pregnancy and lactation. Despite offspring not having consumed added 
fructose themselves, data in this chapter show that excess fructose exposure in 
utero has programmed long-term effects and significantly alters adult offspring 
liver weight, metabolic status, lipid synthesis and metabolism, hepatic protein 
expression, metabolic signalling pathway activation and mitochondrial 
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function. The underlying ‘asymptomatic’ programmed and sustained hepatic 
mitochondrial dysregulation, circulating palmitoleic acid and triglycerides 
following increased fructose exposure in utero, could explain the increased 
predisposition to metabolic diseases during adult life which may be 
exacerbated in those consuming excess fructose during later life. 
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Limitations 
There are a limited number of potential confounders and limitations that may 
influence the observed programmed changes on fructose offspring physiology 
in our study, including: 
The effects of maternal fructose upon maternal physiology and the potential 
confounding influences of increased weight gain prior to and/or during 
pregnancy. The amount of fructose in water was sufficient to elicit 
programmed changes in offspring. However, we would discount the effects of 
secondary conditions such as maternal obesity and/or any overt adverse 
metabolic function following fructose consumption was not present per se. 
Consideration of the fructose content of a wild guinea pig diet. Since the 
fructose-fed and control pre-pregnant and pregnant dams did not differ in 
weight gain, are guinea pigs better at metabolising fructose? There is little 
information in the literature with regards to wild guinea pig energy 
requirements and nutrient intake. However, the fact that the guinea pig did not 
gain weight following fructose feeding and be physiologically ‘normal’ may 
indicate that the diets contained the necessary energy density. We must 
consider that the guinea pig can derive energy from fibrous foods, and this 
may alter the way in which fructose is metabolised in the guinea pig. However, 
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as our animals all received the standard chow and only extra fructose (10% 
w/v) in water, we would suggest the adaptation to diet in a laboratory-bred 
guinea pig would have very little influence on our results. 
The effects of maternal fructose upon lactation. The current study 
demonstrated differences in milk FFA composition in fructose-fed dams when 
compared to the control dams. However, these differences were not mirrored 
in FFA changes observed in offspring whole blood. Furthermore, elevated FFA 
observed in weanling (day 0, 7, 14, 21) were identical in significance within the 
group and present in both male and female fructose offspring. At 4 months of 
age, a reduction in the number of individual FFA was observed, with only 
palmitoleic acid being present at all ages (day 0, 7, 14, 21 and 2, 4 months). 
Importantly, all of these consistent changes were observed at day 0 before the 
offspring received their first feed from the dam. Taken together, we would 
suggest that fructose-fed dam milk FFA composition will obviously play some 
role in offspring metabolism but did not adversely affect the offspring 
programmed changes reported in fructose offspring. 
The potential confounding influence of maternal differential calorie intake 
between groups. Maternal caloric intake from food and water was calculated 
daily during pre-pregnancy and pregnancy. Fructose-fed dams did not weigh 
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more than control dams, and there were no significant differences in OGTT 
glucose or insulin concentrations. Therefore, we are confident that increased 
calorie intake in the fructose-fed dams had no effect on the programmed 
changes observed in the offspring of either group. 
The potential confounding influence of offspring differential food/calorie 
intake. Our offspring never consumed fructose themselves. Offspring 
food/calorie and water intake were calculated during adulthood, and apart 
from the obvious sex difference of weight gain, fructose offspring did not gain 
weight or weigh more than control adult offspring at 4 months of age. 
Therefore, we are confident that altered food or calorie intake over the life 
course had no effect on the programmed changes observed in the offspring of 
either group. 
Studies have shown increased ROS activity following fructose feeding, with 
mitochondrial dysfunction and Redox status likely being the main mechanisms 
(Gaspers, Thomas, Douard, & Ferraris, 2010, Kelley, Allan, & Azhar, 2004, 
Jaiswal et al., 2015). Additionally, many studies within developmental 
programming research have also reported increases in offspring ROS of 
different organs. Similarly, oxidative stress measurements would have been 
very interesting and useful for further interpretation of results presented in this 
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thesis. However, due to markers of oxidative stress being sensitive to tissue 
handling and storage following cull and the amounts of tissue needed for 
lipidomics, proteomics, metabolomics, western blot analysis and future 
methylation analysis, measures of oxidative stress could not be taken at this 
time.  
Many studies support the concept that maternal nutrition, environment, 
pollutants and stress can all adversely affect the offspring physiology. 
Moreover, the timing of these insults during critical stages of development and 
growth have also been reported (McCance & Widdowson, 1974, Lucas, 1998). 
In the current study, our mothers were fed excess fructose prior to and during 
pregnancy. Further studies would be necessary to elucidate at which time point 
exerted the largest programming effects. However, we designed the study so 
that our mothers received fructose in the amounts that could be compared to 
modern westernised dietary trends seen in humans, and generally, pregnant 
women will tend to carry the same or similar diet throughout these time points 
and perhaps, not be aware of this ‘excessive’ fructose intake. Moreover, the 
amount of fructose consumed would not exert any confounding effects of 
weight gain and/or too many metabolic disturbances. Additionally, we still 
present evidence of the likely time points of fructose feeding in the mothers 
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that exert more of a programming effect using our comprehensive analysis of 
whole blood at different time points throughout pregnancy and lactation. 
To examine the ‘true’ effects of programming in our results, a more targeted 
gene expression and abundance analysis may have been necessary. The 
examination of methylation across our gene candidates would have been an 
interesting avenue of investigation to pinpoint the exact genes involved in the 
programmed changes observed in our offspring. We have the capability to 
analyse methylation profiles, and this work is currently being planned. 
However, due to time and economic constraints, we were unable to perform 
methylation profiling at this stage. 
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General Discussion: Effects of Excess Maternal 
Fructose Intake on Offspring Metabolic Function and 
Predisposition to Metabolic Disease 
The prevalence of metabolic diseases such as obesity, type 2 diabetes, 
cardiovascular disease and NAFLD, has increased worldwide over the last 
three decades (Saklayen, 2018, Kopp, 2019) and are major causes of death in 
both men and women (Kopp, 2019). Lifestyle factors, such as a Westernised 
diet and sedentary behaviour, are considered to be driving factors of metabolic 
disease (Pitsavos, Panagiotakos, Weinem, & Stefanadis, 2006). In particular, the 
typical daily intake of fructose in Westernized diets has become a major public 
health concern due to the paralleled increase of metabolic diseases such as; 
dyslipidaemia, hyperlipidaemia, insulin resistance, visceral adiposity, obesity, 
diabetes, high blood pressure, cardiovascular disease and NAFLD (D.-M. 
Zhang et al., 2017, Lee et al., 2018, Bidwell, 2017, Lustig et al., 2012, Dekker et 
al., 2010, Basciano et al., 2005, Smith et al., 2020). However, the underlying 
mechanisms remain unclear. In addition to environmental, socioeconomic and 
genetic factors, the intrauterine environment is now recognized as a principal 
factor contributing to establishing physiological set-points leading towards a 
potential susceptibility or predisposition of metabolic disease throughout life 
(Barker, 1990, Gluckman & Hanson, 2004, Gluckman, Hanson, Cooper, & 
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Thornburg, 2008). Developmental trajectory in the short term, in response to 
nutrient restriction or excessive nutrient availability, may promote adaptations 
that serve to maintain organ functionality necessary for immediate survival 
and fetal development. Consequently, this may lead to exacerbated adverse 
function of organ systems when presented with an unfavourable or imbalanced 
neonatal, adolescent and/or adult offspring nutritional environment. Currently, 
the mechanisms by which maternal diets high in fructose may lead to the 
predisposition to adult disease are poorly understood. In this thesis, we have 
discussed the potential contribution of excess maternal fructose intake in the 
predisposition towards adult offspring metabolic disease risk.  
Many mechanisms involved in the developmental programming of 
predisposition to adult health and disease have been postulated. Structural and 
functional perturbations reported in circulation and organs, including the 
underlying molecular mechanisms, have been shown to play a role in the 
development or predisposition to metabolic pathophysiologic conditions. 
There is now a growing body of scientific literature demonstrating the 
importance of maternal environmental stimuli, diet and the intrauterine 
environment. These can have an impact upon the development of the 
preimplantational blastocyst, placenta and fetus, inducing a predisposition to 
offspring metabolic dysfunction and progression towards disease during 
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adulthood. The mechanisms involved represent fundamental and important 
biological processes and can include structural, functional changes and 
epigenetic modifications that lead to permanent changes in gene and protein 
expression in key tissues and organs. The relative contribution of these 
physiological and molecular mechanisms remains unclear. However, there is 
previously published evidence, including data presented here, indicating that 
epigenetic modification of mitochondrial genes and subsequent mitochondrial 
dysfunction may be a key factor in a range of programmed phenotypes in 
models of developmental programming of health and disease.  
Therefore, in this study, we chose to investigate the effects of excess maternal 
fructose intake prior to pregnancy and during pregnancy to examine the 
potential hepatic mitochondrial programming of metabolic dysfunction and 
lipid synthesis and metabolism in weanling (day21) and adult (month 4) 
offspring. We hypothesised that maternal fructose would lead to permanent 
alterations in offspring liver physiology, altered mitochondrial function and 
lipid synthesis and metabolism. We also hypothesised that these changes 
would lead to an underlying molecular phenotype that lends itself to the 
potential predisposition of asymptomatic liver dysfunction and metabolic 
disease during adulthood. This is characterised by increased circulating TAG 
and FFA, including altered whole blood FFA composition and programmed 
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changes in proteins and molecular markers of increased de novo lipogenesis and 
mitochondrial dysfunction in fructose offspring. We have employed a well-
established animal model of developmental programming in the guinea pig, a 
well-designed, balanced, adequately powered study utilising appropriate 
statistical models and using the gold standard in proteomics technology and in 
vivo protocols. Following analysis of our results, we have supported our 
original hypothesis in that excess maternal fructose altered maternal metabolic 
status and milk lipid concentrations of FFA, as well as evidence of permanent 
molecular changes in offspring hepatic protein expression and abundance 
observed to be involved in key signalling pathways of de novo lipogenesis, lipid 
metabolism and mitochondrial dysfunction. 
Research has shown evidence that excess maternal fructose causes 
developmental programming of altered liver function such as increased de novo 
lipogenesis and associated proteins, which may underpin this phenotype. We 
would add to the scientific literature and further hypothesise in that increased 
fructose exposure during in utero development and vulnerable periods for 
hepatic mitochondrial development may adversely affect the hepatic 
developmental processes by epigenetic regulation, permanently altering 
mitochondrial function and potentially ROS levels (although not measured 
here). Which, in turn, affects lifelong lipid synthesis and metabolism in 
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offspring. We acknowledge there are some gaps in this hypothesis without 
looking specifically at methylated promoter regions of target genes and overall 
epigenetic regulation of associated pathways involved. However, due to the 
bottom-up/shotgun proteomic methodology and the fact we are the first to 
conduct such a comprehensive proteomic analysis of offspring livers of 
maternally fructose-fed dams. It would be difficult to predict the infinite 
amount of differential protein expression that may or may not have occurred 
prior to performing these experiments. Therefore, more targeted molecular 
analysis is warranted to investigate the specific proteins involved in our 
results’ key pathways of interest. Indeed, epigenetic and methylation data 
would be of great interest to elucidate these observations.  
Our study shows the potential of maternal fructose intake, at a seemingly 
modest intake of 10% w/v, to have adverse effects on the mother and her 
developing fetus. Maternal fructose supplementation was calculated to provide 
~16% of total daily caloric intake, equivalent to drinking ~16oz soda/day during 
or prior to pregnancy. We show specific metabolic sequelae of fructose feeding 
in the mothers and a permanent programmed increase in FAS, causing a 
consistently increased level of circulating palmitoleic acid and increased 
plasma triglyceride concentrations throughout life. Based on our data, we 
propose that excess maternal fructose intake increases maternal hepatic de novo 
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lipogenesis and production of triglycerides and circulating free fatty acids. 
Increased maternal circulating free fatty acids subsequently increased lipid 
availability to the fetus, increasing fetal circulating fatty acids. Increased fetal 
circulating fatty acids may have altered the metabolic homeostatic set-points, 
increasing hepatic de novo lipogenesis. Following birth, specific changes in milk 
free fatty acid composition resulting from gestational fructose intake may 
further contribute to the already increased circulating free fatty acid profile 
observed in the fructose offspring. This may indicate an additional route by 
which offspring are further exposed to the deleterious effects of maternal 
fructose-feeding despite the mothers never receiving fructose during lactation 
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Figure 7.1. Overview of Proposed Mechanisms Influencing Offspring 
Predisposition to Metabolic Disease 
 
Figure 7.1. High-level overview demonstrating the proposed mechanisms influencing offspring 
predisposition to metabolic disease. Excess maternal fructose intake during pregnancy increased fatty 
acids and fructose in breast milk. Excess maternal fructose intake altered placental function and/or altered 
nutrient supply to the fetus during pregnancy. Fetal in utero environment causes nuclear epigenetic 
changes in hepatic mitochondria. Fetal in utero environment alters offspring mitochondrial dysfunction 
and altered lipid metabolism. Early life exposures to increased fatty acids and fructose influence the 
developmental programming of offspring mitochondrial dysfunction and altered lipid metabolism. These 
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The primary underlying mechanism of this developmentally programmed 
increase in de novo lipogenesis may be altered β-oxidation in combination with 
mitochondrial oxidative phosphorylation dysfunction, which is shown to be 
consistently increased in fructose offspring. Our results show, in both male and 
female fructose offspring, consistent increases in mitochondrial oxidative 
phosphorylation complexes II and IV and FAS at both weanling and adult ages. 
However, because the pathways of de novo lipogenesis, β-oxidation and 
oxidative phosphorylation are intimately linked, it is a classic ‘chicken or the 
egg’ scenario. Meaning, are programmed changes in FAS contributing to 
increased activation of TCA cycle and β-oxidation, subsequently increasing 
complex II and IV protein expression, are the programmed changes in 
mitochondrial nDNA in complex II and IV driving an altered proton gradient 
and decrease of ATP movement across the mitochondria matrix by VDAC1 
causing mitochondrial dysfunction or a combination of both? Mitochondrial 
control of metabolic signalling pathways may be an epigenetically 
programmed effect of mitochondrial genes, including the electron transport 
chain subunits of mitochondrial proteins encoded by nuclear DNA (nDNA) 
genes. All four subunits of complex II are encoded by nDNA, while complexes 
I, III and IV  are encoded by nDNA and mtDNA, the majority of which are 
encoded by nDNA (Smeitink et al. 1998). Although the mitochondrial genome 
(mtDNA) does not contain histones and, therefore, not believed to be 
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epigenetically regulated (Mechta et al. 2017), the nDNA can be epigenetically 
programmed. Energetic adaptations by mtDNA are understood to be rapid and 
localised to specific regions of a cell. Conversely, energetic adaptations by 
nDNA are slower and more uniform. Therefore, overall mitochondrial function 
plays a critical role in directing nDNA gene expression via epigenetic 
modifications, which in turn greatly affect mitochondrial function.  
The adverse gestational environment from excess maternal fructose intake 
could lead to a negative-feedback cycle of progressive dysregulation and 
mitochondrial dysfunction. The hepatic unbalanced intracellular citrate and 
ATP build-up may affect the negative feedback inhibition of glycolysis which 
may also result in a metabolic shift favouring lipogenesis, increased circulating 
FFA and predisposition to metabolic disease. We would further hypothesise in 
our study, that complex II and IV subunits are likely to have epigenetically 
modified, which also contributes to the mitochondrial dysfunction observed in 
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Figure 7.2. Proposed Developmentally Programmed Mechanisms of Long-
term Mitochondrial Function  
 
Figure 7.2. Red indicates proposed developmentally programmed mechanisms of long-term 
mitochondrial function and subsequent predisposition to metabolic dysfunction. Following exposure to a 
‘second hit’ of over-nutrition during adulthood increase the risk of experiencing metabolic disease(s). 
These programmed mitochondrial effects in F1 may affect germline modifications of F1 fetal gametes, 
potentially programming F2 and F3 metabolic function.  
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In support of our hypothesis, we take into consideration the observed down-
regulated VDAC1 abundance, increased SREBP-1c in adulthood, permanently 
increased FAS and subsequent increase in products of the malonyl – palmitate 
– palmitoleic acid metabolism pathway throughout life in our fructose 
offspring. Our findings show that a maternal diet providing a seemingly 
moderate total daily caloric intake (~16.5%) of free-fructose from a 10% w/v 
fructose-sweetened beverage adversely influences developmental 
programming of a) lipid synthesis and β-oxidation evidenced by consistent up-
regulation of the β-oxidation pathway in female offspring and increased 
circulating FFAs in whole blood of male and female weanlings and adults. 
Specifically, palmitoleic acid and the potential for this FFA to play a role in the 
early stages and progression of hepatic lipid accretion and a pro-NAFLD 
phenotype b) oxidative phosphorylation and mitochondrial function more so in 
males, evidenced by proteomic network and pathway analysis and western 
blot of target proteins in male and female livers (FAS, SREBP-1c, mitochondrial 
complexes II, IV and VDAC1). More remarkably, all of these changes were 
significantly altered in fructose male and female weanling and adult offspring 
who had never consumed any fructose themselves. It would be of great interest 
to examine the effects of fructose feeding in these adult offspring and whether 
an exacerbation of hepatic lipid deposition, FFA, plasma metabolites and/or 
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general physiology would be significantly altered following this ‘second hit’ in 
this vulnerable population. 
In conclusion, this thesis adds to the current narrative based on robust 
evidence, demonstrating the detrimental effects of maternal fructose intake on 
offspring physiology and the asymptomatic molecular phenotype predisposing 
offspring to hepatic metabolic dysregulation throughout life. Our study is the 
first to employ whole hepatic proteomics showing a clear indication of in utero 
programming effects of excess maternal fructose intake on offspring 
mitochondrial function, de novo lipogenesis and associated increases of key 
proteins (FAS and SREBP1-c), increased triglyceride production, and 
programmed increases in circulating palmitoleic acid throughout life. This data 
may assist in further understanding of how excess maternal fructose influences 
offspring mechanistic pathways, including associated genes and proteins, 
intimately linked with β-oxidation and oxidative phosphorylation and/or 
pharmacologic and therapeutic modalities.  
  Bibliography 
 315 
Bibliography 
Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J., & Diehl, 
A. M. (2010). Increased fructose consumption is associated with fibrosis severity in 
patients with nonalcoholic fatty liver disease. Hepatology, 51(6), 1961–1971. 
https://doi.org/10.1002/hep.23535 
Abdulla, M. H., Sattar, M. A., & Johns, E. J. (2011). The Relation between Fructose-Induced 
Metabolic Syndrome and Altered Renal Haemodynamic and Excretory Function in the 
Rat. International Journal of Nephrology, 2011, 1–17. 
https://doi.org/10.4061/2011/934659 
Abdullah, A., Kitteringham, N. R., Jenkins, R. E., Goldring, C., Higgins, L., Yamamoto, M., … 
Park, B. K. (2012). Analysis of the role of Nrf2 in the expression of liver proteins in mice 
using two-dimensional gel-based proteomics. Pharmacological Reports, 64(3), 680–697. 
https://doi.org/10.1016/S1734-1140(12)70863-0 
Abraha, A., Humphreys, S. M., Clark, M. L., Matthews, D. R., & Frayn, K. N. (1998). Acute 
effect of fructose on postprandial lipaemia in diabetic and non-diabetic subjects. British 
Journal of Nutrition, 80(2), 169–175. https://doi.org/10.1017/s000711459800107x 
Aiken, C. E., Tarry-Adkins, J. L., Penfold, N. C., Dearden, L., & Ozanne, S. E. (2016). 
Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid 
peroxidation in female mouse offspring exposed to an obesogenic maternal diet. FASEB 
Journal, 30(4), 1548–1556. https://doi.org/10.1096/fj.15-280800 
Alzamendi, A., Giovambattista, A., Raschia, A., Madrid, V., Gaillard, R. C., Rebolledo, O., … 
Spinedi, E. (2009). Fructose-rich diet-induced abdominal adipose tissue endocrine 
dysfunction in normal male rats. Endocrine, 35(2), 227–232. 
https://doi.org/10.1007/s12020-008-9143-1 
Ameer, F., Scandiuzzi, L., Hasnain, S., Kalbacher, H., & Zaidi, N. (2014, July 1). De novo 
lipogenesis in health and disease. Metabolism: Clinical and Experimental. W.B. Saunders. 
https://doi.org/10.1016/j.metabol.2014.04.003 
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981). Uric acid provides an 
antioxidant defense in humans against oxidant- and radical-caused aging and cancer: A 
hypothesis. Proceedings of the National Academy of Sciences of the United States of 
America, 78(11 II), 6858–6862. https://doi.org/10.1073/pnas.78.11.6858 
Angelin, B. O., Olivecrona, H., Reihner, E., Stahlberg, D., Henriksson, P., & Einarsson, K. 
(1992). Hepatic Cholesterol Metabolism in Estrogen-Treated Men. 
GASTROENTEROLOGY (Vol. 103). Elsevier. 
https://doi.org/10.5555/URI:PII:0016508592911927 
  Bibliography 
 316 
Angueira, A. R., Ludvik, A. E., Reddy, T. E., Wicksteed, B., Lowe, W. L., & Layden, B. T. 
(2015). New insights into gestational glucose metabolism: Lessons learned from 21st 
century approaches. Diabetes, 64(2), 327–334. https://doi.org/10.2337/db14-0877 
Apovian, C. M. (2004, August 25). Sugar-sweetened soft drinks, obesity, and type 2 diabetes. 
Journal of the American Medical Association. https://doi.org/10.1001/jama.292.8.978 
Asghar, Z. A., Thompson, A., Chi, M., Cusumano, A., Scheaffer, S., Al-Hammadi, N., … 
Moley, K. H. (2016). Maternal fructose drives placental uric acid production leading to 
adverse fetal outcomes. Scientific Reports, 6(1), 25091. https://doi.org/10.1038/srep25091 
Barcroft, J. (1946). Researches on Pre-Natal Life (Vol. Vol. 1). Oxford:  Blackwell Scientific 
Publications.  
Barker, D. J. P. (1990). The fetal and infant origins of adult disease. British Medical Journal. 
BMJ Publishing Group. https://doi.org/10.1136/bmj.301.6761.1111 
Barker, D. J. P., Osmond, C., Winter, P. D., Margetts, B., & Simmonds, S. J. (1989). WEIGHT 
IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASE. The Lancet, 
334(8663), 577–580. https://doi.org/10.1016/S0140-6736(89)90710-1 
Basaranoglu, M., Basaranoglu, G., Sabuncu, T., & Sentürk, H. (2013). Fructose as a key player 
in the development of fatty liver disease. World Journal of Gastroenterology, 19(8), 
1166–1172. https://doi.org/10.3748/wjg.v19.i8.1166 
Basciano, H., Federico, L., & Adeli, K. (2005). Fructose, insulin resistance, and metabolic 
dyslipidemia. Nutrition & Metabolism, 2(1), 1–14. https://doi.org/10.1186/1743-7075-2-5 
Baynes, J. W., & Dominiczak, M. H. (2005). Medical Biochemistry, 2d ed (Second). Florida: 
Elsevier Mosby.  
Bayol, S. A., Simbi, B. H., Fowkes, R. C., & Stickland, N. C. (2010). A maternal “junk food” 
diet in pregnancy and lactation promotes nonalcoholic Fatty liver disease in rat offspring. 
Endocrinology, 151(4), 1451–1461. https://doi.org/10.1210/en.2009-1192 
Berg, J. M., Tymoczko, J. L., & Stryer, L. (2002). The Utilization of Fatty Acids as Fuel 
Requires Three Stages of Processing. Retrieved from 
https://www.ncbi.nlm.nih.gov/books/NBK22581/ 
Berger, P. K., Fields, D. A., Demerath, E. W., Fujiwara, H., & Goran, M. I. (2018). High-
fructose corn-syrup-sweetened beverage intake increases 5-hour breast milk fructose 
concentrations in lactating women. Nutrients, 10(6). https://doi.org/10.3390/nu10060669 
  Bibliography 
 317 
Bernardi, J. R., Ferreira, C. F., Senter, G., Krolow, R., de Aguiar, B. W., Portella, A. K., … 
Silveira, P. P. (2013). Early Life Stress Interacts with the Diet Deficiency of Omega-3 
Fatty Acids during the Life Course Increasing the Metabolic Vulnerability in Adult Rats. 
PLoS ONE, 8(4), e62031. https://doi.org/10.1371/journal.pone.0062031 
Bezerra, R. M., Ueno, M., Silva, M. S., Tavares, D. Q., Carvalho, C. R., Saad, M. J., & Gontijo, 
J. A. (2001). A high-fructose diet induces insulin resistance but not blood pressure 
changes in normotensive rats. Brazilian Journal of Medical and Biological Research = 
Revista Brasileira de Pesquisas Medicas e Biologicas, 34(9), 1155–1160. 
https://doi.org/10.1590/s0100-879x2001000900008 
Bidwell, A. J. (2017). Chronic Fructose Ingestion as a Major Health Concern: Is a Sedentary 
Lifestyle Making It Worse? A Review. Nutrients, 9(6). https://doi.org/10.3390/nu9060549 
Biro, G. (2018). Human biological characteristics of fructose No title View project. Retrieved 
from https://www.researchgate.net/publication/325022390 
Bitter, A., Rümmele, P., Klein, K., Kandel, B. A., Rieger, J. K., Nüssler, A. K., … Burk, O. 
(2015). Pregnane X receptor activation and silencing promote steatosis of human hepatic 
cells by distinct lipogenic mechanisms. Archives of Toxicology, 89(11), 2089–2103. 
https://doi.org/10.1007/s00204-014-1348-x 
Blacker, T. S., & Duchen, M. R. (2016, November 1). Investigating mitochondrial redox state 
using NADH and NADPH autofluorescence. Free Radical Biology and Medicine. 
Elsevier Inc. https://doi.org/10.1016/j.freeradbiomed.2016.08.010 
Boden, G. (2008, September). Obesity and Free Fatty Acids. Endocrinology and Metabolism 
Clinics of North America. https://doi.org/10.1016/j.ecl.2008.06.007 
Bolsoni-Lopes, A., Festuccia, W. T., Farias, T. S. M., Chimin, P., Torres-Leal, F. L., Derogis, 
P. B. M., … Alonso-Vale, M. I. C. (2013). Palmitoleic acid (n-7) increases white 
adipocyte lipolysis and lipase content in a PPARα-dependent manner. American Journal 
of Physiology-Endocrinology and Metabolism, 305(9), E1093–E1102. 
https://doi.org/10.1152/ajpendo.00082.2013 
Bosch, P. J., Peng, L., & Kivell, B. M. (2015). Proteomics Analysis of Dorsal Striatum Reveals 
Changes in Synaptosomal Proteins following Methamphetamine Self-Administration in 
Rats. PLOS ONE, 10(10), e0139829. https://doi.org/10.1371/journal.pone.0139829 
Bray, G. A. (2008). Fructose: Should we worry? International Journal of Obesity. Int J Obes 
(Lond). https://doi.org/10.1038/ijo.2008.248 
 
  Bibliography 
 318 
Bray, George A. (2013, January). Potential health risks from beverages containing fructose 
found in sugar or high-fructose corn syrup. Diabetes Care. American Diabetes 
Association. https://doi.org/10.2337/dc12-1631 
Briscoe, T. A., Rehn, A. E., Dieni, S., Duncan, J. R., Wlodek, M. E., Owens, J. A., & Rees, S. 
M. (2004). Cardiovascular and renal disease in the adolescent guinea pig after chronic 
placental insufficiency. American Journal of Obstetrics and Gynecology, 191(3), 847–
855. https://doi.org/10.1016/j.ajog.2004.01.050 
Bruin, J. E., Petre, M. A., Raha, S., Morrison, K. M., Gerstein, H. C., & Holloway, A. C. 
(2008). Fetal and neonatal nicotine exposure in wistar rats causes progressive pancreatic 
mitochondrial damage and beta cell dysfunction. PLoS ONE, 3(10). 
https://doi.org/10.1371/journal.pone.0003371 
Brumbaugh, D. E., Tearse, P., Cree-Green, M., Fenton, L. Z., Brown, M., Scherzinger, A., … 
Barbour, L. A. (2013). Intrahepatic fat is increased in the neonatal offspring of obese 
women with gestational diabetes. Journal of Pediatrics, 162(5). 
https://doi.org/10.1016/j.jpeds.2012.11.017 
Brunst, K. J., Sanchez-Guerra, M., Chiu, Y. H. M., Wilson, A., Coull, B. A., Kloog, I., … 
Wright, R. J. (2018). Prenatal particulate matter exposure and mitochondrial dysfunction 
at the maternal-fetal interface: Effect modification by maternal lifetime trauma and child 
sex. Environmental International, 112, 49–58. 
https://doi.org/10.1016/j.envint.2017.12.020 
Byrne, C. D., Olufad, R., Bruce, K. D., Cagampang, F. R., & Ahmed, M. H. (2009, April). 
Metabolic disturbances in non-alcoholic fatty liver disease. Clinical Science. Clin Sci 
(Lond). https://doi.org/10.1042/CS20080253 
Camara, A. K. S., Zhou, Y. F., Wen, P. C., Tajkhorshid, E., & Kwok, W. M. (2017, June 30). 
Mitochondrial VDAC1: A key gatekeeper as potential therapeutic target. Frontiers in 
Physiology. Frontiers Media S.A. https://doi.org/10.3389/fphys.2017.00460 
Campbell, E., Schlappal, A., Geller, E., & Castonguay, T. W. (2014). Fructose-Induced 
Hypertriglyceridemia: A Review. In Nutrition in the Prevention and Treatment of 
Abdominal Obesity (pp. 197–205). Elsevier Inc. https://doi.org/10.1016/B978-0-12-
407869-7.00019-2 
Capurso, C., & Capurso, A. (2012, September). From excess adiposity to insulin resistance: 
The role of free fatty acids. Vascular Pharmacology. 
https://doi.org/10.1016/j.vph.2012.05.003 
Carberry, A. E., Colditz, P. B., & Lingwood, B. E. (2010). Body composition from birth to 4.5 
months in infants born to non-obese women. Pediatric Research, 68(1), 84–88. 
https://doi.org/10.1203/PDR.0b013e3181df5421 
  Bibliography 
 319 
Carta, G., Murru, E., Banni, S., & Manca, C. (2017, November 8). Palmitic acid: Physiological 
role, metabolism and nutritional implications. Frontiers in Physiology. Frontiers Media 
S.A. https://doi.org/10.3389/fphys.2017.00902 
Castañeda-Gutiérrez, E., Pouteau, E., Pescia, G., Moulin, J., Aprikian, O., & Macé, K. (2011). 
The guinea pig as a model for metabolic programming of adiposity. In American Journal 
of Clinical Nutrition (Vol. 94). Am J Clin Nutr. https://doi.org/10.3945/ajcn.110.000794 
Chappel, J. E., Clandinin, M. T., & Kearney-Volpe, C. (1985). Trans fatty acids in human milk 
lipids: Influence of maternal diet and weight loss. American Journal of Clinical Nutrition, 
42(1), 49–56. https://doi.org/10.1093/ajcn/42.1.49 
Chen, L., Pei, J. H., Kuang, J., Chen, H. M., Chen, Z., Li, Z. W., & Yang, H. Z. (2015). Effect 
of lifestyle intervention in patients with type 2 diabetes: A meta-analysis. Metabolism: 
Clinical and Experimental, 64(2), 338–347. https://doi.org/10.1016/j.metabol.2014.10.018 
Chiu, S., Sievenpiper, J. L., De Souza, R. J., Cozma, A. I., Mirrahimi, A., Carleton, A. J., … 
Jenkins, D. J. A. (2014). Effect of fructose on markers of non-alcoholic fatty liver disease 
(NAFLD): A systematic review and meta-analysis of controlled feeding trials. European 
Journal of Clinical Nutrition. Nature Publishing Group. 
https://doi.org/10.1038/ejcn.2014.8 
Cioffi, F., Senese, R., Lasala, P., Ziello, A., Mazzoli, A., Crescenzo, R., … Iossa, S. (2017). 
Fructose-Rich Diet Affects Mitochondrial DNA Damage and Repair in Rats. Nutrients, 
9(4), 323. https://doi.org/10.3390/nu9040323 
Clayton, Z. E., Vickers, M. H., Bernal, A., Yap, C., & Sloboda, D. M. (2015). Early Life 
Exposure to Fructose Alters Maternal, Fetal and Neonatal Hepatic Gene Expression and 
Leads to Sex-Dependent Changes in Lipid Metabolism in Rat Offspring. PLOS ONE, 
10(11), e0141962. https://doi.org/10.1371/journal.pone.0141962 
Clemente, D. B. P., Casas, M., Vilahur, N., Begiristain, H., Bustamante, M., Carsin, A. E., … 
Nawrot, T. S. (2016). Prenatal ambient air pollution, placental mitochondrial DNA 
content, and birth weight in the INMA (Spain) and ENVIRONAGE (Belgium) birth 
Cohorts. Environmental Health Perspectives, 124(5), 659–665. 
https://doi.org/10.1289/ehp.1408981 
Cordain, L., Eaton, S. B., Sebastian, A., Mann, N., Lindeberg, S., Watkins, B. A., … Brand-
Miller, J. (2005). Origins and evolution of the Western diet: health implications for the 
21st century. The American Journal of Clinical Nutrition, 81(2), 341–354. 
https://doi.org/10.1093/ajcn.81.2.341 
 
  Bibliography 
 320 
Cruz, M. M., Lopes, A. B., Crisma, A. R., De Sá, R. C. C., Kuwabara, W. M. T., Curi, R., … 
Alonso-Vale, M. I. C. (2018). Palmitoleic acid (16:1n7) increases oxygen consumption, 
fatty acid oxidation and ATP content in white adipocytes. Lipids in Health and Disease, 
17(1). https://doi.org/10.1186/s12944-018-0710-z 
Cummings, D. E., & Shannon, M. H. (2003). Roles for ghrelin in the regulation of appetite and 
body weight. In Archives of Surgery (Vol. 138, pp. 389–396). American Medical 
Association. https://doi.org/10.1001/archsurg.138.4.389 
D’Autréaux, B., & Toledano, M. B. (2007, October). ROS as signalling molecules: 
Mechanisms that generate specificity in ROS homeostasis. Nature Reviews Molecular 
Cell Biology. Nat Rev Mol Cell Biol. https://doi.org/10.1038/nrm2256 
De Koning, L., Malik, V. S., Rimm, E. B., Willett, W. C., & Hu, F. B. (2011). Sugar-sweetened 
and artificially sweetened beverage consumption and risk of type 2 diabetes in men. 
American Journal of Clinical Nutrition, 93(6), 1321–1327. 
https://doi.org/10.3945/ajcn.110.007922 
Dekker, M. J., Qiaozhu, S., Baker, C., Rutledge, A. C., & Adeli, K. (2010). Fructose: A highly 
lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic 
syndrome Mechanism of liponecrosis, a distinct mode of programmed cell death View 
project. Article in AJP Endocrinology and Metabolism, 299(5), E685–E694. 
https://doi.org/10.1152/ajpendo.00283.2010 
Dewdney, B., Roberts, A., Qiao, L., George, J., & Hebbard, L. (2020, April 1). A sweet 
connection? Fructose’s role in hepatocellular carcinoma. Biomolecules. MDPI AG. 
https://doi.org/10.3390/biom10040496 
DiNicolantonio, J. J., & Berger, A. (2016, August 1). Added sugars drive nutrient and energy 
deficit in obesity: A new paradigm. Open Heart. BMJ Publishing Group. 
https://doi.org/10.1136/openhrt-2016-000469 
Douard, V., & Ferraris, R. P. (2008, August). Regulation of the fructose transporter GLUT5 in 
health and disease. American Journal of Physiology - Endocrinology and Metabolism. Am 
J Physiol Endocrinol Metab. https://doi.org/10.1152/ajpendo.90245.2008 
Eaton, S. B. (2006). The ancestral human diet: what was it and should it be a paradigm for 
contemporary nutrition? Proceedings of the Nutrition Society, 65(1), 1–6. 
https://doi.org/10.1079/pns2005471 
Eberlé, D., Hegarty, B., Bossard, P., Ferré, P., & Foufelle, F. (2004, November 1). SREBP 
transcription factors: Master regulators of lipid homeostasis. Biochimie. Elsevier B.V. 
https://doi.org/10.1016/j.biochi.2004.09.018 
  Bibliography 
 321 
Ebert, K., Ludwig, M., Geillinger, K. E., Schoberth, G. C., Essenwanger, J., Stolz, J., … Witt, 
H. (2017). Reassessment of GLUT7 and GLUT9 as Putative Fructose and Glucose 
Transporters. Journal of Membrane Biology, 250(2), 171–182. 
https://doi.org/10.1007/s00232-016-9945-7 
Elliott, S. S., Keim, N. L., Stern, J. S., Teff, K., & Havel, P. J. (2002). Fructose, weight gain, 
and the insulin resistance syndrome. American Journal of Clinical Nutrition, 76(5), 911–
922. https://doi.org/10.1093/ajcn/76.5.911 
Emanuele, N. V., Emanuele, M. A., Morgan, M. O., Sulo, D., Yong, S., Kovacs, E. J., … 
Callaci, J. J. (2009). Ethanol potentiates the acute fatty infiltration of liver caused by burn 
injury: Prevention by insulin treatment. Journal of Burn Care and Research, 30(3), 482–
488. https://doi.org/10.1097/BCR.0b013e3181a28df3 
Fernandez, M. L., & McNamara, D. J. (1991). Regulation of cholesterol and lipoprotein 
metabolism in guinea pigs mediated by dietary fat quality and quantity. Journal of 
Nutrition, 121(7), 934–943. https://doi.org/10.1093/jn/121.7.934 
Fernandez, Maria Luz, & McNamara, D. J. (1989). Dietary fat-mediated changes in hepatic 
apoprotein B E receptor in the guinea pig: Effect of polyunsaturated, monounsaturated, 
and saturated fat. Metabolism, 38(11), 1094–1102. https://doi.org/10.1016/0026-
0495(89)90046-2 
Fernandez, Maria Luz, Ruiz, L. R., Conde, A. K., Sun, D.-M., Erickson, S. K., Mcnamara, D. 
J., … Erickson, D. J. (1995). Psyllium reduces plasma LDL in guinea pigs by altering 
hepatic cholesterol homeostasis. Retrieved from www.jlr.org 
Fernandez, Maria Luz, Yount, N. Y., & McNamara, D. J. (1990). Whole body and hepatic 
cholesterol synthesis rates in the guinea-pig: effect of dietary fat quality. Biochimica et 
Biophysica Acta (BBA)/Lipids and Lipid Metabolism, 1044(3), 340–348. 
https://doi.org/10.1016/0005-2760(90)90078-C 
Ferraris, R. P., Choe, J. Y., & Patel, C. R. (2018, August 21). Intestinal absorption of fructose. 
Annual Review of Nutrition. Annual Reviews Inc. https://doi.org/10.1146/annurev-nutr-
082117-051707 
Fox, I. H., & Kelley, W. N. (1972). Studies on the mechanism of fructose-induced 
hyperuricemia in man. Metabolism, 21(8), 713–721. https://doi.org/10.1016/0026-
0495(72)90120-5 
Frederico, M. J. S., Vitto, M. F., Cesconetto, P. A., Engelmann, J., De Souza, D. R., Luz, G., … 
De Souza, C. T. (2011). Short-term inhibition of SREBP-1c expression reverses diet-
induced non-alcoholic fatty liver disease in mice. Scandinavian Journal of 
Gastroenterology, 46(11), 1381–1388. https://doi.org/10.3109/00365521.2011.613945 
  Bibliography 
 322 
Furugen, M., Saitoh, S., Ohnishi, H., Akasaka, H., Mitsumata, K., Chiba, M., … Miura, T. 
(2012). Matsuda-DeFronzo insulin sensitivity index is a better predictor than HOMA-IR 
of hypertension in Japanese: The Tanno-Sobetsu study. Journal of Human Hypertension, 
26(5), 325–333. https://doi.org/10.1038/jhh.2011.23 
Galley, H. F. (2011, July 1). Oxidative stress and mitochondrial dysfunction in sepsis. British 
Journal of Anaesthesia. Oxford University Press. https://doi.org/10.1093/bja/aer093 
Gao, C., Gibson, R. A., Mcphee, A. J., Zhou, S. J., Collins, C. T., Makrides, M., … Liu, G. 
(2018). Comparison of breast milk fatty acid composition from mothers of premature 
infants of three countries using novel dried milk spot technology. Prostaglandins 
Leukotrienes and Essential Fatty Acids, 139, 3–8. 
https://doi.org/10.1016/j.plefa.2018.08.003 
Gao, C., Liu, G., Whitfield, K. C., Kroeun, H., Green, T. J., Gibson, R. A., … Zhou, S. J. 
(2018). Comparison of Human Milk Fatty Acid Composition of Women From Cambodia 
and Australia. Journal of Human Lactation, 34(3), 585–591. 
https://doi.org/10.1177/0890334418772279 
Gaspers, L. D., Thomas, A. P., Douard, V., & Ferraris, R. P. (2010). Mechanisms Underlying 
Fructose-Induced Oxidative Stress in the Cytosol and Mitochondria. Biophysical Journal, 
98(3), 377a. https://doi.org/10.1016/j.bpj.2009.12.2031 
George, G. C., Hanss-Nuss, H., Milani, T. J., & Freeland-Graves, J. H. (2005). Food Choices of 
Low-Income Women during Pregnancy and Postpartum. Journal of the American Dietetic 
Association, 105(6), 899–907. https://doi.org/10.1016/j.jada.2005.03.028 
Gibson, T., Rodgers, A. V, Simmonds, H. A., Court-Brown, F., Todd, E., & Meilton, V. (1983). 
A controlled study of diet in patients with gout. Annals of the Rheumatic Diseases, 42, 
123–127. https://doi.org/10.1136/ard.42.2.123 
Gluckman, P. D., & Hanson, M. A. (2004). Developmental origins of disease paradigm: A 
mechanistic and evolutionary perspective. Pediatric Research. Lippincott Williams and 
Wilkins. https://doi.org/10.1203/01.PDR.0000135998.08025.FB 
Gluckman, P. D., Hanson, M. A., Cooper, C., & Thornburg, K. L. (2008). Effect of In Utero 
and Early-Life Conditions on Adult Health and Disease. New England Journal of 
Medicine, 359(1), 61–73. https://doi.org/10.1056/nejmra0708473 
Goran, M. I., Dumke, K., Bouret, S. G., Kayser, B., Walker, R. W., & Blumberg, B. (2013). 
The obesogenic effect of high fructose exposure during early development. Nature 
Reviews Endocrinology, 9(8), 494–500. https://doi.org/10.1038/nrendo.2013.108 
 
  Bibliography 
 323 
Gray, C., Gardiner, S. M., Elmes, M., & Gardner, D. S. (2016). Excess maternal salt or fructose 
intake programmes sex-specific, stress-and fructose-sensitive hypertension in the 
offspring. British Journal of Nutrition, 115(4), 594–604. 
https://doi.org/10.1017/S0007114515004936 
Grove, D., & Pownall, H. J. (1991). Comparative specificity of plasma lecithin: Cholesterol 
acyltransferase from ten animal species. Lipids, 26(6), 416–420. 
https://doi.org/10.1007/BF02536066 
Gruzieva, O., Xu, C. J., Breton, C. V., Annesi-Maesano, I., Antó, J. M., Auffray, C., … Melén, 
E. (2017). Epigenome-wide meta-analysis of methylation in children related to prenatal 
NO2 air pollution exposure. Environmental Health Perspectives, 125(1), 104–110. 
https://doi.org/10.1289/EHP36 
Guilloteau, P., Zabielski, R., Hammon, H. M., & Metges, C. C. (2009, October). Adverse 
effects of nutritional programming during prenatal and early postnatal life, some aspects 
of regulation and potential prevention and treatments. Journal of Physiology and 
Pharmacology. 
Guo, C. Y., Sun, L., Chen, X. P., & Zhang, D. S. (2013). Oxidative stress, mitochondrial 
damage and neurodegenerative diseases. Neural Regeneration Research, 8(21), 2003–
2014. https://doi.org/10.3969/j.issn.1673-5374.2013.21.009 
Gyllenhammer, L. E., Entringer, S., Buss, C., & Wadhwa, P. D. (2020, May 13). 
Developmental programming of mitochondrial biology: A conceptual framework and 
review. Proceedings of the Royal Society B: Biological Sciences. Royal Society 
Publishing. https://doi.org/10.1098/rspb.2019.2713 
Haa, Y. C., & Barter, P. J. (1982). Differences in plasma cholesteryl ester transfer activity in 
sixteen vertebrate species. Comparative Biochemistry and Physiology -- Part B: 
Biochemistry And, 71(2), 265–269. https://doi.org/10.1016/0305-0491(82)90252-8 
Hallfrisch, J. (1990). Metabolic effects of dietary fructose. The FASEB Journal, 4(9), 2652–
2660. https://doi.org/10.1096/fasebj.4.9.2189777 
Hannou, S. A., Haslam, D. E., McKeown, N. M., & Herman, M. A. (2018, February 1). 
Fructose metabolism and metabolic disease. Journal of Clinical Investigation. American 
Society for Clinical Investigation. https://doi.org/10.1172/JCI96702 
Hanson, M. A., & Gluckman, P. D. (2014, October 1). Early developmental conditioning of 
later health and disease: physiology or pathophysiology? Physiological Reviews.  
American Physiological Society Bethesda, MD. 
https://doi.org/10.1152/physrev.00029.2013 
  Bibliography 
 324 
Hastie, R., & Lappas, M. (2014). The effect of pre-existing maternal obesity and diabetes on 
placental mitochondrial content and electron transport chain activity. Placenta, 35(9), 
673–683. https://doi.org/10.1016/j.placenta.2014.06.368 
Havel, P. J. (2005, May). Dietary fructose: Implications for dysregulation of energy 
homeostasis and lipid/carbohydrate metabolism. Nutrition Reviews. 
https://doi.org/10.1301/nr.2005.may.133-157 
Hawkins, M., Gabriely, I., Wozniak, R., Vilcu, C., Shamoon, H., & Rossetti, L. (2002). 
Fructose improves the ability of hyperglycemia per se to regulate glucose production in 
type 2 diabetes. Diabetes, 51(3), 606–614. https://doi.org/10.2337/diabetes.51.3.606 
Hengist, A., Koumanov, F., & Gonzalez, J. T. (2019). Fructose and metabolic health: governed 
by hepatic glycogen status? The Journal of Physiology, 597(14), 3573–3585. 
https://doi.org/10.1113/JP277767 
Herman, M. A., & Samuel, V. T. (2016). The Sweet Path to Metabolic Demise: Fructose and 
Lipid Synthesis. Trends in Endocrinology and Metabolism. 
https://doi.org/10.1016/j.tem.2016.06.005 
Herman, R., Zakim, D., & Stifel, F. B. (1970). Effect of diet on lipid metabolism in 
experimental animals and man. Undefined. 
Hoffmann, A., & Spengler, D. (2018, December 6). The mitochondrion as potential interface in 
early-life stress brain programming. Frontiers in Behavioral Neuroscience. Frontiers 
Media S.A. https://doi.org/10.3389/fnbeh.2018.00306 
Holmström, K. M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J. M., … 
Abramov, A. Y. (2013). Nrf2 impacts cellular bioenergetics by controlling substrate 
availability for mitochondrial respiration. Biology Open, 2(8), 761–770. 
https://doi.org/10.1242/bio.20134853 
Hong, M., Cai, Z., Song, L., Liu, Y., Wang, Q., & Feng, X. (2018). Gynostemma pentaphyllum 
Attenuates the Progression of Nonalcoholic Fatty Liver Disease in Mice: A Biomedical 
Investigation Integrated with In Silico Assay . Evidence-Based Complementary and 
Alternative Medicine, 2018, 1–13. https://doi.org/10.1155/2018/8384631 
Horton, D. M., Saint, D. A., Owens, J. A., Gatford, K. L., & Kind, K. L. (2017). Use of the 
hyperinsulinemic euglycemic clamp to assess insulin sensitivity in guinea pigs: Dose 
response, partitioned glucose metabolism, and species comparisons. American Journal of 
Physiology - Regulatory Integrative and Comparative Physiology, 313(1), R19–R28. 
https://doi.org/10.1152/ajpregu.00028.2017 
 
  Bibliography 
 325 
Huang, D., Dhawan, T., Young, S., Yong, W. H., Boros, L. G., & Heaney, A. P. (2011). 
Fructose impairs glucose-induced hepatic triglyceride synthesis. 
https://doi.org/10.1186/1476-511X-10-20 
Hübner, N. F., Horch, R. E., Polykandriotis, E., Rau, T. T., & Dragu, A. (2014). A 
Histopathologic and Immunohistochemical Study on Liquification of Human Adipose 
Tissue Ex Vivo. Aesthetic Plastic Surgery, 38(5), 976–984. 
https://doi.org/10.1007/s00266-014-0371-x 
Huh, J., Kwon, J. Y., Kim, H. R., Lee, E. H., Rhie, Y. J., Choi, B. M., & Lee, K. H. (2018). 
Comparison of postnatal catch-up growth according to definitions of small for gestational 
age infants. Korean Journal of Pediatrics, 61(3), 71–77. 
https://doi.org/10.3345/kjp.2018.61.3.71 
Huizing, M., Ruitenbeek, W., Thinnes, F. P., DePinto, V., Wendel, U., Trijbels, F. J. M., … 
Van Den Heuvel, L. P. (1996). Deficiency of the voltage-dependent anion channel: A 
novel cause of mitochondriopathy. Pediatric Research, 39(5), 760–765. 
https://doi.org/10.1203/00006450-199605000-00003 
Igosheva, N., Abramov, A. Y., Poston, L., Eckert, J. J., Fleming, T. P., Duchen, M. R., & 
McConnell, J. (2010). Maternal Diet-Induced Obesity Alters Mitochondrial Activity and 
Redox Status in Mouse Oocytes and Zygotes. PLoS ONE, 5(4), e10074. 
https://doi.org/10.1371/journal.pone.0010074 
Inoue, I., Takahashi, K., Katayama, S., Harada, Y., Negishi, K., Itabashi, A., & Ishii, J. (1995). 
Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, Liver Glycogen 
synthase activity, and β-oxidation in fructose-fed rats. Metabolism, 44(12), 1626–1630. 
https://doi.org/10.1016/0026-0495(95)90085-3 
Jaiswal, N., Maurya, C. K., Arha, D., Avisetti, D. R., Prathapan, A., Raj, P. S., … Tamrakar, A. 
K. (2015). Fructose induces mitochondrial dysfunction and triggers apoptosis in skeletal 
muscle cells by provoking oxidative stress. Apoptosis, 20(7), 930–947. 
https://doi.org/10.1007/s10495-015-1128-y 
Janssen, B. G., Byun, H. M., Gyselaers, W., Lefebvre, W., Baccarelli, A. A., & Nawrot, T. S. 
(2015). Placental mitochondrial methylation and exposure to airborne particulate matter in 
the early life environment: An ENVIRONAGE birth cohort study. Epigenetics, 10(6), 
536–544. https://doi.org/10.1080/15592294.2015.1048412 
Janssen, B. G., Munters, E., Pieters, N., Smeets, K., Cox, B., Cuypers, A., … Nawrot, T. S. 
(2012). Placental mitochondrial DNA content and particulate air pollution during in utero 
life. Environmental Health Perspectives, 120(9), 1346–1352. 
https://doi.org/10.1289/ehp.1104458 
 
  Bibliography 
 326 
Jegatheesan, P., & De Bandt, J. P. (2017, March 3). Fructose and NAFLD: The multifaceted 
aspects of fructose metabolism. Nutrients. MDPI AG. https://doi.org/10.3390/nu9030230 
Jen, K. L. C., Rochon, C., Zhong, S., & Whitcomb, L. (1991). Fructose and sucrose feeding 
during pregnancy and lactation in rats changes maternal and pup fuel metabolism. Journal 
of Nutrition, 121(12), 1999–2005. https://doi.org/10.1093/jn/121.12.1999 
Jideonwo, V., Hou, Y., Ahn, M., Surendran, S., & Morral, N. (2018). Impact of silencing 
hepatic SREBP-1 on insulin signaling. PLOS ONE, 13(5), e0196704. 
https://doi.org/10.1371/journal.pone.0196704 
Johnson, R. J., Andrews, P., Benner, S. A., & Oliver, W. (2010). Theodore E. Woodward 
award. The evolution of obesity: insights from the mid-Miocene. Transactions of the 
American Clinical and Climatological Association, 121, 295. Retrieved from 
/pmc/articles/PMC2917125/?report=abstract 
Johnson, R. J., Segal, M. S., Sautin, Y., Nakagawa, T., Feig, D. I., Kang, D. H., … Sánchez-
Lozada, L. G. (2007, October 1). Potential role of sugar (fructose) in the epidemic of 
hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and 
cardiovascular disease1-3. American Journal of Clinical Nutrition. 
https://doi.org/10.1093/ajcn/86.4.899 
Johnson, R. K., Appel, L. J., Brands, M., Howard, B. V., Lefevre, M., Lustig, R. H., … Wylie-
Rosett, J. (2009). Dietary sugars intake and cardiovascular health a scientific statement 
from the american heart association. Circulation. Circulation. 
https://doi.org/10.1161/CIRCULATIONAHA.109.192627 
Jones, C. T., & Parer, J. T. (1983). The effect of alterations in placental blood flow on the 
growth of and nutrient supply to the fetal guinea‐pig. The Journal of Physiology, 343(1), 
525–537. https://doi.org/10.1113/jphysiol.1983.sp014907 
Jornayvaz, F. R., & Shulman, G. I. (2012, May 2). Diacylglycerol activation of protein kinase 
Cε and hepatic insulin resistance. Cell Metabolism. NIH Public Access. 
https://doi.org/10.1016/j.cmet.2012.03.005 
Karpe, F., Dickmann, J. R., & Frayn, K. N. (2011, October). Fatty acids, obesity, and insulin 
resistance: Time for a reevaluation. Diabetes. https://doi.org/10.2337/db11-0425 
Kawano, Y., & Cohen, D. E. (2013, April). Mechanisms of hepatic triglyceride accumulation in 
non-alcoholic fatty liver disease. Journal of Gastroenterology. Springer. 
https://doi.org/10.1007/s00535-013-0758-5 
 
  Bibliography 
 327 
Keller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002). Empirical statistical model to 
estimate the accuracy of peptide identifications made by MS/MS and database search. 
Analytical Chemistry, 74(20), 5383–5392. https://doi.org/10.1021/ac025747h 
Kelley, G. L., Allan, G., & Azhar, S. (2004). High Dietary Fructose Induces a Hepatic Stress 
Response Resulting in Cholesterol and Lipid Dysregulation. Endocrinology, 145(2), 548–
555. https://doi.org/10.1210/en.2003-1167 
Kermack, W. O., Mckendrick, A. G., & Mckinlay, P. L. (1934). Death-Rates in Great Britain 
and Sweden. Some General Regularities and their Significance. Lancet, 698–703. 
Kernan, W. N., Inzucchi, S. E., Viscoli, C. M., Brass, L. M., Bravata, D. M., Shulman, G. I., … 
Horwitz, R. I. (2003). Pioglitazone improves insulin sensitivity among nondiabetic 
patients with a recent transient ischemic attack or ischemic stroke. Stroke, 34(6), 1431–
1436. https://doi.org/10.1161/01.STR.0000071108.00234.0E 
Khitan, Z., & Kim, D. H. (2013). Fructose: a key factor in the development of metabolic 
syndrome and hypertension. Journal of Nutrition and Metabolism, 2013, 682673. 
https://doi.org/10.1155/2013/682673 
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010). Improving 
Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research. 
PLoS Biology, 8(6), e1000412. https://doi.org/10.1371/journal.pbio.1000412 
Kisioglu, B., & Nergiz-Unal, R. (2020). Potential effect of maternal dietary sucrose or fructose 
syrup on CD36, leptin, and ghrelin-mediated fetal programming of obesity. Nutritional 
Neuroscience, 23(3), 210–220. https://doi.org/10.1080/1028415X.2018.1491151 
Kojima, M., & Kangawa, K. (2005, April). Ghrelin: Structure and function. Physiological 
Reviews. American Physiological Society. https://doi.org/10.1152/physrev.00012.2004 
Kopp, W. (2019). How western diet and lifestyle drive the pandemic of obesity and civilization 
diseases. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 2221–
2236. https://doi.org/10.2147/DMSO.S216791 
Korshunov, S. S., Skulachev, V. P., & Starkov, A. A. (1997). High protonic potential actuates a 
mechanism of production of reactive oxygen species in mitochondria. FEBS Letters, 
416(1), 15–18. https://doi.org/10.1016/S0014-5793(97)01159-9 
Kota, S., Kota, S., Krishna, S. V. S., Modi, K., & Jammula, S. (2012). Hypertriglyceridemia-
induced recurrent acute pancreatitis: A case-based review. Indian Journal of 
Endocrinology and Metabolism, 16(1), 141. https://doi.org/10.4103/2230-8210.91211 
  Bibliography 
 328 
Lambert, J. E., Ramos-Roman, M. A., Browning, J. D., & Parks, E. J. (2014). Increased de 
novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver 
disease. Gastroenterology, 146(3), 726–735. https://doi.org/10.1053/j.gastro.2013.11.049 
Laughlin, M. R. (2014, August 5). Normal roles for dietary fructose in carbohydrate 
metabolism. Nutrients. MDPI AG. https://doi.org/10.3390/nu6083117 
Laughon, S. K., Catov, J., Powers, R. W., Roberts, J. M., & Gandley, R. E. (2011). First 
trimester uric acid and adverse pregnancy outcomes. American Journal of Hypertension, 
24(4), 489–495. https://doi.org/10.1038/ajh.2010.262 
Lê, K.-A., Faeh, D., Stettler, R., Ith, M., Kreis, R., Vermathen, P., … Tappy, L. (2006). A 4-wk 
high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic 
lipids in healthy humans. The American Journal of Clinical Nutrition, 84(6), 1374–1379. 
https://doi.org/10.1093/ajcn/84.6.1374 
Lê, K.-A., Ith, M., Kreis, R., Faeh, D., Bortolotti, M., Tran, C., … Tappy, L. (2009). Fructose 
overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects 
with and without a family history of type 2 diabetes. The American Journal of Clinical 
Nutrition, 89(6), 1760–1765. https://doi.org/10.3945/ajcn.2008.27336 
Leary, C., Leese, H. J., & Sturmey, R. G. (2015). Human embryos from overweight and obese 
women display phenotypic and metabolic abnormalities. Human Reproduction, 30(1), 
122–132. https://doi.org/10.1093/humrep/deu276 
Lee, W.-C., Wu, K. L. H., Leu, S., & Tain, Y.-L. (2018). Translational insights on 
developmental origins of metabolic syndrome: Focus on fructose consumption. 
Biomedical Journal, 41(2), 96–101. https://doi.org/10.1016/j.bj.2018.02.006 
Lepage, G., & Roy, C. C. (1986). Direct transesterification of all classes of lipids in a one-step 
reaction. Journal of Lipid Research, 27(1), 114–120. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/3958609 
Lewis, G. F., Carpentier, A., Adeli, K., & Giacca, A. (2002). Disordered Fat Storage and 
Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes. Retrieved 
from https://academic.oup.com/edrv/article/23/2/201/2424219 
Li, X. Y., Goh, G. B.-B., Shim, H. H., Fook-Chong, S. M. C., Loh, Y. H., & Chow, W. C. 
(2019). Fructose intake in patients with non-alcoholic fatty liver disease. Proceedings of 
Singapore Healthcare, 28(4), 218–223. https://doi.org/10.1177/2010105819840370 
 
  Bibliography 
 329 
Litherland, G. J., Hajduch, E., Gould, G. W., & Hundal, H. S. (2004). Fructose transport and 
metabolism in adipose tissue of Zucker rats: Diminished GLUT5 activity during obesity 
and insulin resistance. Molecular and Cellular Biochemistry, 261(1), 23–33. 
https://doi.org/10.1023/B:MCBI.0000028734.77867.d2 
Liu, G., Mühlhäusler, B. S., & Gibson, R. A. (2014). A method for long term stabilisation of 
long chain polyunsaturated fatty acids in dried blood spots and its clinical application. 
Prostaglandins, Leukotrienes and Essential Fatty Acids, 91(6), 251–260. 
https://doi.org/10.1016/J.PLEFA.2014.09.009 
Liu, X., & Chen, Z. (2017, October 13). The pathophysiological role of mitochondrial oxidative 
stress in lung diseases. Journal of Translational Medicine. BioMed Central Ltd. 
https://doi.org/10.1186/s12967-017-1306-5 
Lorenzo, C., Haffner, S. M., Stančáková, A., Kuusisto, J., & Laakso, M. (2015). Fasting and 
OGTT-derived Measures of Insulin Resistance as Compared With the Euglycemic-
Hyperinsulinemic Clamp in Nondiabetic Finnish Offspring of Type 2 Diabetic 
Individuals. The Journal of Clinical Endocrinology & Metabolism, 100(2), 544–550. 
https://doi.org/10.1210/jc.2014-2299 
Lucas, A. (1998). Programming by early nutrition: An experimental approach. In Journal of 
Nutrition (Vol. 128, pp. 401S-406S). American Society for Nutrition. 
https://doi.org/10.1093/jn/128.2.401s 
Ludwig, D. S., Peterson, K. E., & Gortmaker, S. L. (2001). Relation between consumption of 
sugar-sweetened drinks and childhood obesity: A prospective, observational analysis. 
Lancet, 357(9255), 505–508. https://doi.org/10.1016/S0140-6736(00)04041-1 
Luo, S., Valencia, C. A., Zhang, J., Lee, N. C., Slone, J., Gui, B., … Huang, T. (2018). 
Biparental inheritance of mitochondrial DNA in humans. Proceedings of the National 
Academy of Sciences of the United States of America, 115(51), 13039–13044. 
https://doi.org/10.1073/pnas.1810946115 
Lustig, R. H., Schmidt, L. A., & Brindis, C. D. (2012). The toxic truth about sugar. Nature, 
482(7383), 27–29. https://doi.org/10.1038/482027a 
Ma, X., Lin, L., Yue, J., Wu, C.-S., Guo, C., Wang, R., … Sun, Y. (2017). Suppression of 
Ghrelin Exacerbates HFCS-Induced Adiposity and Insulin Resistance. International 
Journal of Molecular Sciences, 18(6), 1302. https://doi.org/10.3390/ijms18061302 
Macé, K., Shahkhalili, Y., Aprikian, O., & Stan, S. (2006). Dietary fat and fat types as early 
determinants of childhood obesity: A reappraisal. International Journal of Obesity, 30, 
S50–S57. https://doi.org/10.1038/sj.ijo.0803519 
  Bibliography 
 330 
Mandò, C., Anelli, G. M., Novielli, C., Panina-Bordignon, P., Massari, M., Mazzocco, M. I., & 
Cetin, I. (2018). Impact of obesity and hyperglycemia on placental mitochondria. 
Oxidative Medicine and Cellular Longevity, 2018. https://doi.org/10.1155/2018/2378189 
Marriott, B. P., Cole, N., & Lee, E. (2009). National Estimates of Dietary Fructose Intake 
Increased from 1977 to 2004 in the United States. The Journal of Nutrition, 139(6), 
1228S-1235S. https://doi.org/10.3945/jn.108.098277 
Martínez-Reyes, I., & Chandel, N. S. (2020). Mitochondrial TCA cycle metabolites control 
physiology and disease. Nature Communications, 11(1), 102. 
https://doi.org/10.1038/s41467-019-13668-3 
Martinez, F. J., Rizza, R. A., & Romero, J. C. (1994). High-fructose feeding elicits insulin 
resistance, hyperinsulinism, and hypertension in normal mongrel dogs. Hypertension, 
23(4), 456–463. https://doi.org/10.1161/01.HYP.23.4.456 
Matsuda, M., & DeFronzo, R. A. (1999). Insulin sensitivity indices obtained from oral glucose 
tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care, 22(9), 
1462–1470. https://doi.org/10.2337/diacare.22.9.1462 
McCance, R. A., & Widdowson, E. M. (1974). Review lecture - The determinants of growth 
and form. Proceedings of the Royal Society of London. Series B. Biological Sciences, 
185(1078), 1–17. https://doi.org/10.1098/rspb.1974.0001 
McDevitt, R. M., Poppitt, S. D., Murgatroyd, P. R., & Prentice, A. M. (2000). Macronutrient 
disposal during controlled overfeeding with glucose, fructose, sucrose, or fat in lean and 
obese women. The American Journal of Clinical Nutrition, 72(2), 369–377. 
https://doi.org/10.1093/ajcn/72.2.369 
Mechta, Mie, Lars R. Ingerslev, Odile Fabre, Martin Picard, and Romain Barrès. 2017. 
“Evidence Suggesting Absence of Mitochondrial DNA Methylation.” Frontiers in 
Genetics 8 (NOV). https://doi.org/10.3389/fgene.2017.00166. 
Meissner, F., & Mann, M. (2014, February 21). Quantitative shotgun proteomics: 
Considerations for a high-quality workflow in immunology. Nature Immunology. Nature 
Publishing Group. https://doi.org/10.1038/ni.2781 
Mele, J., Muralimanoharan, S., Maloyan, A., & Myatt, L. (2014). Impaired mitochondrial 
function in human placenta with increased maternal adiposity. American Journal of 
Physiology - Endocrinology and Metabolism, 307(5), E419–E425. 
https://doi.org/10.1152/ajpendo.00025.2014 
 
  Bibliography 
 331 
Menè, P., & Punzo, G. (2008). Uric acid: bystander or culprit in hypertension and progressive 
renal disease? Journal of Hypertension, 26(11), 2085–2092. 
https://doi.org/10.1097/HJH.0b013e32830e4945 
Mennitti, L. V., Oliveira, J. L., Morais, C. A., Estadella, D., Oyama, L. M., Oller do 
Nascimento, C. M., & Pisani, L. P. (2015, February 1). Type of fatty acids in maternal 
diets during pregnancy and/or lactation and metabolic consequences of the offspring. 
Journal of Nutritional Biochemistry. Elsevier Inc. 
https://doi.org/10.1016/j.jnutbio.2014.10.001 
Modi, N., Murgasova, D., Ruager-Martin, R., Thomas, E. L., Hyde, M. J., Gale, C., … Bell, J. 
D. (2011). The Influence of Maternal Body Mass Index on Infant Adiposity and Hepatic 
Lipid Content. Pediatr Res (Vol. 70). Retrieved from www.vardisgroup.com 
Morrison, J. L., Botting, K. J., Darby, J. R. T., David, A. L., Dyson, R. M., Gatford, K. L., … 
Berry, M. J. (2018). Guinea pig models for translation of the developmental origins of 
health and disease hypothesis into the clinic. The Journal of Physiology, 596(23), 5535–
5569. https://doi.org/10.1113/JP274948 
Mortensen, O. H., Larsen, L. H., Ørstrup, L. K. H., Hansen, L. H. L., Grunnet, N., & Quistorff, 
B. (2014). Developmental programming by high fructose decreases phosphorylation 
efficiency in aging offspring brain mitochondria, correlating with enhanced UCP5 
expression. Journal of Cerebral Blood Flow and Metabolism, 34(7), 1205–1211. 
https://doi.org/10.1038/jcbfm.2014.72 
Müller-Wille, S., & Rheinberger, H.-J. (2012). A Cultural History of Heredity. Chicago: 
University of Chicago Press. 
Mulvey, C. K., McNeill, A. M., Girman, C. J., Churchill, T. W., Terembula, K., Ferguson, J. F., 
… Reilly, M. P. (2014). Differential associations of oral glucose tolerance test-derived 
measures of insulin sensitivity and pancreatic b-cell function with coronary artery 
calcification and microalbuminuria in type 2 Diabetes. Diabetes Care, 37(1), 124–133. 
https://doi.org/10.2337/dc12-1880 
Myers, M. G., Cowley, M. A., & Münzberg, H. (2008, February 13). Mechanisms of leptin 
action and leptin resistance. Annual Review of Physiology.  Annual Reviews . 
https://doi.org/10.1146/annurev.physiol.70.113006.100707 
Nakagawa, T., Hu, H., Zharikov, S., Tuttle, K. R., Short, R. A., Glushakova, O., … Johnson, R. 
J. (2006). A causal role for uric acid in fructose-induced metabolic syndrome. American 
Journal of Physiology - Renal Physiology, 290(3), 625–631. 
https://doi.org/10.1152/ajprenal.00140.2005 
 
  Bibliography 
 332 
Nasri, R., Abdelhedi, O., Jemil, I., Ben Amor, I., Elfeki, A., Gargouri, J., … Nasri, M. (2018). 
Preventive effect of goby fish protein hydrolysates on hyperlipidemia and cardiovascular 
disease in Wistar rats fed a high-fat/fructose diet. RSC Advances, 8(17), 9383–9393. 
https://doi.org/10.1039/c7ra13102j 
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003). A statistical model for 
identifying proteins by tandem mass spectrometry. Analytical Chemistry, 75(17), 4646–
4658. https://doi.org/10.1021/ac0341261 
Nih, Od, Oer, & Olaw. (2011). GUIDE LABORATORY ANIMALS FOR THE CARE AND USE 
OF Eighth Edition Committee for the Update of the Guide for the Care and Use of 
Laboratory Animals Institute for Laboratory Animal Research Division on Earth and Life 
Studies. Retrieved from http://www.nap.edu. 
Ogawa, Y., Imajo, K., Honda, Y., Kessoku, T., Tomeno, W., Kato, S., … Nakajima, A. (2018). 
Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver 
disease in cooperation with gut-derived endotoxin. Scientific Reports, 8(1), 1–14. 
https://doi.org/10.1038/s41598-018-29735-6 
Okada, T., Furuhashi, N., Kuromori, Y., Miyashita, M., Iwata, F., & Harada, K. (2005). Plasma 
palmitoleic acid content and obesity in children. The American Journal of Clinical 
Nutrition, 82(4), 747–750. https://doi.org/10.1093/ajcn/82.4.747 
Okazaki, M., Zhang, H., Yoshida, Y., Ichino, K., Nakayama, S., & Oguchi, K. (1994). 
Correlation between Plasma Fibrinogen and Serum Lipids in Rats with Hyperlipidemia 
Induced by Cholesterol Free-High Fructose or High Cholesterol Diet. Journal of 
Nutritional Science and Vitaminology, 40(5), 479–489. 
https://doi.org/10.3177/jnsv.40.479 
Ouellette, R. J. & Rawn, J. D. (2018). Carbohydrates. Organic Chemestry. Academic Press. 
https://doi.org/10.1016/B978-0-12-812838-1.50028-1 
Ouyang, X., Cirillo, P., Sautin, Y., McCall, S., Bruchette, J. L., Diehl, A. M., … Abdelmalek, 
M. F. (2008). Fructose consumption as a risk factor for non-alcoholic fatty liver disease. 
Journal of Hepatology, 48(6), 993–999. https://doi.org/10.1016/j.jhep.2008.02.011 
Pasalic, D., Marinkovic, N., & Feher-Turkovic, L. (2012). Uric acid as one of the important 
factors in multifactorial disorders-facts and controversies. Biochemia Medica (Vol. 22). 
Patel, C., Douard, V., Yu, S., Gao, N., & Ferraris, R. P. (2015). Transport, metabolism, and 
endosomal trafficking-dependent regulation of intestinal fructose absorption. The FASEB 
Journal, 29(9), 4046–4058. https://doi.org/10.1096/fj.15-272195 
 
  Bibliography 
 333 
Pfanner, N., Warscheid, B., & Wiedemann, N. (2019, May 1). Mitochondrial proteins: from 
biogenesis to functional networks. Nature Reviews Molecular Cell Biology. Nature 
Publishing Group. https://doi.org/10.1038/s41580-018-0092-0 
Pileggi, C. A., Hedges, C. P., Segovia, S. A., Markworth, J. F., Durainayagam, B. R., Gray, C., 
… Cameron-Smith, D. (2016). Maternal high fat diet alters skeletal muscle mitochondrial 
catalytic activity in adult male rat offspring. Frontiers in Physiology, 7(NOV), 546. 
https://doi.org/10.3389/fphys.2016.00546 
Pitkänen, S., & Robinson, B. H. (1996). Mitochondrial complex I deficiency leads to increased 
production of superoxide radicals and induction of superoxide dismutase. Journal of 
Clinical Investigation, 98(2), 345–351. https://doi.org/10.1172/JCI118798 
Pitsavos, C., Panagiotakos, D., Weinem, M., & Stefanadis, C. (2006). Diet, Exercise and the 
Metabolic Syndrome. The Review of Diabetic Studies, 3(3), 118–118. 
https://doi.org/10.1900/rds.2006.3.118 
Podell, B. K., Ackart, D. F., Richardson, M. A., DiLisio, J. E., Pulford, B., & Basaraba, R. J. 
(2017). A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose 
intolerance and streptozotocin treatment. Disease Models & Mechanisms, 10(2), 151–162. 
https://doi.org/10.1242/dmm.025593 
Postic, C., & Girard, J. (2008, March). Contribution of de novo fatty acid synthesis to hepatic 
steatosis and insulin resistance: Lessons from genetically engineered mice. Journal of 
Clinical Investigation. American Society for Clinical Investigation. 
https://doi.org/10.1172/JCI34275 
Prinz, P. (2019, February 20). The role of dietary sugars in health: molecular composition or 
just calories? European Journal of Clinical Nutrition. Nature Publishing Group. 
https://doi.org/10.1038/s41430-019-0407-z 
Puri, P., Baillie, R. A., Wiest, M. M., Mirshahi, F., Choudhury, J., Cheung, O., … Sanyal, A. J. 
(2007). A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology, 46(4), 1081–
1090. https://doi.org/10.1002/hep.21763 
Ravelli, A. C. J., Van Der Meulen, J. H. P., Michels, R. P. J., Osmond, C., Barker, D. J. P., 
Hales, C. N., & Bleker, O. P. (1998). Glucose tolerance in adults after prenatal exposure 
to famine. Lancet, 351(9097), 173–177. https://doi.org/10.1016/S0140-6736(97)07244-9 
Ravelli, G.-P., Stein, Z. A., & Susser, M. W. (1976). Obesity in Young Men after Famine 
Exposure in Utero and Early Infancy. New England Journal of Medicine, 295(7), 349–
353. https://doi.org/10.1056/nejm197608122950701 
 
  Bibliography 
 334 
Rawana, S., Clark, K., Zhong, S., Buison, A., Chackunkal, S., & Jen, K.-L. C. (1993). Low 
Dose Fructose Ingestion during Gestation and Lactation Affects Carbohydrate 
Metabolism in Rat Dams and Their Offspring. The Journal of Nutrition, 123(12), 2158–
2165. https://doi.org/10.1093/jn/123.12.2158 
Rebollo, A., Roglans, N., Baena, M., Padrosa, A., Sánchez, R. M., Merlos, M., … Laguna, J. C. 
(2014). Liquid fructose down-regulates liver insulin receptor substrate 2 and 
gluconeogenic enzymes by modifying nutrient sensing factors in rats. Journal of 
Nutritional Biochemistry, 25(2), 250–258. https://doi.org/10.1016/j.jnutbio.2013.10.014 
Regnault, T. R., Gentili, S., Sarr, O., Toop, C. R., & Sloboda, D. M. (2013). Fructose, 
pregnancy and later life impacts. Clinical and Experimental Pharmacology and 
Physiology, 40(11), 824–837. https://doi.org/10.1111/1440-1681.12162 
Reiser, S. (1985, January 1). Effect of dietary sugars on metabolic risk factors associated with 
heart disease. Nutrition and Health (Berkhamsted, Hertfordshire). Retrieved from 
https://europepmc.org/article/med/3906452 
Rippe, J. M., & Angelopoulos, T. J. (2016, March 1). Added sugars and risk factors for obesity, 
diabetes and heart disease. International Journal of Obesity. Nature Publishing Group. 
https://doi.org/10.1038/ijo.2016.10 
Rodríguez, L., Panadero, M. I., Roglans, N., Otero, P., Álvarez-Millán, J. J., Laguna, J. C., & 
Bocos, C. (2013). Fructose during pregnancy affects maternal and fetal leptin signaling. 
The Journal of Nutritional Biochemistry, 24(10), 1709–1716. 
https://doi.org/10.1016/j.jnutbio.2013.02.011 
Saad, A. F., Dickerson, J., Kechichian, T. B., Yin, H., Gamble, P., Salazar, A., … Costantine, 
M. M. (2016). High-fructose diet in pregnancy leads to fetal programming of 
hypertension, insulin resistance, and obesity in adult offspring. American Journal of 
Obstetrics and Gynecology, 215(3), 985–994. https://doi.org/10.1016/j.ajog.2016.03.038 
Saad, A., Thibodeaux, C., Kechichian, T., Yin, H., Orise, P., Salazar, A., & Saade, G. (2019). 
3: Pregnancy high fructose diet: pathways involved in fetal programming of metabolic 
syndrome in adult offspring. American Journal of Obstetrics and Gynecology, 220(1), 
S3–S4. https://doi.org/10.1016/j.ajog.2018.11.004 
Saklayen, M. G. (2018). The Global Epidemic of the Metabolic Syndrome. Current 
Hypertension Reports, 20(2), 12. https://doi.org/10.1007/s11906-018-0812-z 
Samuel, V. T., & Shulman, G. I. (2012, March 2). Mechanisms for insulin resistance: Common 
threads and missing links. Cell. Cell. https://doi.org/10.1016/j.cell.2012.02.017 
 
  Bibliography 
 335 
Sanders, F. W. B., & Griffin, J. L. (2016). De novo lipogenesis in the liver in health and 
disease: More than just a shunting yard for glucose. Biological Reviews, 91(2), 452–468. 
https://doi.org/10.1111/brv.12178 
Sarr, O., Thompson, J. A., Zhao, L., Lee, T.-Y., & Regnault, T. R. H. (2014). Low Birth 
Weight Male Guinea Pig Offspring Display Increased Visceral Adiposity in Early 
Adulthood. PLoS ONE, 9(6), e98433. https://doi.org/10.1371/journal.pone.0098433 
Schulze, M. B., Manson, J. A. E., Ludwig, D. S., Colditz, G. A., Stampfer, M. J., Willett, W. 
C., & Hu, F. B. (2004). Sugar-sweetened beverages, weight gain, and incidence of type 2 
diabetes in young and middle-aged women. Journal of the American Medical Association, 
292(8), 927–934. https://doi.org/10.1001/jama.292.8.927 
Sears, B., & Perry, M. (2015, September 29). The role of fatty acids in insulin resistance. Lipids 
in Health and Disease. BioMed Central Ltd. https://doi.org/10.1186/s12944-015-0123-1 
Segovia, S. A., Vickers, M. H., Gray, C., & Reynolds, C. M. (2014). Maternal obesity, 
inflammation, and developmental programming. BioMed Research International. 
Hindawi Publishing Corporation. https://doi.org/10.1155/2014/418975 
Shapiro, A., Mu, W., Roncal, C., Cheng, K. Y., Johnson, R. J., & Scarpace, P. J. (2008). 
Fructose-induced leptin resistance exacerbates weight gain in response to subsequent 
high-fat feeding. American Journal of Physiology - Regulatory Integrative and 
Comparative Physiology, 295(5), 1370–1375. https://doi.org/10.1152/ajpregu.00195.2008 
Shildrick, M. (2000). Maternal imagination: Reconceiving first impressions. Rethinking 
History.  Taylor & Francis . https://doi.org/10.1080/136425200456958 
Shimano, H., Horton, J. D., Shimomura, I., Hammer, R. E., Brown, M. S., & Goldstein, J. L. 
(1997). Isoform 1c of sterol regulatory element binding protein is less active than isoform 
1a in livers of transgenic mice and in cultured cells. Journal of Clinical Investigation, 
99(5), 846–854. https://doi.org/10.1172/JCI119248 
Sloboda, D. M., Li, M., Patel, R., Clayton, Z. E., Yap, C., & Vickers, M. H. (2014). Early life 
exposure to fructose and offspring phenotype: implications for long term metabolic 
homeostasis. Journal of Obesity, 2014, 203474. https://doi.org/10.1155/2014/203474 
Smeitink, J. A.M., J. L.C.M. Loeffen, R. H. Triepels, R. J.P. Smeets, J. M.F. Trijbels, and L. P. 
Van Den Heuvel. 1998. “Nuclear Genes of Human Complex I of the Mitochondrial 
Electron Transport Chain: State of the Art.” Human Molecular Genetics. Oxford 
Academic. https://doi.org/10.1093/hmg/7.10.1573. 
 
  Bibliography 
 336 
Smith, E. V. L., Dyson, R. M., Berry, M. J., & Gray, C. (2020). Fructose Consumption During 
Pregnancy Influences Milk Lipid Composition and Offspring Lipid Profiles in Guinea 
Pigs. Frontiers in Endocrinology, 11, 550. https://doi.org/10.3389/fendo.2020.00550 
Softic, S., Cohen, D. E., & Kahn, C. R. (2016, May 1). Role of Dietary Fructose and Hepatic 
De Novo Lipogenesis in Fatty Liver Disease. Digestive Diseases and Sciences. Springer 
New York LLC. https://doi.org/10.1007/s10620-016-4054-0 
Softic, S., Meyer, J. G., Wang, G. X., Gupta, M. K., Batista, T. M., Lauritzen, H. P. M. M., … 
Kahn, C. R. (2019). Dietary Sugars Alter Hepatic Fatty Acid Oxidation via 
Transcriptional and Post-translational Modifications of Mitochondrial Proteins. Cell 
Metabolism, 30(4), 735-753.e4. https://doi.org/10.1016/j.cmet.2019.09.003 
Song, Z., Xiaoli, A. M., & Yang, F. (2018, October 1). Regulation and metabolic significance 
of De Novo lipogenesis in adipose tissues. Nutrients. MDPI AG. 
https://doi.org/10.3390/nu10101383 
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., … 
Arner, P. (2008). Dynamics of fat cell turnover in humans. Nature, 453(7196), 783–787. 
https://doi.org/10.1038/nature06902 
Srinivasan, S. R., Clevidence, B. A., Pargaonkar, P. S., Radhakrishnamurthy, B., & Berenson, 
G. S. (1979). Varied effects of dietary sucrose and cholesterol on serum lipids, 
lipoproteins and apolipoproteins in rhesus monkeys. Atherosclerosis, 33(3), 301–314. 
https://doi.org/10.1016/0021-9150(79)90182-5 
Srisowanna, N., Choijookhuu, N., Yano, K., Batmunkh, B., Ikenoue, M., Mai, N. N. H., … 
Hishikawa, Y. (2019). The effect of estrogen on hepatic fat accumulation during early 
phase of liver regeneration after partial hepatectomy in rats. Acta Histochemica et 
Cytochemica, 52(4), 67–75. https://doi.org/10.1267/ahc.19018 
Stanhope, K. L., & Havel, P. J. (2008, February). Fructose consumption: Potential mechanisms 
for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. 
Current Opinion in Lipidology. NIH Public Access. 
https://doi.org/10.1097/MOL.0b013e3282f2b24a 
Stanhope, K. L., & Havel, P. J. (2010). Fructose consumption: recent results and their potential 
implications. Annals of the New York Academy of Sciences, 1190, 15–24. 
https://doi.org/10.1111/j.1749-6632.2009.05266.x 
Stanhope, K. L., Medici, V., Bremer, A. A., Lee, V., Lam, H. D., Nunez, M. V, … Havel, P. J. 
(2015). A dose-response study of consuming high-fructose corn syrup–sweetened 
beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. The 
American Journal of Clinical Nutrition, 101(6), 1144–1154. 
https://doi.org/10.3945/ajcn.114.100461 
  Bibliography 
 337 
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., … 
Havel, P. J. (2009). Consuming fructose-sweetened, not glucose-sweetened, beverages 
increases visceral adiposity and lipids and decreases insulin sensitivity in 
overweight/obese humans. Journal of Clinical Investigation, 119(5), 1322–1334. 
https://doi.org/10.1172/JCI37385 
Stanhope, L. K., & Havel, J. P. (2017). Effects and mechanisms of fructose-containing sugars 
in the pathophysiology of metabolic syndrome — UC Davis. CRC Press. 
https://doi.org/doi.org/10.1201/9781315119410 
Stavric, B., Johnson, W. J., Clayman, S., Gadd, R. E. A., & Chartrand, A. (1976). Effect of 
fructose administration on serum urate levels in the uricase inhibited rat. Experientia, 
32(3), 373–374. https://doi.org/10.1007/BF01940847 
Stern, S. E., Williams, K., Ferrannini, E., DeFronzo, R. A., Bogardus, C., & Stern, M. P. (2005, 
February 1). Identification of individuals with insulin resistance using routine clinical 
measurements. Diabetes. American Diabetes Association. 
https://doi.org/10.2337/diabetes.54.2.333 
Storlien, L. H., Oakes, N. D., Pan, D. A., Kusunoki, M., & Jenkins, A. B. (1993). Syndromes of 
insulin resistance in the rat: Inducement by diet and amelioration with benfluorex. 
Diabetes, 42(3), 457–462. https://doi.org/10.2337/diab.42.3.457 
Sun, S. Z., Anderson, G. H., Flickinger, B. D., Williamson-Hughes, P. S., & Empie, M. W. 
(2011). Fructose and non-fructose sugar intakes in the US population and their 
associations with indicators of metabolic syndrome. Food and Chemical Toxicology, 
49(11), 2875–2882. https://doi.org/10.1016/j.fct.2011.07.068 
Sun, S. Z., & Empie, M. W. (2012). Fructose metabolism in humans - What isotopic tracer 
studies tell us. Nutrition and Metabolism. BioMed Central. https://doi.org/10.1186/1743-
7075-9-89 
Tappy, L., & Le, K. A. (2010). Metabolic effects of fructose and the worldwide increase in 
obesity. Physiological Reviews. https://doi.org/10.1152/physrev.00019.2009 
Tappy, L., Lê, K. A., Tran, C., & Paquot, N. (2010, November). Fructose and metabolic 
diseases: New findings, new questions. Nutrition. Nutrition. 
https://doi.org/10.1016/j.nut.2010.02.014 
Tarry-Adkins, J. L., Fernandez-Twinn, D. S., Chen, J. H., Hargreaves, I. P., Neergheen, V., 
Aiken, C. E., & Ozanne, S. E. (2016). Poor maternal nutrition and accelerated postnatal 
growth induces an accelerated aging phenotype and oxidative stress in skeletal muscle of 
male rats. DMM Disease Models and Mechanisms, 9(10), 1221–1229. 
https://doi.org/10.1242/dmm.026591 
  Bibliography 
 338 
Taylor, R. W., & Turnbull, D. M. (2005, May). Mitochondrial DNA mutations in human 
disease. Nature Reviews Genetics. Nat Rev Genet. https://doi.org/10.1038/nrg1606 
Teff, K. L., Elliott, S. S., Tschöp, M., Kieffer, T. J., Rader, D., Heiman, M., … Havel, P. J. 
(2004). Dietary Fructose Reduces Circulating Insulin and Leptin, Attenuates Postprandial 
Suppression of Ghrelin, and Increases Triglycerides in Women. The Journal of Clinical 
Endocrinology & Metabolism, 89(6), 2963–2972. https://doi.org/10.1210/jc.2003-031855 
Ter Horst, K. W., & Serlie, M. J. (2017). Fructose Consumption, Lipogenesis, and Non-
Alcoholic Fatty Liver Disease. Nutrients, 9(9). https://doi.org/10.3390/nu9090981 
Theytaz, F., de Giorgi, S., Hodson, L., Stefanoni, N., Rey, V., Schneiter, P., … Tappy, L. 
(2014). Metabolic fate of fructose ingested with and without glucose in a mixed meal. 
Nutrients, 6(7), 2632–2649. https://doi.org/10.3390/nu6072632 
Thiam, A. R., Farese, R. V., & Walther, T. C. (2013, November 13). The biophysics and cell 
biology of lipid droplets. Nature Reviews Molecular Cell Biology. Nature Publishing 
Group. https://doi.org/10.1038/nrm3699 
Thompson, L. P., Song, H., & Polster, B. M. (2019). Fetal programming and sexual 
dimorphism of mitochondrial protein expression and activity of hearts of prenatally 
hypoxic Guinea pig offspring. Oxidative Medicine and Cellular Longevity, 2019. 
https://doi.org/10.1155/2019/7210249 
Toop, C. R., Muhlhausler, B. S., O’Dea, K., & Gentili, S. (2017). Impact of perinatal exposure 
to sucrose or high fructose corn syrup (HFCS-55) on adiposity and hepatic lipid 
composition in rat offspring. Journal of Physiology, 595(13), 4379–4398. 
https://doi.org/10.1113/JP274066 
Torres-Gonzalez, M., Leite, J. O., Volek, J. S., Contois, J. H., & Fernandez, M. L. (2008). 
Carbohydrate restriction and dietary cholesterol distinctly affect plasma lipids and 
lipoprotein subfractions in adult guinea pigs. Journal of Nutritional Biochemistry, 19(12), 
856–863. https://doi.org/10.1016/j.jnutbio.2007.11.007 
Torres-Gonzalez, M., Volek, J. S., Sharman, M., Contois, J. H., & Fernandez, M. L. (2006). 
Dietary carbohydrate and cholesterol influence the number of particles and distributions 
of lipoprotein subfractions in guinea pigs. Journal of Nutritional Biochemistry, 17(11), 
773–779. https://doi.org/10.1016/j.jnutbio.2006.01.004 
Tricò, D., Mengozzi, A., Nesti, L., Hatunic, M., Gabriel Sanchez, R., Konrad, T., … Natali, A. 
(2020). Circulating palmitoleic acid is an independent determinant of insulin sensitivity, 
beta cell function and glucose tolerance in non-diabetic individuals: a longitudinal 
analysis. Diabetologia, 63(1), 206–218. https://doi.org/10.1007/s00125-019-05013-6 
  Bibliography 
 339 
Tu, W. C., Cook-Johnson, R. J., James, M. J., Mühlhäusler, B. S., & Gibson, R. A. (2010). 
Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene 
expression. Prostaglandins, Leukotrienes and Essential Fatty Acids, 83(2), 61–68. 
https://doi.org/10.1016/J.PLEFA.2010.04.001 
Turner, A. J., & Trudinger, B. J. (2009). A Modification of the Uterine Artery Restriction 
Technique in the Guinea Pig Fetus Produces Asymmetrical Ultrasound Growth. Placenta, 
30(3), 236–240. https://doi.org/10.1016/j.placenta.2008.11.023 
Vartanian, L. R., Schwartz, M. B., & Brownell, K. D. (2007, April 10). Effects of soft drink 
consumption on nutrition and health: A systematic review and meta-analysis. American 
Journal of Public Health. American Public Health Association. 
https://doi.org/10.2105/AJPH.2005.083782 
Vickers, M. H., Clayton, Z. E., Yap, C., & Sloboda, D. M. (2011). Maternal Fructose Intake 
during Pregnancy and Lactation Alters Placental Growth and Leads to Sex-Specific 
Changes in Fetal and Neonatal Endocrine Function. Endocrinology, 152(4), 1378–1387. 
https://doi.org/10.1210/en.2010-1093 
Vilà, L., Rebollo, A., Adalsteisson, G. S., Alegret, M., Merlos, M., Roglans, N., & Laguna, J. 
C. (2011). Reduction of liver fructokinase expression and improved hepatic inflammation 
and metabolism in liquid fructose-fed rats after atorvastatin treatment. Toxicology and 
Applied Pharmacology, 251(1), 32–40. https://doi.org/10.1016/j.taap.2010.11.011 
Vrána, A., Fábry, P., Slabochová, Z., & Kazdová, L. (1974). Effect of Dietary Fructose on Free 
Fatty Acid Release from Adipose Tissue and Serum Free Fatty Acid Concentration in the 
Rat. Annals of Nutrition and Metabolism, 17(2), 74–83. 
https://doi.org/10.1159/000175521 
Waddell, M., & Fallon, H. J. (1973). The effect of high carbohydrate diets on liver triglyceride 
formation in the rat. Journal of Clinical Investigation, 52(11), 2725–2731. 
https://doi.org/10.1172/JCI107467 
Walton, A., & Hammond, J. (1938). The maternal effects on growth and conformation in shire 
horse-shetland pony crosses. Proceedings of the Royal Society of London. Series B - 
Biological Sciences, 125(840), 311–335. https://doi.org/10.1098/rspb.1938.0029 
Welsh, J. A., Sharma, A., Abramson, J. L., Vaccarino, V., Gillespie, C., & Vos, M. B. (2010). 
Caloric sweetener consumption and dyslipidemia among US adults. JAMA - Journal of 
the American Medical Association, 303(15), 1490–1497. 
https://doi.org/10.1001/jama.2010.449 
White, J. S. (2008). Straight talk about high-fructose corn syrup: what it is and what it ain’t. 
The American Journal of Clinical Nutrition, 88(6), 1716S-1721S. 
https://doi.org/10.3945/ajcn.2008.25825B 
  Bibliography 
 340 
Winett, L., Wallack, L., Richardson, D., Boone-Heinonen, J., & Messer, L. (2016). A 
Framework to Address Challenges in Communicating the Developmental Origins of 
Health and Disease. Current Environmental Health Reports, 3(3), 169–177. 
https://doi.org/10.1007/s40572-016-0102-3 
Wittekind, A., & Walton, J. (2014, July 8). Worldwide trends in dietary sugars intake. Nutrition 
Research Reviews. Cambridge University Press. 
https://doi.org/10.1017/S0954422414000237 
World Health Organization. (2015). WHO Guideline: Sugars intake for adults and children. 
WHO Library Cataloguing-in-Publication Data, 26(4), 34–36. https://doi.org/978 92 4 
154902 8 
Xu, X., So, J. S., Park, J. G., & Lee, A. H. (2013). Transcriptional control of hepatic lipid 
metabolism by SREBP and ChREBP. Seminars in Liver Disease, 33(4), 301–311. 
https://doi.org/10.1055/s-0033-1358523 
Yakubu, D. P., Mostyn, A., Hyatt, M. A., Kurlak, L. O., Budge, H., Stephenson, T., & 
Symonds, M. E. (2007). Ontogeny and nutritional programming of mitochondrial proteins 
in the ovine kidney, liver and lung. Reproduction, 134(6), 823–830. 
https://doi.org/10.1530/REP-07-0155 
Yang, R., Guo, P., Song, X., Liu, F., & Gao, N. (2011). Hyperlipidemic guinea pig model: 
Mechanisms of triglyceride metabolism disorder and comparison to rat. Biological and 
Pharmaceutical Bulletin, 34(7), 1046–1051. https://doi.org/10.1248/bpb.34.1046 
Yudkin, J. (1967). Evolutionary and historical changes in dietary carbohydrates. The American 
Journal of Clinical Nutrition, 20(2), 108–115. https://doi.org/10.1093/ajcn/20.2.108 
Zavaroni, I., Chen, Y. D., & Reaven, G. M. (1982). Studies of the mechanism of fructose-
induced hypertriglyceridemia in the rat. Metabolism: Clinical and Experimental, 31(11), 
1077–1083. https://doi.org/10.1016/0026-0495(82)90155-x 
Zhang, B., VerBerkmoes, N. C., Langston, M. A., Uberbacher, E., Hettich, R. L., & Samatova, 
N. F. (2006). Detecting differential and correlated protein expression in label-free shotgun 
proteomics. Journal of Proteome Research, 5(11), 2909–2918. 
https://doi.org/10.1021/pr0600273 
Zhang, D.-M., Jiao, R.-Q., & Kong, L.-D. (2017). High Dietary Fructose: Direct or Indirect 
Dangerous Factors Disturbing Tissue and Organ Functions. Nutrients, 9(4). 
https://doi.org/10.3390/nu9040335 
 
  Bibliography 
 341 
Zhang, Q., Qian, Z. Y., Zhou, P. H., Zhou, X. L., Zhang, D. L., He, N., … Gu, Q. (2018). 
Effects of oral selenium and magnesium co-supplementation on lipid metabolism, 
antioxidative status, histopathological lesions, and related gene expression in rats fed a 
high-fat diet. Lipids in Health and Disease, 17(1), 165. https://doi.org/10.1186/s12944-
018-0815-4 
Zhang, Y., Fonslow, B. R., Shan, B., Baek, M.-C., Yates, J. R., & III. (2013). Protein analysis 
by shotgun/bottom-up proteomics. Chemical Reviews, 113(4), 2343–2394. 
https://doi.org/10.1021/cr3003533 
Zheng, J., Feng, Q., Zhang, Q., Wang, T., & Xiao, X. (2016, November 1). Early life fructose 
exposure and its implications for long-term cardiometabolic health in offspring. Nutrients. 
MDPI AG. https://doi.org/10.3390/nu8110685 
Zorov, D. B., Juhaszova, M., & Sollott, S. J. (2006, May 1). Mitochondrial ROS-induced ROS 
release: An update and review. Biochimica et Biophysica Acta - Bioenergetics. Elsevier. 
https://doi.org/10.1016/j.bbabio.2006.04.029 
Zou, M., Arentson, E. J., Teegarden, D., Koser, S. L., Onyskow, L., & Donkin, S. S. (2012). 
Fructose consumption during pregnancy and lactation induces fatty liver and glucose 
intolerance in rats. Nutrition Research, 32(8), 588–598. 
https://doi.org/10.1016/j.nutres.2012.06.012  
 
  Appendix 
 342 
Appendix 
  Appendix 
 343 
  Appendix 
 344 
  Appendix 
 345 
  Appendix 
 346 
  Appendix 
 347 
  Appendix 
 348 
  Appendix 
 349 
  Appendix 
 350 
  Appendix 
 351 
  Appendix 
 352 
  Appendix 
 353 
  Appendix 
 354 
 
  Appendix 
 355 
Copy of Article in the New Zealand Listener Magazine 
 
  Appendix 
 356 
 
  Appendix 
 357 

















Reagent Amount Process 
Disodium  23.7 g    
Sodium dihydrogen 6.75 g  
Distilled water 2 L  
   
Reagent Amount Process 
99% Ethanol  900 ml    
Distilled water 100 ml  
   
Reagent Amount Process 
99% Ethanol  800 ml    
Distilled water 200 ml  
   
Reagent Amount Process 
99% Ethanol  700 ml    
Distilled water 300 ml  
   
Reagent Amount Process 
99% Ethanol  1400 ml    
Tap water 600 ml  
Concentrated HCL 20 ml  
   


















Reagent Amount Process 
Eosin yellowish 1B423  20 g    
Ethanol 1600 ml  
Distilled water 400 ml  
   
Reagent Amount Process 
Stock Solution 400 ml    
Ethanol 1200 ml  
Glacial acetic acid 8 ml  
Distilled water 240ml  
   
Reagent Amount Process 
Haematoxylin  10 g    
70% Ethanol 150 ml  
   
Reagent Amount Process 
Aluminium potassium sulphate 200 g    
Distilled water 2000 ml  
   
Reagent Amount Process 
Solution A 150 ml    
Solution B 2000 ml  
Sodium iodate  1 g  
  Filter before each use. 
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Oil-red-O in Dextrin 
 
Oil Red O Stock Solution  





Reagent Amount Process 
Oil Red O  0.5 g    
Absolute isopropyl alcohol 100 ml  
  Allow to stand overnight. 
   
Reagent Amount Process 
Dextrin  1 g    
Distilled water 100 ml  
   
   
Reagent Amount Process 
Stock Oil Red O 60 ml    
Dextrin 40 ml  
  Allow to stand for 24hours or 
more. Stable for months.  
Filter before each use. 
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Chapter 4 Effects of Excess Maternal Fructose Intake on 
Weanling Offspring  
Weanling Brain Weight 
FD males and females showed significantly decreased brain weight, an effect of 
diet, compared to CD offspring (CMD, 3.20 ±0.02 vs FDM, 2.97 ±0.02 vs  CDF, 
3.08 ±0.02 vs FDF 3.02 ±0.02g;P=0.001) (Figure 1A). In addition, there was an 
interaction effect of diet and sex (P=0.03) with FD males brain weights being 
reduced when compared to any other group (Figure 1A). Brain to body weight 
ratios were observed to be significantly increased in FD males and females, an 
effect of diet, when compared to CD males and females (CMD, 0.015 ±0.00 vs 
FDM, 0.017 ±0.00 vs  CDF, 0.016 ±0.00 vs FDF 0.018 ±0.00g;P=0.001) (Figure 1B). 
Taking the results of the brain weight and brain to body weight ratios together, 
this suggests there is larger proportion of brain tissue per gram of body weight 
in FD offspring.  
Cerebellar weights were observed to be significantly decreased in FD males 
and significantly increased in FD females, an interaction effect of diet and sex, 
with FD males cerebellar weights shown to be significantly decreased 
compared to CD male and female offspring, while FD females were shown to 
be significantly increased compared to CD females and FD males (CMD, 0.41 
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±0.01 vs FDM, 0.34 ±0.01 vs  CDF, 0.30 ±0.01 vs FDF 0.39 ±0.01g;P=0.02) (Figure 
1C). No significant differences were observed between CD and FD offspring 
hippocampal weights (Figure 1D). 
 
Figure 1. Weanling Brain Weights 
 
Figure 1. Weanling offspring brain weight, brain to body weight ratio, cerebellar and hippocampal 
weights. Control males (n=7); fructose males (n=7); control females (n=7) and fructose females (n=7). A) 
Represents offspring brain weight at d21. B) Represents offspring brain to body weight ratio at d21. C) 
Represents offspring cerebellum weight at d21. D) Represents offspring hippocampus weight at d21. All 
data were analysed using a 2x2 factorial design with diet*sex*interaction include as factors (general 
analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes 
significance of P<0.05. 
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Weanling Heart Weight and Heart to Body Weight Ratio 
FD males and females were observed to have significantly decreased heart 
weights, an effect of diet, compared to CD males and females (CMD, 0.79 ±0.02 
vs FDM, 0.58 ±0.02 vs  CDF, 0.71 ±0.02 vs FDF 0.56 ±0.02g;P<0.0001) (Figure 2A). 
Similarly, FD males and females were observed to have significantly decreased 
heart to body weight ratio, as effect of diet, compared to CD counterparts 
(CMD, 0.0038 ±0.00 vs FDM, 0.0033 ±0.00 vs  CDF, 0.0037 ±0.00 vs FDF 0.0033 
±0.00g;P=0.01) (Figure 2B).
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Figure 2. Weanling Heart Weight and Heart to Body Weight Ratio 
 
Figure 2. Weanling offspring heart weight and heart to body weight ratio. Control males (n=7); fructose males (n=7); control females (n=6) and fructose females (n=7). A) 
Represents offspring heart weight at d21. B) Represents offspring heart to body weight ratio at d21. All data were analysed using a 2x2 factorial design with 
diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ±SEM.* denotes significance of p<0.05; ** 
denotes significance of P<0.0001. 
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4.1.1.1 Weanling Kidney and Adrenal Weights 
FD males and females were observed to have significantly decreased kidney 
weight, an effects of diet, compared to CD offspring (CMD, 1.69 ±0.03 vs FDM, 
1.38 ±0.03 vs  CDF, 1.57 ±0.03 vs FDF 1.34 ±0.03g;P<0.0001). In addition, there 
was a significant decrease in CD and FD females, an effect of sex (P=0.04) 
compared to CD and FD males (Figure 3A). No significant differences were 
observed between CD and FD offspring kidney to body weight ratio (Figure 
3B). Taking the results of the kidney weight and kidney to body weight ratio 
together, this suggests there is a larger proportion of kidney tissue per gram of 
body weight in FD offspring. No significant differences were observed between 
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Figure 3. Weanling Kidney and Adrenal Weights 
 
Figure 3. Weanling offspring kidney weight, kidney to body weight ratio and adrenal weights. Control 
males (n=6); fructose males (n=7); control females (n=7) and fructose females (n=7). A) Represents 
offspring kidney weight at d21. B) Represents offspring kidney to body weight ratio at d21. C) Represents 
offspring adrenal weight at d21. All data were analysed using a 2x2 factorial design with 
diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data 
presented as group mean ±SEM.* denotes significance of p<0.05; ** denotes significance of P<0.0001. 
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Weanling Subcutaneous Fat Weights 
FD males and females were observed to have significantly decreased subcutaneous fat 
weight, an effect of diet compared to CD offspring (CMD, 1.93 ±0.09 vs FDM, 1.05 ±0.09 vs  
CDF, 1.72 ±0.09 vs FDF 1.17 ±0.09g;P<0.0001) (Figure 4C). 
 
Figure 4. Weanling Subcutaneous Fat Weights 
 
Figure 4. Figure represents offspring subcutaneous fat weights at d21. All data were analysed using a 2x2 factorial design 
with diet*sex*interaction include as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as 
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Table 1. Weanling male offspring hepatic up-regulated and down-regulated molecules. Control (n=6); fructose male (n=6). 
All data was analysed using Ingenuity Pathway Analysis (IPA). Data represents hepatic molecules with alterations in FD 
females compared to CD males. Red indicated up-regulated and green indicates down-regulated. 
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Table 2. Weanling FD Females Hepatic Up-Regulated and Down-Regulated Proteins 
 
Table 2. Weanling female offspring hepatic up-regulated and down-regulated molecules. Control (n=6); fructose female 
(n=6). All data was analysed using Ingenuity Pathway Analysis (IPA). Data represents hepatic molecules with alterations in 
FD females compared to CD females. Red indicated up-regulated and green indicates down-regulated. 
 
  Appendix 
369 
Chapter 5 Effects of Excess Maternal Fructose Intake on Adult 
Offspring  
Adult Brain Weights 
CD and FD males had shown significantly increased brain weight compared to CD and FD 
females, an effect of sex (CDM, 4.05 ±0.02 vs. FDM, 4.01 ±0.02 vs. CDF, 3.95 ±0.02 vs. FDF, 
3.82 ±0.02g; P=0.008) (Figure 5A). CD and FD females had shown significantly increased 
brain to body weight ratio compared to CD counterparts, an effect of sex (CDM, 0.005 ±0.00 
vs. FDM, 0.005 ±0.00 vs. CDF, 0.006 ±0.00 vs. FDF, 0.005 ±0.00g; P=0.001) (Figure 5B).  
Cerebellar weights were observed to be significantly decreased in FD females compared to 
any other group, an interaction effect of diet and sex (CDM, 0.51 ±0.02 vs. FDM, 0.57 ±0.02 vs. 
CDF, 0.63 ±0.02 vs. FDF, 0.44 ±0.02g; P=0.03) (Figure 5C). CD and FD male offspring 
hippocampal weight was observed to be significantly increased compared to CD and FD 
female offspring, an effect of sex (CDM, 0.15 ±0.00 vs. FDM, 0.16 ±0.00 vs. CDF, 0.15 ±0.00 vs. 
FDF, 0.12 ±0.00g; P=0.003). In addition, there was a significant decrease shown in FDF 
hippocampus weight compared to any other group, an interaction effect of diet and sex 
(P=0.02) (Figure 5D). 
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Figure 5. Adult Offspring Brain Weights 
 
Figure 5 Adult Offspring brain weight, brain to body weight ratio, cerebellum and hippocampus weights. Control males 
(n=5); fructose males (n=7); control females (n=6) and fructose females (n=6). A) Represents offspring brain weight at month 
4. B) Represents offspring brain to body weight ratio at month 4. C) Represents offspring cerebellum weight at month 4. D) 
Represents offspring hippocampus weight at month 4. All data were analysed using a 2x2 factorial design with 
diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group 
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Adult Heart Weight and Heart to Body Weight Ratio 
No significant differences were observed between CD and FD offspring heart weight and 
heart to body weight ratio (Figure 6A and 6B). 
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Figure 6. Adult Offspring Heart Weight and Heart to Body Weight Ratio 
 
Figure 6 Adult Offspring heart weight and heart to body weight ratio. Control males (n=5); fructose males (n=7); control females (n=6) and fructose females (n=6). A) 
Represents offspring heart weight at month 4. B) Represents offspring heart to body weight ratio at month 4. All data were analysed using a 2x2 factorial design with 
diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ± SEM.
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Adult Kidney and Adrenal Weights 
FD male and female offspring were observed to have significantly increased 
kidney weight compared to CD counterparts, an effect of diet (CDM, 4.22 ±0.11 
vs. FDM, 4.64 ±0.11 vs. CDF, 3.51 ±0.11 vs. FDF, 3.80 ±0.11g; P=0.02). In 
addition, there was a significant increase shown in CD and FD male offspring 
kidney weight compared to CD and FD female offspring, an effect of sex 
(P<0.0001) (Figure 7A). CD and FD male offspring kidney to body weight ratio 
was shown to be significantly increased compared to CD and FD female 
offspring, an effect of sex (CDM, 0.005 ±0.00 vs. FDM, 0.006 ±0.00 vs. CDF, 0.005 
±0.00 vs. FDF, 0.005 ±0.00g; P=0.01) (Figure 7B). No significant differences were 
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Figure 7. Adult Kidney and Adrenal Weights 
 
Figure 7 Adult Offspring kidney weight, kidney to body weight ratio and adrenal weights. Control males 
(n=5); fructose males (n=7); control females (n=6) and fructose females (n=6). A) Represents offspring 
kidney weight at month 4. B) Represents offspring kidney to body weight ratio at month 4. C) Represents 
offspring adrenal weight at month 4. All data were analysed using a 2x2 factorial design with 
diet*sex*interaction included as factors (general analysis of variance) using IBM SPSS statistics 25. Data 
presented as group mean ± SEM.* denotes significance of P<0.05. 
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Adult Subcutaneous Fat Weights 
CD and FD female offspring subcutaneous fat weight was shown to be 
significantly increased compared to CD and FD males, an effect of sex (CDM, 
7.76 ±0.48 vs. FDM, 6.62 ±0.48 vs. CDF, 8.08 ±0.48 vs. FDF, 10.55 ±0.48g; P=0.01). 
In addition, FD female offspring was subcutaneous fat weight was shown to be 
significantly increased compared to any other group, an interaction effect of 
diet and sex (P=0.03) (Figure 8C). 
 
Figure 8. Adult Subcutaneous Fat Weights 
 
Figure 8. Adult Offspring subcutaneous fat weights. Control males (n=5); fructose males (n=7); control 
females (n=6) and fructose females (n=6). Represents offspring subcutaneous fat weight at month 4. All 
data were analysed using a 2x2 factorial design with diet*sex*interaction included as factors (general 
analysis of variance) using IBM SPSS statistics 25. Data presented as group mean ± SEM.* denotes 
significance of P<0.05. 
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Table 3. Adult FD Males Hepatic proteins 
 
Table 3. Adult FD male offspring hepatic up-regulated and down-regulated molecules. Control (n=6); 
fructose male (n=6). All data was analysed using Ingenuity Pathway Analysis (IPA). Data represents 
hepatic molecules with alterations in FD males compared to CD males. Red indicated up-regulated and 
green indicates down-regulated. 
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Table 4. Adult FD Female Hepatic Up-regulated and Down-regulated 
Proteins 
 
Table 4. Adult FD male offspring hepatic up-regulated and down-regulated molecules. Control (n=6); 
fructose male (n=6). All data was analysed using Ingenuity Pathway Analysis (IPA). Data represents 
hepatic molecules with alterations in FD males compared to CD males. Red indicated up-regulated and 
green indicates down-regulated. 
 
